http://www.pharma-marketer.com/ 2010-03-12T01:06:12+00:00 daily 1.0 http://www.pharma-marketer.com/videocramer-abbotts-a-growth-stock/ 2010-03-12T01:06:12+00:00 daily 0.8 http://www.pharma-marketer.com/biosante-rallies-on-study-drug-stocks-slip/ 2010-03-12T01:06:03+00:00 daily 0.8 http://www.pharma-marketer.com/how-many-reps-visit-a-doctora%c2%80%c2%99s-office-each-week/ 2010-03-12T01:05:59+00:00 daily 0.8 http://www.pharma-marketer.com/facet-biotech-has-722m-that-says-it-pays-to-stand-up-to-bullies/ 2010-03-12T01:05:55+00:00 daily 0.8 http://www.pharma-marketer.com/merck-joins-consortium-on-vax-plant/ 2010-03-12T00:09:26+00:00 daily 0.8 http://www.pharma-marketer.com/aveo-pharma-delays-ipo-at-least-briefly/ 2010-03-11T23:56:26+00:00 daily 0.8 http://www.pharma-marketer.com/yahoo-submits-document-to-fda-social-media-docket-and-status-of-submissions/ 2010-03-11T23:43:19+00:00 daily 0.8 http://www.pharma-marketer.com/common-sense-approach-to-internet-marketing-guidelines/ 2010-03-11T23:42:00+00:00 daily 0.8 http://www.pharma-marketer.com/patient-unadvocate-lays-siege-to-sanofi-aventis-voices-facebook-page-wheres-s-as-social-media-voice/ 2010-03-11T23:32:43+00:00 daily 0.8 http://www.pharma-marketer.com/bay-area-biotech-blueprints-100m-china-biologics-hub/ 2010-03-11T23:24:11+00:00 daily 0.8 http://www.pharma-marketer.com/nonsense-about-lsd/ 2010-03-11T22:42:03+00:00 daily 0.8 http://www.pharma-marketer.com/biosante-shares-surge-as-cancer-vax-performs-in-small-study/ 2010-03-11T22:14:18+00:00 daily 0.8 http://www.pharma-marketer.com/basilea-mounts-last-ditch-effort-to-gain-quick-ceftobiprole-ok/ 2010-03-11T21:41:55+00:00 daily 0.8 http://www.pharma-marketer.com/nabi-biopharmaceuticals-logs-revenue-from-glaxo-sale/ 2010-03-11T21:34:31+00:00 daily 0.8 http://www.pharma-marketer.com/chelsea-therapeutics-4q-loss-narrows-on-costs/ 2010-03-11T21:34:29+00:00 daily 0.8 http://www.pharma-marketer.com/obamacare-who-cares-there-are-drug-deals-to-do/ 2010-03-11T21:34:27+00:00 daily 0.8 http://www.pharma-marketer.com/drug-safety-social-media-a-universal-symbol/ 2010-03-11T21:34:23+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-teams-up-with-indiaa%c2%80%c2%99s-torrent-in-generics/ 2010-03-11T21:34:21+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-successfully-completes-the-acquisition-of-chattem-inc/ 2010-03-11T21:34:18+00:00 daily 0.8 http://www.pharma-marketer.com/did-jj-plan-to-break-rules/ 2010-03-11T21:34:17+00:00 daily 0.8 http://www.pharma-marketer.com/at-novartis-its-pregnant-women-vs-cheerleaders-among-the-sales-reps/ 2010-03-11T21:34:16+00:00 daily 0.8 http://www.pharma-marketer.com/mercka%c2%80%c2%99s-stromectol-wipes-out-hard-to-treat-lice-study-finds/ 2010-03-11T21:34:11+00:00 daily 0.8 http://www.pharma-marketer.com/10-biotech-stocks-on-the-line/ 2010-03-11T21:34:10+00:00 daily 0.8 http://www.pharma-marketer.com/stemcells-pares-4q-loss-after-acquisition/ 2010-03-11T21:34:08+00:00 daily 0.8 http://www.pharma-marketer.com/nonoyes-pirfenidone-and-the-power-of-orphan-drugs/ 2010-03-11T21:34:06+00:00 daily 0.8 http://www.pharma-marketer.com/fda-to-review-bone-drugs-after-studies-report-hip-breaks/ 2010-03-11T21:34:04+00:00 daily 0.8 http://www.pharma-marketer.com/emarketing-guidelines-for-health-a-common-sense-approach/ 2010-03-11T20:32:10+00:00 daily 0.8 http://www.pharma-marketer.com/intermunes-rise/ 2010-03-11T20:30:46+00:00 daily 0.8 http://www.pharma-marketer.com/pioneering-sequencing-projects-unveil-triggers-for-disease/ 2010-03-11T17:38:29+00:00 daily 0.8 http://www.pharma-marketer.com/pioneering-personal-sequencing-projects-unveil-disease-triggers/ 2010-03-11T17:38:29+00:00 daily 0.8 http://www.pharma-marketer.com/good-health-has-a-lot-of-benefits-including-more-sex-but-are-americans-interested/ 2010-03-11T16:46:24+00:00 daily 0.8 http://www.pharma-marketer.com/phrma-recommended-guidelines-for-drug-internet-marketing-but-who-speaks-for-patients/ 2010-03-11T16:44:19+00:00 daily 0.8 http://www.pharma-marketer.com/intermunea%c2%80%c2%99s-lung-drug-gets-backing-from-fda-panel/ 2010-03-11T02:56:45+00:00 daily 0.8 http://www.pharma-marketer.com/a-tale-of-two-sectors/ 2010-03-11T02:56:42+00:00 daily 0.8 http://www.pharma-marketer.com/biotechs-jump-on-facet-intermune-deal/ 2010-03-11T02:56:39+00:00 daily 0.8 http://www.pharma-marketer.com/phrma-recommended-guidelines-for-drug-internet-marketing-are-silly-who-speaks-for-patients/ 2010-03-11T01:50:38+00:00 daily 0.8 http://www.pharma-marketer.com/vaccines-in-the-court/ 2010-03-10T23:43:36+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-wins-ok-for-cataract-lens-implant/ 2010-03-10T23:27:50+00:00 daily 0.8 http://www.pharma-marketer.com/cardiome-reports-2009-results/ 2010-03-10T23:27:45+00:00 daily 0.8 http://www.pharma-marketer.com/jj-pushed-risperdal-for-elderly-after-u-s-warning-files-show/ 2010-03-10T23:27:42+00:00 daily 0.8 http://www.pharma-marketer.com/transgene-sells-option-on-cancer-vaccine-to-novartis/ 2010-03-10T23:27:40+00:00 daily 0.8 http://www.pharma-marketer.com/fda-grants-cytokinetics-treatment-orphan-status/ 2010-03-10T23:27:38+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-vcs-big-pharma-stepping-outside-the-comfort-zone/ 2010-03-10T23:27:37+00:00 daily 0.8 http://www.pharma-marketer.com/5-star-stocks-poised-to-pop-teva-pharmaceutical/ 2010-03-10T23:27:36+00:00 daily 0.8 http://www.pharma-marketer.com/amylin-lilly-gear-up-for-big-fda-ruling/ 2010-03-10T23:01:53+00:00 daily 0.8 http://www.pharma-marketer.com/cytokinetics-gets-orphan-drug-status-for-als-drug/ 2010-03-10T22:13:20+00:00 daily 0.8 http://www.pharma-marketer.com/social-health-2010-sxsh/ 2010-03-10T22:05:51+00:00 daily 0.8 http://www.pharma-marketer.com/neuropharm-mulls-voluntary-liquidation-as-it-waits-for-deal/ 2010-03-10T20:52:19+00:00 daily 0.8 http://www.pharma-marketer.com/ekr-names-interim-president-ceo/ 2010-03-10T20:46:04+00:00 daily 0.8 http://www.pharma-marketer.com/data-driven-relationships/ 2010-03-10T20:45:48+00:00 daily 0.8 http://www.pharma-marketer.com/how-not-to-do-it-liquid-oxygen-cylinders/ 2010-03-10T20:40:33+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-offers-955m-deal-to-snare-transgene-drug-option/ 2010-03-10T16:09:43+00:00 daily 0.8 http://www.pharma-marketer.com/facet-biotech-stock-soars-on-abbott-bid/ 2010-03-10T11:58:54+00:00 daily 0.8 http://www.pharma-marketer.com/making-sense-out-pharma-dtc-spending-trends/ 2010-03-10T11:37:17+00:00 daily 0.8 http://www.pharma-marketer.com/in-9-3-vote-expert-panel-backs-intermunes-pirfenidone/ 2010-03-10T08:56:36+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-labs-to-buy-facet-biotech-for-722-million/ 2010-03-10T08:04:12+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-ceos-2009-compensation-down-22-pct/ 2010-03-10T08:04:09+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-botox-for-elbow-wrist-finger-spasms/ 2010-03-10T08:04:07+00:00 daily 0.8 http://www.pharma-marketer.com/missing-data-feh-in-sequenoms-hall-of-mirrors-investors-see-only-what-they-want/ 2010-03-10T08:04:05+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-abbott-buys-facet-biotech-for-450m/ 2010-03-10T07:47:06+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-buys-facet-biotech-for-450m/ 2010-03-10T07:47:06+00:00 daily 0.8 http://www.pharma-marketer.com/facebook-and-web-pages-what-pharma-and-fda-need-to-know/ 2010-03-10T04:00:47+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-feels-the-social-media-pain-but-is-it-authentic/ 2010-03-10T04:00:16+00:00 daily 0.8 http://www.pharma-marketer.com/20-drug-sales-reps-a-week/ 2010-03-10T03:59:26+00:00 daily 0.8 http://www.pharma-marketer.com/watson-says-it-seeks-approval-for-generic-opana-er/ 2010-03-10T03:36:40+00:00 daily 0.8 http://www.pharma-marketer.com/big-biotech-ma-targets-who-could-follow-astellas-3-5b-bid-for-osi/ 2010-03-10T03:36:38+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-to-add-ethics-watchdogs/ 2010-03-10T03:36:35+00:00 daily 0.8 http://www.pharma-marketer.com/tocagen-raises-7-8m-ista-gets-pdufa-date/ 2010-03-09T23:56:09+00:00 daily 0.8 http://www.pharma-marketer.com/autoimmune-calls-it-quits/ 2010-03-09T23:29:28+00:00 daily 0.8 http://www.pharma-marketer.com/cellzome-partners-with-gsk-on-inflammatory-diseases/ 2010-03-09T23:24:11+00:00 daily 0.8 http://www.pharma-marketer.com/merck-sanofi-create-animal-health-giant/ 2010-03-09T23:15:48+00:00 daily 0.8 http://www.pharma-marketer.com/more-doctors-are-using-e-prescribing/ 2010-03-09T23:15:47+00:00 daily 0.8 http://www.pharma-marketer.com/wuxi-pharmatech-moves-to-4th-quarter-profit/ 2010-03-09T23:15:46+00:00 daily 0.8 http://www.pharma-marketer.com/osi-bid-likely-to-rise-as-astellas-seeks-cancer-sales/ 2010-03-09T23:15:45+00:00 daily 0.8 http://www.pharma-marketer.com/intermunes-fda-panel-live-blog-2/ 2010-03-09T23:15:43+00:00 daily 0.8 http://www.pharma-marketer.com/intermune-shares-halted-drug-stocks-slip-2/ 2010-03-09T23:15:42+00:00 daily 0.8 http://www.pharma-marketer.com/a-cautious-look-at-amgens-denosumab/ 2010-03-09T23:15:40+00:00 daily 0.8 http://www.pharma-marketer.com/immunogen-cancer-drug-gets-orphan-drug-status-2/ 2010-03-09T23:15:38+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-and-vanda-pharmas-schizophrenia-treatment-may-be-doa/ 2010-03-09T23:15:36+00:00 daily 0.8 http://www.pharma-marketer.com/whos-the-next-biotech-buyout-target/ 2010-03-09T23:04:11+00:00 daily 0.8 http://www.pharma-marketer.com/i-will-never-go-away-a-patient-says-but-who-set-up-this-page-and-who-was-responsible-for-maintaining-it/ 2010-03-09T22:58:11+00:00 daily 0.8 http://www.pharma-marketer.com/intermune-trading-halted-on-panel-review-2/ 2010-03-09T22:08:25+00:00 daily 0.8 http://www.pharma-marketer.com/a-gsksirtris-wrap-up-2/ 2010-03-09T20:46:28+00:00 daily 0.8 http://www.pharma-marketer.com/externalization-takes-center-stage-at-bio-europe-spring/ 2010-03-09T19:48:51+00:00 daily 0.8 http://www.pharma-marketer.com/ark-in-sales-talks-after-regulators-demand-new-trial/ 2010-03-09T18:09:57+00:00 daily 0.8 http://www.pharma-marketer.com/exelixis-chops-270-jobs-in-restructuring/ 2010-03-09T15:25:58+00:00 daily 0.8 http://www.pharma-marketer.com/bald-women-lash-out-at-sanofi-aventis-taxotere/ 2010-03-09T08:28:43+00:00 daily 0.8 http://www.pharma-marketer.com/xenoport-narrows-focus-cuts-jobs/ 2010-03-09T08:28:41+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-still-dealing-with-antitrust-issues/ 2010-03-09T08:28:40+00:00 daily 0.8 http://www.pharma-marketer.com/acura-king-cite-positive-study-on-pain-drug/ 2010-03-09T08:28:38+00:00 daily 0.8 http://www.pharma-marketer.com/vivus-q4-loss-nearly-doubles-to-13-2m/ 2010-03-09T08:28:36+00:00 daily 0.8 http://www.pharma-marketer.com/nabi-pharmaceuticals-closes-glaxosmithkline-license-deal-for-experimental-smoking-vaccine/ 2010-03-09T08:28:34+00:00 daily 0.8 http://www.pharma-marketer.com/bad-news-at-exelixis/ 2010-03-09T02:51:44+00:00 daily 0.8 http://www.pharma-marketer.com/china-biotech-week-in-review-china-life-science-to-grow-22-yearly-through-2013/ 2010-03-09T02:03:13+00:00 daily 0.8 http://www.pharma-marketer.com/video-medivations-next-moves/ 2010-03-09T02:03:09+00:00 daily 0.8 http://www.pharma-marketer.com/investors-show-confidence-in-dendreon/ 2010-03-09T02:03:05+00:00 daily 0.8 http://www.pharma-marketer.com/how-mercks-price-freeze-on-hiv-drugs-kept-prices-red-hot/ 2010-03-09T02:03:03+00:00 daily 0.8 http://www.pharma-marketer.com/few-pharmas-to-profit-off-cv-growth/ 2010-03-09T02:03:00+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-recentin-not-better-vs-rival-in-trial/ 2010-03-09T02:02:59+00:00 daily 0.8 http://www.pharma-marketer.com/isis-to-receive-6m-payment-from-bristol-myers/ 2010-03-09T02:02:55+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-expects-japan-sales-to-grow-in-a%c2%80%c2%98mid-teensa%c2%80%c2%99-in-2010/ 2010-03-09T02:02:54+00:00 daily 0.8 http://www.pharma-marketer.com/roche-biogen-idec-suspend-tests-for-arthritis-drug/ 2010-03-09T02:02:52+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-to-acquire-european-rights-to-pfizer-animal-health-assets/ 2010-03-09T02:02:51+00:00 daily 0.8 http://www.pharma-marketer.com/drugmakers-nix-long-term-study-on-adhd-meds/ 2010-03-09T02:02:49+00:00 daily 0.8 http://www.pharma-marketer.com/lesson-from-an-alzheimer-drug-failure-beware-russian-clinical-trial-data/ 2010-03-09T02:02:48+00:00 daily 0.8 http://www.pharma-marketer.com/five-biotech-takeout-targets/ 2010-03-09T02:02:44+00:00 daily 0.8 http://www.pharma-marketer.com/for-biotech-in-2010-its-da%c2%a9ja%c2%a0-vu-all-over-again/ 2010-03-09T02:02:39+00:00 daily 0.8 http://www.pharma-marketer.com/supreme-court-steps-into-dispute-over-parents-lawsuits-against-vaccine-makers/ 2010-03-09T02:02:38+00:00 daily 0.8 http://www.pharma-marketer.com/use-of-social-media-for-health-a-common-sense-approach/ 2010-03-09T00:24:35+00:00 daily 0.8 http://www.pharma-marketer.com/interesting-history-at-fda-as-alliance-for-a-stronger-fda-goes-to-bat-for-bigger-agency-budget/ 2010-03-08T23:22:19+00:00 daily 0.8 http://www.pharma-marketer.com/exonhit-biomerieux-nix-colon-cancer-program/ 2010-03-08T23:16:13+00:00 daily 0.8 http://www.pharma-marketer.com/fda-oks-cell-therapeutics-manufacturing-plant/ 2010-03-08T23:01:44+00:00 daily 0.8 http://www.pharma-marketer.com/intermune-stock-rise-ahead-of-meeting/ 2010-03-08T21:18:52+00:00 daily 0.8 http://www.pharma-marketer.com/xenoport-cuts-50-of-workforce/ 2010-03-08T20:53:53+00:00 daily 0.8 http://www.pharma-marketer.com/the-biotech-spring-arrives-in-barcelona/ 2010-03-08T20:51:54+00:00 daily 0.8 http://www.pharma-marketer.com/not-gonna-make-that-one/ 2010-03-08T20:25:45+00:00 daily 0.8 http://www.pharma-marketer.com/azs-recentin-flunks-head-to-head-trial-with-avastin/ 2010-03-08T19:27:51+00:00 daily 0.8 http://www.pharma-marketer.com/infections-and-deaths-force-biogen-roche-to-suspend-blockbuster-program/ 2010-03-08T19:10:05+00:00 daily 0.8 http://www.pharma-marketer.com/chelsea-therapeutics-completes-18-2-million-registered-direct-offering/ 2010-03-07T04:01:49+00:00 daily 0.8 http://www.pharma-marketer.com/neurocrine-falls-after-pricing-stock-offer/ 2010-03-07T04:01:48+00:00 daily 0.8 http://www.pharma-marketer.com/intermunes-big-rally-pushes-biotech-index-higher/ 2010-03-07T04:01:46+00:00 daily 0.8 http://www.pharma-marketer.com/intermune-still-has-lingering-questions/ 2010-03-07T04:01:43+00:00 daily 0.8 http://www.pharma-marketer.com/street-cheers-prospects-for-intermune-drug/ 2010-03-07T04:01:42+00:00 daily 0.8 http://www.pharma-marketer.com/the-egleston-law-firm-and-rigrodsky-long-p-a-file-class-action-suit-against-novelos-therapeutics-inc/ 2010-03-07T04:01:39+00:00 daily 0.8 http://www.pharma-marketer.com/nasdaq-biotech-ishares-may-pull-back/ 2010-03-07T04:01:38+00:00 daily 0.8 http://www.pharma-marketer.com/drugmakers-boost-consumer-ad-spending-2-pct-in-09/ 2010-03-07T04:01:36+00:00 daily 0.8 http://www.pharma-marketer.com/miracle-cancer-drug-extends-life-with-48720-cost-update1/ 2010-03-07T04:01:34+00:00 daily 0.8 http://www.pharma-marketer.com/painless-vaccine-needle-invented-in-japan/ 2010-03-07T04:01:33+00:00 daily 0.8 http://www.pharma-marketer.com/watson-acquires-us-rights-to-columbia-labs-crinone-progesterone-gel-products/ 2010-03-07T04:01:31+00:00 daily 0.8 http://www.pharma-marketer.com/vioxx-ruling-gives-hope-for-payouts-to-british-a%c2%80%c2%98victimsa%c2%80%c2%99/ 2010-03-07T04:01:28+00:00 daily 0.8 http://www.pharma-marketer.com/la-jolla-pharmaceutical-adamis-pharmaceuticals-to-terminate-merger-agreement/ 2010-03-07T04:01:25+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-raises-bid-for-ratiopharm-wsj/ 2010-03-07T04:01:23+00:00 daily 0.8 http://www.pharma-marketer.com/dusa-to-release-upgraded-blu-u-for-health-care-practitioners/ 2010-03-07T04:01:22+00:00 daily 0.8 http://www.pharma-marketer.com/nicox-bausch-lomb-enter-into-licensing-pact-for-ncx116/ 2010-03-07T04:01:20+00:00 daily 0.8 http://www.pharma-marketer.com/endo-pharmaceuticals-steady-growth/ 2010-03-07T04:01:17+00:00 daily 0.8 http://www.pharma-marketer.com/sitemap/ 2010-03-06T11:50:39+00:00 weekly 0.6 http://www.pharma-marketer.com/merckschering-plough-people/ 2010-03-06T03:14:59+00:00 daily 0.8 http://www.pharma-marketer.com/uptrend-in-gileads-estimates/ 2010-03-06T01:30:28+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-cholesterol-failures-cleared-path-for-canadian-upstart/ 2010-03-06T01:30:26+00:00 daily 0.8 http://www.pharma-marketer.com/astellas-needs-to-raise-osi-bid-by-15-orbimed-says/ 2010-03-06T01:30:23+00:00 daily 0.8 http://www.pharma-marketer.com/house-subcommittee-to-hold-drug-safety-hearing/ 2010-03-06T01:30:22+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-could-face-6bn-avandia-liability-says-ubs/ 2010-03-06T01:30:21+00:00 daily 0.8 http://www.pharma-marketer.com/4-star-stocks-poised-to-pop-glaxosmithkline/ 2010-03-06T01:30:17+00:00 daily 0.8 http://www.pharma-marketer.com/bayer-merck-teva-rambus-intellectual-property/ 2010-03-06T01:30:14+00:00 daily 0.8 http://www.pharma-marketer.com/friday-book-recommendation/ 2010-03-06T00:45:54+00:00 daily 0.8 http://www.pharma-marketer.com/twelve-and-one-half-per-cent/ 2010-03-06T00:41:20+00:00 daily 0.8 http://www.pharma-marketer.com/alnara-rises-from-altus-ashes/ 2010-03-05T23:17:55+00:00 daily 0.8 http://www.pharma-marketer.com/bms-talks-pipeline-at-analyst-meeting/ 2010-03-05T22:36:58+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-looks-for-more-china-partnerships/ 2010-03-05T21:37:14+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-and-bristol-myers-say-their-blood-thinner-apixaban-worked-better-than-lovenox-in-study/ 2010-03-05T21:37:12+00:00 daily 0.8 http://www.pharma-marketer.com/csl-rises-on-u-s-approval-for-immune-system-therapy-hizentra/ 2010-03-05T21:37:11+00:00 daily 0.8 http://www.pharma-marketer.com/merck-sues-to-block-generic-vytorin/ 2010-03-05T21:37:09+00:00 daily 0.8 http://www.pharma-marketer.com/unusual-trading-in-cell-therapeutics/ 2010-03-05T21:37:06+00:00 daily 0.8 http://www.pharma-marketer.com/intermune-says-fda-panel-will-review-its-lung-drug/ 2010-03-05T21:37:04+00:00 daily 0.8 http://www.pharma-marketer.com/australian-court-vioxx-doubled-heart-attack-risk/ 2010-03-05T21:37:02+00:00 daily 0.8 http://www.pharma-marketer.com/intermune-gears-up-for-panel-review/ 2010-03-05T21:03:59+00:00 daily 0.8 http://www.pharma-marketer.com/apixaban-superior-to-lovenox-in-study/ 2010-03-05T21:02:56+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-should-leave-unmoderated-sm-discussions-to-3rd-parties/ 2010-03-05T20:59:54+00:00 daily 0.8 http://www.pharma-marketer.com/resverlogix-looks-to-succeed-where-pfizer-failed/ 2010-03-05T20:57:32+00:00 daily 0.8 http://www.pharma-marketer.com/the-bleeding-has-stopped/ 2010-03-05T20:20:43+00:00 daily 0.8 http://www.pharma-marketer.com/your-own-personal-bacteria/ 2010-03-05T19:53:52+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-3410/ 2010-03-05T18:57:20+00:00 daily 0.8 http://www.pharma-marketer.com/merck-says-fda-should-approve-the-%e2%80%9cone-click-rule%e2%80%9d/ 2010-03-05T16:48:08+00:00 daily 0.8 http://www.pharma-marketer.com/a-ray-of-hope-for-medivation/ 2010-03-05T10:00:36+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-60-drugs-in-testing-to-boost-sales/ 2010-03-05T10:00:34+00:00 daily 0.8 http://www.pharma-marketer.com/dendreon-and-the-prostate-cancer-battle/ 2010-03-05T10:00:32+00:00 daily 0.8 http://www.pharma-marketer.com/justice-departments-botox-probe-costing-allergan-100m-and-theres-no-end-in-sight/ 2010-03-05T10:00:27+00:00 daily 0.8 http://www.pharma-marketer.com/fda-getting-tough-with-everyone/ 2010-03-05T03:57:30+00:00 daily 0.8 http://www.pharma-marketer.com/dimebon-grasping-at-straws/ 2010-03-05T03:04:15+00:00 daily 0.8 http://www.pharma-marketer.com/merck-presents-positive-data/ 2010-03-05T02:21:13+00:00 daily 0.8 http://www.pharma-marketer.com/fda-may-prosecute-more-pharmaceutical-execs/ 2010-03-05T02:21:12+00:00 daily 0.8 http://www.pharma-marketer.com/eisai-says-aricepts-u-s-sales-to-more-than-halve/ 2010-03-05T02:21:09+00:00 daily 0.8 http://www.pharma-marketer.com/osi-pharmaceuticals-board-to-consider-astellas-unsolicited-tender-offer/ 2010-03-05T02:21:07+00:00 daily 0.8 http://www.pharma-marketer.com/fda-says-takeda-has-agreed-to-rename-kadipex-to-avoid-confusion-with-other-drugs/ 2010-03-05T02:21:05+00:00 daily 0.8 http://www.pharma-marketer.com/mental-health-break-the-alkali-metals-show-their-personalities/ 2010-03-05T00:17:10+00:00 daily 0.8 http://www.pharma-marketer.com/tolerx-faces-moment-of-truth-with-pivotal-trial/ 2010-03-05T00:05:51+00:00 daily 0.8 http://www.pharma-marketer.com/experimental-vax-could-reverse-parkinsons/ 2010-03-04T23:14:37+00:00 daily 0.8 http://www.pharma-marketer.com/vaxart-lands-12-5m-round-readies-phase-i-trial/ 2010-03-04T22:59:41+00:00 daily 0.8 http://www.pharma-marketer.com/sanofis-cancer-drug-may-set-new-standard/ 2010-03-04T22:52:23+00:00 daily 0.8 http://www.pharma-marketer.com/rogue-analyst-provides-questionable-fodder-for-dendreon-conspiracy-theorists/ 2010-03-04T22:52:20+00:00 daily 0.8 http://www.pharma-marketer.com/astellas-ceo-a-logical-idealist/ 2010-03-04T22:52:18+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-sets-baseline-for-profits-post-plavix/ 2010-03-04T22:52:15+00:00 daily 0.8 http://www.pharma-marketer.com/inspire-posts-smaller-loss-as-azasite-sales-rise/ 2010-03-04T22:52:14+00:00 daily 0.8 http://www.pharma-marketer.com/want-a-good-sales-rep-poach-from-your-rival/ 2010-03-04T22:52:13+00:00 daily 0.8 http://www.pharma-marketer.com/merckgtx-if-a-collaboration-fails-in-the-forest-does-it-make-a-sound/ 2010-03-04T22:52:11+00:00 daily 0.8 http://www.pharma-marketer.com/merck-kgaa-to-restructure-u-s-ops-after-millipore-buyout/ 2010-03-04T22:49:13+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-urges-fda-to-regulate-the-whole-and-nothing-but-the-whole-sm-conversation/ 2010-03-04T21:46:38+00:00 daily 0.8 http://www.pharma-marketer.com/time-for-medical-device-manfufacturers-to-be-held-to-same-standards-as-pharma/ 2010-03-04T21:10:41+00:00 daily 0.8 http://www.pharma-marketer.com/new-provenge-data-confirms-3-year-survival-benefit/ 2010-03-04T20:29:39+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-offers-promising-survival-data-on-prostate-cancer-drug/ 2010-03-04T19:52:37+00:00 daily 0.8 http://www.pharma-marketer.com/flowing-not-so-gently/ 2010-03-04T19:44:44+00:00 daily 0.8 http://www.pharma-marketer.com/whats-cookin-good-lookin-fda-issues-17-warning-letters-on-22-products-re-labeling/ 2010-03-04T17:21:00+00:00 daily 0.8 http://www.pharma-marketer.com/why-its-time-to-sell-cephalon/ 2010-03-04T11:06:48+00:00 daily 0.8 http://www.pharma-marketer.com/bullish-on-pozen/ 2010-03-04T07:44:07+00:00 daily 0.8 http://www.pharma-marketer.com/will-andreotti-merge-bristol-myers-squibb/ 2010-03-04T07:44:06+00:00 daily 0.8 http://www.pharma-marketer.com/drug-developers-show-little-reaction-to-obama-push-on-health-care-reform/ 2010-03-04T07:44:04+00:00 daily 0.8 http://www.pharma-marketer.com/fda-sees-increasing-number-of-insulin-pump-problems/ 2010-03-04T07:44:03+00:00 daily 0.8 http://www.pharma-marketer.com/questcor-biotech-winner/ 2010-03-04T07:44:02+00:00 daily 0.8 http://www.pharma-marketer.com/another-torrent-of-comments-to-fda-social-media-docket/ 2010-03-04T04:11:45+00:00 daily 0.8 http://www.pharma-marketer.com/ratiopharm-sale-in-final-stages/ 2010-03-04T03:22:17+00:00 daily 0.8 http://www.pharma-marketer.com/merck-cites-positive-study-results-on-allergy-drug/ 2010-03-04T03:21:59+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-starts-to-slash/ 2010-03-04T03:21:58+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-newly-approved-vaccine-should-be-huge-growth-driver/ 2010-03-04T03:21:56+00:00 daily 0.8 http://www.pharma-marketer.com/transition-therapeutics-and-lilly-in-diabetes-deal/ 2010-03-04T03:21:50+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-medivationa%c2%80%c2%99s-drug-fails-in-alzheimera%c2%80%c2%99s-study/ 2010-03-04T03:21:27+00:00 daily 0.8 http://www.pharma-marketer.com/nicox-sells-eye-treatment-rights-to-bausch-lomb/ 2010-03-04T03:21:23+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-allergan-in-413m-pain-drug-deal/ 2010-03-04T03:21:18+00:00 daily 0.8 http://www.pharma-marketer.com/lower-q4-loss-for-human-genome/ 2010-03-04T03:21:15+00:00 daily 0.8 http://www.pharma-marketer.com/lessons-from-mead-johnsons-ipo-stock-spin-off/ 2010-03-04T03:21:12+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-said-to-set-sights-on-german-drug-maker/ 2010-03-04T03:21:08+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-climb-medivation-sinks-on-drug-study/ 2010-03-04T03:21:04+00:00 daily 0.8 http://www.pharma-marketer.com/the-incompetent-monopolist-genzymes-drug-screwups-invite-attacks-by-shire-pfizer/ 2010-03-04T03:20:58+00:00 daily 0.8 http://www.pharma-marketer.com/pfizera%c2%80%c2%99s-jeff-kindler-gets-a-hefty-raise/ 2010-03-04T03:20:54+00:00 daily 0.8 http://www.pharma-marketer.com/covidien-launches-generic-version-of-actiq/ 2010-03-04T03:20:53+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-reports-26000-layoffs-in-2010/ 2010-03-04T03:20:52+00:00 daily 0.8 http://www.pharma-marketer.com/why-are-more-people-going-online-for-health-information-just-look-at-the-headlines/ 2010-03-04T02:17:20+00:00 daily 0.8 http://www.pharma-marketer.com/la-jolla-pharma-to-be-delisted-after-merger-flop/ 2010-03-03T23:39:05+00:00 daily 0.8 http://www.pharma-marketer.com/how-did-pfizer-get-so-many-twitter-followers/ 2010-03-03T23:02:57+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-asks-for-new-fda-regulations-not-guidance-for-social-media/ 2010-03-03T23:01:42+00:00 daily 0.8 http://www.pharma-marketer.com/the-line-between-media-and-social-media-is-rapidly-blurring/ 2010-03-03T22:59:40+00:00 daily 0.8 http://www.pharma-marketer.com/nicox-gains-new-partner-on-glaucoma-program/ 2010-03-03T22:52:37+00:00 daily 0.8 http://www.pharma-marketer.com/archimedes-readies-u-s-commercial-ops-for-cancer-pain/ 2010-03-03T22:36:19+00:00 daily 0.8 http://www.pharma-marketer.com/compugen-announces-management-changes/ 2010-03-03T22:28:31+00:00 daily 0.8 http://www.pharma-marketer.com/dimebon-comes-crashing-to-earth/ 2010-03-03T21:53:32+00:00 daily 0.8 http://www.pharma-marketer.com/ptcs-lead-drug-ataluren-flunks-phiib/ 2010-03-03T21:36:22+00:00 daily 0.8 http://www.pharma-marketer.com/bms-inks-413m-pain-pact-with-allergan/ 2010-03-03T20:58:25+00:00 daily 0.8 http://www.pharma-marketer.com/fat-rats-make-poor-test-subjects/ 2010-03-03T20:45:57+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-outlines-deep-cuts-in-global-rd-ops-2/ 2010-03-03T20:17:42+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-medivations-dimebon-fails-phase-iii-for-alzheimers/ 2010-03-03T19:51:44+00:00 daily 0.8 http://www.pharma-marketer.com/medivations-dimebon-fails-phase-iii-for-alzheimers-shares-collapse-2/ 2010-03-03T19:51:44+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-ceo-to-retire-cfo-to-succeed-him/ 2010-03-03T08:02:16+00:00 daily 0.8 http://www.pharma-marketer.com/mobile-marketing-is-growing-fast-but-where-is-pharma/ 2010-03-03T04:22:45+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-shuffles-eliminates-del-rd-jobs/ 2010-03-03T04:09:56+00:00 daily 0.8 http://www.pharma-marketer.com/az-pitches-social-media-rules-to-fda/ 2010-03-03T04:09:55+00:00 daily 0.8 http://www.pharma-marketer.com/teva-regains-exclusivity-on-blood-pressure-drugs/ 2010-03-03T04:09:53+00:00 daily 0.8 http://www.pharma-marketer.com/no-panel-for-provenge/ 2010-03-03T04:09:51+00:00 daily 0.8 http://www.pharma-marketer.com/todays-fiercebiotech-research/ 2010-03-03T02:00:57+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-fda-panel-clears-a-transplant-drug-bristol-myers-fda-panel-clears-a-transplant-drug/ 2010-03-03T00:07:46+00:00 daily 0.8 http://www.pharma-marketer.com/anthera-ipo-second-biotech-to-price-low-but-price-isnt-everything/ 2010-03-03T00:07:41+00:00 daily 0.8 http://www.pharma-marketer.com/bayers-birth-control-problem-is-exploding-1100-lawsuits-allege-yaz-causes-blood-clots/ 2010-03-03T00:07:37+00:00 daily 0.8 http://www.pharma-marketer.com/connecticut-ag-urges-curbs-on-pharma-influence/ 2010-03-03T00:07:34+00:00 daily 0.8 http://www.pharma-marketer.com/hedge-funds-heart-pfizer/ 2010-03-03T00:07:33+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-chief-talks-pharma-challenges/ 2010-03-03T00:07:31+00:00 daily 0.8 http://www.pharma-marketer.com/impax-gets-fda-ok-for-prostate-drug/ 2010-03-03T00:07:28+00:00 daily 0.8 http://www.pharma-marketer.com/allos-extends-losses/ 2010-03-03T00:07:26+00:00 daily 0.8 http://www.pharma-marketer.com/will-osi-offer-touch-off-a-bidding-war/ 2010-03-03T00:07:24+00:00 daily 0.8 http://www.pharma-marketer.com/specialty-drugs-medicare-d-catastrophic-coverage/ 2010-03-03T00:07:24+00:00 daily 0.8 http://www.pharma-marketer.com/three-undervalued-cancer-drug-makers/ 2010-03-03T00:07:20+00:00 daily 0.8 http://www.pharma-marketer.com/report-claims-dendreon-facing-fda-panel/ 2010-03-03T00:07:16+00:00 daily 0.8 http://www.pharma-marketer.com/sequenom-combinatorrx-lead-drug-stocks-north/ 2010-03-03T00:07:09+00:00 daily 0.8 http://www.pharma-marketer.com/pluristem-therapeutics-compugen-antares-early-volume-plays/ 2010-03-03T00:07:05+00:00 daily 0.8 http://www.pharma-marketer.com/are-activist-shareholders-poison-for-biotech/ 2010-03-03T00:06:56+00:00 daily 0.8 http://www.pharma-marketer.com/covidien-combinatorx-painkiller-exalgo-gets-fda-nod/ 2010-03-03T00:06:54+00:00 daily 0.8 http://www.pharma-marketer.com/covidien-to-expand-sales-force-thanks-to-fda-drug-approval/ 2010-03-03T00:06:46+00:00 daily 0.8 http://www.pharma-marketer.com/controlling-astellass-ma-urges/ 2010-03-03T00:06:43+00:00 daily 0.8 http://www.pharma-marketer.com/quatrx-gains-125m-licensing-pact/ 2010-03-02T23:42:48+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-backs-bms-new-transplant-therapy/ 2010-03-02T23:22:32+00:00 daily 0.8 http://www.pharma-marketer.com/dendreon-shares-gyrate-on-provenge-panel-rumor/ 2010-03-02T23:08:05+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-makes-its-move/ 2010-03-02T22:31:50+00:00 daily 0.8 http://www.pharma-marketer.com/leveraging-digital-technology-in-pharmaceutical-marketing-a-new-agency-model/ 2010-03-02T21:31:00+00:00 daily 0.8 http://www.pharma-marketer.com/commercial-compliance-for-pharmaceutical-and-medical-device-companies/ 2010-03-02T21:26:01+00:00 daily 0.8 http://www.pharma-marketer.com/summary-box-merck-drug-pipeline/ 2010-03-02T21:02:23+00:00 daily 0.8 http://www.pharma-marketer.com/astellas-sues-osi-for-rejecting-3-5-billion-offer/ 2010-03-02T21:02:21+00:00 daily 0.8 http://www.pharma-marketer.com/ucb-drops-after-forecasting-2010-earnings-wona%c2%80%c2%99t-rise/ 2010-03-02T21:02:20+00:00 daily 0.8 http://www.pharma-marketer.com/summary-box-merck-pays-last-4-1b-for-vioxx-patient-settlements-some-other-suits-continue/ 2010-03-02T21:02:18+00:00 daily 0.8 http://www.pharma-marketer.com/combinatorx-scores-40m-payout-on-fda-approval/ 2010-03-02T20:45:20+00:00 daily 0.8 http://www.pharma-marketer.com/patientslikeme-reports-high-rate-of-adverse-event-reporting-among-its-members/ 2010-03-02T20:43:03+00:00 daily 0.8 http://www.pharma-marketer.com/osi-shares-soar-as-astellas-brawls-over-rejected-bid/ 2010-03-02T20:23:04+00:00 daily 0.8 http://www.pharma-marketer.com/why-you-dont-want-to-make-death-star-sized-drugs/ 2010-03-02T20:07:15+00:00 daily 0.8 http://www.pharma-marketer.com/the-plasmid-committee-will-see-you-now/ 2010-03-02T19:56:01+00:00 daily 0.8 http://www.pharma-marketer.com/archimedes-gets-100m-bankroll-and-names-a-new-ceo/ 2010-03-02T19:46:02+00:00 daily 0.8 http://www.pharma-marketer.com/when-it-rains-it-pours-pharma-companies-finally-submit-comments-to-fda-social-media-docket-lots-of-them/ 2010-03-02T18:44:22+00:00 daily 0.8 http://www.pharma-marketer.com/content-marketing-when-will-the-drug-industry-get-it/ 2010-03-02T03:35:23+00:00 daily 0.8 http://www.pharma-marketer.com/the-expanding-role-of-twitter-in-governance/ 2010-03-02T03:28:19+00:00 daily 0.8 http://www.pharma-marketer.com/fdasm-survey-results/ 2010-03-02T03:27:17+00:00 daily 0.8 http://www.pharma-marketer.com/daiichi-sankyo-unit-to-sell-generic-drugs/ 2010-03-02T00:52:31+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-science-dominance-in-the-hiv-market/ 2010-03-02T00:52:29+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-to-pay-merck-647m-for-drug-interests/ 2010-03-02T00:52:27+00:00 daily 0.8 http://www.pharma-marketer.com/merck-kgaa-to-buy-millipore-for-about-6-billion/ 2010-03-02T00:52:26+00:00 daily 0.8 http://www.pharma-marketer.com/experimental-alzheimers-drug-shows-promise/ 2010-03-02T00:52:25+00:00 daily 0.8 http://www.pharma-marketer.com/fda-accepts-viaject-nda-for-review/ 2010-03-02T00:52:21+00:00 daily 0.8 http://www.pharma-marketer.com/california-county-sues-glaxo-over-avandia-risks/ 2010-03-02T00:52:20+00:00 daily 0.8 http://www.pharma-marketer.com/merck-announces-robust-integrated-pipeline-with-more-than-20-medicines-and-vaccines-in-late-stage-development/ 2010-03-02T00:52:19+00:00 daily 0.8 http://www.pharma-marketer.com/fda-accepts-vivus-application-for-obesity-drug/ 2010-03-02T00:52:17+00:00 daily 0.8 http://www.pharma-marketer.com/stronger-label-for-biogens-tysabri/ 2010-03-02T00:52:15+00:00 daily 0.8 http://www.pharma-marketer.com/heart-association-finds-drug-risks-inconclusive-after-taking-3-6m-from-its-maker-glaxo/ 2010-03-02T00:52:10+00:00 daily 0.8 http://www.pharma-marketer.com/japans-astellas-bids-3-5-billion-for-osi-pharma/ 2010-03-02T00:52:06+00:00 daily 0.8 http://www.pharma-marketer.com/ariad-cancer-treatment-gets-orphan-drug-status/ 2010-03-02T00:52:03+00:00 daily 0.8 http://www.pharma-marketer.com/osi-millipore-takeover-bids-stoke-biotech-stocks/ 2010-03-02T00:52:02+00:00 daily 0.8 http://www.pharma-marketer.com/should-generic-drugmakers-pay-user-fees/ 2010-03-02T00:51:58+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-squibb-looks-like-a-good-value/ 2010-03-02T00:51:57+00:00 daily 0.8 http://www.pharma-marketer.com/elan-execs-get-8m-in-stock-awards/ 2010-03-02T00:51:55+00:00 daily 0.8 http://www.pharma-marketer.com/gentium-names-ceo-closes-ny-office/ 2010-03-02T00:35:26+00:00 daily 0.8 http://www.pharma-marketer.com/ppd-to-create-250-jobs-in-ireland/ 2010-03-01T23:55:43+00:00 daily 0.8 http://www.pharma-marketer.com/anthera-ipo-limps-out-at-half-price/ 2010-03-01T23:51:50+00:00 daily 0.8 http://www.pharma-marketer.com/blog-traffic-thanks/ 2010-03-01T23:34:59+00:00 daily 0.8 http://www.pharma-marketer.com/cellcentric-builds-on-a-global-epigenetics-platform/ 2010-03-01T22:15:10+00:00 daily 0.8 http://www.pharma-marketer.com/fda-well-issue-social-media-guidelines-later-this-year-consumers-who-cares/ 2010-03-01T21:27:56+00:00 daily 0.8 http://www.pharma-marketer.com/merck-updates-pipeline-with-schering-additions/ 2010-03-01T21:20:44+00:00 daily 0.8 http://www.pharma-marketer.com/ctic-gets-going-concern-warning-new-odac-date/ 2010-03-01T21:12:56+00:00 daily 0.8 http://www.pharma-marketer.com/calorimetry-what-say-you/ 2010-03-01T21:07:36+00:00 daily 0.8 http://www.pharma-marketer.com/merck-kgaa-offers-7-2b-for-millipore/ 2010-03-01T20:32:46+00:00 daily 0.8 http://www.pharma-marketer.com/layoffs-coming-at-eli-lilly/ 2010-03-01T20:19:03+00:00 daily 0.8 http://www.pharma-marketer.com/astellas-makes-3-5b-hostile-bid-for-osi/ 2010-03-01T20:14:52+00:00 daily 0.8 http://www.pharma-marketer.com/health-care-reform-and-its-impact-on-fda-and-pharma/ 2010-03-01T17:11:00+00:00 daily 0.8 http://www.pharma-marketer.com/china-biotech-week-in-review-new-deals-in-china-life-science/ 2010-03-01T06:00:03+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-merck-pfizer-team-up-to-accelerate-cancer-research-in-asia/ 2010-03-01T06:00:00+00:00 daily 0.8 http://www.pharma-marketer.com/copaxone-15-year-study-in-multiple-sclerosis-patients-demonstrates-robust-long-term-efficacy-and-safety/ 2010-03-01T05:59:57+00:00 daily 0.8 http://www.pharma-marketer.com/cannabis-science-moves-its-fda-clinical-trial-process-forward/ 2010-03-01T05:59:52+00:00 daily 0.8 http://www.pharma-marketer.com/kv-pharmaceutical-reaches-agreement-with-u-s-department-of-justice/ 2010-03-01T05:59:46+00:00 daily 0.8 http://www.pharma-marketer.com/battle-brews-for-control-of-genzyme/ 2010-03-01T01:41:04+00:00 daily 0.8 http://www.pharma-marketer.com/genta-starts-phase-2-trial-of-oncology-product-tesetaxal/ 2010-02-28T05:06:13+00:00 daily 0.8 http://www.pharma-marketer.com/adamis-pharma-signs-pact-to-acquire-prostate-cancer-drug-candidates-from-colby-pharma/ 2010-02-28T05:06:11+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-were-here-to-develop-new-drugs/ 2010-02-28T03:50:40+00:00 daily 0.8 http://www.pharma-marketer.com/hope-for-muscular-dystrophy-patients/ 2010-02-28T01:35:48+00:00 daily 0.8 http://www.pharma-marketer.com/our-top-five-biotech-takeout-picks/ 2010-02-28T01:35:46+00:00 daily 0.8 http://www.pharma-marketer.com/savient-posts-smaller-loss-due-to-warrant-gain/ 2010-02-28T01:35:45+00:00 daily 0.8 http://www.pharma-marketer.com/vion-pharmaceuticals-receives-response-from-fda-on-special-protocol-assessment-for-onrigintm/ 2010-02-28T01:35:43+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-shire-drug-for-gaucher-disease/ 2010-02-28T01:35:41+00:00 daily 0.8 http://www.pharma-marketer.com/chelsea-therapeutics-to-raise-18-2-million-in-registered-direct-offering/ 2010-02-28T01:35:39+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-covance-add-biotech-drugs-to-research-deal/ 2010-02-28T01:35:36+00:00 daily 0.8 http://www.pharma-marketer.com/stroke-study-finds-neck-stents-safe-effective/ 2010-02-28T01:35:35+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-eyes-smaller-than-alcon-deals-holders-okay-a%c2%80%c2%98say-on-paya%c2%80%c2%99/ 2010-02-28T01:35:34+00:00 daily 0.8 http://www.pharma-marketer.com/boning-up-on-pfizers-drug/ 2010-02-28T01:35:32+00:00 daily 0.8 http://www.pharma-marketer.com/drug-company-cost-cuts-careful-what-you-wish-for/ 2010-02-28T01:35:30+00:00 daily 0.8 http://www.pharma-marketer.com/abbotts-estimates-on-the-rise/ 2010-02-28T01:35:27+00:00 daily 0.8 http://www.pharma-marketer.com/roche-says-avastin-phase-iii-study-shows-positive-results-in-women-with-advanced-ovarian-cancer/ 2010-02-28T01:35:25+00:00 daily 0.8 http://www.pharma-marketer.com/u-s-food-and-drug-administration-approves-caystonr-for-the-improvement-of-respiratory-symptoms-in-cystic-fibrosis-pat/ 2010-02-28T01:35:22+00:00 daily 0.8 http://www.pharma-marketer.com/forest-laboratories-receives-decision-from-fda-for-supplemental-new-drug-application-for-bystolicr/ 2010-02-28T01:35:21+00:00 daily 0.8 http://www.pharma-marketer.com/wuxi-pharma-coo-highlights-planned-growth/ 2010-02-26T22:34:40+00:00 daily 0.8 http://www.pharma-marketer.com/ranbaxy-shares-fall-on-earnings-forecast-fda-issues/ 2010-02-26T22:34:38+00:00 daily 0.8 http://www.pharma-marketer.com/merck-puts-up-its-asset-sale-shingle/ 2010-02-26T22:34:37+00:00 daily 0.8 http://www.pharma-marketer.com/amylin-pharmaceuticals-may-have-a-great-shot/ 2010-02-26T22:34:36+00:00 daily 0.8 http://www.pharma-marketer.com/avanir-pharmaceuticals-warming-up-or-cooling-off/ 2010-02-26T22:34:32+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-stock-mailbag-biosante-pharma/ 2010-02-26T22:34:31+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-loses-bid-to-preempt-paxil-lawsuit/ 2010-02-26T22:34:28+00:00 daily 0.8 http://www.pharma-marketer.com/13-is-pfizers-lucky-number/ 2010-02-26T22:34:26+00:00 daily 0.8 http://www.pharma-marketer.com/what-investors-think-about-immunogen/ 2010-02-26T22:34:25+00:00 daily 0.8 http://www.pharma-marketer.com/fda-staffers-balance-risks-benefits-of-bms-belatacept-4/ 2010-02-26T22:31:27+00:00 daily 0.8 http://www.pharma-marketer.com/arena-gets-1022-pdufa-date-for-lorcaserin/ 2010-02-26T22:14:03+00:00 daily 0.8 http://www.pharma-marketer.com/new-novartis-chief-scouting-for-bolt-on-buyouts/ 2010-02-26T21:46:28+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-bait-and-switch-facebook-pfan-strategy/ 2010-02-26T21:43:24+00:00 daily 0.8 http://www.pharma-marketer.com/rockwell-shares-plunge-after-renal-drug-fails-iib-endpoint/ 2010-02-26T21:32:24+00:00 daily 0.8 http://www.pharma-marketer.com/her2-confusion/ 2010-02-26T21:02:18+00:00 daily 0.8 http://www.pharma-marketer.com/layoff-news/ 2010-02-26T20:55:19+00:00 daily 0.8 http://www.pharma-marketer.com/is-transgene-closing-in-on-a-major-collaboration/ 2010-02-26T20:23:06+00:00 daily 0.8 http://www.pharma-marketer.com/health-summit-promising-start/ 2010-02-26T20:05:53+00:00 daily 0.8 http://www.pharma-marketer.com/thermo-fisher-may-sweeten-offer-for-millipore/ 2010-02-26T19:52:33+00:00 daily 0.8 http://www.pharma-marketer.com/a-top-cardiologist-explains-why-glaxosmithklines-behavior-upsets-him/ 2010-02-26T15:44:43+00:00 daily 0.8 http://www.pharma-marketer.com/wellpoint-rate-hikes-who-do-you-believe/ 2010-02-26T15:42:33+00:00 daily 0.8 http://www.pharma-marketer.com/fda-says-bristol-myers-kidney-transplant-drug-extends-life-but-carries-side-effects/ 2010-02-26T08:25:09+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-experimental-bone-drug-shows-mixed-results-in-study/ 2010-02-26T08:25:08+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-strikes-back-at-drug-critics-but-its-a-big-swing-and-a-miss/ 2010-02-26T08:25:06+00:00 daily 0.8 http://www.pharma-marketer.com/if-drugs-were-like-automobiles/ 2010-02-26T04:36:12+00:00 daily 0.8 http://www.pharma-marketer.com/a-balanced-approach-to-avandia-data/ 2010-02-26T02:50:22+00:00 daily 0.8 http://www.pharma-marketer.com/video-prescription-for-pfizer/ 2010-02-26T00:45:45+00:00 daily 0.8 http://www.pharma-marketer.com/king-pharmaceuticals-4q-profit-misses-expectations/ 2010-02-26T00:45:43+00:00 daily 0.8 http://www.pharma-marketer.com/rochea%c2%80%c2%99s-avastin-drug-stalls-ovarian-cancer-in-study/ 2010-02-26T00:45:42+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-chief-tests-assembly-line-drug-hunt-to-offset-sales-loss/ 2010-02-26T00:45:41+00:00 daily 0.8 http://www.pharma-marketer.com/mylan-reports-4q-profit-on-generic-drug-sales/ 2010-02-26T00:45:40+00:00 daily 0.8 http://www.pharma-marketer.com/shire-gets-fast-track-status-for-replagal-from-fda/ 2010-02-26T00:45:38+00:00 daily 0.8 http://www.pharma-marketer.com/anadys-study-results-show-little-difference-between-hepatitis-c-drug-placebo-shares-slide/ 2010-02-26T00:45:37+00:00 daily 0.8 http://www.pharma-marketer.com/ties-to-glaxo-led-to-favorable-avandia-studies/ 2010-02-26T00:45:14+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-layoffs-coming-in-dribs-and-drabs/ 2010-02-26T00:45:10+00:00 daily 0.8 http://www.pharma-marketer.com/ranbaxy-swings-to-fourth-quarter-net-profit-generic-sales-help/ 2010-02-26T00:45:08+00:00 daily 0.8 http://www.pharma-marketer.com/aveo-pharma-ups-targeted-range-for-ipo/ 2010-02-26T00:45:07+00:00 daily 0.8 http://www.pharma-marketer.com/hgsi-pipeline-bigger-than-earnings/ 2010-02-26T00:44:58+00:00 daily 0.8 http://www.pharma-marketer.com/adolor-narrows-4q-loss-as-entereg-sales-increase/ 2010-02-26T00:44:57+00:00 daily 0.8 http://www.pharma-marketer.com/these-drugs-generated-most-adverse-event-reports/ 2010-02-26T00:44:56+00:00 daily 0.8 http://www.pharma-marketer.com/anadys-shares-sink-as-investors-spot-flaws-in-ph2/ 2010-02-25T23:57:15+00:00 daily 0.8 http://www.pharma-marketer.com/cranking-away/ 2010-02-25T22:48:58+00:00 daily 0.8 http://www.pharma-marketer.com/regulus-wins-150m-hep-c-pact-with-glaxo/ 2010-02-25T21:48:31+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-chief-vows-to-create-lean-mean-drug-making-machine/ 2010-02-25T20:59:47+00:00 daily 0.8 http://www.pharma-marketer.com/fda-nih-partnership-promises-better-science-faster-reviews/ 2010-02-25T20:39:48+00:00 daily 0.8 http://www.pharma-marketer.com/anthera-delays-ipo-and-sends-a-chilling-message/ 2010-02-25T19:59:27+00:00 daily 0.8 http://www.pharma-marketer.com/icahn-pledges-to-fix-whats-broken-at-genzyme/ 2010-02-25T10:23:37+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-a-step-in-the-right-direction/ 2010-02-25T06:49:21+00:00 daily 0.8 http://www.pharma-marketer.com/the-fda-fires-a-warning-shot-at-disease-mongering-drug-companies-maybe/ 2010-02-25T06:49:20+00:00 daily 0.8 http://www.pharma-marketer.com/ftc-loses-pay-for-delay-claim-against-solvay/ 2010-02-25T06:49:17+00:00 daily 0.8 http://www.pharma-marketer.com/osiris-says-stem-cell-therapy-meets-study-goals/ 2010-02-25T06:49:16+00:00 daily 0.8 http://www.pharma-marketer.com/wellpoint-ceo-blames-policy-price-increases-on-doctors-hospitals-and-drug-companies/ 2010-02-25T06:15:25+00:00 daily 0.8 http://www.pharma-marketer.com/progress-for-dynavax-pipeline/ 2010-02-25T00:12:29+00:00 daily 0.8 http://www.pharma-marketer.com/millipore-hires-goldman-sachs-to-assess-alternatives/ 2010-02-25T00:12:27+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-sees-bearish-move/ 2010-02-25T00:12:24+00:00 daily 0.8 http://www.pharma-marketer.com/video-watch-why-one-hospital-restricts-sales-reps/ 2010-02-25T00:12:18+00:00 daily 0.8 http://www.pharma-marketer.com/amylina%c2%80%c2%99s-other-drug-to-watch/ 2010-02-25T00:12:17+00:00 daily 0.8 http://www.pharma-marketer.com/analyst-reiterates-market-perform-on-acorda-says-value-reflects-ampyra-launch-prospect/ 2010-02-25T00:12:15+00:00 daily 0.8 http://www.pharma-marketer.com/why-big-pharmas-15b-international-tax-dodge-is-coming-to-an-end/ 2010-02-25T00:12:13+00:00 daily 0.8 http://www.pharma-marketer.com/is-obama-backing-down-on-biosimilars/ 2010-02-25T00:12:10+00:00 daily 0.8 http://www.pharma-marketer.com/basilea-eases-funding-concerns-with-astellas-deal/ 2010-02-25T00:12:09+00:00 daily 0.8 http://www.pharma-marketer.com/novelos-therapeutics-pivotal-phase-3-lung-cancer-trial-does-not-meet-the-primary-survival-endpoint/ 2010-02-25T00:12:08+00:00 daily 0.8 http://www.pharma-marketer.com/bayer-to-keep-dividend-unchanged-in-a%c2%80%c2%98difficult-environmenta%c2%80%c2%99/ 2010-02-25T00:12:05+00:00 daily 0.8 http://www.pharma-marketer.com/refinancing-charge-saps-talecrisa%c2%80%c2%99-4q-profit/ 2010-02-25T00:12:03+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-says-fda-oks-updated-prevnar-vaccine/ 2010-02-25T00:11:58+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-u-s-report-on-avandia-inaccurate/ 2010-02-25T00:11:56+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-pfizers-new-megablockbuster-vax/ 2010-02-24T23:15:11+00:00 daily 0.8 http://www.pharma-marketer.com/top-20-biotech-venture-capital-deals-of-2009/ 2010-02-24T23:11:47+00:00 daily 0.8 http://www.pharma-marketer.com/francois-martelet-named-ceo-of-topotarget/ 2010-02-24T23:04:16+00:00 daily 0.8 http://www.pharma-marketer.com/icahn-says-hes-ready-to-fix-genzyme/ 2010-02-24T23:00:49+00:00 daily 0.8 http://www.pharma-marketer.com/basilea-lands-510m-co-marketing-pact-with-astellas/ 2010-02-24T22:16:56+00:00 daily 0.8 http://www.pharma-marketer.com/disclosure-does-it-blur-the-facts/ 2010-02-24T22:00:33+00:00 daily 0.8 http://www.pharma-marketer.com/the-lists-that-big-pharma-is-and-isnt-on/ 2010-02-24T21:55:46+00:00 daily 0.8 http://www.pharma-marketer.com/will-fdas-sm-guidance-resemble-suggestions-made-by-industry-group-back-in-october/ 2010-02-24T21:43:05+00:00 daily 0.8 http://www.pharma-marketer.com/salix-wins-fda-panel-backing-on-xifaxan/ 2010-02-24T21:10:27+00:00 daily 0.8 http://www.pharma-marketer.com/novelos-shares-hammered-after-ph3-fiasco/ 2010-02-24T20:52:39+00:00 daily 0.8 http://www.pharma-marketer.com/steve-nissens-meeting-with-gsk/ 2010-02-24T20:31:41+00:00 daily 0.8 http://www.pharma-marketer.com/millipore-says-its-in-play-shares-rocket-on-buyout-rumor/ 2010-02-24T20:21:51+00:00 daily 0.8 http://www.pharma-marketer.com/millipore-confirms-its-in-play-after-shares-rocket-on-rumors/ 2010-02-24T20:21:51+00:00 daily 0.8 http://www.pharma-marketer.com/write-a-book-why-dont-you/ 2010-02-24T19:33:59+00:00 daily 0.8 http://www.pharma-marketer.com/fda-says-hiv-drugs-from-roche-and-abbott-can-be-dangerous-when-used-together/ 2010-02-24T05:57:09+00:00 daily 0.8 http://www.pharma-marketer.com/icahn-to-nominate-four-directors-to-genzyme-board/ 2010-02-24T05:57:08+00:00 daily 0.8 http://www.pharma-marketer.com/jjs-dilemma-marketing-new-drugs-without-cannibalizing-its-lead-product/ 2010-02-24T05:57:06+00:00 daily 0.8 http://www.pharma-marketer.com/generic-drug-approvals-languish-at-fda/ 2010-02-24T02:02:58+00:00 daily 0.8 http://www.pharma-marketer.com/cardiologist-to-glaxo-put-patients-first/ 2010-02-24T02:02:52+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-recommends-single-flu-vaccine/ 2010-02-24T02:02:42+00:00 daily 0.8 http://www.pharma-marketer.com/fda-faces-more-pressure-to-pull-avandia/ 2010-02-24T02:02:36+00:00 daily 0.8 http://www.pharma-marketer.com/is-astrazenecas-crestor-cresting/ 2010-02-24T02:02:30+00:00 daily 0.8 http://www.pharma-marketer.com/double-short-pfizer-and-merck/ 2010-02-24T02:02:26+00:00 daily 0.8 http://www.pharma-marketer.com/a-huge-business-wrapped-up-in-tiny-packages-otc-drugs/ 2010-02-24T02:02:22+00:00 daily 0.8 http://www.pharma-marketer.com/johnson-johnson-spotting-a-good-entry-point/ 2010-02-24T02:02:20+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-must-pay-9-45-million-in-damages-over-prempro/ 2010-02-24T02:02:15+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-settles-tax-dispute-lifts-10-outlook/ 2010-02-24T02:02:13+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-merck-pfizer-starting-not-for-profit-cancer-research-center-in-asia/ 2010-02-24T02:02:11+00:00 daily 0.8 http://www.pharma-marketer.com/diabetes-rivals-lick-chops-over-avandia-setback/ 2010-02-24T02:02:09+00:00 daily 0.8 http://www.pharma-marketer.com/in-vaccines-ma-may-be-the-only-way-to-compete/ 2010-02-24T02:02:08+00:00 daily 0.8 http://www.pharma-marketer.com/the-secret-glaxo-tape-recording-by-steve-nissen/ 2010-02-24T02:02:04+00:00 daily 0.8 http://www.pharma-marketer.com/meet-glaxos-fixer-the-man-who-scuttles-drug-critics-with-one-phone-call/ 2010-02-24T02:02:02+00:00 daily 0.8 http://www.pharma-marketer.com/jj-risperdal-dementia-a-smoking-gun/ 2010-02-24T02:01:59+00:00 daily 0.8 http://www.pharma-marketer.com/gileada%c2%80%c2%99s-inhaled-antibiotic-for-lungs-wins-approval/ 2010-02-24T02:01:57+00:00 daily 0.8 http://www.pharma-marketer.com/avastin-fails-stomach-cancer-trial/ 2010-02-24T02:01:56+00:00 daily 0.8 http://www.pharma-marketer.com/drugmaker-funded-food-accepted-by-half-of-u-s-doctor-programs/ 2010-02-24T02:01:54+00:00 daily 0.8 http://www.pharma-marketer.com/a-tale-of-2-drug-ceos-sepracors-succeeded-enzons-failed-yet-both-are-showered-with-cash/ 2010-02-24T02:01:52+00:00 daily 0.8 http://www.pharma-marketer.com/white-house-tilts-at-barrier-to-cheap-drugs/ 2010-02-24T02:01:47+00:00 daily 0.8 http://www.pharma-marketer.com/thermo-fisher-said-to-make-6-billion-millipore-bid/ 2010-02-24T02:01:35+00:00 daily 0.8 http://www.pharma-marketer.com/medtronic-profit-rises-more-than-analyst-estimates/ 2010-02-24T02:01:31+00:00 daily 0.8 http://www.pharma-marketer.com/the-year-for-biotechs/ 2010-02-24T02:01:29+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-sluggish-roche-falls/ 2010-02-24T02:01:25+00:00 daily 0.8 http://www.pharma-marketer.com/doc-pleads-guilty-in-pfizer-fraud-case/ 2010-02-24T02:01:23+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-venture-arm-inks-200m-deal-with-tiny-viamet/ 2010-02-24T02:01:21+00:00 daily 0.8 http://www.pharma-marketer.com/geez-gsk-find-another-source-of-balanced-commentary/ 2010-02-23T22:10:11+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-giants-create-asian-cancer-rd-group/ 2010-02-23T21:53:36+00:00 daily 0.8 http://www.pharma-marketer.com/cephalon-pays-250m-to-snare-ception-therapeutics/ 2010-02-23T21:24:37+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-wins-fda-approval-of-new-cystic-fibrosis-drug/ 2010-02-23T20:23:35+00:00 daily 0.8 http://www.pharma-marketer.com/salix-braces-for-harsh-panel-review-of-xifaxan/ 2010-02-23T20:12:19+00:00 daily 0.8 http://www.pharma-marketer.com/things-i-wont-work-with-dioxygen-difluoride/ 2010-02-23T20:05:03+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-insiders-predict-showdown-between-termeer-icahn/ 2010-02-23T19:38:46+00:00 daily 0.8 http://www.pharma-marketer.com/is-congress-the-new-fda/ 2010-02-23T19:05:02+00:00 daily 0.8 http://www.pharma-marketer.com/is-the-critical-path-initiative-in-critical-condition-is-the-advancing-regulatory-science-initiative-replacing-the-critical-path/ 2010-02-23T17:24:00+00:00 daily 0.8 http://www.pharma-marketer.com/steve-nissen-to-gsk-and-fda-put-patients-first-its-time-to-pull-avandia-from-the-market/ 2010-02-22T23:29:55+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-avandia-an-example-of-everything-thats-wrong-with-pharma/ 2010-02-22T23:17:41+00:00 daily 0.8 http://www.pharma-marketer.com/a-physicians-perspective-on-recent-avandia-news-2/ 2010-02-22T23:12:09+00:00 daily 0.8 http://www.pharma-marketer.com/anthera-looks-to-raise-70m-with-ipo/ 2010-02-22T23:03:06+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-falls-on-u-s-report-over-avandiaa%c2%80%c2%99s-heart-risk/ 2010-02-22T23:02:29+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-gets-fda-approval-for-menveo/ 2010-02-22T23:02:27+00:00 daily 0.8 http://www.pharma-marketer.com/early-earnings-winners-endo-pharma/ 2010-02-22T23:02:25+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-in-icahns-sights/ 2010-02-22T23:02:04+00:00 daily 0.8 http://www.pharma-marketer.com/maybe-a-merck-drug-swap-with-jj-could-make-its-remicade-headache-go-away/ 2010-02-22T23:01:54+00:00 daily 0.8 http://www.pharma-marketer.com/biosante-says-panel-recommends-drug-trial-to-continue/ 2010-02-22T23:01:52+00:00 daily 0.8 http://www.pharma-marketer.com/valeant-q4-tops-estimates-backs-10-profit-view/ 2010-02-22T23:01:49+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-rejects-conclusions-of-senate-committee-on-finance-staff-report-on-avandia/ 2010-02-22T23:01:46+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-consistently-shared-avandia-data-excepta%c2%80%c2%a6/ 2010-02-22T23:01:43+00:00 daily 0.8 http://www.pharma-marketer.com/does-fda-need-more-power/ 2010-02-22T23:01:39+00:00 daily 0.8 http://www.pharma-marketer.com/wider-q4-loss-for-regeneron/ 2010-02-22T23:01:36+00:00 daily 0.8 http://www.pharma-marketer.com/biotechs-proceed-with-social-media-caution/ 2010-02-22T23:01:35+00:00 daily 0.8 http://www.pharma-marketer.com/jj-returns-drug-rights/ 2010-02-22T23:01:29+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-rise-nominally-glaxo-slides/ 2010-02-22T23:01:27+00:00 daily 0.8 http://www.pharma-marketer.com/ethicon-endo-surgery-hologic-settle-patent-dispute/ 2010-02-22T23:01:25+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-off-2-as-senators-slam-avandia-another-vioxx/ 2010-02-22T23:01:23+00:00 daily 0.8 http://www.pharma-marketer.com/reneuron-raises-7-3m/ 2010-02-22T22:44:25+00:00 daily 0.8 http://www.pharma-marketer.com/biosante-gets-good-news-on-libigel/ 2010-02-22T22:09:15+00:00 daily 0.8 http://www.pharma-marketer.com/was-rigels-1-2b-ra-deal-over-hyped/ 2010-02-22T21:52:42+00:00 daily 0.8 http://www.pharma-marketer.com/the-hunt-is-on-for-next-biogen-ceo/ 2010-02-22T21:30:00+00:00 daily 0.8 http://www.pharma-marketer.com/avandia-off-the-market-or-not/ 2010-02-22T21:07:15+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-gets-menveo-vaccine-approval/ 2010-02-22T21:01:48+00:00 daily 0.8 http://www.pharma-marketer.com/the-front-lines-of-cancer-treatment/ 2010-02-22T20:51:48+00:00 daily 0.8 http://www.pharma-marketer.com/report-icahn-to-launch-bid-for-genzyme-control/ 2010-02-22T20:19:01+00:00 daily 0.8 http://www.pharma-marketer.com/a-snarky-look-at-sneaky-marketing-tactics-pharma-hasnt-avoided/ 2010-02-22T15:40:27+00:00 daily 0.8 http://www.pharma-marketer.com/7-things-i-learned-at-the-epharma-summit-2010/ 2010-02-22T12:32:12+00:00 daily 0.8 http://www.pharma-marketer.com/fda-now-suggesting-treatment-options/ 2010-02-22T04:00:16+00:00 daily 0.8 http://www.pharma-marketer.com/senate-report-glaxo-knew-of-avandia-risks/ 2010-02-22T00:22:50+00:00 daily 0.8 http://www.pharma-marketer.com/theres-a-sea-change-coming/ 2010-02-22T00:22:48+00:00 daily 0.8 http://www.pharma-marketer.com/solvay-operating-result-in-the-fourth-quarter-eur-313-million-clearly-improved-compared-to-last/ 2010-02-22T00:22:46+00:00 daily 0.8 http://www.pharma-marketer.com/nasvax-signs-flu-vaccine-deal-with-novartis/ 2010-02-22T00:22:45+00:00 daily 0.8 http://www.pharma-marketer.com/barclays-raises-teva-target-price/ 2010-02-22T00:22:43+00:00 daily 0.8 http://www.pharma-marketer.com/dendreon-redux/ 2010-02-22T00:22:41+00:00 daily 0.8 http://www.pharma-marketer.com/ddmac-now-interrupting-tv-ad-creatives/ 2010-02-21T21:50:18+00:00 daily 0.8 http://www.pharma-marketer.com/ddmac-now-interpreting-tv-ad-creatives/ 2010-02-21T21:50:18+00:00 daily 0.8 http://www.pharma-marketer.com/ouch-patients-trust-drug-companies-with-their-health-and-their-lives-and-glaxosmithkline-abused-that-trust/ 2010-02-21T15:02:13+00:00 daily 0.8 http://www.pharma-marketer.com/can-pharma-fill-the-hcp-to-patient-social-media-vacuum/ 2010-02-21T14:55:45+00:00 daily 0.8 http://www.pharma-marketer.com/six-million-asthma-patients-wondering-what-to-do-now/ 2010-02-21T14:53:15+00:00 daily 0.8 http://www.pharma-marketer.com/healthcare-legistlation-is-needed-now/ 2010-02-21T14:33:15+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-labs-hikes-quarterly-dividend-by-10/ 2010-02-21T03:10:57+00:00 daily 0.8 http://www.pharma-marketer.com/dhs-extends-genvec-vaccine-contract/ 2010-02-21T03:10:55+00:00 daily 0.8 http://www.pharma-marketer.com/attention-deficit-drug-maker-shire-up-5-on-blow-out-q4-outlook-in-line/ 2010-02-21T03:10:53+00:00 daily 0.8 http://www.pharma-marketer.com/breathe-deep-it-might-not-be-that-bad-fda-and-asthma-drugs/ 2010-02-21T03:10:52+00:00 daily 0.8 http://www.pharma-marketer.com/summary-box-jj-cuts-swiss-partner-mrsa-rights/ 2010-02-21T03:10:51+00:00 daily 0.8 http://www.pharma-marketer.com/pharmas-mega-deals-no-tonic-for-rd/ 2010-02-21T03:10:50+00:00 daily 0.8 http://www.pharma-marketer.com/novavax-says-swine-flu-vaccine-works/ 2010-02-21T03:10:49+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-turn-higher-shire-xenoport-gain/ 2010-02-21T03:10:47+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-drug-okd-for-leukemia-treatment/ 2010-02-21T03:10:45+00:00 daily 0.8 http://www.pharma-marketer.com/la-jolla-pharmaceutical-company-provides-responses-to-frequently-asked-questions-about-merger-vote/ 2010-02-21T03:10:44+00:00 daily 0.8 http://www.pharma-marketer.com/life-technologies-announces-completion-of-1-5-billion-senior-notes-offering/ 2010-02-21T03:10:43+00:00 daily 0.8 http://www.pharma-marketer.com/fda-classifies-proliatm-denosumab-complete-response-submission-and-targets-action-date/ 2010-02-21T03:10:42+00:00 daily 0.8 http://www.pharma-marketer.com/sac-capital-turns-the-tables-on-biovail/ 2010-02-21T03:10:41+00:00 daily 0.8 http://www.pharma-marketer.com/epo-dosage-regime-patentable-even-if-it-is-the-only-novel-feature/ 2010-02-21T03:10:39+00:00 daily 0.8 http://www.pharma-marketer.com/chugai-pharma-to-develop-commercialize-cancer-drug-gdc-0449-in-japan/ 2010-02-21T03:10:37+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-receives-positive-opinions-in-europe-for-tyverba%c2%ae-lapatinib-and-votrienta%c2%84%c2%a2-pazopanib/ 2010-02-21T03:10:35+00:00 daily 0.8 http://www.pharma-marketer.com/controversial-diabetes-drug-avandia-harms-heart-u-s-concludes/ 2010-02-21T03:10:33+00:00 daily 0.8 http://www.pharma-marketer.com/an-eye-on-big-pharma-i-am-feautured-in-nyit-magazine-article/ 2010-02-20T22:28:05+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-that-deserve-a-closer-look/ 2010-02-19T23:45:36+00:00 daily 0.8 http://www.pharma-marketer.com/shire-profit-rises-on-higher-vyvanse-sales/ 2010-02-19T23:45:35+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-reviewing-fda-labelling-proposals/ 2010-02-19T23:45:34+00:00 daily 0.8 http://www.pharma-marketer.com/united-therapeutics-pulls-tyvaso-application/ 2010-02-19T23:45:32+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-tasigna-gets-fda-priority-review/ 2010-02-19T23:45:31+00:00 daily 0.8 http://www.pharma-marketer.com/7-reasons-curis-is-worth-the-risk/ 2010-02-19T23:45:30+00:00 daily 0.8 http://www.pharma-marketer.com/cytrx-puts-its-cancer-pipeline-to-the-test/ 2010-02-19T23:45:28+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-cancer-drugs-given-european-greenlight/ 2010-02-19T23:45:26+00:00 daily 0.8 http://www.pharma-marketer.com/aryx-cuts-staff-explores-future-options/ 2010-02-19T23:45:25+00:00 daily 0.8 http://www.pharma-marketer.com/fda-boasts-about-approvals-of-cancer-drugs/ 2010-02-19T23:45:17+00:00 daily 0.8 http://www.pharma-marketer.com/obama-takes-new-tack-on-healthcare-reform/ 2010-02-19T23:45:15+00:00 daily 0.8 http://www.pharma-marketer.com/new-york-bill-on-gardasil-vaccination-on-hold/ 2010-02-19T23:45:14+00:00 daily 0.8 http://www.pharma-marketer.com/sepracor-merges-and-ceo-adams-jumps-to-inspire/ 2010-02-19T23:45:12+00:00 daily 0.8 http://www.pharma-marketer.com/healthcare-a-focus-for-big-moves-by-icahn/ 2010-02-19T23:45:09+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-slip-shire-climbs-on-earnings-report/ 2010-02-19T23:45:08+00:00 daily 0.8 http://www.pharma-marketer.com/genentech-and-ucsf-to-join-forces-on-drug-development/ 2010-02-19T23:33:51+00:00 daily 0.8 http://www.pharma-marketer.com/shire-ready-to-undercut-cerezyme-price-by-15/ 2010-02-19T22:40:36+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-021910/ 2010-02-19T22:34:06+00:00 daily 0.8 http://www.pharma-marketer.com/two-for-one-sale/ 2010-02-19T22:01:06+00:00 daily 0.8 http://www.pharma-marketer.com/licensing-talks-collapse-at-struggling-aryx-fresh-cuts-follow/ 2010-02-19T21:35:16+00:00 daily 0.8 http://www.pharma-marketer.com/tko-ema-rejects-ph3-ceftobiprole-data-jj-bails/ 2010-02-19T21:19:56+00:00 daily 0.8 http://www.pharma-marketer.com/xenoport-meltdown-triggers-collateral-damage-at-depomed/ 2010-02-19T20:51:41+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-set-to-benefit-from-newest-hiv-drug/ 2010-02-19T09:07:26+00:00 daily 0.8 http://www.pharma-marketer.com/asthma-drugs-get-stiff-new-warnings/ 2010-02-19T09:07:25+00:00 daily 0.8 http://www.pharma-marketer.com/jazz-files-nda-for-fibromyalgia-treatment/ 2010-02-19T09:07:23+00:00 daily 0.8 http://www.pharma-marketer.com/rochea%c2%80%c2%99s-rituxan-gains-u-s-backing-for-new-cancer-use/ 2010-02-19T09:07:21+00:00 daily 0.8 http://www.pharma-marketer.com/at-last-pharma-emarketing-comes-of-age-2/ 2010-02-19T05:28:47+00:00 daily 0.8 http://www.pharma-marketer.com/jj-reportedly-cutting-bonus-targets/ 2010-02-19T00:54:23+00:00 daily 0.8 http://www.pharma-marketer.com/where-are-mercks-cuts-coming-from/ 2010-02-19T00:54:21+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-xenoport-face-additional-fda-questions/ 2010-02-19T00:54:19+00:00 daily 0.8 http://www.pharma-marketer.com/does-india-want-drug-innovation-or-not/ 2010-02-19T00:54:18+00:00 daily 0.8 http://www.pharma-marketer.com/fda-ruling-is-a-relief-for-amgens-anemia-drugs-but-the-storms-not-over-yet/ 2010-02-19T00:54:17+00:00 daily 0.8 http://www.pharma-marketer.com/enzon-beats-estimates/ 2010-02-19T00:54:15+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-gets-manufacturing-rights-for-hemophilia-therapy/ 2010-02-19T00:54:14+00:00 daily 0.8 http://www.pharma-marketer.com/gsks-advair-up-for-dispute-in-germany/ 2010-02-19T00:54:13+00:00 daily 0.8 http://www.pharma-marketer.com/adverse-reaction-to-astrazenecaa%c2%80%c2%99s-rigel-deal-is-justified/ 2010-02-19T00:54:12+00:00 daily 0.8 http://www.pharma-marketer.com/what-investors-think-about-clinical-data/ 2010-02-19T00:54:10+00:00 daily 0.8 http://www.pharma-marketer.com/even-me-too-drugs-get-the-blues/ 2010-02-19T00:54:09+00:00 daily 0.8 http://www.pharma-marketer.com/regeneron-pharma-4q-loss-widens-on-costs/ 2010-02-19T00:54:07+00:00 daily 0.8 http://www.pharma-marketer.com/anatomy-of-the-white-houses-big-pharma-healthcare-deal/ 2010-02-19T00:54:06+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-faces-first-trial-over-seroquel-diabetes-claims/ 2010-02-19T00:53:59+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-commits-e50m-to-academic-rd-alliance-2/ 2010-02-19T00:06:25+00:00 daily 0.8 http://www.pharma-marketer.com/merck-will-gamble-big-on-late-stage-prospects/ 2010-02-19T00:02:22+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-shares-rise-on-hiv-combo-data/ 2010-02-18T23:27:37+00:00 daily 0.8 http://www.pharma-marketer.com/regeneron-eye-therapy-looks-positive-in-ph2/ 2010-02-18T23:21:09+00:00 daily 0.8 http://www.pharma-marketer.com/whos-up-for-a-big-fda-approval-decision-in-the-first-half/ 2010-02-18T22:48:51+00:00 daily 0.8 http://www.pharma-marketer.com/fda-spurns-xenoports-horizant-app/ 2010-02-18T20:03:49+00:00 daily 0.8 http://www.pharma-marketer.com/biology-by-the-numbers/ 2010-02-18T20:02:33+00:00 daily 0.8 http://www.pharma-marketer.com/physicians-dont-advertise-medications-to-treat-mental-illness/ 2010-02-18T18:04:30+00:00 daily 0.8 http://www.pharma-marketer.com/medicines-co-4q-loss-widens-on-charges/ 2010-02-18T11:27:55+00:00 daily 0.8 http://www.pharma-marketer.com/1-24-billion-deal-shares-fall-9-that-makes-sense-rigel/ 2010-02-18T04:39:38+00:00 daily 0.8 http://www.pharma-marketer.com/mercks-marginal-merger-3-5b-in-savings-from-layoffs-that-cost-3-3b/ 2010-02-18T04:39:37+00:00 daily 0.8 http://www.pharma-marketer.com/non-adherence-study-finds-patients-not-filling-rxs-even-among-patients-that-have-serious-health-conditions/ 2010-02-18T04:24:05+00:00 daily 0.8 http://www.pharma-marketer.com/fda-fan-club-launched-on-facebook-2/ 2010-02-18T04:18:42+00:00 daily 0.8 http://www.pharma-marketer.com/become-a-fan-shouldnt-fda-have-a-facebook-page/ 2010-02-18T04:12:47+00:00 daily 0.8 http://www.pharma-marketer.com/genzymes-quarterly-profit-falls-2/ 2010-02-18T01:10:45+00:00 daily 0.8 http://www.pharma-marketer.com/cadence-why-fda-approval-is-imminent-2/ 2010-02-18T01:10:42+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-edge-higher-genzyme-slips-2/ 2010-02-18T01:10:40+00:00 daily 0.8 http://www.pharma-marketer.com/top-10-drugs-from-new-merck-new-pfizer/ 2010-02-18T01:10:37+00:00 daily 0.8 http://www.pharma-marketer.com/merck-announces-cuts-2/ 2010-02-17T23:39:44+00:00 daily 0.8 http://www.pharma-marketer.com/la-jolla-pleads-for-shareholders-to-vote-on-merger/ 2010-02-17T23:24:19+00:00 daily 0.8 http://www.pharma-marketer.com/drug-patents-in-india-2/ 2010-02-17T22:39:08+00:00 daily 0.8 http://www.pharma-marketer.com/jjs-prostate-cancer-drug-proves-promising-in-ph2/ 2010-02-17T22:38:47+00:00 daily 0.8 http://www.pharma-marketer.com/rigel-says-its-nearing-psoriasis-pact/ 2010-02-17T22:15:35+00:00 daily 0.8 http://www.pharma-marketer.com/merck-studies-boost-gardasil-for-new-uses/ 2010-02-17T22:08:49+00:00 daily 0.8 http://www.pharma-marketer.com/cholesterol-cutting-drugs-raise-diabetes-risk-by-9-in-study/ 2010-02-17T22:08:47+00:00 daily 0.8 http://www.pharma-marketer.com/teva-actavis-said-to-be-final-ratiopharm-bidders-as-eqt-exits/ 2010-02-17T22:08:46+00:00 daily 0.8 http://www.pharma-marketer.com/roche-to-pay-25m-over-accutane-and-bowel-disease/ 2010-02-17T22:08:44+00:00 daily 0.8 http://www.pharma-marketer.com/tevaa%c2%80%c2%99s-ms-treatment-copaxone-chalks-up-25-sales-gain/ 2010-02-17T22:08:43+00:00 daily 0.8 http://www.pharma-marketer.com/why-tevas-dip-on-earnings-is-an-opportunity/ 2010-02-17T22:08:41+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-damp-squib-diabetes-drug-onglyza-nets-only-6m-in-q4/ 2010-02-17T22:08:38+00:00 daily 0.8 http://www.pharma-marketer.com/csl-profit-beats-estimates-on-swine-flu-vaccine-sales/ 2010-02-17T22:08:36+00:00 daily 0.8 http://www.pharma-marketer.com/ark-announces-18-5m-settlement-with-eli-lilly/ 2010-02-17T22:08:35+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-pyramid-of-doom-or-how-the-drugmaker-oversold-the-market-for-cholesterol-drugs-by-28-million-americans/ 2010-02-17T22:08:34+00:00 daily 0.8 http://www.pharma-marketer.com/combinatorx-will-have-to-wait-another-week-on-exalgo/ 2010-02-17T21:35:26+00:00 daily 0.8 http://www.pharma-marketer.com/tioga-raises-18m-for-phase-iii-clinical-trial/ 2010-02-17T20:59:31+00:00 daily 0.8 http://www.pharma-marketer.com/vcs-pump-35m-into-protein-based-drug-developer/ 2010-02-17T20:11:06+00:00 daily 0.8 http://www.pharma-marketer.com/a-lesson-why-a-patient-uses-the-internet-for-health-information-in-his-own-words/ 2010-02-17T13:06:10+00:00 daily 0.8 http://www.pharma-marketer.com/weakening-outlook-on-sanofi/ 2010-02-17T07:47:11+00:00 daily 0.8 http://www.pharma-marketer.com/its-the-end-of-days-for-celgenes-multiple-myeloma-drug-franchise/ 2010-02-17T07:47:10+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeutics-still-waiting-on-its-diagnosis/ 2010-02-17T04:22:11+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-gets-a-healthy-shot-with-crestor/ 2010-02-17T04:22:09+00:00 daily 0.8 http://www.pharma-marketer.com/pharmas-walking-the-patent-tightrope/ 2010-02-17T04:22:08+00:00 daily 0.8 http://www.pharma-marketer.com/analysts-effient-wont-be-a-blockbuster/ 2010-02-17T04:22:06+00:00 daily 0.8 http://www.pharma-marketer.com/teva-and-novartis-reach-settlement-on-famvir-suit/ 2010-02-17T04:22:05+00:00 daily 0.8 http://www.pharma-marketer.com/china-biotech-week-in-review/ 2010-02-17T04:22:03+00:00 daily 0.8 http://www.pharma-marketer.com/teva-swings-to-profit-adjusted-net-up-18/ 2010-02-17T04:22:02+00:00 daily 0.8 http://www.pharma-marketer.com/cubist-pharmaceuticals-a-drug-stock-with-potential-for-solid-gain/ 2010-02-17T04:21:57+00:00 daily 0.8 http://www.pharma-marketer.com/3sbio-ascentage-form-alliance-to-develop-cancer-drugs/ 2010-02-17T04:21:56+00:00 daily 0.8 http://www.pharma-marketer.com/boston-scientific-to-cut-up-to-1300-employees-biotechs-weekly-mishaps-report/ 2010-02-17T04:21:55+00:00 daily 0.8 http://www.pharma-marketer.com/fda-delay-leaves-cadence-tapping-feet-once-again/ 2010-02-17T04:21:53+00:00 daily 0.8 http://www.pharma-marketer.com/combinatorx-founder-heads-new-launch/ 2010-02-17T04:21:51+00:00 daily 0.8 http://www.pharma-marketer.com/botox-may-reduce-migraine-headaches-described-as-a%c2%80%c2%98eye-poppinga%c2%80%c2%99/ 2010-02-17T04:21:49+00:00 daily 0.8 http://www.pharma-marketer.com/merck-profit-rises-more-than-analysts-estimated/ 2010-02-17T04:21:48+00:00 daily 0.8 http://www.pharma-marketer.com/fda-asks-amgen-jj-to-discuss-anemia-drug-risks/ 2010-02-17T04:21:47+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-suit-may-open-skeleton-filled-closet-on-side-effects-of-cholesterol-drug-lipitor/ 2010-02-17T04:21:46+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-to-pay-rigel-up-to-1-25-billion-in-arthritis-pact/ 2010-02-17T04:21:43+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-to-increase-headcount-introduce-more-products-in-india/ 2010-02-17T04:21:42+00:00 daily 0.8 http://www.pharma-marketer.com/the-medicines-company-of-parsippany-to-cut-26-of-its-u-s-sales-force/ 2010-02-17T04:21:41+00:00 daily 0.8 http://www.pharma-marketer.com/imclone-founder-waksal-forming-new-biotech-venture/ 2010-02-17T04:21:39+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-completes-acquisition-of-solvay-pharmaceuticals/ 2010-02-17T04:21:38+00:00 daily 0.8 http://www.pharma-marketer.com/quintiles-expands-stake-in-big-pharma/ 2010-02-17T04:21:37+00:00 daily 0.8 http://www.pharma-marketer.com/path-to-surfaxin-approval-looks-less-costly-for-discovery-labs-after-fda-guidance/ 2010-02-17T04:21:35+00:00 daily 0.8 http://www.pharma-marketer.com/affymax-targets-amgen-anemia-drug-aided-by-u-s-rules/ 2010-02-17T04:21:32+00:00 daily 0.8 http://www.pharma-marketer.com/commonly-used-diabetes-drug-metformin-stinks-literally-and-this-may-explain-why-many-patients-stop-taking-it-u-s-doc/ 2010-02-17T04:21:30+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-aims-its-brands-at-emerging-markets/ 2010-02-17T04:21:29+00:00 daily 0.8 http://www.pharma-marketer.com/merck-to-slash-15-of-workforce-save-up-to-3b-cbl/ 2010-02-17T04:21:28+00:00 daily 0.8 http://www.pharma-marketer.com/a-big-upgrade-for-vical/ 2010-02-17T04:21:26+00:00 daily 0.8 http://www.pharma-marketer.com/rigel-investors-balk-at-astrazeneca-deal/ 2010-02-17T04:21:25+00:00 daily 0.8 http://www.pharma-marketer.com/imclone-scandal-a-timeline/ 2010-02-17T04:21:24+00:00 daily 0.8 http://www.pharma-marketer.com/for-blockbuster-cancer-drugs-approvals-are-the-easy-part/ 2010-02-17T04:21:22+00:00 daily 0.8 http://www.pharma-marketer.com/hugues-lecat-tapped-as-chair-ceo-of-ethypharm/ 2010-02-17T04:15:06+00:00 daily 0.8 http://www.pharma-marketer.com/thallion-inks-130m-licensing-deal-with-lfb/ 2010-02-16T23:54:46+00:00 daily 0.8 http://www.pharma-marketer.com/surfaxin-approval-will-hinge-on-preclinical-work/ 2010-02-16T23:28:04+00:00 daily 0.8 http://www.pharma-marketer.com/mpm-rounds-up-140m-for-new-biotech-venture-fund/ 2010-02-16T23:16:48+00:00 daily 0.8 http://www.pharma-marketer.com/xmrv-and-chronic-fatigue-syndrome-more-negative-data/ 2010-02-16T22:53:21+00:00 daily 0.8 http://www.pharma-marketer.com/waksals-back-raising-50m-for-new-biotech-venture/ 2010-02-16T22:08:42+00:00 daily 0.8 http://www.pharma-marketer.com/marketers-what-would-jake-and-rocket-do-13-imperatives-for-2010-part-3-of-4/ 2010-02-16T22:07:01+00:00 daily 0.8 http://www.pharma-marketer.com/marketers-what-would-google-do-ten-imperatives-for-2010-part-2-of-4/ 2010-02-16T22:06:30+00:00 daily 0.8 http://www.pharma-marketer.com/new-article-what-would-steve-jobs-do-six-marketing-imperatives-for-2010-part-1-of-4/ 2010-02-16T22:05:19+00:00 daily 0.8 http://www.pharma-marketer.com/what-is-preventing-pharma-from-going-digital/ 2010-02-16T22:04:11+00:00 daily 0.8 http://www.pharma-marketer.com/2010-outlook-10-ways-to-win-with-patients-and-improve-dtc-efforts/ 2010-02-16T21:57:27+00:00 daily 0.8 http://www.pharma-marketer.com/affymax-readies-blockbuster-alternative-to-epogen/ 2010-02-16T21:53:59+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-and-the-health-care-bill-value-for-the-money/ 2010-02-16T21:23:15+00:00 daily 0.8 http://www.pharma-marketer.com/rigel-scores-blockbuster-1-24b-pact-with-astrazeneca/ 2010-02-16T19:42:06+00:00 daily 0.8 http://www.pharma-marketer.com/picking-up-industrial-hires/ 2010-02-16T19:35:56+00:00 daily 0.8 http://www.pharma-marketer.com/twitter-and-science-revisited/ 2010-02-16T19:29:48+00:00 daily 0.8 http://www.pharma-marketer.com/mccain-moves-to-give-fda-more-authority-over-supplements/ 2010-02-16T17:45:00+00:00 daily 0.8 http://www.pharma-marketer.com/allergans-eye-popping-migraine-botox-study-freedom-of-expression-or-off-label-promo-tool/ 2010-02-16T04:02:50+00:00 daily 0.8 http://www.pharma-marketer.com/rozerem-really-bad-marketing/ 2010-02-16T01:37:56+00:00 daily 0.8 http://www.pharma-marketer.com/hot-u-s-attorney-action-in-drug-misbranding-device-sales-and-supplement-frauds/ 2010-02-15T17:52:00+00:00 daily 0.8 http://www.pharma-marketer.com/ask-our-experts/ 2010-02-15T14:54:54+00:00 weekly 0.6 http://www.pharma-marketer.com/i-could-have-been-a-blockbuster/ 2010-02-15T13:33:32+00:00 daily 0.8 http://www.pharma-marketer.com/phrma-intern-finds-replacement-for-billy-tauzin/ 2010-02-15T13:27:06+00:00 daily 0.8 http://www.pharma-marketer.com/sally-church-sales-hcp-expert/ 2010-02-15T12:15:04+00:00 weekly 0.6 http://www.pharma-marketer.com/john-mack-pharma-marketing-expert/ 2010-02-15T12:14:59+00:00 weekly 0.6 http://www.pharma-marketer.com/jim-dayton-new-media-expert/ 2010-02-15T12:14:51+00:00 weekly 0.6 http://www.pharma-marketer.com/alex-savic-ehealth-expert/ 2010-02-15T12:04:13+00:00 weekly 0.6 http://www.pharma-marketer.com/curis-lands-8m-as-cancer-drug-trial-advances/ 2010-02-14T01:12:42+00:00 daily 0.8 http://www.pharma-marketer.com/zymogenetics-beats-by-a-penny/ 2010-02-14T01:12:40+00:00 daily 0.8 http://www.pharma-marketer.com/theravance-misses-estimates/ 2010-02-14T01:12:39+00:00 daily 0.8 http://www.pharma-marketer.com/martek-closes-on-purchase-of-amerifit-brands-inc/ 2010-02-14T01:12:38+00:00 daily 0.8 http://www.pharma-marketer.com/anacor-merck-returns-fungal-infection-drug-rights/ 2010-02-14T01:12:37+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-diverge-astrazeneca-declines/ 2010-02-14T01:12:36+00:00 daily 0.8 http://www.pharma-marketer.com/alcon-profit-rises-as-novartis-takeover-looms/ 2010-02-14T01:12:34+00:00 daily 0.8 http://www.pharma-marketer.com/dont-ignore-this-potential-blockbuster-taspoglutide-roche/ 2010-02-14T01:12:33+00:00 daily 0.8 http://www.pharma-marketer.com/drug-industry-signals-lobbying-shift/ 2010-02-14T01:12:32+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-pressured-as-its-first-new-drug-in-4-years-falters/ 2010-02-14T01:12:30+00:00 daily 0.8 http://www.pharma-marketer.com/as-labopharm-prepares-for-oleptro-launch-it-seeks-20m/ 2010-02-14T01:12:26+00:00 daily 0.8 http://www.pharma-marketer.com/gardens-drug-start-up-finds-success-in-canada-with-safe-dosing-device/ 2010-02-14T01:12:25+00:00 daily 0.8 http://www.pharma-marketer.com/perrigo-wins-patent-suit-on-mucinex/ 2010-02-14T01:12:23+00:00 daily 0.8 http://www.pharma-marketer.com/us-patent-for-avanir-pharmas-low-dose-quinidine-formulations-of-zeniva/ 2010-02-14T01:12:20+00:00 daily 0.8 http://www.pharma-marketer.com/data-monitoring-committee-recommends-continuation-of-phase-iii-study-of-stemexr-a-cord-blood-stem-cell-product-for-l/ 2010-02-14T01:12:18+00:00 daily 0.8 http://www.pharma-marketer.com/circassia-achieves-positive-phase-ii-clinical-results-with-ragweed-allergy-t-cell-vaccine/ 2010-02-14T01:12:17+00:00 daily 0.8 http://www.pharma-marketer.com/qiagen-and-celera-establish-distribution-agreement-for-respiratory-pathogen-panel/ 2010-02-14T01:12:15+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-reassures-investors-on-earnings/ 2010-02-14T01:12:14+00:00 daily 0.8 http://www.pharma-marketer.com/takeda-announced-today-that-it-has-initiated-a-trial-to-study-how-dexlansoprazole-and-several-other-proton-pump-inhibito/ 2010-02-14T01:12:12+00:00 daily 0.8 http://www.pharma-marketer.com/drug-industry-gambled-on-health-reform-and-lost/ 2010-02-13T02:00:23+00:00 daily 0.8 http://www.pharma-marketer.com/more-vintage-ads-just-for-fun/ 2010-02-13T00:58:56+00:00 daily 0.8 http://www.pharma-marketer.com/who-follows-these-things/ 2010-02-13T00:08:43+00:00 daily 0.8 http://www.pharma-marketer.com/publishing-holiday-for-presidents-day/ 2010-02-12T23:27:29+00:00 daily 0.8 http://www.pharma-marketer.com/medicines-co-cuts-staff-again/ 2010-02-12T22:34:52+00:00 daily 0.8 http://www.pharma-marketer.com/investors-are-sick-of-boston-scientific/ 2010-02-12T22:29:33+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-gets-approval-for-new-formula-of-hiv-drug/ 2010-02-12T22:29:32+00:00 daily 0.8 http://www.pharma-marketer.com/drugmaker-deal-negotiator-tauzin-to-step-down-from-trade-group/ 2010-02-12T22:29:31+00:00 daily 0.8 http://www.pharma-marketer.com/cephalon-fourth-quarter-profit-jumps-to-96-6-mln/ 2010-02-12T22:29:30+00:00 daily 0.8 http://www.pharma-marketer.com/simcere-wins-ok-for-flu-drug-relenza/ 2010-02-12T22:29:29+00:00 daily 0.8 http://www.pharma-marketer.com/roche-moleculor-diagnostics-unit-sues-qiagen-unit/ 2010-02-12T22:29:27+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-says-a%c2%80%c2%98dona%c2%80%c2%99t-judgea%c2%80%c2%99-earnings-for-payoff/ 2010-02-12T22:29:26+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-stock-mailbag-nexmed/ 2010-02-12T22:29:24+00:00 daily 0.8 http://www.pharma-marketer.com/call-selling-in-vanda-pharma/ 2010-02-12T22:29:22+00:00 daily 0.8 http://www.pharma-marketer.com/china-amends-patent-law-for-compulsory-licensing/ 2010-02-12T22:29:21+00:00 daily 0.8 http://www.pharma-marketer.com/former-schering-ceo-hassan-sees-more-deals-among-drugmakers/ 2010-02-12T22:29:20+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-rivals-unleash-barrage-of-promising-gaucher-data/ 2010-02-12T22:29:18+00:00 daily 0.8 http://www.pharma-marketer.com/curis-gets-8m-milestone-from-debiopharm/ 2010-02-12T22:26:19+00:00 daily 0.8 http://www.pharma-marketer.com/melnyk-contemplates-ipo-for-trimel/ 2010-02-12T21:24:44+00:00 daily 0.8 http://www.pharma-marketer.com/anacor-regains-anti-fungal-drug-rights-from-merck/ 2010-02-12T21:12:32+00:00 daily 0.8 http://www.pharma-marketer.com/prevention-and-cost-control/ 2010-02-12T20:54:52+00:00 daily 0.8 http://www.pharma-marketer.com/slu-hires-laid-off-pfizerites-for-research-center/ 2010-02-12T20:15:51+00:00 daily 0.8 http://www.pharma-marketer.com/2-7-billion-profit-in-last-quarter-and-wellpoint-hikes-rates-38/ 2010-02-12T14:02:16+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-gets-european-clearance-for-solvay-deal/ 2010-02-12T07:33:29+00:00 daily 0.8 http://www.pharma-marketer.com/sanofis-sleight-of-hand/ 2010-02-12T07:33:27+00:00 daily 0.8 http://www.pharma-marketer.com/no-generics-push-for-az-brennan-says/ 2010-02-12T07:33:26+00:00 daily 0.8 http://www.pharma-marketer.com/safety-concerns-continue-to-dog-isis-genzyme-partnership/ 2010-02-12T07:33:25+00:00 daily 0.8 http://www.pharma-marketer.com/fda-puts-cadence-pain-drug-app-on-hold/ 2010-02-11T23:53:42+00:00 daily 0.8 http://www.pharma-marketer.com/is-it-time-to-ditch-tradional-media-for-all-dtc/ 2010-02-11T23:46:39+00:00 daily 0.8 http://www.pharma-marketer.com/oxigene-axes-half-its-staff-halts-enrollment-in-restructuring-3/ 2010-02-11T23:43:17+00:00 daily 0.8 http://www.pharma-marketer.com/rochea%c2%80%c2%99s-diabetes-drug-meets-goals-in-five-studies/ 2010-02-11T23:31:37+00:00 daily 0.8 http://www.pharma-marketer.com/boston-scientific-to-restructure-cut-1000-jobs/ 2010-02-11T23:31:36+00:00 daily 0.8 http://www.pharma-marketer.com/cel-sci-cancer-drug-claims-crumble-part-1/ 2010-02-11T23:31:35+00:00 daily 0.8 http://www.pharma-marketer.com/cel-sci-cancer-drug-claims-crumble-part-2/ 2010-02-11T23:31:33+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-says-heart-drug-multaq-is-on-track-numbers-suggest-its-derailed/ 2010-02-11T23:31:32+00:00 daily 0.8 http://www.pharma-marketer.com/and-the-future-for-pharma-looks-likea%c2%80%c2%a6/ 2010-02-11T23:31:29+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-salary-freeze-affects-only-6-of-ceos-total-pay/ 2010-02-11T23:31:28+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-touts-2-year-results-for-oral-gaucher-drug-5/ 2010-02-11T23:23:18+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-cuts-back/ 2010-02-11T23:00:23+00:00 daily 0.8 http://www.pharma-marketer.com/ex-combinatorx-ceo-gets-back-to-start-up-mode/ 2010-02-11T22:29:16+00:00 daily 0.8 http://www.pharma-marketer.com/somnus-reaps-15m-in-vc-cash-for-ph2-sleep-drug/ 2010-02-11T21:59:17+00:00 daily 0.8 http://www.pharma-marketer.com/another-new-med-chem-journal/ 2010-02-11T20:42:22+00:00 daily 0.8 http://www.pharma-marketer.com/roche-diabetes-drug-performs-like-a-blockbuster-in-ph3/ 2010-02-11T19:33:33+00:00 daily 0.8 http://www.pharma-marketer.com/waiting-for-goduidance/ 2010-02-11T15:48:50+00:00 daily 0.8 http://www.pharma-marketer.com/vioxx-lawsuits-whata%c2%80%c2%99s-been-settled-whata%c2%80%c2%99s-still-going/ 2010-02-11T09:34:26+00:00 daily 0.8 http://www.pharma-marketer.com/boston-scientific-narrows-loss-on-higher-sales/ 2010-02-11T09:34:25+00:00 daily 0.8 http://www.pharma-marketer.com/investors-give-isis-the-cold-shoulder/ 2010-02-11T09:34:23+00:00 daily 0.8 http://www.pharma-marketer.com/fast-growing-generics-ripe-for-consolidation/ 2010-02-11T09:34:22+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-dip-isis-tumbles-on-drug-data/ 2010-02-11T02:19:59+00:00 daily 0.8 http://www.pharma-marketer.com/boehringer-to-buy-japanese-consumer-drug-producer-ssp/ 2010-02-11T02:19:56+00:00 daily 0.8 http://www.pharma-marketer.com/medicare-pay-cuts-to-doctors-the-latest-patch/ 2010-02-11T02:19:54+00:00 daily 0.8 http://www.pharma-marketer.com/icahns-smiling-should-we-be/ 2010-02-11T02:19:50+00:00 daily 0.8 http://www.pharma-marketer.com/rexahn-the-undiscovered-biotech/ 2010-02-11T02:19:48+00:00 daily 0.8 http://www.pharma-marketer.com/the-art-of-the-deal-sanofi-style/ 2010-02-11T02:19:43+00:00 daily 0.8 http://www.pharma-marketer.com/im-not-the-only-one-to-suggest-corporate-donation-to-haiti-relief-is-lagging/ 2010-02-11T00:28:19+00:00 daily 0.8 http://www.pharma-marketer.com/where-would-you-start-a-company/ 2010-02-11T00:23:45+00:00 daily 0.8 http://www.pharma-marketer.com/chemical-supplier-question/ 2010-02-11T00:09:52+00:00 daily 0.8 http://www.pharma-marketer.com/manhattan-research-internet-rules-for-dtc-marketing-duh/ 2010-02-10T23:52:53+00:00 daily 0.8 http://www.pharma-marketer.com/ricerca-shells-out-45m-for-mds-early-stage-ops/ 2010-02-10T23:29:03+00:00 daily 0.8 http://www.pharma-marketer.com/adeona-taps-james-kuo-as-ceo-chairman-and-president/ 2010-02-10T23:27:03+00:00 daily 0.8 http://www.pharma-marketer.com/alexza-scores-130m-pact-for-agitation-therapy/ 2010-02-10T22:51:21+00:00 daily 0.8 http://www.pharma-marketer.com/isis-hits-ph3-endpoint-but-shares-slide-on-liver-worries/ 2010-02-10T22:39:07+00:00 daily 0.8 http://www.pharma-marketer.com/ceos-turn-out-in-ny-to-talk-up-new-deals-for-a-new-year/ 2010-02-10T22:16:14+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-q4-profit-up-on-swine-flu-vaccines/ 2010-02-10T22:05:20+00:00 daily 0.8 http://www.pharma-marketer.com/cel-sci-drops-mystery-partner/ 2010-02-10T22:05:18+00:00 daily 0.8 http://www.pharma-marketer.com/merck-to-change-safety-procedures-pay-fees-to-end-vioxx-suits/ 2010-02-10T22:05:12+00:00 daily 0.8 http://www.pharma-marketer.com/elan-expects-rare-operating-profit-in-2010/ 2010-02-10T22:05:08+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-gets-more-good-data-with-bone-drug-prolia-but-other-risks-await/ 2010-02-10T22:05:07+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-isis-report-positive-study-on-heart-drug/ 2010-02-10T22:05:03+00:00 daily 0.8 http://www.pharma-marketer.com/alexza-biovail-to-commercialize-psychiatric-drug/ 2010-02-10T22:05:02+00:00 daily 0.8 http://www.pharma-marketer.com/reneuron-okd-for-worlds-first-stem-cell-trial-for-strokes/ 2010-02-10T21:05:51+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-chops-into-rd-budget-drops-cancer-drug/ 2010-02-10T20:36:00+00:00 daily 0.8 http://www.pharma-marketer.com/botox-curbs-emotions-study-says-and-now-allergan-is-marketing-it-to-men/ 2010-02-10T10:24:03+00:00 daily 0.8 http://www.pharma-marketer.com/fda-agreements-should-be-public/ 2010-02-10T10:23:59+00:00 daily 0.8 http://www.pharma-marketer.com/ista-forecasts-first-annual-profit-in-2010/ 2010-02-10T10:23:57+00:00 daily 0.8 http://www.pharma-marketer.com/ligand-posts-4q-profit-as-charge-comes-off-books/ 2010-02-10T10:23:55+00:00 daily 0.8 http://www.pharma-marketer.com/seattle-genetics-4q-loss-narrows-on-higher-revenue/ 2010-02-10T10:23:53+00:00 daily 0.8 http://www.pharma-marketer.com/uk-court-overturns-gsk-patent-for-lupus-drug/ 2010-02-10T10:23:51+00:00 daily 0.8 http://www.pharma-marketer.com/mobile-applications-from-sanofi/ 2010-02-10T02:14:13+00:00 daily 0.8 http://www.pharma-marketer.com/social-media-tools-and-strategy-a-webinar-coming-up/ 2010-02-10T02:07:08+00:00 daily 0.8 http://www.pharma-marketer.com/once-again-a-lot-of-duh-at-epharma-summit/ 2010-02-10T02:06:19+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-tops-novartis-at-reducing-fractures-in-prostate-patients/ 2010-02-10T02:04:53+00:00 daily 0.8 http://www.pharma-marketer.com/bmss-information-security-department-has-spyware-for-employee-laptops/ 2010-02-10T02:04:51+00:00 daily 0.8 http://www.pharma-marketer.com/paxil-linked-to-deaths-in-breast-cancer-patients/ 2010-02-10T02:04:48+00:00 daily 0.8 http://www.pharma-marketer.com/videoorexigen-ceo-talks-obesity/ 2010-02-10T02:04:42+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeuticsa%c2%80%c2%99-last-hope-for-survival-dashed/ 2010-02-10T02:04:41+00:00 daily 0.8 http://www.pharma-marketer.com/fujifilm-aims-for-japanese-generics-market/ 2010-02-10T02:04:36+00:00 daily 0.8 http://www.pharma-marketer.com/adoption-of-cerus-technology-makes-its-valuation-look-ridiculous/ 2010-02-10T02:04:35+00:00 daily 0.8 http://www.pharma-marketer.com/sequenom-licenses-rights-to-potential-test/ 2010-02-10T02:04:34+00:00 daily 0.8 http://www.pharma-marketer.com/2010-fda-approvals-could-lead-to-launch-of-eight-new-biotech-blockbusters/ 2010-02-10T02:04:32+00:00 daily 0.8 http://www.pharma-marketer.com/chemgenex-shares-dive-on-fdas-leukemia-drug-critique/ 2010-02-10T00:25:58+00:00 daily 0.8 http://www.pharma-marketer.com/medivations-dimebon-turns-in-promising-results-for-huntingtons/ 2010-02-09T23:59:11+00:00 daily 0.8 http://www.pharma-marketer.com/crucell-plots-major-boost-in-rd-spending/ 2010-02-09T23:45:44+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-denosumab-demonstrates-superiority-over-zometa/ 2010-02-09T23:17:54+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-lays-plans-to-pink-slip-rd-workers/ 2010-02-09T22:49:24+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-ceoa%c2%80%c2%99s-2009-compensation-totaled-16-4-million/ 2010-02-09T22:36:52+00:00 daily 0.8 http://www.pharma-marketer.com/alkermes-retains-neutral-rec/ 2010-02-09T22:36:50+00:00 daily 0.8 http://www.pharma-marketer.com/a-win-for-crestor-astrazeneca/ 2010-02-09T22:36:46+00:00 daily 0.8 http://www.pharma-marketer.com/dynavax-starts-hepatitis-b-trial/ 2010-02-09T22:36:45+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-fourth-quarter-profit-rises-on-tysabri-sales/ 2010-02-09T22:36:40+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-licenses-hep-c-drug-from-debiopharm/ 2010-02-09T22:22:44+00:00 daily 0.8 http://www.pharma-marketer.com/acknowledge-how-americans-trust-has-been-lost-and-take-the-first-steps-to-earn-it-back/ 2010-02-09T21:02:35+00:00 daily 0.8 http://www.pharma-marketer.com/more-on-pharmas-ugly-finances/ 2010-02-09T20:44:55+00:00 daily 0.8 http://www.pharma-marketer.com/bio-chief-maps-salvage-plan-for-the-12-year-umbrella/ 2010-02-09T20:18:39+00:00 daily 0.8 http://www.pharma-marketer.com/are-the-people-at-astra-zenica-that-clueless/ 2010-02-09T13:16:39+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-submits-new-automated-ovarian-cancer-test-for-u-s-approval/ 2010-02-09T03:24:19+00:00 daily 0.8 http://www.pharma-marketer.com/4-winning-biotechs-for-your-portfolio-senior-analyst/ 2010-02-09T03:24:17+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-rare-diseases-now-big-business/ 2010-02-09T03:24:15+00:00 daily 0.8 http://www.pharma-marketer.com/fda-raises-concerns-about-cell-therapeutics-cancer-drug/ 2010-02-09T03:24:13+00:00 daily 0.8 http://www.pharma-marketer.com/video-is-biotech-back/ 2010-02-09T03:24:12+00:00 daily 0.8 http://www.pharma-marketer.com/fda-ad-division-objects-to-user-friendly-efficacy-claims-with-jargon/ 2010-02-09T02:30:28+00:00 daily 0.8 http://www.pharma-marketer.com/together-at-last/ 2010-02-09T00:55:32+00:00 daily 0.8 http://www.pharma-marketer.com/fda-blasts-lillys-pah-ecommunity-videos/ 2010-02-09T00:18:07+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-launches-e-payment-system/ 2010-02-09T00:12:01+00:00 daily 0.8 http://www.pharma-marketer.com/large-pharma-and-small-biotech-deals-expected-to-increase-in-2010/ 2010-02-09T00:11:54+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-to-decide-soon-on-reviving-merck-venture/ 2010-02-09T00:11:51+00:00 daily 0.8 http://www.pharma-marketer.com/lillys-cialis-meets-with-success-challenges/ 2010-02-09T00:11:50+00:00 daily 0.8 http://www.pharma-marketer.com/novavax-rovi-end-flu-vaccine-development-plan/ 2010-02-09T00:11:48+00:00 daily 0.8 http://www.pharma-marketer.com/eventful-year-expected-for-access-pharma/ 2010-02-09T00:11:47+00:00 daily 0.8 http://www.pharma-marketer.com/broker-comments-lift-pharma-stocks/ 2010-02-09T00:11:46+00:00 daily 0.8 http://www.pharma-marketer.com/sciclone-drug-sustains-swine-flu-shot-in-study/ 2010-02-09T00:11:44+00:00 daily 0.8 http://www.pharma-marketer.com/eu-approval-for-mercks-elonva/ 2010-02-09T00:11:42+00:00 daily 0.8 http://www.pharma-marketer.com/vermont-mulls-free-sample-disclosure-rule/ 2010-02-09T00:11:41+00:00 daily 0.8 http://www.pharma-marketer.com/teva-active-extend-pact-on-oral-ms-therapy/ 2010-02-09T00:11:36+00:00 daily 0.8 http://www.pharma-marketer.com/is-the-sec-probing-trading-in-dendreon/ 2010-02-09T00:11:32+00:00 daily 0.8 http://www.pharma-marketer.com/novavax-rovi-end-talks-over-flu-vax/ 2010-02-08T23:32:11+00:00 daily 0.8 http://www.pharma-marketer.com/senate-provision-could-benefit-industry/ 2010-02-08T23:09:28+00:00 daily 0.8 http://www.pharma-marketer.com/senate-provision-could-benefit-biotech-industry/ 2010-02-08T23:09:28+00:00 daily 0.8 http://www.pharma-marketer.com/fda-questions-cell-therapeutics-pixantrone/ 2010-02-08T22:56:34+00:00 daily 0.8 http://www.pharma-marketer.com/the-quality-of-online-health-information/ 2010-02-08T22:56:15+00:00 daily 0.8 http://www.pharma-marketer.com/a-few-pharma-companies-speak-to-fda-social-media-docket/ 2010-02-08T22:53:05+00:00 daily 0.8 http://www.pharma-marketer.com/hallelujah-the-recession-is-over-sales-of-lifestyle-drugs-like-botox-cialis-on-the-rebound/ 2010-02-08T22:52:18+00:00 daily 0.8 http://www.pharma-marketer.com/solace-shutters-boston-based-office/ 2010-02-08T21:29:40+00:00 daily 0.8 http://www.pharma-marketer.com/polluting-the-literature-with-pains/ 2010-02-08T20:41:34+00:00 daily 0.8 http://www.pharma-marketer.com/incomplete-plant-inspections-prevent-zuplenz-approval/ 2010-02-08T19:59:07+00:00 daily 0.8 http://www.pharma-marketer.com/optimer-trial-results-lead-to-takeover-talks/ 2010-02-08T19:51:18+00:00 daily 0.8 http://www.pharma-marketer.com/bioheart-launches-first-us-fda-approved-clinical-trial-that-tests-gene-modified-stem-cell-therapy-in-patients-with-conge/ 2010-02-08T03:20:01+00:00 daily 0.8 http://www.pharma-marketer.com/avi-biopharmas-drug-candidate-avi-5038-receives-european-orphan-drug-designation-for-duchenne-muscular-dystrophy/ 2010-02-08T03:20:00+00:00 daily 0.8 http://www.pharma-marketer.com/teva-allocates-315m-for-medicaid-settlement/ 2010-02-08T03:19:54+00:00 daily 0.8 http://www.pharma-marketer.com/how-big-pharma-got-in-this-fix/ 2010-02-08T03:19:51+00:00 daily 0.8 http://www.pharma-marketer.com/one-in-five-physicians-interested-in-ipad/ 2010-02-07T14:58:08+00:00 daily 0.8 http://www.pharma-marketer.com/optimer-pharma-rises-on-fidaxomicin-study-data-5/ 2010-02-07T02:43:10+00:00 daily 0.8 http://www.pharma-marketer.com/fda-orders-stronger-label-for-tysabri-3/ 2010-02-07T02:43:05+00:00 daily 0.8 http://www.pharma-marketer.com/talecris-biotherapeutics-receives-orphan-drug-designation-for-aerosolized-alpha1-proteinase-inhibitor-to-treat-alpha1-an/ 2010-02-07T02:43:03+00:00 daily 0.8 http://www.pharma-marketer.com/inhibitex-regains-compliance-with-nasdaq-listing-requirements/ 2010-02-07T02:43:01+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-fall-alkermes-rallies-on-upgrade-2/ 2010-02-07T02:43:00+00:00 daily 0.8 http://www.pharma-marketer.com/fda-clears-drug-chief-of-conflict-2/ 2010-02-07T02:42:58+00:00 daily 0.8 http://www.pharma-marketer.com/fda-decision-due-on-wider-use-of-crestor/ 2010-02-07T02:42:55+00:00 daily 0.8 http://www.pharma-marketer.com/keryx-biopharmaceuticals-nasdaq-kerx-responds-to-erroneous-report-about-planned-phase-iii-study-for-patients-with-col-2/ 2010-02-07T02:42:53+00:00 daily 0.8 http://www.pharma-marketer.com/how-generic-medications-can-put-patients-at-risk-3/ 2010-02-07T02:42:51+00:00 daily 0.8 http://www.pharma-marketer.com/ag-questions-drug-firms-use-of-free-samples-2/ 2010-02-07T02:42:49+00:00 daily 0.8 http://www.pharma-marketer.com/lannett-to-submit-nda-for-morphine-sulfate-products-3/ 2010-02-07T02:42:47+00:00 daily 0.8 http://www.pharma-marketer.com/qiagen-unit-and-pfizer-enter-into-an-agreement-to-develop-a-companion-diagnostic-for-brain-tumor-patients-2/ 2010-02-07T02:42:44+00:00 daily 0.8 http://www.pharma-marketer.com/radient-pharmaceuticals-announces-onko-sure-in-vitro-diagnostic-cancer-test-sales-for-q1-2010-on-track-2/ 2010-02-07T02:42:43+00:00 daily 0.8 http://www.pharma-marketer.com/tevaa%c2%80%c2%99s-needle-free-tjeta%c2%ae-device-takes-a-kid-friendly-approach-to-growth-hormone-deficiency-treatment-2/ 2010-02-07T02:42:41+00:00 daily 0.8 http://www.pharma-marketer.com/killing-research-no-certain-cure-for-big-pharma/ 2010-02-07T02:42:39+00:00 daily 0.8 http://www.pharma-marketer.com/time-to-embrace-change-not-fight-it/ 2010-02-06T16:43:22+00:00 daily 0.8 http://www.pharma-marketer.com/a-more-vigilant-fda/ 2010-02-06T16:39:41+00:00 daily 0.8 http://www.pharma-marketer.com/danica-patrick-nascar-driver-super-model-superbowl-lingerie-ad-model-copd-spokesperson-all-rolled-into-one/ 2010-02-06T16:37:28+00:00 daily 0.8 http://www.pharma-marketer.com/novo-reps-train-for-victoza-launch/ 2010-02-06T03:49:08+00:00 daily 0.8 http://www.pharma-marketer.com/experts-predict-biotech-doom-with-loss-of-gene-patents/ 2010-02-06T03:49:07+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-020510/ 2010-02-05T23:59:12+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-growth-proves-drugmaker-made-right-moves/ 2010-02-05T23:44:37+00:00 daily 0.8 http://www.pharma-marketer.com/stalled-health-care-bill-leaves-drug-makers-in-regulatory-limbo/ 2010-02-05T23:44:35+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-and-novartis-looking-good/ 2010-02-05T23:44:32+00:00 daily 0.8 http://www.pharma-marketer.com/allergana%c2%80%c2%99s-looking-real-pretty-right-now/ 2010-02-05T23:44:31+00:00 daily 0.8 http://www.pharma-marketer.com/ranbaxy-drops-on-report-u-s-fda-sent-letter-on-manufacturing/ 2010-02-05T23:44:28+00:00 daily 0.8 http://www.pharma-marketer.com/cvs-may-get-earnings-a%c2%80%c2%98windfalla%c2%80%c2%99-from-lipitor-plavix-generics/ 2010-02-05T23:44:27+00:00 daily 0.8 http://www.pharma-marketer.com/teva-pharma-settles-some-medicaid-drug-price-suits/ 2010-02-05T23:44:26+00:00 daily 0.8 http://www.pharma-marketer.com/fda-derides-a%c2%80%c2%98conspiracy-theorya%c2%80%c2%99-over-provenge-delay/ 2010-02-05T23:44:24+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-still-waiting-for-the-upside-to-medimmune-acquisition/ 2010-02-05T23:44:23+00:00 daily 0.8 http://www.pharma-marketer.com/spending-on-prescription-drugs-rose-5-2-in-2009/ 2010-02-05T23:44:14+00:00 daily 0.8 http://www.pharma-marketer.com/wall-street-unleashes-fury-at-pfizers-1-5b-revenue-discrepancy/ 2010-02-05T23:44:13+00:00 daily 0.8 http://www.pharma-marketer.com/allergan-buys-serica-tech/ 2010-02-05T22:58:15+00:00 daily 0.8 http://www.pharma-marketer.com/optimer-shares-buoyed-by-promising-ph3-c-diff-data/ 2010-02-05T22:39:58+00:00 daily 0.8 http://www.pharma-marketer.com/sf-execs-call-for-new-incentives-to-boost-biotech/ 2010-02-05T22:20:30+00:00 daily 0.8 http://www.pharma-marketer.com/diagnostic-group-predicts-biotech-doom-with-loss-of-gene-patents/ 2010-02-05T21:52:25+00:00 daily 0.8 http://www.pharma-marketer.com/what-would-a-pharma-marketing-champ-do-9-imperatives-for-2010/ 2010-02-05T21:41:38+00:00 daily 0.8 http://www.pharma-marketer.com/sheer-economics-how-we-got-in-this-fix/ 2010-02-05T20:19:23+00:00 daily 0.8 http://www.pharma-marketer.com/unions-riled-xenoport-scrambles-as-glaxo-changes-rd-course/ 2010-02-05T20:18:21+00:00 daily 0.8 http://www.pharma-marketer.com/biomarin-inks-97m-deal-to-buy-lead-therapeutics/ 2010-02-05T19:28:28+00:00 daily 0.8 http://www.pharma-marketer.com/a-focus-on-diseases-for-which-it-believes-it-can-develop-more-valuable-drugs/ 2010-02-05T17:55:40+00:00 daily 0.8 http://www.pharma-marketer.com/fda-warns-meda-pharmaceuticals-that-astelin-isnt-approved-as-a-cure-for-house-cleaning/ 2010-02-05T13:42:29+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-feeling-frisky/ 2010-02-05T05:20:06+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-savings-plan-may-hit-xenoport-partnership/ 2010-02-05T05:20:05+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-retreat-allergan-zigzags-on-forecast/ 2010-02-05T05:20:02+00:00 daily 0.8 http://www.pharma-marketer.com/biomarin-to-acquire-lead-therapeutics/ 2010-02-05T05:19:57+00:00 daily 0.8 http://www.pharma-marketer.com/did-cephalon-pay-james-mcmillen-101650-to-help-promote-actiq-for-off-label-use/ 2010-02-05T05:08:58+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-new-alzheimers-drug-a-black-box-indeed/ 2010-02-05T02:03:29+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-4th-quarter-profit-up-66-pct-with-strong-boost-from-swine-flu-vaccine/ 2010-02-05T02:03:28+00:00 daily 0.8 http://www.pharma-marketer.com/alkermes-testing-schizophrenia-drug/ 2010-02-05T02:03:27+00:00 daily 0.8 http://www.pharma-marketer.com/allergan-4q-profit-grows-51-percent-as-sales-climb/ 2010-02-05T02:03:24+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-to-stop-pain-research-start-rare-disease-unit/ 2010-02-05T02:03:23+00:00 daily 0.8 http://www.pharma-marketer.com/dr-reddya%c2%80%c2%99s-finance-chief-says-no-plan-to-sell-shares-to-glaxo/ 2010-02-05T02:03:22+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-squibb-is-freezing-salaries/ 2010-02-05T02:03:21+00:00 daily 0.8 http://www.pharma-marketer.com/10-biotech-stocks-on-clinical-trials-watch/ 2010-02-05T02:03:20+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeutics-options-show-record-bets-on-drugmaker-retreat/ 2010-02-05T02:03:15+00:00 daily 0.8 http://www.pharma-marketer.com/achillion-pharma-out-licensed-china-rights-for-hiv-hepatitis-treatment/ 2010-02-05T02:03:13+00:00 daily 0.8 http://www.pharma-marketer.com/ftc-wants-more-staff-to-tackle-biopharma-mergers/ 2010-02-05T02:03:12+00:00 daily 0.8 http://www.pharma-marketer.com/pfizera%c2%80%c2%99s-china-strategy-a%c2%80%c2%98feet-on-the-streeta%c2%80%c2%99-a%c2%80%c2%98key-opinion-leadersa%c2%80%c2%99/ 2010-02-05T02:03:11+00:00 daily 0.8 http://www.pharma-marketer.com/is-novartis-shopping-its-roche-stake/ 2010-02-05T02:03:09+00:00 daily 0.8 http://www.pharma-marketer.com/dems-writing-compromise-healthcare-bill/ 2010-02-05T02:03:08+00:00 daily 0.8 http://www.pharma-marketer.com/us-fda-asks-for-4bn-for-2011/ 2010-02-05T02:03:07+00:00 daily 0.8 http://www.pharma-marketer.com/could-the-healthcare-system-be-any-more-broken/ 2010-02-05T01:37:05+00:00 daily 0.8 http://www.pharma-marketer.com/adcica-cialis-gets-a-letter-from-the-fda-for-omitting-key-risk-information/ 2010-02-05T01:32:03+00:00 daily 0.8 http://www.pharma-marketer.com/adcica-cialis-letter-from-the-fda/ 2010-02-05T01:25:59+00:00 daily 0.8 http://www.pharma-marketer.com/heres-a-business-plan-for-you/ 2010-02-05T01:23:49+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-ceo-white-still-interested-in-fresh-acquisitions/ 2010-02-04T23:38:11+00:00 daily 0.8 http://www.pharma-marketer.com/traders-betting-against-cell-therapeutics-drug/ 2010-02-04T23:28:02+00:00 daily 0.8 http://www.pharma-marketer.com/lux-files-for-luveniq-approval-in-u-s-and-europe/ 2010-02-04T23:04:22+00:00 daily 0.8 http://www.pharma-marketer.com/bms-freezes-salaries/ 2010-02-04T22:39:42+00:00 daily 0.8 http://www.pharma-marketer.com/is-ma-frenzy-short-circuiting-pharma-rd/ 2010-02-04T20:55:30+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-to-shutter-neurological-programs-creates-new-unit-for-rare-diseases/ 2010-02-04T20:53:34+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-to-shutter-neurological-programs-create-rare-diseases-unit/ 2010-02-04T20:53:34+00:00 daily 0.8 http://www.pharma-marketer.com/poniard-unveils-staff-cuts-new-ceo-in-restructuring/ 2010-02-04T20:31:16+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-to-chop-up-to-3b-from-rd-budget/ 2010-02-04T20:14:12+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-day/ 2010-02-04T19:17:28+00:00 daily 0.8 http://www.pharma-marketer.com/lessons-from-toyota-disaster-for-the-drug-industry/ 2010-02-04T12:45:58+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-drags-down-pharma/ 2010-02-04T10:30:28+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-and-glaxosmithkline-a-tale-of-two-different-pharmas/ 2010-02-04T10:30:27+00:00 daily 0.8 http://www.pharma-marketer.com/wyeth-cant-save-pfizer/ 2010-02-04T07:25:06+00:00 daily 0.8 http://www.pharma-marketer.com/keryx-biopharma-fda-agree-on-design-of-late-stage-trial-for-drug-against-colorectal-cancer/ 2010-02-04T07:25:04+00:00 daily 0.8 http://www.pharma-marketer.com/medicis-gets-fda-nod-for-pain-wrinkle-treatment/ 2010-02-04T07:25:03+00:00 daily 0.8 http://www.pharma-marketer.com/fda-should-begin-a-collaborative-wiki-to-innovate-more-quickly/ 2010-02-04T02:50:40+00:00 daily 0.8 http://www.pharma-marketer.com/do-you-suffer-from-smhf-social-media-hype-fatigue/ 2010-02-04T02:41:25+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-profit-more-than-doubles/ 2010-02-04T00:31:26+00:00 daily 0.8 http://www.pharma-marketer.com/roche-second-half-profit-rises-on-genentech-savings/ 2010-02-04T00:31:24+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-in-line-guidance-down/ 2010-02-04T00:31:23+00:00 daily 0.8 http://www.pharma-marketer.com/auxilium-says-fda-approved-hand-drug-xiaflex/ 2010-02-04T00:31:21+00:00 daily 0.8 http://www.pharma-marketer.com/jj-sales-rep-denied-overtime-pay-by-court/ 2010-02-04T00:31:19+00:00 daily 0.8 http://www.pharma-marketer.com/novo-nordisk-has-high-hopes-for-diabetes-blockbuster/ 2010-02-04T00:31:18+00:00 daily 0.8 http://www.pharma-marketer.com/cephalon-long-term-support-starting-to-line-up/ 2010-02-04T00:31:17+00:00 daily 0.8 http://www.pharma-marketer.com/is-there-a-sunny-side-to-pharma-layoffs/ 2010-02-04T00:31:15+00:00 daily 0.8 http://www.pharma-marketer.com/ironwood-cuts-ipo-by-30-in-biggest-reduction-of-2010/ 2010-02-04T00:31:13+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-inks-330m-pact-for-apeiron-lung-drug/ 2010-02-04T00:31:11+00:00 daily 0.8 http://www.pharma-marketer.com/teva-amgen-duke-it-out-over-generic-biotech/ 2010-02-04T00:31:10+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-plans-to-cut-billions-in-annual-rd-spending/ 2010-02-04T00:31:08+00:00 daily 0.8 http://www.pharma-marketer.com/a-modest-literature-proposal/ 2010-02-03T23:59:57+00:00 daily 0.8 http://www.pharma-marketer.com/labopharm-shares-jump-after-fda-approves-antidepressant/ 2010-02-03T22:12:21+00:00 daily 0.8 http://www.pharma-marketer.com/sources-ab-science-readies-70m-ipo/ 2010-02-03T21:49:44+00:00 daily 0.8 http://www.pharma-marketer.com/roche-ceo-offers-his-vision-for-new-rd-era/ 2010-02-03T21:44:54+00:00 daily 0.8 http://www.pharma-marketer.com/auxilium-readies-sales-force-on-fda-xiaflex-approval/ 2010-02-03T21:07:19+00:00 daily 0.8 http://www.pharma-marketer.com/melanie-lee-to-become-syntaxin-ceo/ 2010-02-03T20:56:21+00:00 daily 0.8 http://www.pharma-marketer.com/transparency-vs-translucency-in-reporting-physician-payments/ 2010-02-03T20:34:33+00:00 daily 0.8 http://www.pharma-marketer.com/fda-takes-up-javelin-drug-for-review/ 2010-02-03T20:19:37+00:00 daily 0.8 http://www.pharma-marketer.com/takeda-profit-falls-on-cost-to-buy-experimental-drugs/ 2010-02-03T20:19:34+00:00 daily 0.8 http://www.pharma-marketer.com/neurosearch-shares-soar-on-promising-ph3-huntingtons-data/ 2010-02-03T20:14:29+00:00 daily 0.8 http://www.pharma-marketer.com/ironwood-raises-188m-in-ipo-but-takes-a-big-price-cut/ 2010-02-03T19:58:29+00:00 daily 0.8 http://www.pharma-marketer.com/dimebon-for-alzheimers-a-black-box-indeed/ 2010-02-03T19:15:21+00:00 daily 0.8 http://www.pharma-marketer.com/you-belong-to-what-group-on-facebook/ 2010-02-03T14:10:18+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-and-the-depression-diabetes-circle/ 2010-02-03T08:59:04+00:00 daily 0.8 http://www.pharma-marketer.com/fourth-quarter-trends-for-big-pharma/ 2010-02-03T08:59:03+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-ceo-time-to-diversify-help-poor-countries/ 2010-02-03T08:59:00+00:00 daily 0.8 http://www.pharma-marketer.com/shaking-up-the-biotech-industry/ 2010-02-03T08:58:59+00:00 daily 0.8 http://www.pharma-marketer.com/former-wyeth-ceo-pharma-chiefs-face-a%c2%80%c2%98more-punishinga%c2%80%c2%99-environment/ 2010-02-03T08:58:56+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-can-guardrails-help-forward-your-social-media-efforts/ 2010-02-03T04:42:30+00:00 daily 0.8 http://www.pharma-marketer.com/joining-in-the-conversation-quick-social-media-tips-for-pharma/ 2010-02-03T04:42:08+00:00 daily 0.8 http://www.pharma-marketer.com/increasing-patient-engagement/ 2010-02-03T04:41:48+00:00 daily 0.8 http://www.pharma-marketer.com/maximizing-hcp-efforts-in-a-social-media-space/ 2010-02-03T04:41:33+00:00 daily 0.8 http://www.pharma-marketer.com/why-do-pharma-marketers-ignore-the-internet/ 2010-02-03T04:41:11+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-learns-a-lesson-on-cialis-price-hikes-work-2/ 2010-02-03T01:50:45+00:00 daily 0.8 http://www.pharma-marketer.com/mystery-alzheimera%c2%80%c2%99s-drug-may-yield-advance-for-pfizer-2/ 2010-02-03T01:50:41+00:00 daily 0.8 http://www.pharma-marketer.com/medivations-alzheimer-trial-data-in-early-march/ 2010-02-03T01:50:33+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithklines-malaria-database-deserves-more-press/ 2010-02-03T01:50:30+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-moves-toward-goal-of-becoming-top-tier-biotherapeutics-company/ 2010-02-03T01:50:29+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-hug-flat-line-warner-chilcott-climbs/ 2010-02-03T01:50:27+00:00 daily 0.8 http://www.pharma-marketer.com/teva-submits-biosimilar-to-amgen-blockbuster-for-fda-approval-2/ 2010-02-03T00:02:31+00:00 daily 0.8 http://www.pharma-marketer.com/buzz-grows-louder-ahead-of-ironwoods-272m-ipo/ 2010-02-02T23:14:04+00:00 daily 0.8 http://www.pharma-marketer.com/fda-oks-onyxs-blockbuster-ph-iii-cancer-trial/ 2010-02-02T22:54:47+00:00 daily 0.8 http://www.pharma-marketer.com/crowdsourcing-vs-science/ 2010-02-02T22:42:52+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-pays-25m-upfront-for-pierre-fabre-cancer-pact/ 2010-02-02T22:34:56+00:00 daily 0.8 http://www.pharma-marketer.com/novo-nordisk-profit-little-changed-on-higher-costs/ 2010-02-02T22:34:04+00:00 daily 0.8 http://www.pharma-marketer.com/allergan-receives-fda-ok-for-new-juvederm-version/ 2010-02-02T22:34:01+00:00 daily 0.8 http://www.pharma-marketer.com/merck-ceo-clark-gets-a-helipad-on-top-of-old-schering-hq/ 2010-02-02T22:34:00+00:00 daily 0.8 http://www.pharma-marketer.com/europe-matters-says-cephalon-with-590m-mepha-deal/ 2010-02-02T22:33:58+00:00 daily 0.8 http://www.pharma-marketer.com/is-social-media-ready-for-the-drug-industry-or-not/ 2010-02-02T21:24:37+00:00 daily 0.8 http://www.pharma-marketer.com/the-functional-role-of-social-media-in-health-care/ 2010-02-02T21:14:47+00:00 daily 0.8 http://www.pharma-marketer.com/mannkind-opens-up-partnership-talks-2/ 2010-02-02T20:32:37+00:00 daily 0.8 http://www.pharma-marketer.com/a-pile-of-malaria-leads-for-the-taking/ 2010-02-02T20:28:46+00:00 daily 0.8 http://www.pharma-marketer.com/protalix-shares-dip-as-fda-poses-new-gaucher-drug-query/ 2010-02-02T20:06:44+00:00 daily 0.8 http://www.pharma-marketer.com/spectrum-adds-to-cancer-pipeline-with-350m-deal/ 2010-02-02T19:31:15+00:00 daily 0.8 http://www.pharma-marketer.com/cheaper-eye-drug-may-threaten-novartis-and-roche-sales-2/ 2010-02-02T10:50:48+00:00 daily 0.8 http://www.pharma-marketer.com/fda-liver-risk-warning-for-bristol-myers-hiv-drug/ 2010-02-02T10:50:45+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-preview-pfizer-to-report-4q-results-2/ 2010-02-02T10:50:43+00:00 daily 0.8 http://www.pharma-marketer.com/expansion-for-glaxos-tykerb/ 2010-02-02T10:50:42+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-layoffs-follow-promise-of-no-cuts-at-national-sales-meeting/ 2010-02-02T10:50:40+00:00 daily 0.8 http://www.pharma-marketer.com/new-regulatory-wrinkle-cosmetic-doctor-gets-fda-warning-letter-who-snitched/ 2010-02-02T04:28:17+00:00 daily 0.8 http://www.pharma-marketer.com/video-trading-smallcap-biotech/ 2010-02-02T03:52:22+00:00 daily 0.8 http://www.pharma-marketer.com/intermune-gets-march-fda-review-for-lung-drug/ 2010-02-02T03:52:20+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-aims-for-no-1-in-japanese-generics/ 2010-02-02T03:52:19+00:00 daily 0.8 http://www.pharma-marketer.com/leveraging-physician-portals-in-your-hcp-marketing/ 2010-02-02T02:11:39+00:00 daily 0.8 http://www.pharma-marketer.com/top-10-biopharma-deals-of-2009/ 2010-02-02T00:57:11+00:00 daily 0.8 http://www.pharma-marketer.com/looming-fda-panel-review-spurs-questions-about-pixantrone/ 2010-02-01T23:57:01+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-to-announce-more-than-3000-job-cuts/ 2010-02-01T23:51:50+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-makes-notable-ceo-pick/ 2010-02-01T23:51:44+00:00 daily 0.8 http://www.pharma-marketer.com/boston-sci-to-pay-jj-1-7-bln-in-patent-dispute/ 2010-02-01T23:51:43+00:00 daily 0.8 http://www.pharma-marketer.com/venture-financing-comes-through-for-biotech/ 2010-02-01T23:51:41+00:00 daily 0.8 http://www.pharma-marketer.com/daiichi-sankyo-seeks-to-sell-long-acting-flu-drug/ 2010-02-01T23:51:40+00:00 daily 0.8 http://www.pharma-marketer.com/cephalon-acquires-swiss-drugmaker-mepha-ag/ 2010-02-01T23:51:36+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-gain-warner-chilcott-slides/ 2010-02-01T23:51:35+00:00 daily 0.8 http://www.pharma-marketer.com/five-drugs-to-watch-assuming-fda-approval/ 2010-02-01T23:51:33+00:00 daily 0.8 http://www.pharma-marketer.com/judge-refuses-to-dismiss-fosamax-case-sets-trial/ 2010-02-01T23:51:32+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-events-to-watch-in-2010-fda-approvals-expected-deals-and-surprises/ 2010-02-01T23:51:30+00:00 daily 0.8 http://www.pharma-marketer.com/geron-explores-new-application-for-hampered-alzheimers-drug/ 2010-02-01T23:51:27+00:00 daily 0.8 http://www.pharma-marketer.com/bargains-to-be-found-in-health-care-stocks/ 2010-02-01T23:51:25+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeutics-upcoming-fda-worries/ 2010-02-01T23:51:24+00:00 daily 0.8 http://www.pharma-marketer.com/will-ironwoods-267m-ipo-gamble-pay-off/ 2010-02-01T23:51:23+00:00 daily 0.8 http://www.pharma-marketer.com/cordex-exploring-its-strategic-options/ 2010-02-01T23:37:30+00:00 daily 0.8 http://www.pharma-marketer.com/experts-advise-big-pharma-to-shift-to-in-licensing/ 2010-02-01T22:28:12+00:00 daily 0.8 http://www.pharma-marketer.com/a-pharma-social-media-working-group-submits-comments-to-fda/ 2010-02-01T22:09:27+00:00 daily 0.8 http://www.pharma-marketer.com/oxford-nanopore-rounds-up-28m-to-back-sequencing-tech/ 2010-02-01T21:56:38+00:00 daily 0.8 http://www.pharma-marketer.com/warning-letters-double-or-spin/ 2010-02-01T21:54:13+00:00 daily 0.8 http://www.pharma-marketer.com/report-glaxo-slashing-rd-as-it-readies-thousands-of-more-job-cuts/ 2010-02-01T21:33:31+00:00 daily 0.8 http://www.pharma-marketer.com/report-glaxo-slashing-rd-thousands-of-jobs/ 2010-02-01T21:33:31+00:00 daily 0.8 http://www.pharma-marketer.com/and-on-the-carl-icahn-front/ 2010-02-01T21:11:33+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-more-cuts-coming/ 2010-02-01T20:39:04+00:00 daily 0.8 http://www.pharma-marketer.com/the-ipad-future-of-medicine/ 2010-02-01T13:06:06+00:00 daily 0.8 http://www.pharma-marketer.com/zactimaa%c2%80%c2%99s-fda-application-withdrawn-nasdaqazn/ 2010-01-31T20:40:35+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-smith-kline-set-to-slash-4000-jobs/ 2010-01-31T20:40:33+00:00 daily 0.8 http://www.pharma-marketer.com/despite-ma-slowdown-pharmaceutical-deals-remained-plentiful-in-2009/ 2010-01-31T20:40:32+00:00 daily 0.8 http://www.pharma-marketer.com/cellprothera-achieves-a-revolutionary-breakthrough-in-the-treatment-of-myocardial-infarction-with-the-support-of-the-als/ 2010-01-31T20:40:31+00:00 daily 0.8 http://www.pharma-marketer.com/betting-on-the-aging-of-america/ 2010-01-31T20:40:28+00:00 daily 0.8 http://www.pharma-marketer.com/celgene-beats-zacks-estimate/ 2010-01-30T20:16:54+00:00 daily 0.8 http://www.pharma-marketer.com/immunogen-drops-guidance-after-tough-q2/ 2010-01-30T20:16:53+00:00 daily 0.8 http://www.pharma-marketer.com/wake-up-you-still-have-to-pay-attention-celgene/ 2010-01-30T20:16:49+00:00 daily 0.8 http://www.pharma-marketer.com/sqnm-jumps-3-as-blackrock-takes-6-stake/ 2010-01-30T20:16:48+00:00 daily 0.8 http://www.pharma-marketer.com/enzon-completes-sale-of-specialty-pharmaceutical-business/ 2010-01-30T20:16:47+00:00 daily 0.8 http://www.pharma-marketer.com/surmodics-beats/ 2010-01-30T20:16:46+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-eli-lilly-foreboding-for-sector/ 2010-01-30T20:16:45+00:00 daily 0.8 http://www.pharma-marketer.com/pivotal-trial-results-for-motavizumab-published-in-current-issue-of-pediatrics/ 2010-01-30T20:16:43+00:00 daily 0.8 http://www.pharma-marketer.com/all-grown-up-with-cash-to-burn-bms/ 2010-01-30T20:16:42+00:00 daily 0.8 http://www.pharma-marketer.com/flexion-lands-42m-acquires-drug-targets/ 2010-01-30T20:16:41+00:00 daily 0.8 http://www.pharma-marketer.com/how-to-make-billions-of-dollars-without-really-trying/ 2010-01-30T20:16:39+00:00 daily 0.8 http://www.pharma-marketer.com/with-their-rights-squabble-settled-eli-lilly-and-bristol-myers-squibb-look-ahead/ 2010-01-30T20:16:38+00:00 daily 0.8 http://www.pharma-marketer.com/gsks-tykerbr-receives-accelerated-approval-for-first-line-combination-treatment-of-metastatic-breast-cancer/ 2010-01-30T20:16:36+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-once-a-day-lamictalrxrtm-as-add-on-epilepsy-therapy-for-primary-generalized-tonic-clonic-seizures/ 2010-01-30T20:16:36+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-signs-pact-with-minsheng-pharma-to-establish-new-consumer-healthcare-jv-in-china/ 2010-01-30T20:16:35+00:00 daily 0.8 http://www.pharma-marketer.com/watson-pharmaceuticals-closes-acquisition-of-eden-biodesign-for-approximately-15-million/ 2010-01-30T20:16:32+00:00 daily 0.8 http://www.pharma-marketer.com/sun-pharma-suffers-setback-consolidated-net-dips-by-17-in-q3/ 2010-01-30T20:16:30+00:00 daily 0.8 http://www.pharma-marketer.com/fda-wants-drug-companies-to-look-at-potential-for-abuse/ 2010-01-30T20:16:28+00:00 daily 0.8 http://www.pharma-marketer.com/keryx-biopharmaceuticals-announces-positive-phase-2-study-results-of-perifosine-as-a-single-agent-for-the-treatment-of-w/ 2010-01-30T20:16:26+00:00 daily 0.8 http://www.pharma-marketer.com/the-new-kol-your-local-community-doctor/ 2010-01-29T19:44:19+00:00 daily 0.8 http://www.pharma-marketer.com/amylin-misses-estimates/ 2010-01-29T19:31:06+00:00 daily 0.8 http://www.pharma-marketer.com/spectrum-receives-16-million-in-payments/ 2010-01-29T19:31:05+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-chief-warns-states-over-cancelled-vaccine-orders/ 2010-01-29T19:31:04+00:00 daily 0.8 http://www.pharma-marketer.com/keryx-biopharmaceuticals-aeterna-zentaris-report-positive-perifosine-study-data/ 2010-01-29T19:31:03+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-layoffs-blame-the-lawyers-and-the-seroquel-marketers/ 2010-01-29T19:30:54+00:00 daily 0.8 http://www.pharma-marketer.com/1-star-stocks-poised-to-plunge-cytori-therapeutics/ 2010-01-29T19:30:52+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-to-repurchase-up-to-1-billion-shares/ 2010-01-29T19:30:50+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-idec-genzyme-and-the-struggles-of-big-biotech/ 2010-01-29T19:30:48+00:00 daily 0.8 http://www.pharma-marketer.com/fda-seeks-more-data-for-theravance-drug/ 2010-01-29T19:30:47+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-merck-reps-are-tops-to-cardiologists/ 2010-01-29T19:30:45+00:00 daily 0.8 http://www.pharma-marketer.com/lillya%c2%80%c2%99s-effient-slow-start-for-a-new-blood-thinner/ 2010-01-29T19:30:44+00:00 daily 0.8 http://www.pharma-marketer.com/drug-marketing-a-good-source-of-revenue-for-the-government/ 2010-01-29T19:00:15+00:00 daily 0.8 http://www.pharma-marketer.com/johnson-may-have-been-on-to-something/ 2010-01-29T17:54:27+00:00 daily 0.8 http://www.pharma-marketer.com/the-pharma-sponsored-online-communities-of-10-years-ago/ 2010-01-29T17:50:45+00:00 daily 0.8 http://www.pharma-marketer.com/merck-and-sirna/ 2010-01-29T17:09:09+00:00 daily 0.8 http://www.pharma-marketer.com/sure-thing/ 2010-01-29T16:43:42+00:00 daily 0.8 http://www.pharma-marketer.com/gates-pledges-10b-for-decade-of-vaccines/ 2010-01-29T16:41:39+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-ceo-a%c2%80%c2%98out-huntinga%c2%80%c2%99-for-deal-with-10-billion/ 2010-01-29T15:48:22+00:00 daily 0.8 http://www.pharma-marketer.com/merck-pfizer-overcharged-new-york-for-medicines-judge-rules/ 2010-01-29T15:48:21+00:00 daily 0.8 http://www.pharma-marketer.com/safety-board-clears-further-study-of-basilea-drug/ 2010-01-29T15:24:55+00:00 daily 0.8 http://www.pharma-marketer.com/is-biotech-becoming-another-big-pharma/ 2010-01-29T15:24:46+00:00 daily 0.8 http://www.pharma-marketer.com/dutch-biotech-merus-lands-30-7m-in-series-b/ 2010-01-29T15:09:32+00:00 daily 0.8 http://www.pharma-marketer.com/flexion-inks-deals-with-four-big-pharmas/ 2010-01-29T15:03:54+00:00 daily 0.8 http://www.pharma-marketer.com/fines-small-part-of-doing-business/ 2010-01-29T14:57:38+00:00 daily 0.8 http://www.pharma-marketer.com/cro-clusters-swell-as-outsourcing-gets-hot/ 2010-01-29T14:43:12+00:00 daily 0.8 http://www.pharma-marketer.com/growth-in-new-categories/ 2010-01-29T14:35:34+00:00 daily 0.8 http://www.pharma-marketer.com/fda-wants-more-studies-of-vibativ-for-pneumonia/ 2010-01-29T14:26:29+00:00 daily 0.8 http://www.pharma-marketer.com/only-the-strong-survive-at-pfizer/ 2010-01-29T04:45:58+00:00 daily 0.8 http://www.pharma-marketer.com/blueprint-for-the-next-blockbuster-drug/ 2010-01-29T04:45:57+00:00 daily 0.8 http://www.pharma-marketer.com/the-biggest-development-stage-drugmaker-ever/ 2010-01-29T04:45:54+00:00 daily 0.8 http://www.pharma-marketer.com/health-care-reform-is-dead-probably/ 2010-01-29T04:45:52+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-sees-put-buying/ 2010-01-29T04:45:50+00:00 daily 0.8 http://www.pharma-marketer.com/inital-reaction-from-physicians-on-ipad-no-thanks/ 2010-01-28T22:24:15+00:00 daily 0.8 http://www.pharma-marketer.com/sequenom-the-case-for-the-defense/ 2010-01-28T20:58:19+00:00 daily 0.8 http://www.pharma-marketer.com/medivation-poised-for-volatile-spring/ 2010-01-28T20:58:08+00:00 daily 0.8 http://www.pharma-marketer.com/the-rise-of-marketing-based-medicine/ 2010-01-28T20:58:06+00:00 daily 0.8 http://www.pharma-marketer.com/celgene-swings-to-4q-profit-continues-revlimid-push/ 2010-01-28T20:58:03+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-diverge-astrazeneca-falls-on-forecast/ 2010-01-28T20:58:01+00:00 daily 0.8 http://www.pharma-marketer.com/the-i-man-cometh/ 2010-01-28T19:53:49+00:00 daily 0.8 http://www.pharma-marketer.com/your-first-pharma-bloodletting-of-2010-astrazeneca/ 2010-01-28T19:50:50+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-gets-creative-with-its-exec-compensation-program/ 2010-01-28T17:35:15+00:00 daily 0.8 http://www.pharma-marketer.com/a-scorched-earth-policy-at-wyeths-princeton-site/ 2010-01-28T17:24:33+00:00 daily 0.8 http://www.pharma-marketer.com/post-merger-pfizer-says-it-has-500-new-drug-candidates/ 2010-01-28T17:04:13+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-preview-expect-an-earnings-beat/ 2010-01-28T17:04:10+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-forecasts-profit-fall-as-quarterly-net-grows-24/ 2010-01-28T17:04:09+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-swings-to-profit-on-14-higher-revenue/ 2010-01-28T17:04:07+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-earnings-beat-analyst-estimates-on-revenue-gains/ 2010-01-28T17:04:06+00:00 daily 0.8 http://www.pharma-marketer.com/breakthrough-for-novo-nordisk/ 2010-01-28T17:04:04+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-will-cut-8000-jobs-worldwide/ 2010-01-28T17:04:03+00:00 daily 0.8 http://www.pharma-marketer.com/videoeli-lilly-ceo-on-earnings-outlook/ 2010-01-28T17:04:02+00:00 daily 0.8 http://www.pharma-marketer.com/johnson-johnson-a-classic-dividend-company/ 2010-01-28T17:04:00+00:00 daily 0.8 http://www.pharma-marketer.com/drug-lobby-group-health-care-bill-up-in-air/ 2010-01-28T17:03:58+00:00 daily 0.8 http://www.pharma-marketer.com/icahn-pushes-to-seat-three-on-biogen-board/ 2010-01-28T17:03:57+00:00 daily 0.8 http://www.pharma-marketer.com/look-for-cephalon-to-block-generic-nuvigil-with-pay-not-to-play-deals/ 2010-01-28T17:03:55+00:00 daily 0.8 http://www.pharma-marketer.com/sources-otsuka-prepares-to-go-public/ 2010-01-28T16:56:41+00:00 daily 0.8 http://www.pharma-marketer.com/az-restructuring-will-take-1b-bite-out-of-rd/ 2010-01-28T16:43:45+00:00 daily 0.8 http://www.pharma-marketer.com/alnara-grabs-35m-in-vc-cash-as-it-aims-at-nda/ 2010-01-28T16:07:36+00:00 daily 0.8 http://www.pharma-marketer.com/icahn-nominates-three-candidates-for-biogen-idec-board/ 2010-01-28T15:34:31+00:00 daily 0.8 http://www.pharma-marketer.com/consumers-want-transparency-and-tust-so-where-is-the-drug-industry-2/ 2010-01-28T14:01:50+00:00 daily 0.8 http://www.pharma-marketer.com/acorda-and-ampyra/ 2010-01-28T13:35:20+00:00 daily 0.8 http://www.pharma-marketer.com/the-virus-killers-killer-quarter/ 2010-01-28T05:53:17+00:00 daily 0.8 http://www.pharma-marketer.com/nice-novartis-very-nice/ 2010-01-28T05:53:14+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-whittles-post-wyeth-pipeline-2/ 2010-01-28T05:53:12+00:00 daily 0.8 http://www.pharma-marketer.com/should-pharma-develop-facebook-pages/ 2010-01-27T20:23:26+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-dumps-about-100-drug-development-programs/ 2010-01-27T20:04:30+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-reports-flat-4th-quarter-profit-on-11-higher-sales/ 2010-01-27T19:22:02+00:00 daily 0.8 http://www.pharma-marketer.com/spectrum-ends-development-of-prostate-drug/ 2010-01-27T19:22:00+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-earnings-d-mab-cancer-data-could-be-the-biggest-biotech-event-of-2010/ 2010-01-27T19:21:57+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-wont-fall-from-lovenox-patent-cliff/ 2010-01-27T19:21:54+00:00 daily 0.8 http://www.pharma-marketer.com/antidepressants-tied-to-lactation-problems/ 2010-01-27T19:21:52+00:00 daily 0.8 http://www.pharma-marketer.com/class-decertification-in-pfizer-off-label-marketing-case-upheld/ 2010-01-27T19:21:51+00:00 daily 0.8 http://www.pharma-marketer.com/jj-heated-catheter-better-than-drugs-for-irregular-heartbeats/ 2010-01-27T19:21:50+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-pays-185m-fine-for-off-label-marketing/ 2010-01-27T19:21:47+00:00 daily 0.8 http://www.pharma-marketer.com/theres-nothing-generic-about-the-profits/ 2010-01-27T19:21:46+00:00 daily 0.8 http://www.pharma-marketer.com/acordas-ms-drug-may-not-be-the-windfall-investors-expect/ 2010-01-27T19:21:44+00:00 daily 0.8 http://www.pharma-marketer.com/fda-warns-researcher-for-promoting-a-drug/ 2010-01-27T19:21:43+00:00 daily 0.8 http://www.pharma-marketer.com/enzymes-and-fluorines/ 2010-01-27T17:17:37+00:00 daily 0.8 http://www.pharma-marketer.com/uk-blueprints-new-research-labs/ 2010-01-27T16:52:09+00:00 daily 0.8 http://www.pharma-marketer.com/spectrum-pharma-dumps-disappointing-bph-therapy/ 2010-01-27T16:35:21+00:00 daily 0.8 http://www.pharma-marketer.com/new-biotech-venture-firm-targets-privatepublic-deals/ 2010-01-27T16:22:54+00:00 daily 0.8 http://www.pharma-marketer.com/why-does-gsk-prefer-new-york-physicians-will-governor-patterson-ruin-it-for-them/ 2010-01-27T16:19:29+00:00 daily 0.8 http://www.pharma-marketer.com/vertex-ceo-emmens-rolls-out-his-five-year-plan/ 2010-01-27T16:01:03+00:00 daily 0.8 http://www.pharma-marketer.com/joe-jimenez-to-replace-daniel-vasella-as-novartis-ceo/ 2010-01-27T15:53:32+00:00 daily 0.8 http://www.pharma-marketer.com/victoza-approval-fuels-share-spike-for-amylin-alkermes/ 2010-01-27T15:11:36+00:00 daily 0.8 http://www.pharma-marketer.com/juvaris-gains-new-backer-in-second-close-of-series-b/ 2010-01-27T14:35:26+00:00 daily 0.8 http://www.pharma-marketer.com/sequenom-strike-up-the-music-bring-on-the-cream-pies/ 2010-01-27T13:16:55+00:00 daily 0.8 http://www.pharma-marketer.com/social-media-and-medicine-paradox-is-there-a-movement-or-not/ 2010-01-27T06:51:30+00:00 daily 0.8 http://www.pharma-marketer.com/is-victozas-victory-in-vain/ 2010-01-27T02:25:11+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-now-a-pure-pharma-to-post-results-on-thursday/ 2010-01-27T02:25:10+00:00 daily 0.8 http://www.pharma-marketer.com/teva-moves-ahead-in-brain-drug-battle/ 2010-01-27T02:25:08+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-rises-as-q4-sales-profit-beat/ 2010-01-27T02:25:07+00:00 daily 0.8 http://www.pharma-marketer.com/timing-is-everything-for-amgen/ 2010-01-27T02:25:05+00:00 daily 0.8 http://www.pharma-marketer.com/forest-labs-oh-so-healthy-balance-sheet/ 2010-01-26T23:01:45+00:00 daily 0.8 http://www.pharma-marketer.com/genvecs-hearing-loss-program-gets-welcome-boost-from-novartis/ 2010-01-26T18:44:50+00:00 daily 0.8 http://www.pharma-marketer.com/china-aoxing-completes-trial-of-pain-drug/ 2010-01-26T18:44:48+00:00 daily 0.8 http://www.pharma-marketer.com/new-novartis-ceo-cafepharma-reader-former-heinz-exec/ 2010-01-26T18:44:47+00:00 daily 0.8 http://www.pharma-marketer.com/amylin-shares-rise-on-expectations-fda-will-approve-new-byetta/ 2010-01-26T18:44:46+00:00 daily 0.8 http://www.pharma-marketer.com/u-s-oncology-partners-on-big-genetics-venture-in-tx/ 2010-01-26T17:30:32+00:00 daily 0.8 http://www.pharma-marketer.com/a-storm-in-a-teacup/ 2010-01-26T16:55:42+00:00 daily 0.8 http://www.pharma-marketer.com/galapagos-to-focus-on-rare-diseases-in-strategic-shift/ 2010-01-26T16:54:05+00:00 daily 0.8 http://www.pharma-marketer.com/envoy-inks-research-deal-with-merck/ 2010-01-26T16:43:56+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-spurns-new-research-raising-doubts-about-resveratrol/ 2010-01-26T16:21:22+00:00 daily 0.8 http://www.pharma-marketer.com/dynavax-shares-jump-on-promising-hep-c-data/ 2010-01-26T16:05:06+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-novos-blockbuster-diabetes-drug/ 2010-01-26T15:38:03+00:00 daily 0.8 http://www.pharma-marketer.com/pay-for-delay-is-under-the-spotlight/ 2010-01-26T15:31:13+00:00 daily 0.8 http://www.pharma-marketer.com/novartisa%c2%80%c2%99s-jimenez-beats-out-reinhardt-to-replace-ceo-vasella/ 2010-01-26T15:31:11+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-obtains-u-s-antitrust-clearance-on-chattem/ 2010-01-26T15:31:10+00:00 daily 0.8 http://www.pharma-marketer.com/teva-pharmaceuticals-is-the-latest-defendant-in-an-abbott-laboratories-patent-suit/ 2010-01-26T15:31:06+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-reports-slightly-higher-profit/ 2010-01-26T15:31:05+00:00 daily 0.8 http://www.pharma-marketer.com/u-s-drug-giants-outmuscle-sp-500/ 2010-01-26T15:31:04+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-net-rises-54-names-new-ceo/ 2010-01-26T15:31:03+00:00 daily 0.8 http://www.pharma-marketer.com/russia-big-pharma-seeking-out-new-markets/ 2010-01-26T15:31:02+00:00 daily 0.8 http://www.pharma-marketer.com/sirtris-handles-pfizers-sirtuin-work-less-than-admirably/ 2010-01-26T15:31:00+00:00 daily 0.8 http://www.pharma-marketer.com/novo-nordisk-shares-rally-on-diabetes-drug-approval/ 2010-01-26T15:30:59+00:00 daily 0.8 http://www.pharma-marketer.com/acorda-after-fda-approval-whats-next-for-ampyra/ 2010-01-26T15:30:57+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-pressured-medical-mgr-over-seroquel/ 2010-01-26T15:30:55+00:00 daily 0.8 http://www.pharma-marketer.com/aids-group-bans-merck-sales-reps-over-pricing/ 2010-01-26T15:30:54+00:00 daily 0.8 http://www.pharma-marketer.com/jj-sales-climb-but-profit-falls-on-big-charge/ 2010-01-26T15:30:53+00:00 daily 0.8 http://www.pharma-marketer.com/the-infinitely-active-impurity/ 2010-01-26T14:29:04+00:00 daily 0.8 http://www.pharma-marketer.com/jj-btw-is-donating-to-haiti-relief-but-wont-say-how-much/ 2010-01-26T13:37:58+00:00 daily 0.8 http://www.pharma-marketer.com/the-fda-new-drug-approvals-of-2009/ 2010-01-26T13:30:47+00:00 daily 0.8 http://www.pharma-marketer.com/seroquel-xr-print-ad-imitates-art-but-thats-not-the-real-problem/ 2010-01-26T13:00:38+00:00 daily 0.8 http://www.pharma-marketer.com/focus-on-customers-not-shareholders/ 2010-01-26T01:59:33+00:00 daily 0.8 http://www.pharma-marketer.com/keryx-and-aeterna-zentaris-say-perifosine-improved-survival-compared-to-potential-competitor/ 2010-01-26T00:25:12+00:00 daily 0.8 http://www.pharma-marketer.com/ny-governor-to-limit-pharma-influence-over-docs/ 2010-01-26T00:25:11+00:00 daily 0.8 http://www.pharma-marketer.com/the-importance-of-search-in-2010/ 2010-01-25T21:18:21+00:00 daily 0.8 http://www.pharma-marketer.com/video-mercks-move-one-minute-trade/ 2010-01-25T20:30:50+00:00 daily 0.8 http://www.pharma-marketer.com/3-reasons-to-buy-geron-today/ 2010-01-25T20:30:49+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-submits-new-hiv-test-to-fda-for-expedited-review/ 2010-01-25T20:30:47+00:00 daily 0.8 http://www.pharma-marketer.com/harvard-doc-steps-down-to-keep-drug-industry-speaking-gig/ 2010-01-25T20:30:45+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-preview-abbott-laboratories-to-report-4q/ 2010-01-25T20:30:43+00:00 daily 0.8 http://www.pharma-marketer.com/auxilium-earns-milestone-payment/ 2010-01-25T20:30:41+00:00 daily 0.8 http://www.pharma-marketer.com/amylin-braces-for-big-event-of-2010-the-hoped-for-approval-of-once-weekly-diabetes-drug/ 2010-01-25T20:30:37+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-biogen-idec-multiple-sclerosis-treatment-ampyra/ 2010-01-25T20:30:35+00:00 daily 0.8 http://www.pharma-marketer.com/debunking-the-accorda-therapeutics-merger-rumors/ 2010-01-25T20:30:34+00:00 daily 0.8 http://www.pharma-marketer.com/will-generic-wellbutrin-live-up-to-brand/ 2010-01-25T20:30:32+00:00 daily 0.8 http://www.pharma-marketer.com/johnson-johnson-still-loved-by-thestreet/ 2010-01-25T20:30:30+00:00 daily 0.8 http://www.pharma-marketer.com/2010-a-big-year-for-big-pharma/ 2010-01-25T20:30:28+00:00 daily 0.8 http://www.pharma-marketer.com/in-a-makeover-quintiles-to-invest-more-in-experimental-drugs/ 2010-01-25T18:24:32+00:00 daily 0.8 http://www.pharma-marketer.com/thumbs-down-biotech-flops-at-the-box-office/ 2010-01-25T17:57:20+00:00 daily 0.8 http://www.pharma-marketer.com/fda-needs-to-tell-a-coherent-story-on-bpa-bring-back-the-talk-paper/ 2010-01-25T17:54:33+00:00 daily 0.8 http://www.pharma-marketer.com/poniard-shares-dented-by-picoplatin-comparison-data/ 2010-01-25T17:49:05+00:00 daily 0.8 http://www.pharma-marketer.com/dtc-marketing-organizational-change-begins-with-linchpins/ 2010-01-25T17:47:35+00:00 daily 0.8 http://www.pharma-marketer.com/lipitor-co-pay-card-makes-debut-and-allows-patients-to-save-money-2/ 2010-01-25T17:37:04+00:00 daily 0.8 http://www.pharma-marketer.com/antigenics-says-fda-too-rigid-to-approve-oncophage/ 2010-01-25T17:23:54+00:00 daily 0.8 http://www.pharma-marketer.com/keryx-shares-surge-on-promising-colon-cancer-data/ 2010-01-25T16:57:10+00:00 daily 0.8 http://www.pharma-marketer.com/biotechs-latest-failed-trials-missed-targets/ 2010-01-25T16:33:26+00:00 daily 0.8 http://www.pharma-marketer.com/2009s-top-sector-for-venture-investment-biotech/ 2010-01-25T16:33:25+00:00 daily 0.8 http://www.pharma-marketer.com/are-forest-labs-fans-right/ 2010-01-25T16:33:23+00:00 daily 0.8 http://www.pharma-marketer.com/takeda-pharma-plans-to-sell-obesity-drug-in-japan-nikkei-says/ 2010-01-25T16:33:21+00:00 daily 0.8 http://www.pharma-marketer.com/poniard-drug-safe-less-effective/ 2010-01-25T16:33:20+00:00 daily 0.8 http://www.pharma-marketer.com/intercept-pharma-hauls-in-25m-series-b/ 2010-01-25T16:32:27+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-and-sirtris-a-bit-more/ 2010-01-25T14:39:59+00:00 daily 0.8 http://www.pharma-marketer.com/acorda-ms-drug-approval-sparks-buyout-buzz/ 2010-01-25T14:07:43+00:00 daily 0.8 http://www.pharma-marketer.com/genzymes-outlook-stabilizing/ 2010-01-23T23:19:47+00:00 daily 0.8 http://www.pharma-marketer.com/action-date-for-genzymes-lumizyme/ 2010-01-23T19:05:13+00:00 daily 0.8 http://www.pharma-marketer.com/plunging-pharmas-offer-falling-stock/ 2010-01-23T19:05:12+00:00 daily 0.8 http://www.pharma-marketer.com/an-update-on-transcepts-intermezzo/ 2010-01-23T19:05:11+00:00 daily 0.8 http://www.pharma-marketer.com/data-from-tnferadetm-esophageal-cancer-study-presented-at-2010-asco-gastrointestinal-cancer-symposium/ 2010-01-23T19:05:10+00:00 daily 0.8 http://www.pharma-marketer.com/extraordinary-measures-biotech-goes-to-hollywood/ 2010-01-23T19:05:09+00:00 daily 0.8 http://www.pharma-marketer.com/aeterna-zentaris-receives-nasdaq-notification-related-to-minimum-bid-price/ 2010-01-23T19:05:08+00:00 daily 0.8 http://www.pharma-marketer.com/china-cord-blood-genvec-biggest-price-gainers-co-gnvc/ 2010-01-23T19:05:07+00:00 daily 0.8 http://www.pharma-marketer.com/acorda-therapeutics-announces-fda-approval-of-ampyra-dalfampridine-to-improve-walking-in-people-with-multiple-sclerosi/ 2010-01-23T19:05:06+00:00 daily 0.8 http://www.pharma-marketer.com/what-the-new-ms-drug-ampyra-does-and-what-it-doesna%c2%80%c2%99t-do/ 2010-01-23T19:05:05+00:00 daily 0.8 http://www.pharma-marketer.com/the-take-away-statins-are-still-in-the-cabinet/ 2010-01-23T19:05:04+00:00 daily 0.8 http://www.pharma-marketer.com/forests-promising-copd-candidate/ 2010-01-23T19:05:03+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-great-data-wont-do-much/ 2010-01-23T19:05:02+00:00 daily 0.8 http://www.pharma-marketer.com/poniard-pharmaceuticals-a-rebound-is-overdue/ 2010-01-23T19:05:00+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharma-eyes-cure-for-financing-woes/ 2010-01-23T19:04:59+00:00 daily 0.8 http://www.pharma-marketer.com/can-johnson-johnson-heal-itself/ 2010-01-23T19:04:58+00:00 daily 0.8 http://www.pharma-marketer.com/dragon-pharmaceutical-gets-acquisition-proposal-from-ceo-yanlin-han-for-price-of-0-80-per-share/ 2010-01-23T19:04:57+00:00 daily 0.8 http://www.pharma-marketer.com/biovail-comments-on-teva-pharmaceuticals-proposed-budeprion-xl-trial/ 2010-01-23T19:04:55+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-auxilium-announce-start-of-review-of-xiaflex-to-treat-dupuytrena%c2%80%c2%99s-contracture/ 2010-01-23T19:04:54+00:00 daily 0.8 http://www.pharma-marketer.com/brazilian-president-calls-for-more-investment-in-pharmaceuticals/ 2010-01-23T19:04:52+00:00 daily 0.8 http://www.pharma-marketer.com/anadys-pharmaceuticals-provides-progress-update-on-phase-ii-study-of-ana598-in-hepatitis-c-patients/ 2010-01-23T19:04:50+00:00 daily 0.8 http://www.pharma-marketer.com/mark-you-calendar-boniva-tries-its-hand-at-crm-patient-compliance/ 2010-01-23T01:01:40+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-fda-approves-acordas-new-ms-drug/ 2010-01-22T21:49:19+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-acordas-new-ms-drug/ 2010-01-22T21:49:19+00:00 daily 0.8 http://www.pharma-marketer.com/wow-brown-and-healthcare-reform/ 2010-01-22T19:05:29+00:00 daily 0.8 http://www.pharma-marketer.com/drug-industry-innovation-gsks-lovaza-vs-otc-omega-3-fatty-acid-supplements/ 2010-01-22T18:30:47+00:00 daily 0.8 http://www.pharma-marketer.com/decode-emerges-from-bankruptcy-with-new-focus/ 2010-01-22T18:04:19+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-fda-will-decide-lumizymes-fate-in-june/ 2010-01-22T17:46:36+00:00 daily 0.8 http://www.pharma-marketer.com/all-the-views-fit-to-tweet/ 2010-01-22T17:07:19+00:00 daily 0.8 http://www.pharma-marketer.com/aina%c2%80%c2%99t-no-sunshine-for-merck/ 2010-01-22T17:02:36+00:00 daily 0.8 http://www.pharma-marketer.com/teva-gets-tentative-fda-ok-for-generic-femara/ 2010-01-22T17:02:34+00:00 daily 0.8 http://www.pharma-marketer.com/should-the-fda-tell-abbott-to-withdraw-meridia/ 2010-01-22T17:02:32+00:00 daily 0.8 http://www.pharma-marketer.com/cubist-4q-profit-tumbles-without-tax-benefit/ 2010-01-22T17:02:30+00:00 daily 0.8 http://www.pharma-marketer.com/exact-sciences-finds-its-mojo/ 2010-01-22T17:02:28+00:00 daily 0.8 http://www.pharma-marketer.com/the-noble-gesture-that-wasnt-gsk/ 2010-01-22T17:02:25+00:00 daily 0.8 http://www.pharma-marketer.com/hana-biosciences-primed-for-a-major-comeback/ 2010-01-22T17:02:23+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-eyes-fda-ruling-on-pompe-drug/ 2010-01-22T17:02:22+00:00 daily 0.8 http://www.pharma-marketer.com/intermune-to-net-93m-from-stock-sale/ 2010-01-22T17:02:20+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithklines-arzerra-gets-positive-recommendation-for-conditional-eu-approval/ 2010-01-22T17:02:08+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-sutent-effective-against-pancreatic-cancer/ 2010-01-22T17:02:06+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-ceo-on-big-deals-a%c2%80%c2%98paying-a-premium-a%c2%80%c2%a6-to-fire-peoplea%c2%80%c2%99/ 2010-01-22T17:02:03+00:00 daily 0.8 http://www.pharma-marketer.com/watson-grabs-market-share-on-generic-toprol/ 2010-01-22T17:02:01+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-sees-future-deals-as-china-biopharma-consolidates/ 2010-01-22T17:01:52+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharma-faces-tougher-2010-despite-us-boost/ 2010-01-22T17:01:50+00:00 daily 0.8 http://www.pharma-marketer.com/somaxon-pharmaceuticals-nearing-end-of-fda-fatigue-for-silenor/ 2010-01-22T17:01:48+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-preview-amgen-to-report-4q-results/ 2010-01-22T17:01:46+00:00 daily 0.8 http://www.pharma-marketer.com/2009-vc-investing-down-but-biotech-shines-in-q4/ 2010-01-22T17:01:42+00:00 daily 0.8 http://www.pharma-marketer.com/receptors-moving-and-shaking/ 2010-01-22T16:59:55+00:00 daily 0.8 http://www.pharma-marketer.com/emea-approves-gsk-genmabs-arzerra/ 2010-01-22T14:51:28+00:00 daily 0.8 http://www.pharma-marketer.com/somaxon-tries-again-with-silenor/ 2010-01-22T14:43:36+00:00 daily 0.8 http://www.pharma-marketer.com/tanabe-cuts-jobs-as-it-focuses-on-biologics/ 2010-01-22T14:36:52+00:00 daily 0.8 http://www.pharma-marketer.com/maybe-you-need-some-more-testosterone-over-there/ 2010-01-22T14:32:59+00:00 daily 0.8 http://www.pharma-marketer.com/fda-hearing-what-dtc-marketers-need-to-know/ 2010-01-21T23:42:37+00:00 daily 0.8 http://www.pharma-marketer.com/skeptical-of-comscore-report-on-pharma-websites-because-its-doesnt-tell-the-whole-story/ 2010-01-21T23:37:09+00:00 daily 0.8 http://www.pharma-marketer.com/if-your-agency-is-telling-you-to-spend-more-money-on-search-run-away/ 2010-01-21T23:36:40+00:00 daily 0.8 http://www.pharma-marketer.com/the-new-year%e2%80%99s-epiphany/ 2010-01-21T22:45:33+00:00 daily 0.8 http://www.pharma-marketer.com/auxillium-pharmaceuticals-to-receive-15-million-from-pfizer-in-xiaflex-partnership/ 2010-01-21T19:22:26+00:00 daily 0.8 http://www.pharma-marketer.com/setback-for-merck/ 2010-01-21T19:22:24+00:00 daily 0.8 http://www.pharma-marketer.com/roche-drug-keeps-patients-cancer-free-longer/ 2010-01-21T19:22:23+00:00 daily 0.8 http://www.pharma-marketer.com/fda-rejects-skyepharmas-nda-for-flutiform/ 2010-01-21T17:59:41+00:00 daily 0.8 http://www.pharma-marketer.com/an-enzyme-inhibitor-you-have-never-ever-considered/ 2010-01-21T17:36:26+00:00 daily 0.8 http://www.pharma-marketer.com/merck-hiv-drug-fails-phase-iii/ 2010-01-21T17:21:43+00:00 daily 0.8 http://www.pharma-marketer.com/garner-crafts-30m-series-a-to-lift-elevation-pharma/ 2010-01-21T17:00:20+00:00 daily 0.8 http://www.pharma-marketer.com/ipsen-buys-inspiration-stake-in-hemophilia-alliance/ 2010-01-21T15:49:19+00:00 daily 0.8 http://www.pharma-marketer.com/entremed-aims-to-prevent-stock-delisting/ 2010-01-21T15:49:18+00:00 daily 0.8 http://www.pharma-marketer.com/study-orphan-drug-applications-doubled-in-2000s/ 2010-01-21T15:49:16+00:00 daily 0.8 http://www.pharma-marketer.com/investors-betting-heavily-on-vivus-obesity-drug/ 2010-01-21T15:49:15+00:00 daily 0.8 http://www.pharma-marketer.com/video-nothing-generic-about-teva-1-6-min/ 2010-01-21T15:49:13+00:00 daily 0.8 http://www.pharma-marketer.com/inspire-dry-eye-drug-fails-key-test/ 2010-01-21T15:49:12+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-nearly-doubles-amount-spent-on-e-detailing/ 2010-01-21T15:49:11+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-merck-kgaa-pills-bring-a%c2%80%c2%98new-horizona%c2%80%c2%99-for-ms/ 2010-01-21T15:49:10+00:00 daily 0.8 http://www.pharma-marketer.com/will-generex-biotech-be-next-to-join-the-winners-circle/ 2010-01-21T15:49:09+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-214m-deal-with-genvec-tests-gene-therapy-waters/ 2010-01-21T15:49:07+00:00 daily 0.8 http://www.pharma-marketer.com/blockbuster-data-studies-back-efficacy-of-late-stage-ms-pills/ 2010-01-21T15:31:33+00:00 daily 0.8 http://www.pharma-marketer.com/inspire-shares-slide-after-eye-drug-flunks-phase-iii/ 2010-01-21T14:54:31+00:00 daily 0.8 http://www.pharma-marketer.com/ipsen-and-inspiration-join-hands-in-259m-pact/ 2010-01-21T14:24:17+00:00 daily 0.8 http://www.pharma-marketer.com/in-hoc-signo-non-vinces/ 2010-01-21T13:28:49+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-says-3-drugs-approved-in-japan/ 2010-01-21T03:24:44+00:00 daily 0.8 http://www.pharma-marketer.com/fda-petitioned-to-remove-fibromyalgia-drug/ 2010-01-21T03:24:41+00:00 daily 0.8 http://www.pharma-marketer.com/court-voids-jj-patents-in-boston-scientific-suit/ 2010-01-21T03:24:39+00:00 daily 0.8 http://www.pharma-marketer.com/chantix-continues-to-be-a-cancer-on-pfizer/ 2010-01-21T03:24:35+00:00 daily 0.8 http://www.pharma-marketer.com/health-stocks-gain-worldwide-as-outlook-fades-for-u-s-revamp/ 2010-01-20T19:30:35+00:00 daily 0.8 http://www.pharma-marketer.com/glaxoa%c2%80%c2%99s-witty-gives-away-malaria-drug-research-as-vaccine-nears/ 2010-01-20T19:30:34+00:00 daily 0.8 http://www.pharma-marketer.com/if-approved-fda-drug-labeling-could-decide-ultimate-success-of-mannkinds-afrezza/ 2010-01-20T19:30:33+00:00 daily 0.8 http://www.pharma-marketer.com/alcon-group-says-novartis-bid-inadequate/ 2010-01-20T19:30:30+00:00 daily 0.8 http://www.pharma-marketer.com/3-drug-stocks-with-low-pes-healthy-dividends/ 2010-01-20T19:30:28+00:00 daily 0.8 http://www.pharma-marketer.com/this-drugmaker-will-rally-by-summer-mdrna/ 2010-01-20T19:30:26+00:00 daily 0.8 http://www.pharma-marketer.com/is-johnson-johnsons-reputation-scarred/ 2010-01-20T19:30:25+00:00 daily 0.8 http://www.pharma-marketer.com/the-2010-outlook-for-big-pharma-stocks/ 2010-01-20T19:30:23+00:00 daily 0.8 http://www.pharma-marketer.com/dr-reddys-swings-to-loss-after-write-down/ 2010-01-20T19:30:22+00:00 daily 0.8 http://www.pharma-marketer.com/lexicon-diabetes-drug-candidate-meets-study-goals/ 2010-01-20T19:30:20+00:00 daily 0.8 http://www.pharma-marketer.com/risperdal-kickback-case-j-72-market-share-not-good-enough/ 2010-01-20T19:30:18+00:00 daily 0.8 http://www.pharma-marketer.com/what-will-pharma-do-now-on-health-reform/ 2010-01-20T19:30:13+00:00 daily 0.8 http://www.pharma-marketer.com/biomarin-pharmaceutical-is-poised-for-a-technical-breakout/ 2010-01-20T19:30:07+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-vc-trends-to-watch-in-2010/ 2010-01-20T19:30:05+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithklineopen-innovation-strategy-to-aid-poor-countries/ 2010-01-20T19:30:03+00:00 daily 0.8 http://www.pharma-marketer.com/should-pharma-tweet/ 2010-01-20T19:01:11+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-donates-animal-health-products-to-haiti/ 2010-01-20T18:54:34+00:00 daily 0.8 http://www.pharma-marketer.com/china-aoxing-taps-hui-shao-as-cfo/ 2010-01-20T16:51:40+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-opens-its-books-on-malaria-vax-research/ 2010-01-20T16:47:39+00:00 daily 0.8 http://www.pharma-marketer.com/a-database-of-side-effects/ 2010-01-20T16:06:15+00:00 daily 0.8 http://www.pharma-marketer.com/pfizera%c2%80%c2%99s-looking-for-more-sales-reps-in-china/ 2010-01-20T15:51:11+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-job-market-warms-in-san-diego/ 2010-01-20T15:20:20+00:00 daily 0.8 http://www.pharma-marketer.com/promising-diabetes-data-spur-lexicon-shares/ 2010-01-20T15:13:17+00:00 daily 0.8 http://www.pharma-marketer.com/honesty-of-a-sort/ 2010-01-20T14:44:01+00:00 daily 0.8 http://www.pharma-marketer.com/boston-developers-start-chomping-on-the-ipo-bit/ 2010-01-20T14:03:10+00:00 daily 0.8 http://www.pharma-marketer.com/developers-line-up-for-ipos-as-ironwood-outlines-266m-offering/ 2010-01-20T14:03:10+00:00 daily 0.8 http://www.pharma-marketer.com/governors-rush-to-defense-of-bipartisan-biologics-deal/ 2010-01-20T14:00:13+00:00 daily 0.8 http://www.pharma-marketer.com/wyeth-wont-market-sleeplessness-treatment/ 2010-01-20T05:03:06+00:00 daily 0.8 http://www.pharma-marketer.com/encouraging-results-from-bionovo/ 2010-01-20T05:03:04+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-genvec-to-develop-hearing-loss-treatment-in-214m-deal/ 2010-01-20T05:03:02+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-changes-course-as-it-shrinks-its-sales-force/ 2010-01-20T05:02:58+00:00 daily 0.8 http://www.pharma-marketer.com/3500-neurosurgeons-to-receive-ipod-touch-at-medical-convention-in-may/ 2010-01-19T18:12:32+00:00 daily 0.8 http://www.pharma-marketer.com/evotec-maps-path-to-profitability/ 2010-01-19T17:55:23+00:00 daily 0.8 http://www.pharma-marketer.com/depomed-readies-another-phase-iii-for-serada/ 2010-01-19T17:51:40+00:00 daily 0.8 http://www.pharma-marketer.com/what-should-non-chemists-know-about-medicinal-chemistry-anyway/ 2010-01-19T17:45:39+00:00 daily 0.8 http://www.pharma-marketer.com/genvec-scores-213m-licensing-deal-with-novartis/ 2010-01-19T17:20:15+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-donates-antibiotics-to-haiti/ 2010-01-19T17:06:19+00:00 daily 0.8 http://www.pharma-marketer.com/the-long-case-for-pfizer/ 2010-01-19T17:06:12+00:00 daily 0.8 http://www.pharma-marketer.com/jj-has-success-with-psoriasis-treatment/ 2010-01-19T17:06:10+00:00 daily 0.8 http://www.pharma-marketer.com/forest-labs-earnings-per-share-69-cents/ 2010-01-19T17:06:05+00:00 daily 0.8 http://www.pharma-marketer.com/sangamo-says-experimental-therapy-kept-hiv-level-low-in-patient/ 2010-01-19T17:06:02+00:00 daily 0.8 http://www.pharma-marketer.com/aspenbio-pharma-poised-for-a-breakout-year/ 2010-01-19T17:05:59+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-teva-set-to-tussle-for-ratiopharm/ 2010-01-19T17:05:57+00:00 daily 0.8 http://www.pharma-marketer.com/new-illumina-genome-sequencer-dramatically-slashes-costs-time/ 2010-01-19T17:05:54+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-shire-chomping-at-the-bit/ 2010-01-19T17:05:50+00:00 daily 0.8 http://www.pharma-marketer.com/digging-deeper-into-adventrx-pharmaceuticals/ 2010-01-19T17:05:47+00:00 daily 0.8 http://www.pharma-marketer.com/musings-on-commando-teva-besting-big-pharma/ 2010-01-19T17:05:44+00:00 daily 0.8 http://www.pharma-marketer.com/the-top-biotech-layoffs-of-2009-and-a-silver-lining/ 2010-01-19T17:05:41+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-troubled-by-flu-cuts-fake-alli/ 2010-01-19T17:05:35+00:00 daily 0.8 http://www.pharma-marketer.com/indian-biotech-exec-predicts-a-10b-industry-boomind/ 2010-01-19T17:05:29+00:00 daily 0.8 http://www.pharma-marketer.com/pharmas-vaccine-epidemic/ 2010-01-19T17:05:23+00:00 daily 0.8 http://www.pharma-marketer.com/watson-confirms-filing-of-fda-application-for-generic-lidoderm/ 2010-01-19T17:05:19+00:00 daily 0.8 http://www.pharma-marketer.com/republican-win-in-mass-could-derail-a-biotech-victory/ 2010-01-19T16:32:22+00:00 daily 0.8 http://www.pharma-marketer.com/changing-communications-changing-public-policy-and-healthcare-reform/ 2010-01-19T16:02:46+00:00 daily 0.8 http://www.pharma-marketer.com/social-media-vs-social-responsibility-jj-fails-crisis-management-101/ 2010-01-19T15:24:32+00:00 daily 0.8 http://www.pharma-marketer.com/so-far-i-have-donated-more-to-haiti-relief-than-pharma-as-of-daily-income/ 2010-01-19T15:17:33+00:00 daily 0.8 http://www.pharma-marketer.com/indian-biotech-exec-predicts-a-10b-industry-boom/ 2010-01-19T14:18:26+00:00 daily 0.8 http://www.pharma-marketer.com/globeimmune-raises-17-5m-as-it-heads-toward-phase-iii/ 2010-01-19T13:58:49+00:00 daily 0.8 http://www.pharma-marketer.com/neurosurgeons-without-papers-but-with-an-ipod-touch/ 2010-01-19T06:10:23+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-braced-for-low-sales-of-flu-drug/ 2010-01-18T21:57:35+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-invests-wisely-in-smart-pill/ 2010-01-18T21:57:32+00:00 daily 0.8 http://www.pharma-marketer.com/biotechs-latest-failed-trials-mishaps-and-missed-targets/ 2010-01-18T21:57:30+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-sees-10-growth-in-asia-this-year-on-emerging-markets/ 2010-01-18T21:57:29+00:00 daily 0.8 http://www.pharma-marketer.com/isis-expands-pipeline/ 2010-01-18T21:57:26+00:00 daily 0.8 http://www.pharma-marketer.com/at-genzyme-a-long-view/ 2010-01-18T21:57:24+00:00 daily 0.8 http://www.pharma-marketer.com/the-future-of-biotech-party-like-its-1999/ 2010-01-18T21:57:20+00:00 daily 0.8 http://www.pharma-marketer.com/king-pharmaceuticals-faces-setbacks-with-abuse-resistant-pain-medicines/ 2010-01-18T21:57:17+00:00 daily 0.8 http://www.pharma-marketer.com/u-s-accuses-jj-of-kickback-scheme-with-omnicare/ 2010-01-18T18:51:16+00:00 daily 0.8 http://www.pharma-marketer.com/3-different-scenarios-for-glaxosmithklines-sirtris-investment/ 2010-01-18T18:51:14+00:00 daily 0.8 http://www.pharma-marketer.com/oxfords-new-building-one-year-later/ 2010-01-18T18:20:53+00:00 daily 0.8 http://www.pharma-marketer.com//how-would-go-about-developing-an-attitudinal-physician-segmentation-strategy-what-are-the-key-factors-to-consider-what-are-your-thoughts-about-using-attitudes-as-compared-to-using-functional-segment/ 2010-01-18T17:23:40+00:00 weekly 0.6 http://www.pharma-marketer.com//how-would-go-about-developing-an-attitudinal-physician-segmentation-strategy-what-are-the-key-factors-to-consider-what-are-your-thoughts-about-using-attitudes-as-compared-to-using-functional-segment/ 2010-01-18T17:23:33+00:00 weekly 0.6 http://www.pharma-marketer.com/correlations-lovely-correlations/ 2010-01-18T15:48:01+00:00 daily 0.8 http://www.pharma-marketer.com/if-you-cant-beat-the-regulators-sic-em-on-you-competition/ 2010-01-17T05:46:19+00:00 daily 0.8 http://www.pharma-marketer.com/thought-on-compliance-from-reader/ 2010-01-17T05:44:35+00:00 daily 0.8 http://www.pharma-marketer.com/want-to-know-why-the-number-of-prescriptions-are-going-down-try-higher-prices-and-higher-co-pay/ 2010-01-17T05:40:18+00:00 daily 0.8 http://www.pharma-marketer.com/sequenom-settles-lawsuit-for-14-million-stock/ 2010-01-16T21:07:58+00:00 daily 0.8 http://www.pharma-marketer.com/impax-challenges-genzyme-partner-on-welchol/ 2010-01-16T21:07:56+00:00 daily 0.8 http://www.pharma-marketer.com/fda-extends-review-period-for-tarceva-application-for-first-line-maintenance-use-in-advanced-non-small-cell-lung-cancer/ 2010-01-16T21:07:53+00:00 daily 0.8 http://www.pharma-marketer.com/repros-approved-for-trading-on-nasdaq-capital-market/ 2010-01-16T21:07:51+00:00 daily 0.8 http://www.pharma-marketer.com/3-reasons-to-buy-sequenom-today/ 2010-01-16T21:07:50+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-idec-to-report-fourth-quarter-and-full-year-2009-financial-results-on-february-9-2010/ 2010-01-16T21:07:48+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-shifts-gears-in-bid-for-rebound/ 2010-01-16T21:07:46+00:00 daily 0.8 http://www.pharma-marketer.com/oops-sorry-about-that-pfizer/ 2010-01-16T21:07:45+00:00 daily 0.8 http://www.pharma-marketer.com/jnja%c2%80%c2%99s-really-tough-day-of-kickbacks-and-recalls/ 2010-01-16T21:07:43+00:00 daily 0.8 http://www.pharma-marketer.com/the-weekly-layoff-report-more-pharmaceutical-pain/ 2010-01-16T21:07:42+00:00 daily 0.8 http://www.pharma-marketer.com/zacks-analyst-blog-highlights-watson-pharmaceuticals-inc-teva-mylan-dr-reddys-and-par-pharma/ 2010-01-16T21:07:38+00:00 daily 0.8 http://www.pharma-marketer.com/drug-companies-threatening-to-oppose-health-bill/ 2010-01-16T21:07:35+00:00 daily 0.8 http://www.pharma-marketer.com/bionovo-gets-positive-results-from-phase-1b-trial-of-bezielle-for-metastatic-breast-cancer/ 2010-01-16T21:07:33+00:00 daily 0.8 http://www.pharma-marketer.com/rxi-pharmaceuticals-talks-partnerships/ 2010-01-16T21:07:26+00:00 daily 0.8 http://www.pharma-marketer.com/jj-recalls-several-non-prescription-drugs/ 2010-01-15T20:42:09+00:00 daily 0.8 http://www.pharma-marketer.com/dems-may-seek-billions-more-from-drug-and-device-companies/ 2010-01-15T20:42:07+00:00 daily 0.8 http://www.pharma-marketer.com/suits-allege-harm-from-pfizer-quit-smoking-drug/ 2010-01-15T20:42:04+00:00 daily 0.8 http://www.pharma-marketer.com/doj-files-suit-against-jj-for-paying-kickbacks/ 2010-01-15T20:42:01+00:00 daily 0.8 http://www.pharma-marketer.com/here-come-the-lawyers-again/ 2010-01-15T18:08:29+00:00 daily 0.8 http://www.pharma-marketer.com/physics-for-dogs-and-others/ 2010-01-15T17:40:06+00:00 daily 0.8 http://www.pharma-marketer.com/lawsuit-challenges-marketing-of-stents/ 2010-01-15T16:58:51+00:00 daily 0.8 http://www.pharma-marketer.com/mass-doctor-accused-of-faking-painkiller-studies-charged-with-federal-health-care-fraud/ 2010-01-15T16:58:50+00:00 daily 0.8 http://www.pharma-marketer.com/merck-my-favorite-dow-30-stock/ 2010-01-15T16:58:46+00:00 daily 0.8 http://www.pharma-marketer.com/pandemic-flu-scare-fades-vaccine-glut-seen-for-glaxobaxter/ 2010-01-15T16:58:45+00:00 daily 0.8 http://www.pharma-marketer.com/xenoport-says-u-s-fda-wona%c2%80%c2%99t-require-advisory-panel/ 2010-01-15T16:58:29+00:00 daily 0.8 http://www.pharma-marketer.com/a-closer-look-at-cubist-pharma/ 2010-01-15T16:58:25+00:00 daily 0.8 http://www.pharma-marketer.com/an-11th-hour-battle-over-biogenerics-in-congress/ 2010-01-15T16:58:25+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-stock-mailbag-adventrx-pharmaceuticals/ 2010-01-15T16:58:23+00:00 daily 0.8 http://www.pharma-marketer.com/two-biotech-companies-that-make-green-sense/ 2010-01-15T16:58:21+00:00 daily 0.8 http://www.pharma-marketer.com/reality-check-reuters-sees-big-pharma-growing-risk-averse/ 2010-01-15T16:58:20+00:00 daily 0.8 http://www.pharma-marketer.com/hemispherx-offers-more-data-on-ampligen/ 2010-01-15T16:46:10+00:00 daily 0.8 http://www.pharma-marketer.com/proteon-founders-set-out-to-build-spin-out-engine/ 2010-01-15T16:44:32+00:00 daily 0.8 http://www.pharma-marketer.com/publishing-holiday-for-mlk-day/ 2010-01-15T16:28:36+00:00 daily 0.8 http://www.pharma-marketer.com/georgia-officials-map-out-atlanta-rd-complex/ 2010-01-15T15:46:06+00:00 daily 0.8 http://www.pharma-marketer.com/creative-pharma-packaging-design-where-is-it-needed/ 2010-01-15T15:20:32+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeutics-stock-sale-raises-30m-and-eyebrows/ 2010-01-15T15:14:43+00:00 daily 0.8 http://www.pharma-marketer.com/debunking-the-myths/ 2010-01-15T14:24:08+00:00 daily 0.8 http://www.pharma-marketer.com/the-inequality-of-dtc-regulation/ 2010-01-15T14:23:43+00:00 daily 0.8 http://www.pharma-marketer.com/obama-mounts-fight-against-12-years-of-data-exclusivity/ 2010-01-15T13:49:55+00:00 daily 0.8 http://www.pharma-marketer.com/sirtuin-scenarios/ 2010-01-15T13:20:35+00:00 daily 0.8 http://www.pharma-marketer.com/why-is-gsk-making-a-new-movie-about-obesity-hint-it-doesnt-like-the-old-one/ 2010-01-15T12:52:53+00:00 daily 0.8 http://www.pharma-marketer.com/that-novartis-alcon-deal-may-have-a-tax-problem/ 2010-01-14T23:57:09+00:00 daily 0.8 http://www.pharma-marketer.com/fda-finds-no-heart-risk-with-spiriva-inhaler/ 2010-01-14T23:57:07+00:00 daily 0.8 http://www.pharma-marketer.com/moodys-raises-teva-credit-rating/ 2010-01-14T23:57:06+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-interest-in-enzon-may-create-jackpot-payday-for-ceo-buchalter/ 2010-01-14T23:57:04+00:00 daily 0.8 http://www.pharma-marketer.com/hemispherx-submits-new-ampligen-data-to-fda/ 2010-01-14T23:57:02+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-was-also-questioned-in-eu-on-generic-deals/ 2010-01-14T23:57:00+00:00 daily 0.8 http://www.pharma-marketer.com/department-of-placebo-effects/ 2010-01-14T18:34:29+00:00 daily 0.8 http://www.pharma-marketer.com/twongress-the-power-of-twitter-in-congress/ 2010-01-14T17:58:20+00:00 daily 0.8 http://www.pharma-marketer.com/denosumab-could-revive-amgen/ 2010-01-14T17:54:25+00:00 daily 0.8 http://www.pharma-marketer.com/bind-rounds-up-11m-names-new-ceo/ 2010-01-14T17:22:56+00:00 daily 0.8 http://www.pharma-marketer.com/cel-sci-reports-more-cash-higher-year-end-losses/ 2010-01-14T17:08:50+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeutics-has-strange-timing/ 2010-01-14T17:08:45+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-cancer-push-on-bone-drug-may-key-stock-turnaround-in-2010/ 2010-01-14T17:08:44+00:00 daily 0.8 http://www.pharma-marketer.com/merck-submits-data-to-widen-gardasil-use/ 2010-01-14T17:08:43+00:00 daily 0.8 http://www.pharma-marketer.com/mannkind-expects-fda-to-approve-inhaled-insulin/ 2010-01-14T17:08:42+00:00 daily 0.8 http://www.pharma-marketer.com/home-care-mergers-loom-for-amedysis-gentiva-on-overhaul-cuts/ 2010-01-14T17:08:38+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-layoffs-whose-jobs-are-safe-and-whose-arent/ 2010-01-14T17:08:36+00:00 daily 0.8 http://www.pharma-marketer.com/rise-of-multi-site-trials-prompts-fda-guidance-on-irbs/ 2010-01-14T17:08:33+00:00 daily 0.8 http://www.pharma-marketer.com/the-merck-rating-that-got-everybody-so-excited/ 2010-01-14T17:08:30+00:00 daily 0.8 http://www.pharma-marketer.com/here-are-those-fda-warning-lettersbayer-lilly-amylin-cephalon/ 2010-01-14T17:08:27+00:00 daily 0.8 http://www.pharma-marketer.com/enteromedics-bionovo-early-volume-plays/ 2010-01-14T17:08:24+00:00 daily 0.8 http://www.pharma-marketer.com/alnylam-pharma-guides/ 2010-01-14T17:08:20+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-oks-recordatis-carbaglu/ 2010-01-14T17:03:13+00:00 daily 0.8 http://www.pharma-marketer.com/affimed-spins-out-discovery-ops-focuses-on-lymphoma-drug/ 2010-01-14T16:51:18+00:00 daily 0.8 http://www.pharma-marketer.com/deal-on-the-horizon-for-medicures-heart-drug/ 2010-01-14T14:43:29+00:00 daily 0.8 http://www.pharma-marketer.com/gaining-and-losing-and-discovering-and-selling/ 2010-01-14T14:40:11+00:00 daily 0.8 http://www.pharma-marketer.com/2009-in-images-from-pharma-marketing-blog/ 2010-01-14T13:27:51+00:00 daily 0.8 http://www.pharma-marketer.com/the-san-francisco-treat/ 2010-01-14T06:42:34+00:00 daily 0.8 http://www.pharma-marketer.com/ddmac-warning-and-nov-letter-summary-third-and-fourth-quarters-part-1/ 2010-01-14T06:00:57+00:00 daily 0.8 http://www.pharma-marketer.com/ddmac-warning-and-nov-letter-summary-third-and-fourth-quarters-part-2/ 2010-01-14T05:59:02+00:00 daily 0.8 http://www.pharma-marketer.com/ddmac-warning-and-nov-letter-summary-third-and-fourth-quarters-part-3/ 2010-01-14T05:57:51+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-1810/ 2010-01-14T05:50:34+00:00 daily 0.8 http://www.pharma-marketer.com/eu-moves-slowly-to-enhance-patient-information-on-rx-products/ 2010-01-14T05:48:24+00:00 daily 0.8 http://www.pharma-marketer.com/can-pharma-quench-its-appetite/ 2010-01-14T05:20:39+00:00 daily 0.8 http://www.pharma-marketer.com/congratulations-youre-promoted-now-go-find-a-job/ 2010-01-14T05:17:26+00:00 daily 0.8 http://www.pharma-marketer.com/enzon-shares-close-up-after-rising-on-pfizer-rumor/ 2010-01-14T02:48:23+00:00 daily 0.8 http://www.pharma-marketer.com/vertex-adds-color-to-the-jpmorgan-healthcare-conference/ 2010-01-14T02:48:22+00:00 daily 0.8 http://www.pharma-marketer.com/witty-no-rivals-coming-for-advair/ 2010-01-14T02:48:20+00:00 daily 0.8 http://www.pharma-marketer.com/preliminary-data-from-nektar/ 2010-01-13T23:38:38+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-investor-suggests-sale-of-some-businesses/ 2010-01-13T23:38:37+00:00 daily 0.8 http://www.pharma-marketer.com/cubist-drug-cubicin-posted-524m-in-09-sales/ 2010-01-13T23:38:35+00:00 daily 0.8 http://www.pharma-marketer.com/merck-leads-drug-stocks-higher/ 2010-01-13T19:31:41+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-most-cerazyme-patients-resume-therapy/ 2010-01-13T19:31:39+00:00 daily 0.8 http://www.pharma-marketer.com/pdi-announces-recent-business-wins-totaling-51-million-in-revenue-for-2010/ 2010-01-13T19:31:37+00:00 daily 0.8 http://www.pharma-marketer.com/credit-suisse-upgrades-astrazeneca/ 2010-01-13T19:31:35+00:00 daily 0.8 http://www.pharma-marketer.com/lonza-closes-three-sites-cuts-175-jobs/ 2010-01-13T17:47:18+00:00 daily 0.8 http://www.pharma-marketer.com/study-biomedical-research-funding-is-slowing/ 2010-01-13T17:27:28+00:00 daily 0.8 http://www.pharma-marketer.com/despite-delay-mannkind-expects-quick-approval/ 2010-01-13T17:24:54+00:00 daily 0.8 http://www.pharma-marketer.com/treating-patients-means-more-than-writing-an-rx/ 2010-01-13T17:01:21+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-ceo-makes-his-case-but-icahn-looms/ 2010-01-13T16:50:47+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-sanofi-merck-heart-drugs-cut-alzheimera%c2%80%c2%99s-disease/ 2010-01-13T16:29:57+00:00 daily 0.8 http://www.pharma-marketer.com/sec-files-insider-trading-suit-against-drug-exec/ 2010-01-13T16:29:54+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharma-generic-competition-and-cash/ 2010-01-13T16:29:51+00:00 daily 0.8 http://www.pharma-marketer.com/biomedical-research-funding-is-slowing/ 2010-01-13T16:29:49+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-to-seek-u-s-approval-for-lupus-drug-this-year/ 2010-01-13T16:29:48+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-idec-says-tysabri-sales-top-1-billion-new-patients-grow-30-percent/ 2010-01-13T16:29:47+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-as-a-short-candidate/ 2010-01-13T16:29:43+00:00 daily 0.8 http://www.pharma-marketer.com/dendreon-sees-full-provenge-capacity-by-mid-2011/ 2010-01-13T16:29:41+00:00 daily 0.8 http://www.pharma-marketer.com/ahead-of-the-bell-merck-upgraded-on-drug-pipeline/ 2010-01-13T16:29:37+00:00 daily 0.8 http://www.pharma-marketer.com/credit-suisse-downgrades-glaxosmithkline/ 2010-01-13T16:29:35+00:00 daily 0.8 http://www.pharma-marketer.com/ftc-presses-for-an-end-to-a%c2%80%c2%98pay-to-delaya%c2%80%c2%99-deals/ 2010-01-13T16:29:33+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-ceo-on-pharmaa%c2%80%c2%99s-a%c2%80%c2%98lost-decadea%c2%80%c2%99/ 2010-01-13T16:29:32+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-backs-actelions-zavesca/ 2010-01-13T16:13:10+00:00 daily 0.8 http://www.pharma-marketer.com/steven-ratoff-named-novadel-president-and-ceo/ 2010-01-13T15:00:07+00:00 daily 0.8 http://www.pharma-marketer.com/adventrx-on-the-rise-after-near-death-experience/ 2010-01-13T14:27:25+00:00 daily 0.8 http://www.pharma-marketer.com/two-doses-of-crazy/ 2010-01-13T13:31:43+00:00 daily 0.8 http://www.pharma-marketer.com/competitive-schizophrenia-market/ 2010-01-13T04:37:21+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-exercises-drug-option/ 2010-01-13T04:37:20+00:00 daily 0.8 http://www.pharma-marketer.com/videodiabetes-setback/ 2010-01-13T04:37:19+00:00 daily 0.8 http://www.pharma-marketer.com/two-strikes-for-gileads-non-hiv-franchises/ 2010-01-13T04:37:18+00:00 daily 0.8 http://www.pharma-marketer.com/video-stocks-under-10-2-hot-biotech-names/ 2010-01-12T21:46:31+00:00 daily 0.8 http://www.pharma-marketer.com/bdsi-eyes-2b-market-with-fda-meeting/ 2010-01-12T21:46:30+00:00 daily 0.8 http://www.pharma-marketer.com/applause-for-fdas-new-fda-basics-initiative/ 2010-01-12T21:00:02+00:00 daily 0.8 http://www.pharma-marketer.com//davidjust-curious-on-your-insights-on-how-much-time-would-you-say-on-average-specialized-physicians-currently-spend-with-pharma-sales-reps-wk-want-to-spend-with-pharma-sales-reps-wkdo-y/ 2010-01-12T19:21:02+00:00 weekly 0.6 http://www.pharma-marketer.com/johnson-johnson-profitability-from-stability/ 2010-01-12T18:35:08+00:00 daily 0.8 http://www.pharma-marketer.com/the-price-of-lillys-cialis-has-doubled-since-its-launch/ 2010-01-12T18:35:04+00:00 daily 0.8 http://www.pharma-marketer.com/oxycontin-study-concealed-withdrawal-rates-10000-copies-sent-to-doctors/ 2010-01-12T18:34:56+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-says-48800-patients-now-on-tysabri/ 2010-01-12T18:34:52+00:00 daily 0.8 http://www.pharma-marketer.com/early-study-results-show-sciclones-zadaxin-makes-swine-flu-vaccine-focetria-more-effective/ 2010-01-12T18:34:51+00:00 daily 0.8 http://www.pharma-marketer.com/tocilizumab-approval-causes-buzz/ 2010-01-12T18:34:50+00:00 daily 0.8 http://www.pharma-marketer.com/vical-collategene-gets-ok-for-late-stage-trial/ 2010-01-12T18:34:45+00:00 daily 0.8 http://www.pharma-marketer.com/exelixis-volatility-expected-to-subside-in-2010/ 2010-01-12T18:34:44+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-leads-drug-stocks-lower/ 2010-01-12T18:34:43+00:00 daily 0.8 http://www.pharma-marketer.com/notes-from-jp-morgan-rochentech/ 2010-01-12T18:34:42+00:00 daily 0.8 http://www.pharma-marketer.com/antipsychotic-use-dropped-19-after-warning/ 2010-01-12T18:34:41+00:00 daily 0.8 http://www.pharma-marketer.com/what-did-glaxosmithkline-get-in-return-for-buying-sirtris/ 2010-01-12T18:34:40+00:00 daily 0.8 http://www.pharma-marketer.com/dendreon-upbeat-on-ability-to-make-provenge-next-year/ 2010-01-12T17:57:37+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-questions-recordati-drug/ 2010-01-12T17:47:38+00:00 daily 0.8 http://www.pharma-marketer.com/pharmaxis-buys-topigen-in-all-stock-deal/ 2010-01-12T16:25:09+00:00 daily 0.8 http://www.pharma-marketer.com/if-social-media-for-pharma-is-like-space-exploration-how-far-will-it-go-and-how-long-will-it-take/ 2010-01-12T16:25:08+00:00 daily 0.8 http://www.pharma-marketer.com/ventirx-scores-25m-in-vc/ 2010-01-12T14:27:16+00:00 daily 0.8 http://www.pharma-marketer.com/sec-sues-former-indevus-exec-over-insider-trading-allegations/ 2010-01-12T14:21:21+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-says-four-in-one-pill-may-be-key-hiv-product/ 2010-01-12T14:21:19+00:00 daily 0.8 http://www.pharma-marketer.com/medicines-co-cuts-10-of-jobs/ 2010-01-12T14:03:23+00:00 daily 0.8 http://www.pharma-marketer.com//hiwhat-have-you-seen-as-the-most-successful-online-marketing-program-lately-how-was-success-definedthanksdomenicomeasurement-consultant/ 2010-01-12T13:39:02+00:00 weekly 0.6 http://www.pharma-marketer.com/the-sirtris-compounds-worthless-really/ 2010-01-12T13:23:20+00:00 daily 0.8 http://www.pharma-marketer.com/bullish-new-years-resolutions-debut-at-the-j-p-morgan-event/ 2010-01-12T12:48:16+00:00 daily 0.8 http://www.pharma-marketer.com/pharmanewsrss/ 2010-01-12T10:52:50+00:00 weekly 0.6 http://www.pharma-marketer.com/customfeed/ 2010-01-12T10:08:30+00:00 weekly 0.6 http://www.pharma-marketer.com/stocks-to-watch-at-biotecha%c2%80%c2%99s-bellwether-conference/ 2010-01-12T09:51:28+00:00 daily 0.8 http://www.pharma-marketer.com/celgene-revs-up-for-a-new-year/ 2010-01-12T07:32:21+00:00 daily 0.8 http://www.pharma-marketer.com/if-we-are-to-cut-health-care-costs-than-patient-compliance-programs-have-to-get-a-lot-better/ 2010-01-12T07:13:46+00:00 daily 0.8 http://www.pharma-marketer.com/im-your-customer-are-you-listening-to-me-and-i-am-important-to-you/ 2010-01-12T07:11:50+00:00 daily 0.8 http://www.pharma-marketer.com/physicians-use-the-internet-but-who-can-bring-it-all-together/ 2010-01-12T07:10:21+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-rejects-new-use-for-forest-heart-drug/ 2010-01-12T04:17:16+00:00 daily 0.8 http://www.pharma-marketer.com/javelin-merger-hit-by-class-action-flurry/ 2010-01-12T00:56:17+00:00 daily 0.8 http://www.pharma-marketer.com/pharmaceuticals-big-firms-will-fight-the-patent-cliff/ 2010-01-12T00:56:15+00:00 daily 0.8 http://www.pharma-marketer.com/biocryst-says-merck-serono-and-hikma-will-handle-some-international-peramivir-marketing/ 2010-01-12T00:56:14+00:00 daily 0.8 http://www.pharma-marketer.com/cubist-pharmaceuticals-reports-560-3-million-in-2009-revenue-meets-wall-street-forecast/ 2010-01-12T00:56:14+00:00 daily 0.8 http://www.pharma-marketer.com/investigators-say-price-hikes-on-drugs-increasing/ 2010-01-12T00:56:13+00:00 daily 0.8 http://www.pharma-marketer.com/shareholders-file-lawsuit-against-novartis-alcon-over-merger-ksf-announces-lawsuit/ 2010-01-12T00:56:12+00:00 daily 0.8 http://www.pharma-marketer.com/charles-river-cuts-300-jobs/ 2010-01-12T00:38:54+00:00 daily 0.8 http://www.pharma-marketer.com/vertex-2009-loss-less-than-650-million/ 2010-01-11T21:17:42+00:00 daily 0.8 http://www.pharma-marketer.com/johnson-johnson-my-first-pick-of-2010/ 2010-01-11T21:17:39+00:00 daily 0.8 http://www.pharma-marketer.com/vivus-reports-positive-data-on-ed-drug-candidate/ 2010-01-11T21:17:37+00:00 daily 0.8 http://www.pharma-marketer.com/results-of-mercka%c2%80%c2%99s-vytorin-trial-delayed-a-year/ 2010-01-11T21:17:36+00:00 daily 0.8 http://www.pharma-marketer.com/sure-about-that/ 2010-01-11T18:04:47+00:00 daily 0.8 http://www.pharma-marketer.com/david-best-m-d-direct-to-physician-expert/ 2010-01-11T17:59:58+00:00 weekly 0.6 http://www.pharma-marketer.com/fda-to-blame-for-mannkind-delay/ 2010-01-11T17:37:25+00:00 daily 0.8 http://www.pharma-marketer.com/move-to-recover-cost-of-flu-vaccine/ 2010-01-11T17:37:23+00:00 daily 0.8 http://www.pharma-marketer.com/new-market-for-abbotts-xience-v/ 2010-01-11T17:37:21+00:00 daily 0.8 http://www.pharma-marketer.com/sanofia%c2%80%c2%99s-vaccine-for-mosquito-virus-protects-adults-study-says/ 2010-01-11T17:37:20+00:00 daily 0.8 http://www.pharma-marketer.com/isis-pharmaceuticals-adds-new-cardiovascular-drug-to-development-pipeline/ 2010-01-11T17:37:19+00:00 daily 0.8 http://www.pharma-marketer.com/merck-layoffs-whose-jobs-are-safe-and-whose-arent/ 2010-01-11T17:37:18+00:00 daily 0.8 http://www.pharma-marketer.com/acetylon-pharma-lands-2m-in-financing/ 2010-01-11T17:37:15+00:00 daily 0.8 http://www.pharma-marketer.com/former-amgen-rep-stymied-by-arbitration/ 2010-01-11T17:37:15+00:00 daily 0.8 http://www.pharma-marketer.com/map-pharma-says-fda-doesnt-need-new-levadex-study/ 2010-01-11T17:37:13+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-rise-map-and-vivus-gain-on-drug-updates/ 2010-01-11T17:37:12+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-funds-new-unbiased-cme-at-stanford/ 2010-01-11T17:37:11+00:00 daily 0.8 http://www.pharma-marketer.com/galapagos-roche-enter-588-7m-copd-alliance/ 2010-01-11T17:37:02+00:00 daily 0.8 http://www.pharma-marketer.com/u-s-trims-h1n1-vaccine-order-from-csl-as-global-interest-wanes/ 2010-01-11T17:37:01+00:00 daily 0.8 http://www.pharma-marketer.com/vivus-posts-more-positive-ed-data/ 2010-01-11T17:36:08+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-marketing-vs-healthcare-communication/ 2010-01-11T17:30:39+00:00 daily 0.8 http://www.pharma-marketer.com/targacept-gets-200m-payment-from-astrazeneca/ 2010-01-11T15:22:32+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-touts-dengue-fever-vaccine-data/ 2010-01-11T15:12:22+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-to-progress-development-of-chemocentryxs-traficet-en/ 2010-01-11T15:10:46+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-roches-actemra-for-ra/ 2010-01-11T14:47:39+00:00 daily 0.8 http://www.pharma-marketer.com/mannkind-hit-with-insulin-inhaler-delay/ 2010-01-11T14:42:29+00:00 daily 0.8 http://www.pharma-marketer.com/magl-a-new-cancer-target/ 2010-01-11T13:45:04+00:00 daily 0.8 http://www.pharma-marketer.com//richardthere-are-a-number-of-initiatives-in-pharma-to-develop-iphone-apps-for-physicians-what-are-your-thoughts-on-iphone-apps-for-hcps-in-the-pharma-industry-do-you-have-experience-with-efforts/ 2010-01-11T13:07:03+00:00 weekly 0.6 http://www.pharma-marketer.com/is-carl-icahn-going-for-genzyme/ 2010-01-11T07:28:43+00:00 daily 0.8 http://www.pharma-marketer.com/cytori-gets-fda-510k-celution-clearance-heart-data-pending/ 2010-01-10T19:22:51+00:00 daily 0.8 http://www.pharma-marketer.com/keryx-biopharma-a-well-capitalized-comeback-story-with-multiple-catalysts/ 2010-01-10T19:22:50+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharma-feed-biotech-startups-record-funds/ 2010-01-10T19:22:49+00:00 daily 0.8 http://www.pharma-marketer.com/adeona-announces-additional-860000-grant-for-oral-estriol-multiple-sclerosis-clinical-trial/ 2010-01-10T19:22:48+00:00 daily 0.8 http://www.pharma-marketer.com/hi-tech-pharmacal-co-inc-to-introduce-new-dermatitis-treatment/ 2010-01-10T19:22:46+00:00 daily 0.8 http://www.pharma-marketer.com/mylan-pre-pays-all-scheduled-2011-term-loan-borrowings/ 2010-01-10T19:22:45+00:00 daily 0.8 http://www.pharma-marketer.com/biomarin-pharmaceutical-bmrn-downgrade-alert-watch-for-51-8-technical-uptrend-reversal/ 2010-01-10T19:22:44+00:00 daily 0.8 http://www.pharma-marketer.com/acton-pharmaceuticals-raises-15-million-in-series-a-financing/ 2010-01-10T19:22:44+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-gets-a-strong-start-in-financing-for-the-new-year/ 2010-01-10T19:22:43+00:00 daily 0.8 http://www.pharma-marketer.com/pharmaceutical-firm-nanobio-attracts-investments-and-partnerships/ 2010-01-10T19:22:42+00:00 daily 0.8 http://www.pharma-marketer.com/eyegate-pharma-secures-22m-in-series-d-venture-funding-for-continued-development-of-egp-437-for-dry-eye-syndrome/ 2010-01-10T19:22:41+00:00 daily 0.8 http://www.pharma-marketer.com/biovectra-confirms-partnership-to-market-docetaxel-in-the-u-s-a/ 2010-01-10T19:22:40+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-low-debt-high-dividend-healthcare-stock/ 2010-01-10T19:22:38+00:00 daily 0.8 http://www.pharma-marketer.com/october-2009-%e2%80%93-panel-experts/ 2010-01-10T05:12:51+00:00 daily 0.8 http://www.pharma-marketer.com/roche-wins-u-s-approval-for-arthritis-drug-actemra/ 2010-01-09T22:26:17+00:00 daily 0.8 http://www.pharma-marketer.com/biovel-lifesciences-may-be-bought-over-by-ranbaxy-for-about-rs-50-cr/ 2010-01-09T22:26:16+00:00 daily 0.8 http://www.pharma-marketer.com/the-wrong-story-about-depression/ 2010-01-09T22:26:14+00:00 daily 0.8 http://www.pharma-marketer.com/china-sky-one-medical-inc-lists-on-nasdaq-global-select-market/ 2010-01-09T22:26:13+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-and-strides-arcolab-form-partnership-for-generic-products/ 2010-01-09T22:26:12+00:00 daily 0.8 http://www.pharma-marketer.com/watson-laboratories-inc-files-anda-with-fda-for-generic-nuvigil/ 2010-01-09T22:26:12+00:00 daily 0.8 http://www.pharma-marketer.com/china-medicine-corporation-enters-into-a-69-6-million-financing-agreement-with-one-equity-partners/ 2010-01-09T22:26:11+00:00 daily 0.8 http://www.pharma-marketer.com/elixir-announces-first-sirtuin-inhibitor-clinical-trial/ 2010-01-09T22:26:10+00:00 daily 0.8 http://www.pharma-marketer.com/novelos-therapeutics-reaches-725th-event-in-pivotal-phase-3-lung-cancer-trial/ 2010-01-09T22:26:09+00:00 daily 0.8 http://www.pharma-marketer.com/despite-fda-recommendation-for-postmarketing-surveillance-amgens-prolia-will-achieve-blockbuster-sales-for-treatment-o/ 2010-01-09T22:26:09+00:00 daily 0.8 http://www.pharma-marketer.com/sopherion-gets-us-fda-fast-track-status-for-myocet-in-metastatic-breast-cancer/ 2010-01-09T22:26:08+00:00 daily 0.8 http://www.pharma-marketer.com/teva-sees-revenue-more-than-doubling-by-2015/ 2010-01-09T22:26:06+00:00 daily 0.8 http://www.pharma-marketer.com/kindler-reveals-some-dos-and-donts-for-pfizer/ 2010-01-09T22:26:05+00:00 daily 0.8 http://www.pharma-marketer.com/oncogenex-pharmaceutical-downward-momentum-looks-to-continue-ogxi/ 2010-01-09T22:26:02+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-squibb-company-nysebmy-to-release-q4-earnings-january-28/ 2010-01-09T22:26:01+00:00 daily 0.8 http://www.pharma-marketer.com/savient-provides-update-on-krystexxatm-bla-resubmission-activities/ 2010-01-09T19:01:51+00:00 daily 0.8 http://www.pharma-marketer.com/cytori-gets-fda-approval-for-puregraft-system/ 2010-01-09T19:01:50+00:00 daily 0.8 http://www.pharma-marketer.com/mannkind-updates-status-of-new-drug-application/ 2010-01-09T19:01:49+00:00 daily 0.8 http://www.pharma-marketer.com/vical-secures-25-million-issuer-managed-equity-facility-with-azimuth-opportunity-ltd/ 2010-01-09T19:01:48+00:00 daily 0.8 http://www.pharma-marketer.com/emergent-biosolutions-lowers-its-debt-payments/ 2010-01-09T19:01:47+00:00 daily 0.8 http://www.pharma-marketer.com/csi-trimeris-arigene/ 2010-01-09T19:01:46+00:00 daily 0.8 http://www.pharma-marketer.com/teva-and-the-narrowing-gap-between-generics-and-big-pharma/ 2010-01-09T19:01:45+00:00 daily 0.8 http://www.pharma-marketer.com/abbotts-stent-struggling-to-maintain-market-share/ 2010-01-09T19:01:44+00:00 daily 0.8 http://www.pharma-marketer.com/do-social-media-apps-improve-health-care/ 2010-01-09T17:24:14+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-having-a-garage-sale/ 2010-01-09T00:41:53+00:00 daily 0.8 http://www.pharma-marketer.com/a-little-bit-more-on-the-job-cuts-at-merck-pfizer/ 2010-01-08T20:35:22+00:00 daily 0.8 http://www.pharma-marketer.com/boston-scientific-stent-shouldna%c2%80%c2%99t-be-used-regularly-study-says/ 2010-01-08T20:35:21+00:00 daily 0.8 http://www.pharma-marketer.com/house-may-tax-payrolls-drop-wealth-levy-to-finance-health-plan/ 2010-01-08T20:35:20+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-currently-undervalued/ 2010-01-08T20:35:19+00:00 daily 0.8 http://www.pharma-marketer.com/chinas-vaccine-sector-how-to-get-in-the-game/ 2010-01-08T20:35:18+00:00 daily 0.8 http://www.pharma-marketer.com/judge-quashes-subpoenas-in-generic-plavix-case/ 2010-01-08T20:35:17+00:00 daily 0.8 http://www.pharma-marketer.com/biotechs-your-ultimate-survival-guide-for-the-years-biggest-confab-j-p-morgan/ 2010-01-08T20:35:16+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-stock-mailbag-novelos-therapeutics-and-more/ 2010-01-08T20:35:14+00:00 daily 0.8 http://www.pharma-marketer.com/judge-tosses-two-more-seroquel-lawsuits/ 2010-01-08T20:35:14+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-cytori-fat-grafting-system/ 2010-01-08T20:35:13+00:00 daily 0.8 http://www.pharma-marketer.com/fda-review-info-unavailable-for-popular-drugs/ 2010-01-08T20:35:12+00:00 daily 0.8 http://www.pharma-marketer.com/will-teva-join-big-pharma-by-2015/ 2010-01-08T20:35:11+00:00 daily 0.8 http://www.pharma-marketer.com/find-that-pattern/ 2010-01-08T18:48:19+00:00 daily 0.8 http://www.pharma-marketer.com/acell-hunts-for-manufacturing-site/ 2010-01-08T17:22:14+00:00 daily 0.8 http://www.pharma-marketer.com/molecular-insight-cuts-jobs-in-realignment/ 2010-01-08T17:09:35+00:00 daily 0.8 http://www.pharma-marketer.com/phasebio-eyegate-raise-venture-funding/ 2010-01-08T15:23:19+00:00 daily 0.8 http://www.pharma-marketer.com/clavis-pharma-gets-orphan-drug-status-new-ceo/ 2010-01-08T15:17:27+00:00 daily 0.8 http://www.pharma-marketer.com/see-our-ad-in-redbook/ 2010-01-08T15:07:53+00:00 daily 0.8 http://www.pharma-marketer.com/reasons-not-to-go-to-grad-school/ 2010-01-08T14:47:59+00:00 daily 0.8 http://www.pharma-marketer.com/carl-icahn-going-for-genzyme/ 2010-01-08T14:32:33+00:00 daily 0.8 http://www.pharma-marketer.com/2010-what-will-change/ 2010-01-08T14:12:33+00:00 daily 0.8 http://www.pharma-marketer.com/reatas-ckd-program-wins-272m-asian-pact/ 2010-01-08T13:56:58+00:00 daily 0.8 http://www.pharma-marketer.com/how-tablet-computers-will-revolutionize-drug-sales-people/ 2010-01-08T05:04:52+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-were-gonna-make-a-movie-but-its-not-for-promotional-purposes/ 2010-01-08T05:03:24+00:00 daily 0.8 http://www.pharma-marketer.com/states-reach-settlement-with-abbott/ 2010-01-08T04:10:05+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-strides-farther-into-generics/ 2010-01-08T04:10:03+00:00 daily 0.8 http://www.pharma-marketer.com/teva-sets-goal-to-double-revenue-by-2015/ 2010-01-08T04:10:02+00:00 daily 0.8 http://www.pharma-marketer.com/icahn-considering-proxy-battle-at-genzyme-source/ 2010-01-08T04:09:47+00:00 daily 0.8 http://www.pharma-marketer.com/david-best-m-d-%e2%80%93-direct-to-physician-expert/ 2010-01-08T01:27:39+00:00 daily 0.8 http://www.pharma-marketer.com/july-2009-%e2%80%93-panel-experts/ 2010-01-08T01:24:42+00:00 daily 0.8 http://www.pharma-marketer.com/august-2009-panel-experts/ 2010-01-08T01:24:31+00:00 daily 0.8 http://www.pharma-marketer.com/icahn-to-launch-battle-for-genzyme/ 2010-01-07T20:22:10+00:00 daily 0.8 http://www.pharma-marketer.com/healthcare-and-pharma-social-media-it%e2%80%99s-all-about-e-v-e/ 2010-01-07T19:40:39+00:00 daily 0.8 http://www.pharma-marketer.com/navigating-regulatory-issues-on-the-web/ 2010-01-07T19:38:23+00:00 daily 0.8 http://www.pharma-marketer.com/why-we-all-need-to-care-about-diabetes%e2%80%a6and-12-social-initiatives/ 2010-01-07T19:32:40+00:00 daily 0.8 http://www.pharma-marketer.com/jonathan-richman-%e2%80%93-non-personal-promotion-expert/ 2010-01-07T19:13:41+00:00 daily 0.8 http://www.pharma-marketer.com/dawn-obermoeller-%e2%80%93-social-media-expert/ 2010-01-07T19:13:34+00:00 daily 0.8 http://www.pharma-marketer.com/heather-reilly-powell-%e2%80%93-regulatory-expert/ 2010-01-07T19:13:27+00:00 daily 0.8 http://www.pharma-marketer.com/optimize-rx-%e2%80%93-internet-marketing-analytics-expert/ 2010-01-07T19:13:20+00:00 daily 0.8 http://www.pharma-marketer.com/sally-church-%e2%80%93-pharma-strategy-expert/ 2010-01-07T19:13:14+00:00 daily 0.8 http://www.pharma-marketer.com/jae-chung-%e2%80%93-health-systems-2-0-expert/ 2010-01-07T19:13:04+00:00 daily 0.8 http://www.pharma-marketer.com/janet-carlson-%e2%80%93-mobile-marketing-expert/ 2010-01-07T19:12:55+00:00 daily 0.8 http://www.pharma-marketer.com/deborah-newkerk-%e2%80%93-dtc-expert/ 2010-01-07T19:12:48+00:00 daily 0.8 http://www.pharma-marketer.com/richard-prest-%e2%80%93-pharma-technology-expert/ 2010-01-07T19:12:07+00:00 daily 0.8 http://www.pharma-marketer.com/richard-meyer-%e2%80%93-dtc-expert/ 2010-01-07T19:12:00+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-please-invite-me-to-the-sundance-panel-screening-of-your-new-alli-inspired-documentary-film/ 2010-01-07T19:11:53+00:00 daily 0.8 http://www.pharma-marketer.com/ellen-hoenig-carlson-%e2%80%93-strategy-expert/ 2010-01-07T19:11:12+00:00 daily 0.8 http://www.pharma-marketer.com/mannkind-shares-gain-ground-ahead-of-fda-decision/ 2010-01-07T18:09:43+00:00 daily 0.8 http://www.pharma-marketer.com/amgena%c2%80%c2%99s-jja%c2%80%c2%99s-anemia-drugs-face-fda-advisory-review-on-dose/ 2010-01-07T18:09:42+00:00 daily 0.8 http://www.pharma-marketer.com/lundbeck-faces-eu-antitrust-probe-into-generic-sales/ 2010-01-07T18:09:41+00:00 daily 0.8 http://www.pharma-marketer.com/zymogenetics-selling-12m-shares-of-stock-to-raise-80m-2/ 2010-01-07T18:09:40+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-to-buy-aclon-will-the-gurus-sell-2/ 2010-01-07T18:09:35+00:00 daily 0.8 http://www.pharma-marketer.com/ceo-james-mullens-departure-from-biogen-idec-the-good-the-bad-and-the-ugly-2/ 2010-01-07T18:09:33+00:00 daily 0.8 http://www.pharma-marketer.com/videobiotech-2010-winners-2/ 2010-01-07T18:09:31+00:00 daily 0.8 http://www.pharma-marketer.com/cephalons-nuvigil-under-pressure/ 2010-01-07T18:09:29+00:00 daily 0.8 http://www.pharma-marketer.com/diet-drug-maker-glaxo-to-pay-for-a-film-on-eating-2/ 2010-01-07T18:09:29+00:00 daily 0.8 http://www.pharma-marketer.com/analyst-chinas-vax-industry-poised-for-fast-growth/ 2010-01-07T18:09:27+00:00 daily 0.8 http://www.pharma-marketer.com/an-interview-with-somaxon-pharma-ceo-pascoe-part-i-efficacy-and-uncertainty-of-sleep-drug-silenor/ 2010-01-07T18:09:26+00:00 daily 0.8 http://www.pharma-marketer.com/vivus-says-mid-stage-study-shows-its-obesity-drug-candidate-qnexa-reduced-sleep-apnea-symptoms/ 2010-01-07T18:09:25+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-drugs-to-watch-in-2010/ 2010-01-07T18:09:24+00:00 daily 0.8 http://www.pharma-marketer.com/is-xmrv-the-cause-of-chronic-fatigue-syndrome-or-anything-2/ 2010-01-07T17:47:58+00:00 daily 0.8 http://www.pharma-marketer.com/chinas-vax-industry-poised-for-rapid-growth/ 2010-01-07T16:45:41+00:00 daily 0.8 http://www.pharma-marketer.com/embattled-genzyme-chief-wins-key-investors-support/ 2010-01-07T16:41:57+00:00 daily 0.8 http://www.pharma-marketer.com/debiopharm-takes-second-stab-at-failed-pfizer-cancer-drug/ 2010-01-07T15:54:25+00:00 daily 0.8 http://www.pharma-marketer.com/extortion-retractions-and-more/ 2010-01-07T14:27:02+00:00 daily 0.8 http://www.pharma-marketer.com/japanese-cloth-company-trumps-merck-pfizer-in-new-drug-approvals/ 2010-01-07T14:13:44+00:00 daily 0.8 http://www.pharma-marketer.com/vivus-qnexa-also-proves-promising-for-sleep-apnea/ 2010-01-07T14:02:17+00:00 daily 0.8 http://www.pharma-marketer.com/still-fixing-pfizer/ 2010-01-07T02:43:16+00:00 daily 0.8 http://www.pharma-marketer.com/what-mercka%c2%80%c2%99s-ceo-said-today-about-possible-job-cuts/ 2010-01-07T02:43:10+00:00 daily 0.8 http://www.pharma-marketer.com/qa-a-look-at-the-contract-rd-job-market/ 2010-01-06T21:05:21+00:00 daily 0.8 http://www.pharma-marketer.com/five-technologies-for-the-scrap-heap/ 2010-01-06T19:33:00+00:00 daily 0.8 http://www.pharma-marketer.com/a-common-goal-of-research-and-marketing-fool-the-doctor/ 2010-01-06T19:23:27+00:00 daily 0.8 http://www.pharma-marketer.com/vasellaa%c2%80%c2%99s-persistence-pays-off-as-novartis-gains-alcona%c2%80%c2%99s-growth/ 2010-01-06T19:18:14+00:00 daily 0.8 http://www.pharma-marketer.com/gileads-hiv-pill-works-in-mid-stage-study/ 2010-01-06T19:18:13+00:00 daily 0.8 http://www.pharma-marketer.com/a%c2%80%c2%98salami-slicinga%c2%80%c2%99-promoted-lillya%c2%80%c2%99s-cymbalta-study/ 2010-01-06T19:18:11+00:00 daily 0.8 http://www.pharma-marketer.com/the-real-reason-for-lillys-rd-outsourcing/ 2010-01-06T19:18:11+00:00 daily 0.8 http://www.pharma-marketer.com/celgenes-2010-guidance-key-event-next-week/ 2010-01-06T19:18:10+00:00 daily 0.8 http://www.pharma-marketer.com/which-drugs-have-the-biggest-pre-tax-margins/ 2010-01-06T19:18:10+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-and-strides-arcolab-to-collaborate-on-generic-products/ 2010-01-06T19:18:09+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-inch-up-gilead-gains-on-hiv-study/ 2010-01-06T19:18:08+00:00 daily 0.8 http://www.pharma-marketer.com/daiichi-sankyo-subsidiary-acquires-pharmaforce/ 2010-01-06T19:18:07+00:00 daily 0.8 http://www.pharma-marketer.com/vultures-descend-and-phoenixes-rise-in-the-wake-of-biotech-consolidation/ 2010-01-06T19:18:06+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-restructures-hr-with-job-cost-cuts/ 2010-01-06T19:18:04+00:00 daily 0.8 http://www.pharma-marketer.com/how-tablet-computing-will-revolutionize-healthcare/ 2010-01-06T19:14:20+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-shares-surge-on-promising-hiv-trial/ 2010-01-06T17:57:46+00:00 daily 0.8 http://www.pharma-marketer.com/see-you-in-san-francisco%e2%80%a6/ 2010-01-06T17:44:35+00:00 daily 0.8 http://www.pharma-marketer.com/mannkind-defies-analysts-skeptical-of-inhaled-insulin-drug/ 2010-01-06T17:31:40+00:00 daily 0.8 http://www.pharma-marketer.com/marketings-right-message-to-right-person-at-right-time-mantra/ 2010-01-06T17:19:17+00:00 daily 0.8 http://www.pharma-marketer.com/ensemble-discovery-snares-its-second-big-development-pact/ 2010-01-06T16:58:25+00:00 daily 0.8 http://www.pharma-marketer.com/geron-stem-cell-therapy-promising-in-the-lab/ 2010-01-06T16:39:05+00:00 daily 0.8 http://www.pharma-marketer.com/dtc-marketing-oncology-a-perfect-match-for-social-media/ 2010-01-06T15:57:58+00:00 daily 0.8 http://www.pharma-marketer.com/new-ceo-navigates-combinatorxs-revolving-door/ 2010-01-06T15:57:27+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-idecs-mullen-to-step-down/ 2010-01-06T15:15:02+00:00 daily 0.8 http://www.pharma-marketer.com/aryx-gets-fda-guidance-on-blood-clot-drug-that-failed-trial/ 2010-01-06T14:56:51+00:00 daily 0.8 http://www.pharma-marketer.com/fda-cancels-meeting-to-review-lillys-cymbalta/ 2010-01-06T14:56:49+00:00 daily 0.8 http://www.pharma-marketer.com/lillys-rd-outsourcing/ 2010-01-06T14:37:08+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-drug-approvals-spiked-in-2009/ 2010-01-06T14:12:44+00:00 daily 0.8 http://www.pharma-marketer.com/lillys-effient-cheap-enough-for-now/ 2010-01-06T00:41:40+00:00 daily 0.8 http://www.pharma-marketer.com/placebos-vs-antidepressants-not-quite-a-draw/ 2010-01-06T00:41:39+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-highest-margins-in-biotech/ 2010-01-05T20:49:35+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-dip-biogen-climbs-on-ceo-update/ 2010-01-05T20:49:34+00:00 daily 0.8 http://www.pharma-marketer.com/biotechs-best-quotes-go-straight-to-the-heart-of-2009-industry-trends/ 2010-01-05T20:49:33+00:00 daily 0.8 http://www.pharma-marketer.com/geron-reports-anticancer-activity-in-preclinical-study-on-developing-drug-imetelstat/ 2010-01-05T20:49:31+00:00 daily 0.8 http://www.pharma-marketer.com/fda-drug-approvals-mostly-flat-in-2009-as-new-leadership-takes-reins-at-agency/ 2010-01-05T20:49:30+00:00 daily 0.8 http://www.pharma-marketer.com/5-star-stocks-poised-to-pop-johnson-johnson/ 2010-01-05T20:49:30+00:00 daily 0.8 http://www.pharma-marketer.com/always-read-the-fine-print/ 2010-01-05T20:24:37+00:00 daily 0.8 http://www.pharma-marketer.com/former-idera-chief-hunts-money-to-back-biotech-startup/ 2010-01-05T18:12:33+00:00 daily 0.8 http://www.pharma-marketer.com/aryx-gets-fda-nod-on-tecarfarin-path/ 2010-01-05T17:34:02+00:00 daily 0.8 http://www.pharma-marketer.com/paul-capital-earmarks-100m-for-late-stage-developer/ 2010-01-05T17:18:15+00:00 daily 0.8 http://www.pharma-marketer.com/schering-plough-wins-approval-of-165-million-investor-accord/ 2010-01-05T16:33:19+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-links-up-with-hospira-for-manufacturing-help/ 2010-01-05T16:33:18+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-apo-a1-milano-flop-typical-for-big-pharma-deals/ 2010-01-05T16:33:16+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-ceo-calls-it-quits-after-7-turbulent-years/ 2010-01-05T16:33:15+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-taps-contractors-to-revive-pipeline/ 2010-01-05T16:33:00+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-may-raise-bid-to-appease-alcon-holders-analysts-say/ 2010-01-05T16:32:59+00:00 daily 0.8 http://www.pharma-marketer.com/dr-reddya%c2%80%c2%99s-gains-after-diabetes-drug-meets-trial-aim/ 2010-01-05T16:32:58+00:00 daily 0.8 http://www.pharma-marketer.com/dainippon-files-for-approval-of-blockbuster-schizophrenia-drug/ 2010-01-05T16:32:57+00:00 daily 0.8 http://www.pharma-marketer.com/new-yeara%c2%80%c2%99s-resolution-for-biopharma-submit-better-ndas/ 2010-01-05T16:32:42+00:00 daily 0.8 http://www.pharma-marketer.com/speculative-observation-cephalon-at-62-42/ 2010-01-05T16:32:41+00:00 daily 0.8 http://www.pharma-marketer.com/ariad-v-lilly-a-case-that-may-reshape-patent-law/ 2010-01-05T16:32:40+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-sets-out-to-rewrite-the-rd-playbook/ 2010-01-05T16:19:54+00:00 daily 0.8 http://www.pharma-marketer.com/filling-the-social-media-void-shout-or-be-shouted-at/ 2010-01-05T13:29:21+00:00 daily 0.8 http://www.pharma-marketer.com/run-it-past-the-chemists/ 2010-01-05T13:27:52+00:00 daily 0.8 http://www.pharma-marketer.com/alcon-novartis-deal-may-hurt-minority-holders/ 2010-01-05T13:25:32+00:00 daily 0.8 http://www.pharma-marketer.com/daughter-of-new-york-jets-owner-heiress-to-johnson-johnson-empire-found-dead-in-her-home/ 2010-01-05T13:25:31+00:00 daily 0.8 http://www.pharma-marketer.com/sarkozy-under-fire-on-flu-vaccine-a%c2%80%c2%98fiascoa%c2%80%c2%99/ 2010-01-05T13:25:30+00:00 daily 0.8 http://www.pharma-marketer.com/medicines-co-suing-teva-pliva-again-over-patent/ 2010-01-05T13:25:28+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-up-3-as-europe-okays-hypertension-drug/ 2010-01-04T22:56:26+00:00 daily 0.8 http://www.pharma-marketer.com/dynavax-wraps-up-symphony-dynamo-deal/ 2010-01-04T22:56:25+00:00 daily 0.8 http://www.pharma-marketer.com/fda-delay-of-prevnar-13-could-be-trouble-for-pfizer/ 2010-01-04T22:56:20+00:00 daily 0.8 http://www.pharma-marketer.com/once-again-the-fda-gets-it-wrong-when-it-comes-to-fair-balance/ 2010-01-04T19:57:08+00:00 daily 0.8 http://www.pharma-marketer.com/does-alcon-deal-stack-up-for-novartis/ 2010-01-04T19:37:14+00:00 daily 0.8 http://www.pharma-marketer.com/is-the-rally-for-real-biotech-sources-argue-yes-and-no/ 2010-01-04T19:37:13+00:00 daily 0.8 http://www.pharma-marketer.com/valeant-drug-accepted-by-fda/ 2010-01-04T19:37:13+00:00 daily 0.8 http://www.pharma-marketer.com/call-big-pharma-a-dtc-conservative/ 2010-01-04T19:37:11+00:00 daily 0.8 http://www.pharma-marketer.com/scrutiny-of-drug-industry-gifts-to-docs-goes-global/ 2010-01-04T19:37:10+00:00 daily 0.8 http://www.pharma-marketer.com/hire-me-to-speak-to-your-people-cheap/ 2010-01-04T19:07:49+00:00 daily 0.8 http://www.pharma-marketer.com/the-trouble-with-youtube-yaz-case-study/ 2010-01-04T17:35:57+00:00 daily 0.8 http://www.pharma-marketer.com/dicerna-lands-124m-rnai-development-pact/ 2010-01-04T17:02:15+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-looks-to-buy-the-rest-of-alcon/ 2010-01-04T16:37:09+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-discontinues-cancer-drug-biotechs-recently-missed-targets/ 2010-01-04T16:37:07+00:00 daily 0.8 http://www.pharma-marketer.com/senate-likely-to-have-edge-as-democrats-craft-final-health-bill/ 2010-01-04T16:37:06+00:00 daily 0.8 http://www.pharma-marketer.com/intermune-gets-fda-priority-review-for-pirfenidone/ 2010-01-04T16:37:05+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-1-3b-esperion-loss-contained-a-426m-tax-win/ 2010-01-04T16:37:04+00:00 daily 0.8 http://www.pharma-marketer.com/cipher-to-seek-u-s-approval-for-pain-treatment/ 2010-01-04T16:37:02+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-others-may-benefit-from-reform-barrons/ 2010-01-04T16:37:01+00:00 daily 0.8 http://www.pharma-marketer.com/indias-cipla-in-drug-supply-talks-with-gsk-teva/ 2010-01-04T16:37:01+00:00 daily 0.8 http://www.pharma-marketer.com/anesiva-ends-2009-with-a-bankruptcy-petition/ 2010-01-04T16:37:00+00:00 daily 0.8 http://www.pharma-marketer.com/biotechs-movers-and-shakers-2009-biobuzz/ 2010-01-04T16:36:59+00:00 daily 0.8 http://www.pharma-marketer.com/dr-reddys-spotlights-promising-phase-iii-diabetes-data/ 2010-01-04T16:24:10+00:00 daily 0.8 http://www.pharma-marketer.com/bust-proves-a-boon-for-savvy-biotech-scavengers/ 2010-01-04T14:36:08+00:00 daily 0.8 http://www.pharma-marketer.com/analyst-picks-reform-bills-biggest-biotech-winners/ 2010-01-04T14:33:56+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-badge/ 2010-01-04T14:02:23+00:00 weekly 0.6 http://www.pharma-marketer.com/remember-apo-a1-milano-pfizer-does/ 2010-01-04T14:01:47+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-offers-39-3b-for-control-of-alcon/ 2010-01-04T13:45:55+00:00 daily 0.8 http://www.pharma-marketer.com/the-fda-still-hates-antibiotic-makers/ 2010-01-03T21:41:12+00:00 daily 0.8 http://www.pharma-marketer.com/will-biodel-be-the-comeback-company-of-2010/ 2010-01-03T21:41:12+00:00 daily 0.8 http://www.pharma-marketer.com/2010-fda-decisions-to-watch/ 2010-01-03T21:41:11+00:00 daily 0.8 http://www.pharma-marketer.com/facing-stunted-growth-in-adhd-market-shire-clicks-on-twitter/ 2010-01-03T21:41:09+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-must-face-menopause-drug-award-court-finds/ 2010-01-03T21:41:07+00:00 daily 0.8 http://www.pharma-marketer.com/abbotts-purchases-bolster-future/ 2010-01-03T21:41:05+00:00 daily 0.8 http://www.pharma-marketer.com/fair-balance-consumers-want-better-disclosure-another-action-item-for-the-fda/ 2010-01-03T16:45:11+00:00 daily 0.8 http://www.pharma-marketer.com/prescription-supplements-will-insurers-cover-them-and-will-doctors-write-them/ 2010-01-03T01:52:40+00:00 daily 0.8 http://www.pharma-marketer.com/back-to-work-more-of-the-same-ol-same-ol/ 2010-01-02T15:31:57+00:00 daily 0.8 http://www.pharma-marketer.com/happy-new-year-2010/ 2010-01-02T06:47:50+00:00 daily 0.8 http://www.pharma-marketer.com/novos-victoza-hits-another-fda-speed-bump/ 2009-12-31T16:40:50+00:00 daily 0.8 http://www.pharma-marketer.com/king-pharmaceuticals-a-look-ahead-to-dec-2009-quarterly-results/ 2009-12-31T16:35:17+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-pflubs-you-expected-otherwise/ 2009-12-31T16:35:16+00:00 daily 0.8 http://www.pharma-marketer.com/is-a-weak-dollar-the-best-healthcare-bet/ 2009-12-31T16:35:15+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-co-heiress-ruth-lilly-dies-at-94/ 2009-12-31T16:35:14+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-strengthens-pipeline-with-novexel-forest-lab-deals/ 2009-12-31T16:35:13+00:00 daily 0.8 http://www.pharma-marketer.com/fda-rejects-vions-spa-for-cancer-drug/ 2009-12-31T16:32:51+00:00 daily 0.8 http://www.pharma-marketer.com/fda-rejects-antibiotic-developed-by-basilea-jj/ 2009-12-31T16:30:49+00:00 daily 0.8 http://www.pharma-marketer.com/good-news-for-vical-candidate/ 2009-12-31T02:27:53+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-provides-u-s-regulatory-update-on-prevnar-13-vaccine/ 2009-12-31T02:27:51+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-slip-compugen-rallies-on-stock-sale/ 2009-12-30T21:24:23+00:00 daily 0.8 http://www.pharma-marketer.com/myriad-genetics-starting-to-outperform/ 2009-12-30T21:24:21+00:00 daily 0.8 http://www.pharma-marketer.com/affomix-inks-antibody-deal-with-kalgene/ 2009-12-30T18:26:47+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-shutters-troubled-late-stage-cancer-trial/ 2009-12-30T18:19:41+00:00 daily 0.8 http://www.pharma-marketer.com/drugmaker-hikma-has-unique-model-to-compete/ 2009-12-30T17:20:48+00:00 daily 0.8 http://www.pharma-marketer.com/isis-gains-from-teva-oncogenex-deal/ 2009-12-30T17:20:46+00:00 daily 0.8 http://www.pharma-marketer.com/novo-nordisk-awaiting-fda-comment-on-diabetes-drug/ 2009-12-30T17:20:45+00:00 daily 0.8 http://www.pharma-marketer.com/cephalon-sees-bullish-options-move/ 2009-12-30T17:20:45+00:00 daily 0.8 http://www.pharma-marketer.com/santarus-eyes-phase-iii-trials-for-diarrhea-drug/ 2009-12-30T17:20:42+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-stops-cancer-trial-as-survival-didna%c2%80%c2%99t-improve/ 2009-12-30T17:20:41+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-strengthens-pipeline/ 2009-12-30T17:20:41+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-may-sell-bonds-in-2010-for-28-2-billion-alcon-deal/ 2009-12-30T17:20:40+00:00 daily 0.8 http://www.pharma-marketer.com/senate-health-care-bill-shows-sky-is-not-falling-on-drug-makers/ 2009-12-30T17:20:39+00:00 daily 0.8 http://www.pharma-marketer.com/ranbaxy-offloads-chinese-venture-stake/ 2009-12-30T17:20:37+00:00 daily 0.8 http://www.pharma-marketer.com/basilea-plunges-on-fda-rejection-of-jj-drug-trials/ 2009-12-30T17:20:36+00:00 daily 0.8 http://www.pharma-marketer.com/5-star-stocks-poised-to-pop-repligen/ 2009-12-30T17:20:35+00:00 daily 0.8 http://www.pharma-marketer.com/is-the-fda-too-easy-on-medical-devices/ 2009-12-30T17:20:34+00:00 daily 0.8 http://www.pharma-marketer.com/its-time-for-adventrx-to-follow-through-on-nda/ 2009-12-30T17:20:33+00:00 daily 0.8 http://www.pharma-marketer.com/valeant-pharmaceuticals-retigabine-accepted-for-fda-review/ 2009-12-30T17:20:33+00:00 daily 0.8 http://www.pharma-marketer.com/time-for-pharma-marketing-to-take-it-up-in-2010/ 2009-12-30T16:09:49+00:00 daily 0.8 http://www.pharma-marketer.com/jampj-sues-red-cross/ 2009-12-30T13:21:44+00:00 daily 0.8 http://www.pharma-marketer.com/does-president-obama-really-understand-costs-of-todays-healtcare/ 2009-12-30T13:01:02+00:00 daily 0.8 http://www.pharma-marketer.com/fda-needs-to-make-clear-timetables-for-reform-and-repair/ 2009-12-30T12:28:33+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-12-11-09/ 2009-12-30T12:27:05+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-and-twitter-whos-got-hand-and-an-invite-to-the-follow-pharma-twitter-list/ 2009-12-30T12:25:40+00:00 daily 0.8 http://www.pharma-marketer.com/a-cancer-patients-story-of-dealing-with-insurers/ 2009-12-29T19:09:20+00:00 daily 0.8 http://www.pharma-marketer.com/codexis-details-plans-for-100m-ipo/ 2009-12-29T18:53:24+00:00 daily 0.8 http://www.pharma-marketer.com/johnson-johnson-a-compelling-investment-opportunity/ 2009-12-29T18:30:48+00:00 daily 0.8 http://www.pharma-marketer.com/ipos-to-test-financial-biotech-appetite/ 2009-12-29T18:30:47+00:00 daily 0.8 http://www.pharma-marketer.com/pharmaxis-shares-fall-after-fda-turns-down-aridol/ 2009-12-29T18:30:46+00:00 daily 0.8 http://www.pharma-marketer.com/vivus-files-application-with-fda-for-obesity-drug/ 2009-12-29T18:30:45+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-kowa-and-kowa-pharmaceuticals-america-announce-co-promotion-and-licensing-agreement/ 2009-12-29T18:30:43+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-deal-to-sell-livalo-not-without-risks/ 2009-12-29T18:30:42+00:00 daily 0.8 http://www.pharma-marketer.com/fda-jj-recalling-contaminated-tylenol-bottles/ 2009-12-29T18:30:41+00:00 daily 0.8 http://www.pharma-marketer.com/arigene-to-terminate-trimeris-tender-offer/ 2009-12-29T18:30:40+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-inch-higher-trimeris-slides/ 2009-12-29T18:30:39+00:00 daily 0.8 http://www.pharma-marketer.com/the-sanofi-chattem-deal-what-insider-trading-looks-like/ 2009-12-29T18:30:36+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-fda-backs-crestora%c2%80%c2%99s-wider-use/ 2009-12-29T18:30:34+00:00 daily 0.8 http://www.pharma-marketer.com/google-and-pharmacovigilance/ 2009-12-29T10:20:39+00:00 daily 0.8 http://www.pharma-marketer.com/fda-delays-nuvigil-decision/ 2009-12-28T23:35:11+00:00 daily 0.8 http://www.pharma-marketer.com/tengion-blueprints-40m-ipo/ 2009-12-28T23:35:10+00:00 daily 0.8 http://www.pharma-marketer.com/sinovac-biotech-files-for-approval-of-vaccine-for-virus-behind-hand-foot-and-mouth-disease/ 2009-12-28T23:35:09+00:00 daily 0.8 http://www.pharma-marketer.com/elusys-wins-143m-contract-for-new-anthrax-treatment/ 2009-12-28T22:14:37+00:00 daily 0.8 http://www.pharma-marketer.com/healthcare-bill-you-have-a-scale-of-i-think-bribery-in-the-senate-we-have-not-seen-in-our-lifetime/ 2009-12-28T18:27:15+00:00 daily 0.8 http://www.pharma-marketer.com/generics-chafe-under-big-pharmas-us-reform-shadow/ 2009-12-28T16:54:04+00:00 daily 0.8 http://www.pharma-marketer.com/merck-ends-deal-with-arena/ 2009-12-28T16:54:02+00:00 daily 0.8 http://www.pharma-marketer.com/vical-melanoma-drug-gets-positive-safety-review/ 2009-12-28T16:54:01+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeutics-adopts-poison-pill-plan/ 2009-12-28T16:54:01+00:00 daily 0.8 http://www.pharma-marketer.com/la-jolla-pharmaceutical-finally-slain-by-the-wolf-as-luck-runs-out/ 2009-12-28T16:54:00+00:00 daily 0.8 http://www.pharma-marketer.com/trimeris-sale-in-jeopardy-again/ 2009-12-28T16:53:58+00:00 daily 0.8 http://www.pharma-marketer.com/shire-seeks-fda-approval/ 2009-12-28T16:53:56+00:00 daily 0.8 http://www.pharma-marketer.com/setback-for-gileads-pipeline/ 2009-12-28T16:53:55+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-lyrica-for-gad-rejected-by-fda/ 2009-12-28T12:00:21+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-prepares-for-patent-loss-in-psychosis-drug-moves-into-arthritis-market/ 2009-12-28T12:00:20+00:00 daily 0.8 http://www.pharma-marketer.com/compugen-pfizer-deal-what-biotech-dreamers-can-accomplish/ 2009-12-28T12:00:19+00:00 daily 0.8 http://www.pharma-marketer.com/the-5-worst-drug-companies-of-2009/ 2009-12-28T12:00:18+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-said-to-drop-bid-for-german-generics-maker-ratiopharm/ 2009-12-28T12:00:18+00:00 daily 0.8 http://www.pharma-marketer.com/medimmune-responds-to-fda-on-pediatric-drug/ 2009-12-28T12:00:16+00:00 daily 0.8 http://www.pharma-marketer.com/sec-men-made-a%c2%80%c2%98illicit-profitsa%c2%80%c2%99-in-sanofi-chattem-deal/ 2009-12-28T12:00:10+00:00 daily 0.8 http://www.pharma-marketer.com/teva-joint-venture-buys-stake-in-japan-drugmaker/ 2009-12-28T12:00:09+00:00 daily 0.8 http://www.pharma-marketer.com/large-cap-biotechs-face-familiar-problem/ 2009-12-28T12:00:08+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-front-and-center-on-healthcare-reform/ 2009-12-28T12:00:07+00:00 daily 0.8 http://www.pharma-marketer.com/isis-pharma-receives-us-10-mn-from-oncogenex-license-of-ogx-o11-to-teva/ 2009-12-28T12:00:06+00:00 daily 0.8 http://www.pharma-marketer.com/drug-firms-seeking-panacea-many-shifting-focus-to-emerging-economies-in-struggle-to-stay-afloat/ 2009-12-28T12:00:04+00:00 daily 0.8 http://www.pharma-marketer.com/matthew-herper-and-robert-langreth-on-the-pharmaceutical-industry-in-2010-a-major-drug-company-will-break-up/ 2009-12-28T12:00:03+00:00 daily 0.8 http://www.pharma-marketer.com/the-genetic-revolution-takes-aim-at-the-pipeline/ 2009-12-28T12:00:02+00:00 daily 0.8 http://www.pharma-marketer.com/2010-where-does-pharma-marketing-go-from-here/ 2009-12-27T19:38:28+00:00 daily 0.8 http://www.pharma-marketer.com/a-gift-for-pharma-marketers/ 2009-12-25T01:05:23+00:00 daily 0.8 http://www.pharma-marketer.com/holiday-time-off/ 2009-12-24T17:07:42+00:00 daily 0.8 http://www.pharma-marketer.com/a-look-back-at-biotech-in-2009/ 2009-12-24T15:34:35+00:00 daily 0.8 http://www.pharma-marketer.com/arena-shares-slip-after-merck-dumps-pact/ 2009-12-24T14:24:47+00:00 daily 0.8 http://www.pharma-marketer.com/economic-disaster-followed-by-a-revival-in-share-prices/ 2009-12-24T13:26:58+00:00 daily 0.8 http://www.pharma-marketer.com/dealmaking-reaches-fever-pitch-at-years-end/ 2009-12-24T13:25:45+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharma-upends-its-rd-empires/ 2009-12-24T13:24:58+00:00 daily 0.8 http://www.pharma-marketer.com/congress-prepares-to-deliver-for-biotechnology/ 2009-12-24T13:23:58+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-jury-said-to-set-prempro-punitive-damages-at-8-million-2/ 2009-12-23T18:43:42+00:00 daily 0.8 http://www.pharma-marketer.com/astrazenecaa%c2%80%c2%99s-swine-flu-nasal-spray-recalled-for-lower-potency-2/ 2009-12-23T18:43:40+00:00 daily 0.8 http://www.pharma-marketer.com/medicines-co-licenses-potential-anti-plaque-drug-from-pfizer-in-deal-that-could-top-420m-2/ 2009-12-23T18:43:39+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-squibb-and-mead-johnson-announce-final-results-of-the-exchange-offer/ 2009-12-23T18:43:38+00:00 daily 0.8 http://www.pharma-marketer.com/ita%c2%80%c2%99s-official-roche-infringed-on-amgen-patents/ 2009-12-23T18:43:38+00:00 daily 0.8 http://www.pharma-marketer.com/partnering-activity-skyrockets-as-biotechs-close-year-end-deals/ 2009-12-23T18:43:37+00:00 daily 0.8 http://www.pharma-marketer.com/2009-biotech-cheers-and-jeers/ 2009-12-23T18:43:35+00:00 daily 0.8 http://www.pharma-marketer.com/exelixis-inc-warming-up-or-cooling-off/ 2009-12-23T18:43:34+00:00 daily 0.8 http://www.pharma-marketer.com/cephalon-hikes-provigil-price-to-push-new-med-2/ 2009-12-23T18:43:32+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-lowers-2009-outlook-after-mead-deal-3/ 2009-12-23T18:43:31+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-to-pay-up-to-505m-for-novexel/ 2009-12-23T16:38:24+00:00 daily 0.8 http://www.pharma-marketer.com/compugen-shares-rise-on-pfizer-pact/ 2009-12-23T16:21:50+00:00 daily 0.8 http://www.pharma-marketer.com/medicines-co-snags-rights-to-pfizer-heart-drug/ 2009-12-23T15:54:41+00:00 daily 0.8 http://www.pharma-marketer.com/an-alzheimers-compound-runs-into-big-trouble/ 2009-12-23T15:51:45+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-snares-corthera-heart-drug-in-620m-buyout/ 2009-12-23T15:36:04+00:00 daily 0.8 http://www.pharma-marketer.com/report-deal-hungry-sanofi-eyes-stake-in-zealand-pharma/ 2009-12-23T15:20:56+00:00 daily 0.8 http://www.pharma-marketer.com/quite-a-year-more-challenges-are-ahead-though/ 2009-12-23T15:19:48+00:00 daily 0.8 http://www.pharma-marketer.com/acuspheres-oberg-resigns-as-ceo/ 2009-12-23T15:17:46+00:00 daily 0.8 http://www.pharma-marketer.com/psivida-shares-rocket-up-on-late-stage-eye-drug-data/ 2009-12-23T15:09:48+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-buying-u-s-maker-of-heart-drug/ 2009-12-23T15:00:50+00:00 daily 0.8 http://www.pharma-marketer.com/it%e2%80%99s-just-not-about-you/ 2009-12-23T04:32:34+00:00 daily 0.8 http://www.pharma-marketer.com/will-adhd-patients-follow-shire-via-twitter/ 2009-12-23T00:58:15+00:00 daily 0.8 http://www.pharma-marketer.com/fda-says-unlikely-that-vytorin-zetia-increase-cancer-risk/ 2009-12-22T22:54:45+00:00 daily 0.8 http://www.pharma-marketer.com/contract-drugmaking-on-fast-growth-track/ 2009-12-22T22:54:44+00:00 daily 0.8 http://www.pharma-marketer.com/fda-to-issue-decision-on-shires-gaucher-drug/ 2009-12-22T22:54:43+00:00 daily 0.8 http://www.pharma-marketer.com/look-for-novartis-alcon-deal-in-early-2010/ 2009-12-22T22:54:42+00:00 daily 0.8 http://www.pharma-marketer.com/rigel-pharma-gives-up-gains/ 2009-12-22T19:06:33+00:00 daily 0.8 http://www.pharma-marketer.com/sanofis-allegra-gambit/ 2009-12-22T19:06:32+00:00 daily 0.8 http://www.pharma-marketer.com/obesity-becomes-shionogia%c2%80%c2%99s-gamble-for-another-crestor/ 2009-12-22T19:06:31+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-licenses-pdl-type-1-diabetes-drug-candidate/ 2009-12-22T19:06:31+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-sues-sandoz-over-patent-for-muscle-relaxant-nimbex/ 2009-12-22T19:06:30+00:00 daily 0.8 http://www.pharma-marketer.com/mylan-confirms-first-to-file-patent-challenge-relating-to-vytorinr-cholesterol-medication/ 2009-12-22T19:06:29+00:00 daily 0.8 http://www.pharma-marketer.com/fda-extends-decision-on-cephalona%c2%80%c2%99s-nuvigil-for-jet-lag/ 2009-12-22T19:06:28+00:00 daily 0.8 http://www.pharma-marketer.com/roche-genentech-try-to-calm-jittery-partners/ 2009-12-22T19:06:24+00:00 daily 0.8 http://www.pharma-marketer.com/obituaries-ii-metabasis-hit-by-perfect-storm-of-failed-products-partnerships-economy/ 2009-12-22T19:06:23+00:00 daily 0.8 http://www.pharma-marketer.com/videohealthy-drug-deals/ 2009-12-22T19:06:21+00:00 daily 0.8 http://www.pharma-marketer.com/qlt-inc-establishes-sales-force-in-the-united-states/ 2009-12-22T19:06:21+00:00 daily 0.8 http://www.pharma-marketer.com/arena-submits-u-s-application-for-obesity-drug/ 2009-12-22T19:06:20+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-is-a%c2%80%c2%98more-sensitivea%c2%80%c2%99-about-illegal-marketing/ 2009-12-22T19:06:19+00:00 daily 0.8 http://www.pharma-marketer.com/lupin-settles-litigation-with-forest-for-namenda-tablets/ 2009-12-22T19:06:18+00:00 daily 0.8 http://www.pharma-marketer.com/osi-pharmaceuticals-trims-2010-revenue-outlook/ 2009-12-22T19:06:17+00:00 daily 0.8 http://www.pharma-marketer.com/human-genome-sciences-looks-ready-to-break-out/ 2009-12-22T19:06:16+00:00 daily 0.8 http://www.pharma-marketer.com/shire-implements-first-ever-integrated-phone-assisted-social-network-marketing-campaign-for-adhd/ 2009-12-22T18:27:17+00:00 daily 0.8 http://www.pharma-marketer.com/shionogi-aims-for-obesity-drug-success/ 2009-12-22T17:53:38+00:00 daily 0.8 http://www.pharma-marketer.com/despite-novo-deal-vlst-cuts-jobs/ 2009-12-22T17:11:59+00:00 daily 0.8 http://www.pharma-marketer.com/ge-healthcares-idiotic-libel-suit/ 2009-12-22T16:49:44+00:00 daily 0.8 http://www.pharma-marketer.com/ptc-picks-up-50m-in-financing/ 2009-12-22T16:39:23+00:00 daily 0.8 http://www.pharma-marketer.com/genocea-applies-tech-to-therapeutic-vaccines/ 2009-12-22T15:49:00+00:00 daily 0.8 http://www.pharma-marketer.com/fda-hesitates-on-cephalons-jet-lag-drug/ 2009-12-22T15:32:13+00:00 daily 0.8 http://www.pharma-marketer.com/indias-rd-spending-on-the-rise/ 2009-12-22T15:11:12+00:00 daily 0.8 http://www.pharma-marketer.com/pharmaa%c2%80%c2%99s-holiday-shopping-spree/ 2009-12-22T02:26:19+00:00 daily 0.8 http://www.pharma-marketer.com/should-more-prescription-drugs-go-otc/ 2009-12-22T01:06:18+00:00 daily 0.8 http://www.pharma-marketer.com/senate-nips-botax-from-healthcare-reform/ 2009-12-21T19:11:15+00:00 daily 0.8 http://www.pharma-marketer.com/why-drug-companies-want-to-sell-foot-powder/ 2009-12-21T19:11:13+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-climb-athersys-soars-on-pfizer-deal/ 2009-12-21T19:11:12+00:00 daily 0.8 http://www.pharma-marketer.com/white-house-promises-to-allow-drug-imports-after-all/ 2009-12-21T19:11:11+00:00 daily 0.8 http://www.pharma-marketer.com/seattle-genetics-signs-development-deal-with-glaxo/ 2009-12-21T19:11:10+00:00 daily 0.8 http://www.pharma-marketer.com/indian-drugmakers-leap-ahead-with-big-pharma/ 2009-12-21T19:11:09+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-nabs-rights-to-incytes-ra-drug-for-755m/ 2009-12-21T17:17:57+00:00 daily 0.8 http://www.pharma-marketer.com/oncogenex-scores-430-million-deal-but-shares-slide/ 2009-12-21T17:03:41+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-to-buy-chattem-for-1-9b/ 2009-12-21T17:00:44+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-stops-development-of-two-medicines/ 2009-12-21T17:00:43+00:00 daily 0.8 http://www.pharma-marketer.com/a-window-of-opportunity-to-buy-emisphere/ 2009-12-21T17:00:42+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-inks-licensing-deal-for-incyte-drug/ 2009-12-21T17:00:41+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-acquires-a-stem-cell-therapy/ 2009-12-21T17:00:40+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-shifts-focus-to-rare-diseases/ 2009-12-21T17:00:39+00:00 daily 0.8 http://www.pharma-marketer.com/actelion-shares-sink-on-almorexant-safety-woes/ 2009-12-21T17:00:38+00:00 daily 0.8 http://www.pharma-marketer.com/teva-oncogenex-sign-drug-development-deal/ 2009-12-21T17:00:37+00:00 daily 0.8 http://www.pharma-marketer.com/facet-rebuffs-biogen-will-a-white-knight-emerge/ 2009-12-21T17:00:36+00:00 daily 0.8 http://www.pharma-marketer.com/obituaries-i-altus-becomes-a-casualty-of-development-costs-but-drug-may-live-on/ 2009-12-21T17:00:35+00:00 daily 0.8 http://www.pharma-marketer.com/on-a-roll-seattle-genetics-inks-1-1b-in-new-deals/ 2009-12-21T15:37:11+00:00 daily 0.8 http://www.pharma-marketer.com/faking-x-ray-structures-for-fun-or-profit-or-what/ 2009-12-21T15:33:03+00:00 daily 0.8 http://www.pharma-marketer.com/who-do-consumers-trust-when-it-comes-to-healthcare/ 2009-12-21T15:20:10+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-vasella-focuses-on-rare-disease-strategy/ 2009-12-21T14:56:55+00:00 daily 0.8 http://www.pharma-marketer.com/sleep-drugs-safety-issues-torpedo-actelion-shares/ 2009-12-21T14:39:45+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-gambles-up-to-111m-on-athersys-stem-cell-therapy/ 2009-12-21T14:26:35+00:00 daily 0.8 http://www.pharma-marketer.com/seattle-genetics-gets-boost-from-cancer-drug-deal-with-takeda/ 2009-12-21T10:37:17+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-extends-relationship-with-peking-university-for-drug-discovery/ 2009-12-21T10:37:16+00:00 daily 0.8 http://www.pharma-marketer.com/revolade-eltrombopag-receives-positive-opinion-in-europe-for-chronic-immune-thrombocytopenic-purpura/ 2009-12-21T10:37:15+00:00 daily 0.8 http://www.pharma-marketer.com/taro-announces-clinical-trials-with-t2007-its-second-proprietary-non-sedating-barbiturate-drug/ 2009-12-21T10:37:12+00:00 daily 0.8 http://www.pharma-marketer.com/adventrx-pharmaceuticals-anx-ctic-arna-scln-biotech-stocks-to-watch/ 2009-12-21T10:37:10+00:00 daily 0.8 http://www.pharma-marketer.com/addex-ends-migraine-prevention-study/ 2009-12-21T10:37:08+00:00 daily 0.8 http://www.pharma-marketer.com/making-sense-of-a-tumultuous-year-in-biotech/ 2009-12-21T10:37:07+00:00 daily 0.8 http://www.pharma-marketer.com/china-biotech-week-in-review-medical-device-big-pharma-milestones/ 2009-12-21T10:37:06+00:00 daily 0.8 http://www.pharma-marketer.com/alexza-moves-forward-with-az-004-anti-psychotic-drug/ 2009-12-21T10:37:05+00:00 daily 0.8 http://www.pharma-marketer.com/novabay-pharmaceuticals-to-receive-increase-in-funding-and-support-from-alcon/ 2009-12-21T10:37:04+00:00 daily 0.8 http://www.pharma-marketer.com/stockholders-of-combinatorx-and-neuromed-vote-for-merger/ 2009-12-20T00:08:36+00:00 daily 0.8 http://www.pharma-marketer.com/ligand-pharmaceuticals-glaxosmithkline-blood-disorder-drug-moves-closer-to-european-approval/ 2009-12-19T08:15:47+00:00 daily 0.8 http://www.pharma-marketer.com/videobuy-gilead-ignore-study/ 2009-12-19T08:15:47+00:00 daily 0.8 http://www.pharma-marketer.com/feds-probe-high-prescribing-docs-in-florida/ 2009-12-19T08:15:46+00:00 daily 0.8 http://www.pharma-marketer.com/merck-says-u-s-agency-upholds-singulair-patent/ 2009-12-19T08:15:45+00:00 daily 0.8 http://www.pharma-marketer.com/top-pharma-layoffs-of-2009-pfizers-on-first-mercks-on-second-whos-on-third/ 2009-12-19T06:18:56+00:00 daily 0.8 http://www.pharma-marketer.com/celgenes-revlimid-meets-cancer-study-goal/ 2009-12-19T06:18:50+00:00 daily 0.8 http://www.pharma-marketer.com/celgene-sanofi-lead-gainers-in-early-trading/ 2009-12-19T06:18:49+00:00 daily 0.8 http://www.pharma-marketer.com/hedge-funds-help-scuttle-biogena%c2%80%c2%99s-facet-bid/ 2009-12-19T06:18:49+00:00 daily 0.8 http://www.pharma-marketer.com/japans-eisai-to-buy-us-drug-firm-akarx-for-255-mln/ 2009-12-19T06:18:47+00:00 daily 0.8 http://www.pharma-marketer.com/cdc-vaccine-advisers-have-financial-conflicts-ig-says/ 2009-12-19T06:18:46+00:00 daily 0.8 http://www.pharma-marketer.com/amgens-d-mab-one-step-closer-to-eu-approval/ 2009-12-19T06:18:46+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-121809/ 2009-12-18T17:48:51+00:00 daily 0.8 http://www.pharma-marketer.com/drug-re-importation-looks-dead-in-congress/ 2009-12-18T17:41:43+00:00 daily 0.8 http://www.pharma-marketer.com/low-demand-for-flu-vaccine-hurts-suppliers-2/ 2009-12-18T16:42:41+00:00 daily 0.8 http://www.pharma-marketer.com/myriad-grabs-pain-drug-in-91m-javelin-buyout/ 2009-12-18T16:35:50+00:00 daily 0.8 http://www.pharma-marketer.com/eisai-inks-255m-deal-to-buy-akarx/ 2009-12-18T16:05:08+00:00 daily 0.8 http://www.pharma-marketer.com/regado-garners-40m-series-d-for-clotting-tech/ 2009-12-18T15:38:43+00:00 daily 0.8 http://www.pharma-marketer.com/ambit-strikes-390m-deal-with-astellas-for-lead-drug/ 2009-12-18T15:12:08+00:00 daily 0.8 http://www.pharma-marketer.com/mobile-marketing-the-next-wave-to-come-crashing-to-shore/ 2009-12-18T15:03:31+00:00 daily 0.8 http://www.pharma-marketer.com/cash-strapped-vion-files-for-bankruptcy/ 2009-12-18T14:40:13+00:00 daily 0.8 http://www.pharma-marketer.com/gsks-swine-flu-windfall-under-threat/ 2009-12-18T02:59:03+00:00 daily 0.8 http://www.pharma-marketer.com/forest-labs-almirall-to-develop-asthma-drug/ 2009-12-18T02:59:03+00:00 daily 0.8 http://www.pharma-marketer.com/why-big-pharmaa%c2%80%c2%99s-2010-looks-challenging-2/ 2009-12-17T23:10:30+00:00 daily 0.8 http://www.pharma-marketer.com/chinas-drug-industry-on-the-rise-analysts-say-2/ 2009-12-17T23:10:29+00:00 daily 0.8 http://www.pharma-marketer.com/fda-says-medicines-co-recalling-intravenous-hypertension-drug-that-contains-bits-of-steel/ 2009-12-17T23:10:28+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-to-benefit-from-osi-rejection/ 2009-12-17T23:10:27+00:00 daily 0.8 http://www.pharma-marketer.com/merck-and-j-biogen-idec-not-so-much/ 2009-12-17T21:53:13+00:00 daily 0.8 http://www.pharma-marketer.com/arena-pharmaceuticals-shares-fall-on-jefferies-analyst-hold-rating-view-on-obesity-drug/ 2009-12-17T21:53:12+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-sales-rep-sues-for-overtime-pay/ 2009-12-17T21:53:12+00:00 daily 0.8 http://www.pharma-marketer.com/merck-buys-british-maker-of-biotech-medicines/ 2009-12-17T21:53:11+00:00 daily 0.8 http://www.pharma-marketer.com/durect-pain-anesthesia-shows-positive-results/ 2009-12-17T21:53:11+00:00 daily 0.8 http://www.pharma-marketer.com/matthew-herper-on-the-new-genetic-revolution-2/ 2009-12-17T18:11:21+00:00 daily 0.8 http://www.pharma-marketer.com/cytori-therapeutics-dont-buy-in-to-the-momentum-2/ 2009-12-17T18:11:20+00:00 daily 0.8 http://www.pharma-marketer.com/novelos-ceo-very-bullish-about-upcoming-pivotal-phase-iii-results/ 2009-12-17T18:11:19+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-plunges-into-patches-a-technology-with-a-troubled-history/ 2009-12-17T18:11:18+00:00 daily 0.8 http://www.pharma-marketer.com/anadys-shares-slump-despite-upbeat-hep-c-data/ 2009-12-17T18:05:50+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-backs-new-58m-life-sciences-fund-for-indiana/ 2009-12-17T17:29:38+00:00 daily 0.8 http://www.pharma-marketer.com/facet-seeks-new-bids-after-biogen-offer-flops/ 2009-12-17T17:06:28+00:00 daily 0.8 http://www.pharma-marketer.com/panel-rejects-early-use-of-tarceva/ 2009-12-17T15:52:20+00:00 daily 0.8 http://www.pharma-marketer.com/siga-technologies-is-the-volatility-over/ 2009-12-17T15:52:18+00:00 daily 0.8 http://www.pharma-marketer.com/ipsen-rochea%c2%80%c2%99s-taspoglutide-matches-sanofia%c2%80%c2%99s-lantus/ 2009-12-17T15:52:18+00:00 daily 0.8 http://www.pharma-marketer.com/a-certificate-program-for-pharma-sales-reps-is-on-its-way/ 2009-12-17T15:52:17+00:00 daily 0.8 http://www.pharma-marketer.com/talecris-bounces-off-ipo-price-strong-growth-potential/ 2009-12-17T15:52:16+00:00 daily 0.8 http://www.pharma-marketer.com/what-do-ehealth-consumers-want-from-social-media/ 2009-12-17T15:00:44+00:00 daily 0.8 http://www.pharma-marketer.com/pharmas-2009-letter-to-santa/ 2009-12-17T14:41:08+00:00 daily 0.8 http://www.pharma-marketer.com/why-dont-chemists-communicate-or-do-we/ 2009-12-17T14:35:17+00:00 daily 0.8 http://www.pharma-marketer.com/amylin-impresses-in-head-to-head/ 2009-12-17T02:32:47+00:00 daily 0.8 http://www.pharma-marketer.com/johnson-johnsons-ethicon-unit-paying-785-million-for-sinus-surgery-device-maker-acclarent/ 2009-12-17T02:32:47+00:00 daily 0.8 http://www.pharma-marketer.com/better-buy-johnson-johnson-or-bristol-myers-squibb/ 2009-12-17T02:32:46+00:00 daily 0.8 http://www.pharma-marketer.com/efficacy-of-roches-flu-drug-tamiflu-in-doubt/ 2009-12-17T02:32:45+00:00 daily 0.8 http://www.pharma-marketer.com/gileads-phase-3-train-wreck/ 2009-12-16T23:02:31+00:00 daily 0.8 http://www.pharma-marketer.com/a-search-engine-just-for-health/ 2009-12-16T22:36:35+00:00 daily 0.8 http://www.pharma-marketer.com/investors-have-questions-about-pharmas-online-spending-in-2010-and-beyond/ 2009-12-16T20:54:47+00:00 daily 0.8 http://www.pharma-marketer.com/gsks-1b-paxil-problem-highlights-murky-disclosures-from-euro-drug-companies/ 2009-12-16T19:02:27+00:00 daily 0.8 http://www.pharma-marketer.com/4-star-stocks-poised-to-pop-eli-lilly/ 2009-12-16T19:02:25+00:00 daily 0.8 http://www.pharma-marketer.com/antidepressants-and-stroke-risk-in-older-women/ 2009-12-16T19:02:25+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-sets-rate-for-mead-stock-swap/ 2009-12-16T19:02:24+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeutics-gets-fda-panel-for-lymphoma-drug/ 2009-12-16T19:02:23+00:00 daily 0.8 http://www.pharma-marketer.com/five-biotech-events-to-watch-in-2010/ 2009-12-16T19:02:22+00:00 daily 0.8 http://www.pharma-marketer.com/micromet-opportunity-lies-in-breakthrough-bite-antibody/ 2009-12-16T19:02:21+00:00 daily 0.8 http://www.pharma-marketer.com/phrmas-80b-deal-helps-nix-reimportation/ 2009-12-16T19:02:20+00:00 daily 0.8 http://www.pharma-marketer.com/achillion-shares-rocket-up-on-promising-hep-c-data/ 2009-12-16T19:02:19+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-rise-achillion-sanofi-in-play/ 2009-12-16T19:02:18+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-gains-presence-in-diabetes-market-with-takeda-deal/ 2009-12-16T17:02:15+00:00 daily 0.8 http://www.pharma-marketer.com/galapagos-expands-alliance-with-glaxosmithkline/ 2009-12-16T17:02:14+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-purchases-rights-to-syntirona%c2%80%c2%99s-mrsa-vaccine/ 2009-12-16T17:02:13+00:00 daily 0.8 http://www.pharma-marketer.com/roche-should-give-more-data-on-roactemra-drug-u-k-a%c2%80%c2%99s-nice-says/ 2009-12-16T17:02:12+00:00 daily 0.8 http://www.pharma-marketer.com/nanobio-inks-54-5m-development-deal-with-gsk/ 2009-12-16T16:01:21+00:00 daily 0.8 http://www.pharma-marketer.com/silence-and-intradigm-merge-rnai-forces-flag-deals/ 2009-12-16T15:53:54+00:00 daily 0.8 http://www.pharma-marketer.com/pass-the-popcorn/ 2009-12-16T15:50:43+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-and-youtube-where-are-the-eyeballs-going/ 2009-12-16T15:48:36+00:00 daily 0.8 http://www.pharma-marketer.com/bayers-full-page-ad-is-more-proof-that-pharma-is-clueless/ 2009-12-16T15:42:53+00:00 daily 0.8 http://www.pharma-marketer.com/bayers-full-page-ad-whos-more-important-investors-or-patients/ 2009-12-16T15:42:53+00:00 daily 0.8 http://www.pharma-marketer.com/celgene-posts-impressive-iib-data-on-psoriasis/ 2009-12-16T15:21:02+00:00 daily 0.8 http://www.pharma-marketer.com/lundbeck-taps-nolan-as-ceo-of-its-u-s-business/ 2009-12-16T15:10:39+00:00 daily 0.8 http://www.pharma-marketer.com/addex-shares-routed-after-lead-drug-flops/ 2009-12-16T14:18:21+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-idec-threatens-proxy-battle-for-facet/ 2009-12-16T14:05:06+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-backs-new-use-for-astrazenecas-crestor/ 2009-12-16T03:13:44+00:00 daily 0.8 http://www.pharma-marketer.com/swine-flu-vaccine-doses-recalled/ 2009-12-15T23:38:46+00:00 daily 0.8 http://www.pharma-marketer.com/which-doctors-are-getting-paid-by-glaxo-lilly-and-merck/ 2009-12-15T23:38:45+00:00 daily 0.8 http://www.pharma-marketer.com/prospecting-for-stocks-abbott-laboratories/ 2009-12-15T23:38:42+00:00 daily 0.8 http://www.pharma-marketer.com/can-new-zyprexa-fight-generic-competition/ 2009-12-15T23:38:41+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-threatens-proxy-over-rejected-bid-for-facet/ 2009-12-15T23:38:40+00:00 daily 0.8 http://www.pharma-marketer.com/deaths-force-researchers-to-drop-alzheimers-drug-doses/ 2009-12-15T18:00:10+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-dumps-disappointing-late-stage-blood-pressure-drug/ 2009-12-15T17:29:30+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-will-co-promote-takedaa%c2%80%c2%99s-actos-pill-in-china/ 2009-12-15T16:39:21+00:00 daily 0.8 http://www.pharma-marketer.com/senators-may-omit-health-a%c2%80%c2%98public-optiona%c2%80%c2%99-medicare-expansion/ 2009-12-15T16:39:20+00:00 daily 0.8 http://www.pharma-marketer.com/elan-transition-modify-alzheimer-drug-trial-2/ 2009-12-15T16:39:19+00:00 daily 0.8 http://www.pharma-marketer.com/millennium-strikes-365m-deal-for-seattle-genetics-cancer-antibody-2/ 2009-12-15T16:39:17+00:00 daily 0.8 http://www.pharma-marketer.com/warner-chilcott-affirms-global-marketing-and-collaboration-agreement-with-sanofi-aventis/ 2009-12-15T16:39:16+00:00 daily 0.8 http://www.pharma-marketer.com/headache-for-addex-as-migraine-study-is-pulled/ 2009-12-15T16:39:15+00:00 daily 0.8 http://www.pharma-marketer.com/2009-big-pharma-doty-nominee-pfizer-feds-settle-for-2-3-billion/ 2009-12-15T16:39:13+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-conflicts-of-interest-and-fingerpointers/ 2009-12-15T16:39:13+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-delivers-60m-upfront-for-array-diabetes-pact-2/ 2009-12-15T16:39:12+00:00 daily 0.8 http://www.pharma-marketer.com/how-to-be-one-of-one-hundred/ 2009-12-15T16:19:35+00:00 daily 0.8 http://www.pharma-marketer.com/will-patients-find-value-in-discussions-with-pharma-marketers-on-social-media-sites/ 2009-12-15T15:56:17+00:00 daily 0.8 http://www.pharma-marketer.com/ophthotech-nabs-30m-round-to-fund-amd-trial/ 2009-12-15T15:35:34+00:00 daily 0.8 http://www.pharma-marketer.com/safety-issues-force-addex-to-halt-lead-drug-development/ 2009-12-15T15:25:05+00:00 daily 0.8 http://www.pharma-marketer.com/safety-issues-force-addex-to-halt-lead-drug-work/ 2009-12-15T15:25:05+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-calendar-upcoming-fda-dates/ 2009-12-15T15:09:08+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-drops-blood-pressure-drug/ 2009-12-15T15:09:06+00:00 daily 0.8 http://www.pharma-marketer.com/twitter-is-not-the-answer/ 2009-12-15T14:35:07+00:00 daily 0.8 http://www.pharma-marketer.com/manfred-christl-rides-again-bonus-idiotic-lab-accident-too/ 2009-12-15T14:32:54+00:00 daily 0.8 http://www.pharma-marketer.com/struggling-ambrilia-shutters-facility-sheds-jobs/ 2009-12-15T14:05:02+00:00 daily 0.8 http://www.pharma-marketer.com/teva-hails-milder-restrictions-on-parkinsons-drug/ 2009-12-15T06:11:08+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-labs-to-buy-starlims-tech-for-123-mln/ 2009-12-15T02:34:21+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-paid-close-to-15m-a9m-in-speaking-and-consulting-fees-to-us-doctors-in-q2/ 2009-12-15T02:34:20+00:00 daily 0.8 http://www.pharma-marketer.com/nexavar-herceptin-could-gain-from-cancer-meeting/ 2009-12-15T02:34:18+00:00 daily 0.8 http://www.pharma-marketer.com/how-should-big-pharma-handle-newly-reported-side-effects/ 2009-12-15T01:47:52+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-defends-wyeths-conduct-on-hrt-2/ 2009-12-14T20:34:02+00:00 daily 0.8 http://www.pharma-marketer.com/roche-immunogen-to-start-t-dm1-trials/ 2009-12-14T19:04:11+00:00 daily 0.8 http://www.pharma-marketer.com/merck-loses-effort-to-dismiss-24-fosamax-cases/ 2009-12-14T19:04:10+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-loses-a-patent-battle-over-crestor/ 2009-12-14T19:04:10+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-long-acting-zyprexa/ 2009-12-14T19:04:09+00:00 daily 0.8 http://www.pharma-marketer.com/source-sanofi-lays-off-contract-sales-reps/ 2009-12-14T19:04:08+00:00 daily 0.8 http://www.pharma-marketer.com/cubist-pharmaceuticals-pays-92-5m-for-calixa/ 2009-12-14T19:04:06+00:00 daily 0.8 http://www.pharma-marketer.com/sigas-plummet-waiting-for-conference-call-details/ 2009-12-14T19:04:05+00:00 daily 0.8 http://www.pharma-marketer.com/sunesis-pharmaceutical-gains-on-volume-spike/ 2009-12-14T19:04:04+00:00 daily 0.8 http://www.pharma-marketer.com/fda-says-osi-drug-effective-against-lung-cancer/ 2009-12-14T19:04:03+00:00 daily 0.8 http://www.pharma-marketer.com/chemgenex-scores-138m-cancer-licensing-pact/ 2009-12-14T17:46:27+00:00 daily 0.8 http://www.pharma-marketer.com/offering-answers-to-some-tough-clinical-trial-questions/ 2009-12-14T17:40:42+00:00 daily 0.8 http://www.pharma-marketer.com/spurned-by-the-fda-gtx-slashes-its-staff-in-restructuring/ 2009-12-14T15:56:51+00:00 daily 0.8 http://www.pharma-marketer.com/european-biotechs-migrate-to-boston-area/ 2009-12-14T15:29:26+00:00 daily 0.8 http://www.pharma-marketer.com/fast-pfenex-unveils-52m-partnership-deal-with-merck/ 2009-12-14T15:26:30+00:00 daily 0.8 http://www.pharma-marketer.com/the-cost-of-new-drugs/ 2009-12-14T14:54:29+00:00 daily 0.8 http://www.pharma-marketer.com/hawaii-biotech-power-struggle-heads-into-bankruptcy-court/ 2009-12-14T14:53:19+00:00 daily 0.8 http://www.pharma-marketer.com/merck-starts-china-trial-of-cancer-vaccine/ 2009-12-14T14:49:39+00:00 daily 0.8 http://www.pharma-marketer.com/merck-kgaa-sticks-to-pharmaceuticals-strategy-handelsblatt-says/ 2009-12-14T14:49:38+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-said-to-have-paid-1-billion-to-settle-paxil-lawsuits/ 2009-12-14T14:49:38+00:00 daily 0.8 http://www.pharma-marketer.com/allergan-ceo-sounds-off-on-botox-tax/ 2009-12-14T14:49:37+00:00 daily 0.8 http://www.pharma-marketer.com/another-day-another-attack-on-pharma-by-the-new-york-times/ 2009-12-14T14:44:24+00:00 daily 0.8 http://www.pharma-marketer.com/cubist-snares-promising-antibiotic-in-402-5m-calixa-buyout/ 2009-12-14T13:50:19+00:00 daily 0.8 http://www.pharma-marketer.com/hope-for-advanced-thymic-cancer-patients-as-international-study-begins-2/ 2009-12-13T19:19:35+00:00 daily 0.8 http://www.pharma-marketer.com/going-to-bat-for-tax-free-botox-2/ 2009-12-13T19:19:34+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-inc-affirms-confidence-in-its-hormone-therapy-medicines-as-important-treatment-options-2/ 2009-12-13T19:19:32+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-mead-johnson-swap-good-deal-or-smarter-to-wait/ 2009-12-13T19:19:31+00:00 daily 0.8 http://www.pharma-marketer.com/the-historical-success-of-growing-big-pharma-from-small-2/ 2009-12-13T19:19:30+00:00 daily 0.8 http://www.pharma-marketer.com/array-biopharma-announces-positive-interim-results-for-phase-1-study-of-its-her2-inhibitor-arry-380-in-cancer-patients-2/ 2009-12-13T19:19:29+00:00 daily 0.8 http://www.pharma-marketer.com/targacept-initiates-phase-2-study-of-tc-5619-in-cognitive-dysfunction-in-schizophrenia-2/ 2009-12-13T19:19:28+00:00 daily 0.8 http://www.pharma-marketer.com/roche-genentech-and-biogen-idec-announce-positive-results-from-first-phase-iii-trial-of-ocrelizumab/ 2009-12-13T19:19:27+00:00 daily 0.8 http://www.pharma-marketer.com/fda-launches-orphan-drug-workshop-at-kgi/ 2009-12-13T19:19:26+00:00 daily 0.8 http://www.pharma-marketer.com/innexus-bio-enters-research-collaboration-with-xeris-pharma/ 2009-12-12T20:46:05+00:00 daily 0.8 http://www.pharma-marketer.com/mylan-receives-approval-for-generic-version-of-antiepileptic-keppraa%c2%ae-1000-mg/ 2009-12-12T20:46:03+00:00 daily 0.8 http://www.pharma-marketer.com/algeta-announces-first-us-patient-randomized-in-alsympca-phase-iii-study-at-tulane-cancer-center-new-orleans/ 2009-12-12T20:46:01+00:00 daily 0.8 http://www.pharma-marketer.com/drug-makers-quicker-to-embrace-settlements-to-delay-low-cost-generics/ 2009-12-12T20:46:00+00:00 daily 0.8 http://www.pharma-marketer.com/taro-again-warns-shareholders-to-stay-away-from-sun/ 2009-12-12T20:45:59+00:00 daily 0.8 http://www.pharma-marketer.com/httpwww-domain-b-comcompaniescompanies_ssun_pharma20091212_taro_again-html/ 2009-12-12T20:45:58+00:00 daily 0.8 http://www.pharma-marketer.com/why-cell-enriched-fat-grafting-is-safe-effective-new-mechanistic-support-in-preclinical-model/ 2009-12-12T20:45:57+00:00 daily 0.8 http://www.pharma-marketer.com/google-real-time-search-and-crisis-communications/ 2009-12-12T20:30:05+00:00 daily 0.8 http://www.pharma-marketer.com/cytokinetics-announces-non-clinical-data-relating-to-gsk-923295-presented-at-the-32nd-annual-san-antonio-breast-cancer-s/ 2009-12-12T19:45:57+00:00 daily 0.8 http://www.pharma-marketer.com/entremed-reports-receipt-of-third-quarter-royalty-payment/ 2009-12-12T19:45:56+00:00 daily 0.8 http://www.pharma-marketer.com/brower-piven-announces-the-filing-of-a-class-action-lawsuit-against-hemispherx-biopharma-inc/ 2009-12-12T19:45:56+00:00 daily 0.8 http://www.pharma-marketer.com/gtx-announces-reduction-in-force/ 2009-12-12T19:45:55+00:00 daily 0.8 http://www.pharma-marketer.com/ziopharm-the-moneys-in-the-bank-so-whats-next/ 2009-12-12T19:45:54+00:00 daily 0.8 http://www.pharma-marketer.com/nexavar-in-combination-with-chemotherapy-demonstrates-activity-in-patients-with-advanced-breast-cancer-in-two-phase-2-st/ 2009-12-12T19:45:54+00:00 daily 0.8 http://www.pharma-marketer.com/dendreon-announces-exercise-of-option-by-underwriters-in-its-common-stock-offering/ 2009-12-12T19:45:53+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-intercell-deal-could-bring-new-developments-to-vaccine-market/ 2009-12-12T19:45:52+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-labs-sets-dividend-of-40-cents/ 2009-12-12T19:45:51+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-don%e2%80%99t-be-shy-about-social-media/ 2009-12-11T20:01:42+00:00 daily 0.8 http://www.pharma-marketer.com/showdown-over-aids-drugs/ 2009-12-11T17:51:49+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-gets-european-authorization-for-prevenar-13/ 2009-12-11T17:51:48+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-to-buy-stake-in-intercell-in-vaccines-alliance/ 2009-12-11T17:51:47+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-deal-with-white-house-delays-health-reform/ 2009-12-11T17:51:46+00:00 daily 0.8 http://www.pharma-marketer.com/genentech-sheds-pact-as-pipeline-review-claims-another-deal/ 2009-12-11T17:51:44+00:00 daily 0.8 http://www.pharma-marketer.com/roche-arthritis-drug-effective-in-late-stage-study/ 2009-12-11T17:51:42+00:00 daily 0.8 http://www.pharma-marketer.com/fda-says-cholesterol-pill-crestor-curbs-heart-problems-in-patients-but-notes-diabetes-risk/ 2009-12-11T17:51:41+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-says-high-dose-of-faslodex-tops-current-dose-at-reducing-breast-cancer-progression/ 2009-12-11T17:51:40+00:00 daily 0.8 http://www.pharma-marketer.com/sunesis-pharmas-impressive-gain-hoping-for-a-dip/ 2009-12-11T17:51:39+00:00 daily 0.8 http://www.pharma-marketer.com/zymogenetics-claims-court-win-versus-king/ 2009-12-11T17:51:38+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-wins-fda-panel-vote-for-cf-therapy/ 2009-12-11T17:51:37+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-isna%c2%80%c2%99t-planning-to-buy-its-way-around-the-patent-cliff/ 2009-12-11T17:51:33+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-forms-cancer-collaboration-with-crown-bioscience/ 2009-12-11T17:51:32+00:00 daily 0.8 http://www.pharma-marketer.com/videostealth-generic-drug-play-1-minute-trade/ 2009-12-11T17:51:31+00:00 daily 0.8 http://www.pharma-marketer.com/cephalon-sues-actavis/ 2009-12-11T17:51:31+00:00 daily 0.8 http://www.pharma-marketer.com/keeping-an-eye-on-drug-pipelines/ 2009-12-11T17:51:30+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-recruits-star-players-to-calm-rattled-investors/ 2009-12-11T17:15:36+00:00 daily 0.8 http://www.pharma-marketer.com/another-take-on-the-munos-paper/ 2009-12-11T17:13:45+00:00 daily 0.8 http://www.pharma-marketer.com/finally-individuals-speak-out-pro-con-mostly-con-about-online-pharma-marketing/ 2009-12-11T16:34:34+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-inks-173m-deal-for-intercells-vax-patch/ 2009-12-11T15:35:04+00:00 daily 0.8 http://www.pharma-marketer.com/munos-on-big-companies-and-small-ones/ 2009-12-11T14:56:30+00:00 daily 0.8 http://www.pharma-marketer.com/dendreon-stays-focused-on-launch-countdown/ 2009-12-11T14:44:33+00:00 daily 0.8 http://www.pharma-marketer.com/genentech-sheds-860m-seattle-genetics-pact/ 2009-12-11T14:37:59+00:00 daily 0.8 http://www.pharma-marketer.com/roches-ra-drug-posts-blockbuster-results-in-phase-iii/ 2009-12-11T14:34:11+00:00 daily 0.8 http://www.pharma-marketer.com/dtc-not-dead-yet/ 2009-12-11T14:32:16+00:00 daily 0.8 http://www.pharma-marketer.com/pay-as-you-live-health-models/ 2009-12-11T12:04:00+00:00 daily 0.8 http://www.pharma-marketer.com/bears-mauling-this-drug-makers-shares-lilly/ 2009-12-11T05:40:51+00:00 daily 0.8 http://www.pharma-marketer.com/a-tale-of-two-lillys/ 2009-12-11T05:40:50+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-gilead-sciences-drug-to-treat-deadly-lung-infection-appears-safe-and-effective/ 2009-12-11T05:40:49+00:00 daily 0.8 http://www.pharma-marketer.com/senators-move-to-block-drugmakers-from-mining-rx-data/ 2009-12-11T05:40:48+00:00 daily 0.8 http://www.pharma-marketer.com/bone-drugs-appear-to-cut-breast-cancer-risk/ 2009-12-10T22:52:56+00:00 daily 0.8 http://www.pharma-marketer.com/solvays-alleged-off-label-switcheroo-2-legit-indications-reversed/ 2009-12-10T19:27:33+00:00 daily 0.8 http://www.pharma-marketer.com/two-china-pharma-plays/ 2009-12-10T19:27:31+00:00 daily 0.8 http://www.pharma-marketer.com/which-is-the-better-opportunity-glaxosmithkline-or-forest-labs/ 2009-12-10T19:27:30+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-reaches-accord-with-alopexx-on-antibody/ 2009-12-10T19:27:29+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-hands-back-another-cancer-drug-to-cytokinetics/ 2009-12-10T19:27:28+00:00 daily 0.8 http://www.pharma-marketer.com/immunogen-reports-positive-breast-cancer-drug-data/ 2009-12-10T19:27:27+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-rd-productivity/ 2009-12-10T18:13:39+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-forecasts-sidestep-2011-2014-patent-cliff/ 2009-12-10T17:55:59+00:00 daily 0.8 http://www.pharma-marketer.com/dendreons-new-stock-offering-takes-advantage-of-provenge-decision-uncertainty/ 2009-12-10T17:55:58+00:00 daily 0.8 http://www.pharma-marketer.com/fda-complete-response-letters-transparency/ 2009-12-10T17:55:58+00:00 daily 0.8 http://www.pharma-marketer.com/how-gloucester-achieved-the-impossible-even-before-inking-the-celgene-deal/ 2009-12-10T17:55:55+00:00 daily 0.8 http://www.pharma-marketer.com/drugmakers-hospitals-insurers-fight-changes-to-health-bill/ 2009-12-10T17:55:54+00:00 daily 0.8 http://www.pharma-marketer.com/facet-rejects-biogen-idec-offer/ 2009-12-10T17:55:53+00:00 daily 0.8 http://www.pharma-marketer.com/all-eyes-on-cel-sci-will-wednesdays-surge-continue/ 2009-12-10T17:55:52+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-plans-to-beat-rivals-in-emerging-markets/ 2009-12-10T17:55:50+00:00 daily 0.8 http://www.pharma-marketer.com/drug-costs-doubled-in-one-decade/ 2009-12-10T17:55:50+00:00 daily 0.8 http://www.pharma-marketer.com/ranbaxy-generic-version-of-flomax-to-be-launched-in-march/ 2009-12-10T17:55:49+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-commits-up-to-375m-for-alopexx-antibody-deal/ 2009-12-10T17:45:29+00:00 daily 0.8 http://www.pharma-marketer.com/lillys-bullish-pipeline-review-cant-quell-skeptics/ 2009-12-10T16:52:57+00:00 daily 0.8 http://www.pharma-marketer.com/roche-plans-71m-rd-program-in-singapore/ 2009-12-10T16:31:50+00:00 daily 0.8 http://www.pharma-marketer.com/would-complete-disclosure-cure-the-nda-rejection-rash/ 2009-12-10T15:31:27+00:00 daily 0.8 http://www.pharma-marketer.com/watson-acquires-arrow/ 2009-12-10T15:07:22+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-rises-as-analyst-expects-dividend-increase/ 2009-12-10T15:07:21+00:00 daily 0.8 http://www.pharma-marketer.com/h1n1-vaccines-finally-bearing-revenue/ 2009-12-10T15:07:20+00:00 daily 0.8 http://www.pharma-marketer.com/high-hopes-remain-for-celgenes-revlimid/ 2009-12-10T15:07:19+00:00 daily 0.8 http://www.pharma-marketer.com/major-surgery-at-sanofi/ 2009-12-10T15:07:18+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-plans-two-new-drugs-a-year-starting-in-2013-china-focus/ 2009-12-10T15:07:18+00:00 daily 0.8 http://www.pharma-marketer.com/sec-eyes-9-deals-in-insider-trading-probe-report/ 2009-12-10T15:07:17+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-explores-drugmaker-alliances-to-spread-cost-risks/ 2009-12-10T15:07:16+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-outlines-pricey-licensing-strategy/ 2009-12-10T14:44:00+00:00 daily 0.8 http://www.pharma-marketer.com/selective-scaffolds/ 2009-12-10T14:40:12+00:00 daily 0.8 http://www.pharma-marketer.com/protalix-races-to-fda-with-gauchers-drug-app/ 2009-12-10T14:05:27+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-badge-2/ 2009-12-10T09:19:57+00:00 weekly 0.6 http://www.pharma-marketer.com/upcoming-webinar-features-clinical-trial-thought-leaders/ 2009-12-09T17:46:43+00:00 daily 0.8 http://www.pharma-marketer.com/will-pharma-spend-more-on-emarketing-than-on-tv-advertising-by-2019/ 2009-12-09T17:35:44+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-seeks-to-broaden-use-of-some-cancer-drugs-2/ 2009-12-09T17:35:17+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-tidbits-dividend-murmurs-generic-biotech-china-rd-2/ 2009-12-09T17:35:11+00:00 daily 0.8 http://www.pharma-marketer.com/physicians-more-likely-to-report-drug-safety-information-through-electronic-health-records-system-2/ 2009-12-09T17:35:10+00:00 daily 0.8 http://www.pharma-marketer.com/biocryst-shorts-start-to-cover-2/ 2009-12-09T17:35:09+00:00 daily 0.8 http://www.pharma-marketer.com/isis-reacquires-rights-to-drug-will-revamp-cancer-program-2/ 2009-12-09T17:35:09+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-125-million-plavix-accord-is-approved-2/ 2009-12-09T17:35:07+00:00 daily 0.8 http://www.pharma-marketer.com/the-top-10-pharma-layoffs-of-2009/ 2009-12-09T17:35:07+00:00 daily 0.8 http://www.pharma-marketer.com/astrazenecas-new-depression-drug-is-a-cancelled-blood-pressure-medicine-2/ 2009-12-09T17:35:06+00:00 daily 0.8 http://www.pharma-marketer.com/gloucester-pharma-proves-single-drug-model-can-work/ 2009-12-09T17:35:04+00:00 daily 0.8 http://www.pharma-marketer.com/sangamo-drug-looks-promising-in-small-strength-trial-2/ 2009-12-09T17:35:03+00:00 daily 0.8 http://www.pharma-marketer.com/sizzling-market-heats-up-biotech-buyout-fever-2/ 2009-12-09T17:34:56+00:00 daily 0.8 http://www.pharma-marketer.com/repligen-imaging-agent-fails-phase-iii-primary-endpoint/ 2009-12-09T17:30:57+00:00 daily 0.8 http://www.pharma-marketer.com/drug-companies-since-1950/ 2009-12-09T17:22:14+00:00 daily 0.8 http://www.pharma-marketer.com/regeneron-plots-40m-expansion-400-new-hires/ 2009-12-09T17:17:39+00:00 daily 0.8 http://www.pharma-marketer.com/feds-anthrax-shift-triggers-sharp-drop-in-developers-shares/ 2009-12-09T16:19:29+00:00 daily 0.8 http://www.pharma-marketer.com/iphone-application-from-sanofi-aventis-maybe-just-the-start-of-new-marketing-opportunities-in-dtc/ 2009-12-09T15:08:06+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-hunting-for-partners-in-biosimilar-quest/ 2009-12-09T14:47:09+00:00 daily 0.8 http://www.pharma-marketer.com/water-and-proteins-inside-cells-sloshing-around-or-not/ 2009-12-09T14:45:07+00:00 daily 0.8 http://www.pharma-marketer.com/kv-enters-employment-deal-with-van-vliet/ 2009-12-09T14:21:26+00:00 daily 0.8 http://www.pharma-marketer.com/pharmas-next-big-thing-personalized-medicine/ 2009-12-09T10:37:57+00:00 daily 0.8 http://www.pharma-marketer.com/rochea%c2%80%c2%99s-tamiflu-not-proven-to-cut-flu-complications/ 2009-12-09T10:36:02+00:00 daily 0.8 http://www.pharma-marketer.com/early-and-often-a-drug-investors-dream-celgene-2/ 2009-12-09T02:57:50+00:00 daily 0.8 http://www.pharma-marketer.com/gerons-developing-cancer-treatment-meets-midstage-study-goals-2/ 2009-12-09T02:57:49+00:00 daily 0.8 http://www.pharma-marketer.com/mylan-wyeth-ink-effexor-agreements-2/ 2009-12-09T02:57:48+00:00 daily 0.8 http://www.pharma-marketer.com/rochea%c2%80%c2%99s-tamiflu-not-proven-to-cut-flu-complications-2/ 2009-12-09T02:57:48+00:00 daily 0.8 http://www.pharma-marketer.com/analyst-pharma-profit-will-fall-on-patent-losses-2/ 2009-12-09T02:57:47+00:00 daily 0.8 http://www.pharma-marketer.com/what-the-hey-abstract-abstracts-part-ii/ 2009-12-08T21:01:30+00:00 daily 0.8 http://www.pharma-marketer.com/epizyme-amps-up-series-b-to-40m/ 2009-12-08T20:50:14+00:00 daily 0.8 http://www.pharma-marketer.com/more-from-genentechs-mccracken-on-the-future-of-pharmaceutical-sales/ 2009-12-08T19:17:58+00:00 daily 0.8 http://www.pharma-marketer.com/analysts-say-white-house-promised-merck-to-do-what-was-required-to-ax-public-option-from-healthcare-reform/ 2009-12-08T19:17:56+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-retreat-with-broader-market/ 2009-12-08T19:17:54+00:00 daily 0.8 http://www.pharma-marketer.com/better-drug-stock-pfizer-or-merck/ 2009-12-08T19:17:53+00:00 daily 0.8 http://www.pharma-marketer.com/grassley-asks-ama-for-payment-data/ 2009-12-08T19:17:52+00:00 daily 0.8 http://www.pharma-marketer.com/interim-data-lifts-geron-stem-cell-rivals-mixed/ 2009-12-08T19:17:51+00:00 daily 0.8 http://www.pharma-marketer.com/premature-social-media-promotion-psmp-a-new-pharma-syndrome/ 2009-12-08T19:06:42+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-enters-research-partnership-with-tranzyme-worth-up-to-16m-over-2-years/ 2009-12-08T17:54:17+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-to-cover-copays-for-patients-on-its-prescription-savings-plan-starting-jan-1/ 2009-12-08T17:54:16+00:00 daily 0.8 http://www.pharma-marketer.com/actelion-latest-casualty-as-roche-trims-portfolio/ 2009-12-08T17:54:15+00:00 daily 0.8 http://www.pharma-marketer.com/premature-ejaculation-marketing-the-condition-before-the-drug/ 2009-12-08T17:54:14+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-cancer-plan/ 2009-12-08T17:54:13+00:00 daily 0.8 http://www.pharma-marketer.com/prospecting-for-stocks-depomed/ 2009-12-08T17:54:12+00:00 daily 0.8 http://www.pharma-marketer.com/feeling-neurotic-then-take-an-antidepressant/ 2009-12-08T17:54:11+00:00 daily 0.8 http://www.pharma-marketer.com/ash-roundup-ariad-cephalon-and-novartis-make-a-splash/ 2009-12-08T17:46:30+00:00 daily 0.8 http://www.pharma-marketer.com/another-blogroll-update/ 2009-12-08T17:19:56+00:00 daily 0.8 http://www.pharma-marketer.com/therasis-gains-12m-series-a-cash/ 2009-12-08T17:10:35+00:00 daily 0.8 http://www.pharma-marketer.com/roche-dumps-another-partner-as-it-focuses-on-genentech/ 2009-12-08T17:04:16+00:00 daily 0.8 http://www.pharma-marketer.com/ftc-new-efforts-regarding-endorsements-testimonials/ 2009-12-08T16:40:45+00:00 daily 0.8 http://www.pharma-marketer.com/zymogenetics-forges-182m-antibody-deal-with-novo/ 2009-12-08T15:13:27+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-faces-the-tipping-point-for-personalized-meds/ 2009-12-08T14:52:06+00:00 daily 0.8 http://www.pharma-marketer.com/transcripts-of-fdas-november-2009-public-hearing-on-social-media-available/ 2009-12-08T14:35:02+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-pearl-river-layoffs/ 2009-12-08T14:10:36+00:00 daily 0.8 http://www.pharma-marketer.com/aids-still-a-problem-still-big-business-for-pharma/ 2009-12-08T10:18:12+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-12409/ 2009-12-08T07:13:54+00:00 daily 0.8 http://www.pharma-marketer.com/will-google-wave-transform-journalism/ 2009-12-08T07:13:06+00:00 daily 0.8 http://www.pharma-marketer.com/pharmas-missed-opportunity-phone-apps-getting-better-but-not-quite-there/ 2009-12-08T07:10:04+00:00 daily 0.8 http://www.pharma-marketer.com/buyout-buzz-at-ash-hematology-confab/ 2009-12-08T03:33:57+00:00 daily 0.8 http://www.pharma-marketer.com/zyprexa-seroquel-expanded-to-teenagers/ 2009-12-08T00:42:52+00:00 daily 0.8 http://www.pharma-marketer.com/onyx-treatment-fights-cancer-with-few-side-effects/ 2009-12-08T00:42:51+00:00 daily 0.8 http://www.pharma-marketer.com/biotechs-to-watch-in-the-blood-business/ 2009-12-08T00:42:50+00:00 daily 0.8 http://www.pharma-marketer.com/drug-companies-dont-have-the-luxury-of-waiting-for-the-fda-to-issue-guidelines-on-marketing/ 2009-12-07T19:58:35+00:00 daily 0.8 http://www.pharma-marketer.com/elan-jj-unit-seeks-europe-schizophrenia-drug-ok-2/ 2009-12-07T19:41:31+00:00 daily 0.8 http://www.pharma-marketer.com/introducing-the-30000-per-month-cancer-drug-2/ 2009-12-07T19:41:28+00:00 daily 0.8 http://www.pharma-marketer.com/moment-of-truth-for-health-care/ 2009-12-07T19:41:27+00:00 daily 0.8 http://www.pharma-marketer.com/generic-drugs-continue-to-accelerate-market-share-expansion-according-to-sanford-bernstein/ 2009-12-07T19:41:26+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-amends-and-extends-offer/ 2009-12-07T19:41:25+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-off-after-5b-buyback-plan/ 2009-12-07T19:41:24+00:00 daily 0.8 http://www.pharma-marketer.com/santarus-on-a-roll/ 2009-12-07T19:41:23+00:00 daily 0.8 http://www.pharma-marketer.com/somaxon-plunges-on-u-s-rejection-of-insomnia-drug/ 2009-12-07T19:41:22+00:00 daily 0.8 http://www.pharma-marketer.com/cubist-halts-trial-enrollment-over-death-rate-concerns/ 2009-12-07T19:41:21+00:00 daily 0.8 http://www.pharma-marketer.com/celgene-buys-gloucester-pharma/ 2009-12-07T19:41:21+00:00 daily 0.8 http://www.pharma-marketer.com/immunogen-lifted-by-cancer-drug-trial/ 2009-12-07T19:41:19+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-idec-blinks-is-it-enough-for-facet-biotech-or-will-the-drama-continue-2/ 2009-12-07T19:41:18+00:00 daily 0.8 http://www.pharma-marketer.com/zogenix-pushes-its-series-b-to-71m/ 2009-12-07T19:39:49+00:00 daily 0.8 http://www.pharma-marketer.com/blood-thinner-battle-heats-up-2/ 2009-12-07T18:19:49+00:00 daily 0.8 http://www.pharma-marketer.com/france-takes-another-shot-at-combating-h1n1-threat/ 2009-12-07T18:19:47+00:00 daily 0.8 http://www.pharma-marketer.com/cephalona%c2%80%c2%99s-treanda-poised-for-10-fold-sales-surge-2/ 2009-12-07T18:19:46+00:00 daily 0.8 http://www.pharma-marketer.com/novo-starts-first-insulin-pill-test-in-bid-to-replace-injection/ 2009-12-07T18:19:45+00:00 daily 0.8 http://www.pharma-marketer.com/court-agrees-solvay-whistleblower-suit-should-be-tossed/ 2009-12-07T18:19:44+00:00 daily 0.8 http://www.pharma-marketer.com/regulatory-restraints-ignorance-of-social-media-and-empowered-consumers-why-dtc-marketing-is-in-a-funk/ 2009-12-07T17:23:51+00:00 daily 0.8 http://www.pharma-marketer.com/aeterna-drug-fails-late-stage-trial-for-enlarged-prostate/ 2009-12-07T17:21:27+00:00 daily 0.8 http://www.pharma-marketer.com/somaxon-shares-plunge-on-second-fda-rejection/ 2009-12-07T16:57:09+00:00 daily 0.8 http://www.pharma-marketer.com/biosimilar-debate-focuses-on-key-lawmaker/ 2009-12-07T16:16:58+00:00 daily 0.8 http://www.pharma-marketer.com/onyx-touts-data-on-promising-multiple-myeloma-drug/ 2009-12-07T15:21:22+00:00 daily 0.8 http://www.pharma-marketer.com/why-dont-we-have-more-protein-protein-drug-molecules/ 2009-12-07T15:02:35+00:00 daily 0.8 http://www.pharma-marketer.com/once-you-have-paid-him-the-danegeld-2/ 2009-12-07T14:57:14+00:00 daily 0.8 http://www.pharma-marketer.com/genmab-shares-slide-after-roche-dumps-collaboration/ 2009-12-07T14:49:13+00:00 daily 0.8 http://www.pharma-marketer.com/celgene-snares-gloucester-cancer-drug-in-640m-buyout/ 2009-12-07T14:23:35+00:00 daily 0.8 http://www.pharma-marketer.com/ag-design-network/ 2009-12-07T10:09:40+00:00 daily 0.8 http://www.pharma-marketer.com/about-us/ 2009-12-07T09:52:59+00:00 weekly 0.6 http://www.pharma-marketer.com/feedback/ 2009-12-07T05:31:37+00:00 weekly 0.6 http://www.pharma-marketer.com/whats-really-holding-back-dtc-marketing-hint-lets-have-a-meeting-to-talk-about-it/ 2009-12-07T01:43:56+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-could-face-6000-lawsuits-over-seroquel-side-effects-2/ 2009-12-06T20:19:36+00:00 daily 0.8 http://www.pharma-marketer.com/carfilzomib-safety-data-from-ongoing-phase-2b-pivotal-trial-in-relapsed-and-refractory-multiple-myeloma-show-promising-s-2/ 2009-12-06T20:19:34+00:00 daily 0.8 http://www.pharma-marketer.com/better-biotech-buy-celgene-or-genzyme-2/ 2009-12-06T20:19:33+00:00 daily 0.8 http://www.pharma-marketer.com/cytokinetics-announces-clinical-trial-data-regarding-sb-743921-presented-at-the-2009-american-society-of-hematology-annu/ 2009-12-06T20:19:32+00:00 daily 0.8 http://www.pharma-marketer.com/amira-pharmaceuticals-announces-initial-positive-phase-1-clinical-data-for-am461-a-back-up-to-amiras-lead-dp2-antagoni/ 2009-12-06T18:49:24+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-shops-around-for-3bn-worth-of-acquisitions/ 2009-12-06T18:49:21+00:00 daily 0.8 http://www.pharma-marketer.com/velcader-bortezomib-for-injection-based-regimens-result-in-lower-costs-and-less-patient-burden-than-other-commonly-u/ 2009-12-06T18:49:19+00:00 daily 0.8 http://www.pharma-marketer.com/teva-seen-among-leaders-for-ratiopharm/ 2009-12-06T18:49:18+00:00 daily 0.8 http://www.pharma-marketer.com/taros-first-branded-drug-gets-fda-trial-nod/ 2009-12-06T18:49:16+00:00 daily 0.8 http://www.pharma-marketer.com/eshoo-bill-huge-boon-for-silicon-valley-biotech/ 2009-12-06T18:49:14+00:00 daily 0.8 http://www.pharma-marketer.com/if-social-media-is-not-the-answer-whats-the-future-of-dtc/ 2009-12-06T18:39:45+00:00 daily 0.8 http://www.pharma-marketer.com/degarelix-firmagonr-vs-leuprolide-lupron-depotr-in-patients-with-advanced-prostate-cancer-further-analysis-from/ 2009-12-05T20:03:40+00:00 daily 0.8 http://www.pharma-marketer.com/watson-challenges-takedas-rozerem-patent/ 2009-12-05T20:03:39+00:00 daily 0.8 http://www.pharma-marketer.com/cyclacel-reports-phase-2-sapacitabine-data-in-acute-myeloid-leukemia-and-myelodysplastic-syndromes-at-2009-ash-annual-me/ 2009-12-05T20:03:38+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-squibb-and-mead-johnson-announce-amendment-and-extension-of-exchange-offer/ 2009-12-05T20:03:37+00:00 daily 0.8 http://www.pharma-marketer.com/celgenea%c2%80%c2%99s-ash-monday/ 2009-12-05T18:33:49+00:00 daily 0.8 http://www.pharma-marketer.com/ziopharm-oncology-to-raise-45-2m-in-public-offer/ 2009-12-05T18:33:45+00:00 daily 0.8 http://www.pharma-marketer.com/pharmathene-presents-animal-model-data-for-valortimr-at-the-2009-barda-industry-conference-phemce-stakeholders-works/ 2009-12-05T18:33:45+00:00 daily 0.8 http://www.pharma-marketer.com/significant-deal-for-azn/ 2009-12-05T18:33:44+00:00 daily 0.8 http://www.pharma-marketer.com/our-final-offer-maybe-thats-a-fact-biogen-facet/ 2009-12-05T18:33:43+00:00 daily 0.8 http://www.pharma-marketer.com/discovery-labs-receives-nasdaq-notification-related-to-minimum-bid-price/ 2009-12-05T18:33:42+00:00 daily 0.8 http://www.pharma-marketer.com/federman-sherwood-announces-that-a-securities-class-action-lawsuit-has-been-filed-against-hemispherx-biopharma-inc/ 2009-12-05T18:33:41+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-recommends-antipsychotic-drug-review-of-kids-weight-gain/ 2009-12-05T18:33:40+00:00 daily 0.8 http://www.pharma-marketer.com/health-care-stock-picks-video/ 2009-12-05T18:33:39+00:00 daily 0.8 http://www.pharma-marketer.com/drugmakers-tell-fda-that-increased-education-could-curb-misuse-and-abuse-of-painkillers/ 2009-12-05T18:33:38+00:00 daily 0.8 http://www.pharma-marketer.com/after-rising-500-what-did-you-expect-targacept/ 2009-12-05T18:33:37+00:00 daily 0.8 http://www.pharma-marketer.com/lillys-effient-proves-its-worth/ 2009-12-05T18:33:36+00:00 daily 0.8 http://www.pharma-marketer.com/baxter-receives-h1n1-vaccine-order/ 2009-12-05T18:33:35+00:00 daily 0.8 http://www.pharma-marketer.com/access-pharmaceuticalsa%c2%80%c2%99-mugard-used-to-treat-2000-cancer-patients-since-launch-in-europe/ 2009-12-05T18:33:34+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-squibb-and-pfizer-announce-plans-to-submit-regulatory-filing-for-apixaban-in-europe/ 2009-12-05T18:33:34+00:00 daily 0.8 http://www.pharma-marketer.com/consumers-ignore-pharma-risk-warnings/ 2009-12-05T18:33:31+00:00 daily 0.8 http://www.pharma-marketer.com/is-the-pharma-social-media-bubble-about-to-burst/ 2009-12-05T06:50:19+00:00 daily 0.8 http://www.pharma-marketer.com/fda-issues-serious-warning-for-abbotts-depakote/ 2009-12-05T05:33:07+00:00 daily 0.8 http://www.pharma-marketer.com/glaxos-swine-flu-shot-may-give-kids-fever/ 2009-12-04T21:02:32+00:00 daily 0.8 http://www.pharma-marketer.com/can-novartis-win-race-to-launch-first-oral-drug-for-ms/ 2009-12-04T21:02:31+00:00 daily 0.8 http://www.pharma-marketer.com/tianyin-pharma-calls-for-75-improvement-in-2011-2/ 2009-12-04T21:02:29+00:00 daily 0.8 http://www.pharma-marketer.com/siga-thursdays-drop-was-nothing-but-a-tree-shake-2/ 2009-12-04T21:02:28+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-stock-mailbag-hemispherx-biopharma/ 2009-12-04T21:02:26+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approval-boosts-santarus-2/ 2009-12-04T21:02:25+00:00 daily 0.8 http://www.pharma-marketer.com/alkermes-acceleron-in-10m-licensing-deal-2/ 2009-12-04T21:02:24+00:00 daily 0.8 http://www.pharma-marketer.com/fda-practicing-stealth-comparative-effectiveness-in-u-s-2/ 2009-12-04T21:02:23+00:00 daily 0.8 http://www.pharma-marketer.com/normoxys-appoints-ceo-explores-oxyrens/ 2009-12-04T16:54:45+00:00 daily 0.8 http://www.pharma-marketer.com/experts-provide-more-funding-for-tb-drugs-vaccines/ 2009-12-04T16:13:46+00:00 daily 0.8 http://www.pharma-marketer.com/jackson-consultants/ 2009-12-04T16:07:28+00:00 daily 0.8 http://www.pharma-marketer.com/middlebrook-downsizes-following-nasdaq-notice/ 2009-12-04T16:05:08+00:00 daily 0.8 http://www.pharma-marketer.com/the-encima-group/ 2009-12-04T15:55:52+00:00 daily 0.8 http://www.pharma-marketer.com/smi-health/ 2009-12-04T15:55:34+00:00 daily 0.8 http://www.pharma-marketer.com/red-bridge-marketing/ 2009-12-04T15:55:30+00:00 daily 0.8 http://www.pharma-marketer.com/gobalto/ 2009-12-04T15:55:10+00:00 daily 0.8 http://www.pharma-marketer.com/bridge-worldwide/ 2009-12-04T15:54:51+00:00 daily 0.8 http://www.pharma-marketer.com/doctors-are-increasingly-concerned-that-the-sales-pitches-from-drug-reps-are-not-giving-them-the-full-story/ 2009-12-04T15:46:07+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-ups-the-ante-for-facet/ 2009-12-04T15:44:16+00:00 daily 0.8 http://www.pharma-marketer.com/atlas-did-not-shrug-fda-makes-some-comments-public/ 2009-12-04T15:13:42+00:00 daily 0.8 http://www.pharma-marketer.com/caloric-restriction-and-lifespan-without-the-caloric-restriction/ 2009-12-04T15:02:51+00:00 daily 0.8 http://www.pharma-marketer.com/alkermes-acceleron-in-10m-licensing-and-equity-deal/ 2009-12-04T14:47:16+00:00 daily 0.8 http://www.pharma-marketer.com/another-dubious-study/ 2009-12-04T14:38:23+00:00 daily 0.8 http://www.pharma-marketer.com/zymogenetics-halts-immunology-work-cuts-52-jobs/ 2009-12-04T14:36:14+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-gets-fda-ok-for-seroquel-xr-add-on/ 2009-12-04T14:20:12+00:00 daily 0.8 http://www.pharma-marketer.com/knives-drawn-over-the-botax/ 2009-12-04T14:20:11+00:00 daily 0.8 http://www.pharma-marketer.com/pharmacos-spend-more-on-dtc-advertising-when-there-is-no-competition/ 2009-12-04T13:58:00+00:00 daily 0.8 http://www.pharma-marketer.com/fda-intern-the-next-steps-toward-pharma-social-media-salvation/ 2009-12-04T10:35:01+00:00 daily 0.8 http://www.pharma-marketer.com/no-free-lunch-for-doctors-brought-to-you-by-jerseya%c2%80%c2%99s-ag/ 2009-12-04T10:01:27+00:00 daily 0.8 http://www.pharma-marketer.com/facet-biotech-advises-stockholders-to-take-no-action-in-response-to-revised-biogen-idec-tender-offer/ 2009-12-04T01:46:09+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-positive-development-on-the-lumizyme-front/ 2009-12-04T01:46:07+00:00 daily 0.8 http://www.pharma-marketer.com/should-amgen-buy-human-genome-sciences-2/ 2009-12-04T00:15:39+00:00 daily 0.8 http://www.pharma-marketer.com/cubist-pharma-says-reviewers-found-more-deaths-in-patients-taking-its-drug-dyax-stock-skids-2/ 2009-12-04T00:15:39+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-raises-facet-offer-to-17-50-per-share/ 2009-12-04T00:15:38+00:00 daily 0.8 http://www.pharma-marketer.com/no-holiday-for-biopharma-p-a/ 2009-12-03T22:45:07+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-spending-on-detailing-is-up-cbo/ 2009-12-03T22:45:06+00:00 daily 0.8 http://www.pharma-marketer.com/the-willingness-to-try/ 2009-12-03T19:39:27+00:00 daily 0.8 http://www.pharma-marketer.com/behind-the-business-3-questions-for-vical-2/ 2009-12-03T18:44:06+00:00 daily 0.8 http://www.pharma-marketer.com/consumer-safety-group-seeks-fda-ban-of-weight-loss-pill-meridia-citing-heart-attack-risks-2/ 2009-12-03T18:44:05+00:00 daily 0.8 http://www.pharma-marketer.com/drug-reps-or-dtc-congress-checks-it-out-2/ 2009-12-03T18:44:04+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-buy-seen-likely-after-alcon-shares-gain-2/ 2009-12-03T18:44:03+00:00 daily 0.8 http://www.pharma-marketer.com/genzymes-lumizyme-program-back-on-track/ 2009-12-03T17:29:34+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-targacept-to-develop-depression-drug/ 2009-12-03T17:13:45+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-warning-on-antidepressant-norpramin/ 2009-12-03T17:13:44+00:00 daily 0.8 http://www.pharma-marketer.com/vertex-raising-money-again/ 2009-12-03T17:13:43+00:00 daily 0.8 http://www.pharma-marketer.com/cephalon-sues-teva-over-sleep-drug-nuvigil/ 2009-12-03T17:13:42+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-cleared-by-ec-for-a-copd-treatment/ 2009-12-03T17:13:41+00:00 daily 0.8 http://www.pharma-marketer.com/fed-probe-into-johnson-johnson-reaches-zero-hour/ 2009-12-03T17:13:40+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-glaxo-deal-targets-asia/ 2009-12-03T17:13:40+00:00 daily 0.8 http://www.pharma-marketer.com/war-stories-iii-vermillion-up-215000-plans-escape-from-bankruptcy/ 2009-12-03T17:13:39+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-gain-endo-shares-retreat/ 2009-12-03T17:13:37+00:00 daily 0.8 http://www.pharma-marketer.com/isis-pharmaceuticals-adds-two-new-drugs-to-development-pipeline/ 2009-12-03T17:13:36+00:00 daily 0.8 http://www.pharma-marketer.com/vertex-adds-443m-to-its-big-cash-stash/ 2009-12-03T17:07:53+00:00 daily 0.8 http://www.pharma-marketer.com/endo-shares-sink-after-fda-rejects-aveed-nda/ 2009-12-03T16:09:26+00:00 daily 0.8 http://www.pharma-marketer.com/red-flag-forces-cubist-to-halt-phase-ii-enrollment/ 2009-12-03T15:42:21+00:00 daily 0.8 http://www.pharma-marketer.com/targacept-scores-blockbuster-1-2b-deal-with-az/ 2009-12-03T15:15:43+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-ceo-salaries-up-but-bonuses-down/ 2009-12-03T14:02:06+00:00 daily 0.8 http://www.pharma-marketer.com/all-of-you-industrial-scientists-out-of-the-room/ 2009-12-03T13:28:39+00:00 daily 0.8 http://www.pharma-marketer.com/privacy-policy/ 2009-12-03T08:48:18+00:00 weekly 0.6 http://www.pharma-marketer.com/will-pharma-lobbying-ensure-lynching-of-public-insurance-option/ 2009-12-03T07:05:36+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-cos-rise-as-govt-oks-new-stem-cell-lines-biotech-companies-soar-as-federal-government-names-new-stem-cell-line/ 2009-12-03T05:25:07+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-urged-zyprexa-use-without-proper-diagnosis/ 2009-12-03T05:25:06+00:00 daily 0.8 http://www.pharma-marketer.com/shirea%c2%80%c2%99s-replagal-improves-quality-of-life-for-fabrya%c2%80%c2%99s-patients/ 2009-12-03T04:40:01+00:00 daily 0.8 http://www.pharma-marketer.com/contact-us/ 2009-12-03T04:36:57+00:00 weekly 0.6 http://www.pharma-marketer.com/pharma-news/ 2009-12-03T04:35:07+00:00 weekly 0.6 http://www.pharma-marketer.com/roche-makes-strides-in-race-against-merck-2/ 2009-12-02T22:33:24+00:00 daily 0.8 http://www.pharma-marketer.com/human-genome-to-raise-money/ 2009-12-02T21:03:22+00:00 daily 0.8 http://www.pharma-marketer.com/sun-gets-taro-investor-support-for-buyout/ 2009-12-02T21:03:21+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-layoffs-are-a-lesson-in-how-not-to-do-it/ 2009-12-02T21:03:20+00:00 daily 0.8 http://www.pharma-marketer.com/titan-pharmaceutical-more-likely-buyout-target-as-patent-protection-is-approved/ 2009-12-02T21:03:18+00:00 daily 0.8 http://www.pharma-marketer.com/phenomix-forges-191m-pact-for-diabetes-drug/ 2009-12-02T17:44:43+00:00 daily 0.8 http://www.pharma-marketer.com/fda-lifts-its-hold-on-cytrx-als-program/ 2009-12-02T16:59:36+00:00 daily 0.8 http://www.pharma-marketer.com/trial-experts-join-fiercebiotech-webinar-panel/ 2009-12-02T16:24:33+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-ceo-says-he-supports-senate-healthcare-bill/ 2009-12-02T16:14:57+00:00 daily 0.8 http://www.pharma-marketer.com/takeda-plans-to-enter-india-drug-market-to-bolster-sales-growth/ 2009-12-02T16:14:56+00:00 daily 0.8 http://www.pharma-marketer.com/santarus-shares-rise-on-fda-drug-approval/ 2009-12-02T16:14:54+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-wins-zyprexa-case-against-mississippi/ 2009-12-02T16:14:53+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-set-to-benefit-from-hiv-guidelines/ 2009-12-02T16:14:51+00:00 daily 0.8 http://www.pharma-marketer.com/why-pfizers-deal-with-protalix-is-bad-news-for-big-pharma-sales-reps/ 2009-12-02T16:14:49+00:00 daily 0.8 http://www.pharma-marketer.com/shire-teva-settle-adderall-contract-lawsuit/ 2009-12-02T16:14:48+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-two-new-drugs/ 2009-12-02T16:14:45+00:00 daily 0.8 http://www.pharma-marketer.com/clinical-trials-doctors-and-conflicts-of-interest/ 2009-12-02T16:14:44+00:00 daily 0.8 http://www.pharma-marketer.com/immunogens-busy-month-part-ii/ 2009-12-02T16:14:43+00:00 daily 0.8 http://www.pharma-marketer.com/novavax-says-developing-swine-flu-vaccine-meets-midstage-study-goal/ 2009-12-02T16:14:43+00:00 daily 0.8 http://www.pharma-marketer.com/keryx-biopharmaceuticals-cancer-drug-candidate-gets-faster-regulatory-review-by-fda/ 2009-12-02T16:14:42+00:00 daily 0.8 http://www.pharma-marketer.com/sanofis-cancer-division-next-on-the-chopping-block-up-to-1200-jobs-gone-this-week/ 2009-12-02T16:14:40+00:00 daily 0.8 http://www.pharma-marketer.com/h1n1-what-it-means-for-pharma/ 2009-12-02T16:14:40+00:00 daily 0.8 http://www.pharma-marketer.com/dear-fda-where-are-the-public-comments-regarding-regulation-of-internet-docket-fda-2009-n-0441/ 2009-12-02T16:10:03+00:00 daily 0.8 http://www.pharma-marketer.com/partnering-deals-ginning-record-biotech-cash-in-09/ 2009-12-02T15:51:31+00:00 daily 0.8 http://www.pharma-marketer.com/if-consumers-dont-trust-you-than-you-have-a-lot-of-work-to-do-to-make-marketing-relevant-again-2/ 2009-12-02T15:41:57+00:00 daily 0.8 http://www.pharma-marketer.com/dyax-investors-bid-up-shares-on-fdas-kalbitor-approval/ 2009-12-02T15:19:37+00:00 daily 0.8 http://www.pharma-marketer.com/hemispherx-battered-after-fda-rejects-ampligen-nda/ 2009-12-02T14:23:24+00:00 daily 0.8 http://www.pharma-marketer.com/data-raw-and-otherwise/ 2009-12-02T14:14:57+00:00 daily 0.8 http://www.pharma-marketer.com/roche-diabetes-drug-beats-januvia-in-phase-iii/ 2009-12-02T13:47:13+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-takes-19-percent-stake-in-south-africas-aspen-as-it-continues-to-diversify/ 2009-12-02T11:00:42+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-teva-pay-to-delay-or-legit-settlement/ 2009-12-02T11:00:40+00:00 daily 0.8 http://www.pharma-marketer.com/abbotts-tricor-how-a-decades-old-drug-is-still-a-patented-blockbuster/ 2009-12-02T11:00:39+00:00 daily 0.8 http://www.pharma-marketer.com/merck-to-supremes-investors-should-have-sued-us-sooner/ 2009-12-02T11:00:38+00:00 daily 0.8 http://www.pharma-marketer.com/medimmune-licenses-rsv-antibodies-in-338m-deal/ 2009-12-02T11:00:37+00:00 daily 0.8 http://www.pharma-marketer.com/somaxon-pharmaceuticals-fda-close-to-a-decision-for-silenor/ 2009-12-02T11:00:36+00:00 daily 0.8 http://www.pharma-marketer.com/benefits/ 2009-12-02T10:15:44+00:00 weekly 0.6 http://www.pharma-marketer.com/richard-prest-pharma-technology-expert/ 2009-12-02T09:12:18+00:00 weekly 0.6 http://www.pharma-marketer.com/richard-meyer-dtc-expert/ 2009-12-02T09:09:07+00:00 weekly 0.6 http://www.pharma-marketer.com/ellen-hoenig-carlson-strategy-expert/ 2009-12-02T09:06:33+00:00 weekly 0.6 http://www.pharma-marketer.com/our-authors/ 2009-12-02T06:53:02+00:00 weekly 0.6 http://www.pharma-marketer.com/novogen-severs-ties-with-christopher-naughton/ 2009-12-02T05:20:16+00:00 daily 0.8 http://www.pharma-marketer.com/performance-based-pricing-in-patient-recruitment/ 2009-12-02T01:12:35+00:00 daily 0.8 http://www.pharma-marketer.com/better-buy-pfizer-or-teva-pharmaceutical/ 2009-12-02T01:02:08+00:00 daily 0.8 http://www.pharma-marketer.com/merck-lawyers-concede-vioxx-fraud-in-2001/ 2009-12-02T01:02:06+00:00 daily 0.8 http://www.pharma-marketer.com/dec-1st-is-world-aids-day/ 2009-12-01T20:57:32+00:00 daily 0.8 http://www.pharma-marketer.com/twin-brothers-cash-in-on-anaphylaxis-device/ 2009-12-01T17:18:48+00:00 daily 0.8 http://www.pharma-marketer.com/the-fall-of-the-worlds-best-selling-drug-5/ 2009-12-01T17:01:43+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-protalix-agree-deal-on-taliglucerase-2/ 2009-12-01T17:01:41+00:00 daily 0.8 http://www.pharma-marketer.com/impotence-pill-makers-fined-for-price-fixing-2/ 2009-12-01T17:01:39+00:00 daily 0.8 http://www.pharma-marketer.com/immunogens-busy-month-part-i/ 2009-12-01T17:01:36+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-industry-faces-rising-tax-burden-pwc-says/ 2009-12-01T17:01:36+00:00 daily 0.8 http://www.pharma-marketer.com/analyst-note-goldman-cautious-on-abbott-lilly/ 2009-12-01T17:01:35+00:00 daily 0.8 http://www.pharma-marketer.com/5-star-stocks-poised-to-pop-abbott-labs/ 2009-12-01T17:01:31+00:00 daily 0.8 http://www.pharma-marketer.com/if-consumers-dont-trust-you-then-you-have-a-lot-of-work-to-do-to-make-marketing-relevant-again/ 2009-12-01T16:27:53+00:00 daily 0.8 http://www.pharma-marketer.com/jumping-into-rare-diseases-pfizer-inks-115m-protalix-deal/ 2009-12-01T14:45:42+00:00 daily 0.8 http://www.pharma-marketer.com/fda-rejects-merck-kgaas-cladribine-app/ 2009-12-01T14:21:34+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-moves-drug-production-to-china-begging-safety-questions-for-fda/ 2009-12-01T14:21:29+00:00 daily 0.8 http://www.pharma-marketer.com/biomarin-treatment-gets-special-fda-status/ 2009-12-01T14:21:26+00:00 daily 0.8 http://www.pharma-marketer.com/celgene-cancer-pill-to-triple-sales-on-threat-to-jj/ 2009-12-01T14:21:25+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-calendar-key-dates-for-december/ 2009-12-01T14:21:25+00:00 daily 0.8 http://www.pharma-marketer.com/drugs-cost-is-the-highest-barrier-for-treatments/ 2009-12-01T14:21:24+00:00 daily 0.8 http://www.pharma-marketer.com/genentech-insists-it-hasnt-lost-its-rd-mojo/ 2009-12-01T14:21:24+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-reps-await-layoff-news-today/ 2009-12-01T14:21:24+00:00 daily 0.8 http://www.pharma-marketer.com/supreme-court-hears-case-on-whether-shareholders-waited-too-long-to-sue-over-vioxx-losses/ 2009-12-01T14:21:21+00:00 daily 0.8 http://www.pharma-marketer.com/johnson-johnson-good-bad-news/ 2009-12-01T14:21:20+00:00 daily 0.8 http://www.pharma-marketer.com/fda-offers-pfizers-hiv-drug-selzentry-new-life-for-all-the-good-it-will-do/ 2009-12-01T14:21:19+00:00 daily 0.8 http://www.pharma-marketer.com/generics-heat-up-cipla-in-talks-with-big-pharma-takeda-mulls-mas/ 2009-12-01T14:21:15+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-will-start-generic-drug-business-in-japan/ 2009-12-01T14:21:15+00:00 daily 0.8 http://www.pharma-marketer.com/life-sciences-industry-faces-rising-tide-of-taxes/ 2009-12-01T14:00:03+00:00 daily 0.8 http://www.pharma-marketer.com/fast-growing-forma-nabs-25-5m-series-b/ 2009-12-01T13:43:21+00:00 daily 0.8 http://www.pharma-marketer.com/while-the-fda-considers-web-2-0-regulation-web-3-0-is-on-the-way/ 2009-12-01T13:07:20+00:00 daily 0.8 http://www.pharma-marketer.com/colgate-total-floss-fish/ 2009-12-01T11:33:49+00:00 daily 0.8 http://www.pharma-marketer.com/colgate-total-floss-burger/ 2009-12-01T11:33:49+00:00 daily 0.8 http://www.pharma-marketer.com/journee-du-sida-gazette/ 2009-12-01T11:33:14+00:00 daily 0.8 http://www.pharma-marketer.com/journee-du-sida-classifieds/ 2009-12-01T11:33:14+00:00 daily 0.8 http://www.pharma-marketer.com/care-fertility-tin-can/ 2009-12-01T11:32:44+00:00 daily 0.8 http://www.pharma-marketer.com/handi-c-sanitizer-mask/ 2009-12-01T11:32:42+00:00 daily 0.8 http://www.pharma-marketer.com/celgene-new-studies-expected-to-boost-sales/ 2009-12-01T05:17:27+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-laboratories-grants-teva-rights-to-cholesterol-drug-tricor-as-early-as-march-of-2011/ 2009-11-30T22:59:30+00:00 daily 0.8 http://www.pharma-marketer.com/device-maker-bets-525-million-on-recycling-medical-devices/ 2009-11-30T22:58:59+00:00 daily 0.8 http://www.pharma-marketer.com/what-a-shriking-sales-force-means-for-pharma/ 2009-11-30T22:00:25+00:00 daily 0.8 http://www.pharma-marketer.com/china-biotech-week-in-review-two-more-rd-centers-one-pe-fund-one-ipo/ 2009-11-30T18:55:36+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-sales-reps-are-denied-overtime-by-court/ 2009-11-30T18:55:28+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lillys-cymbalta-gets-additional-fda-approval/ 2009-11-30T18:55:24+00:00 daily 0.8 http://www.pharma-marketer.com/patent-issued-for-allos-therapeutics-cancer-drug-folotyn/ 2009-11-30T18:55:23+00:00 daily 0.8 http://www.pharma-marketer.com/daiichi-sankyos-ceo-soft-talking-revolutionary/ 2009-11-30T18:55:19+00:00 daily 0.8 http://www.pharma-marketer.com/sequenom-stock-now-the-plaything-of-rumors/ 2009-11-30T18:55:12+00:00 daily 0.8 http://www.pharma-marketer.com/great-opportunity-for-incyte/ 2009-11-30T18:55:04+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-split-theravance-slides-on-fda-setback/ 2009-11-30T18:55:01+00:00 daily 0.8 http://www.pharma-marketer.com/more-binding-site-weirdness/ 2009-11-30T17:23:31+00:00 daily 0.8 http://www.pharma-marketer.com/terapio-reels-in-5m-for-drug-delivery-program/ 2009-11-30T16:41:19+00:00 daily 0.8 http://www.pharma-marketer.com/infoslate-techsessorize/ 2009-11-30T16:05:21+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-says-fda-approves-agriflu-seasonal-shot/ 2009-11-30T15:52:17+00:00 daily 0.8 http://www.pharma-marketer.com/the-fall-of-the-worlda%c2%a2aea%e2%84%a2s-best-selling-drug/ 2009-11-30T15:52:10+00:00 daily 0.8 http://www.pharma-marketer.com/turning-the-world-of-drugs-upside-down-gsk/ 2009-11-30T15:52:05+00:00 daily 0.8 http://www.pharma-marketer.com/depomed-files-patent-infringement-lawsuit-against-lupin-limited/ 2009-11-30T15:51:56+00:00 daily 0.8 http://www.pharma-marketer.com/13-biotechs-to-watch-for-at-hematology-conference/ 2009-11-30T15:51:54+00:00 daily 0.8 http://www.pharma-marketer.com/theravance-says-fda-wants-more-data-before-ruling-on-vitabix-for-hospital-acquired-pneumonia/ 2009-11-30T15:51:52+00:00 daily 0.8 http://www.pharma-marketer.com/endo-pharma-ceo-plots-new-round-of-deals/ 2009-11-30T15:30:12+00:00 daily 0.8 http://www.pharma-marketer.com/fda-denies-second-approval-for-theravance-drug/ 2009-11-30T14:58:37+00:00 daily 0.8 http://www.pharma-marketer.com/another-wake-up-call-for-social-media-purists/ 2009-11-30T14:51:57+00:00 daily 0.8 http://www.pharma-marketer.com/hgs-seeks-zalbin-ok-as-analysts-revive-buyout-buzz/ 2009-11-30T14:39:47+00:00 daily 0.8 http://www.pharma-marketer.com/brand-biologic-developers-poised-for-victory/ 2009-11-30T14:24:36+00:00 daily 0.8 http://www.pharma-marketer.com/77-percent-transparency-on-fdas-advisory-committees/ 2009-11-30T06:12:00+00:00 daily 0.8 http://www.pharma-marketer.com/fda-social-media-hearing-day-1-my-key-takeaways/ 2009-11-29T15:14:55+00:00 daily 0.8 http://www.pharma-marketer.com/drug-industry-seasonal-depression/ 2009-11-29T14:47:36+00:00 daily 0.8 http://www.pharma-marketer.com/the-direct-medical-cost-of-treating-diabetics-will-rise-from-113-billion-annually-to-336-billion/ 2009-11-27T20:33:29+00:00 daily 0.8 http://www.pharma-marketer.com/la-jolla-pharma-axes-plan-to-dissolve-company/ 2009-11-27T19:19:15+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-partners-with-u-s-government-for-faster-flu-vaccine-manufacturing/ 2009-11-27T19:19:14+00:00 daily 0.8 http://www.pharma-marketer.com/zetias-miraculous-popularity/ 2009-11-27T19:19:12+00:00 daily 0.8 http://www.pharma-marketer.com/insider-buying-bodes-well-for-orexigen/ 2009-11-27T19:19:08+00:00 daily 0.8 http://www.pharma-marketer.com/diabetes-population-to-double-diabetes-costs-to-nearly-triple-in-25-years-new-study-shows/ 2009-11-27T19:19:06+00:00 daily 0.8 http://www.pharma-marketer.com/encouraging-results-for-cumberland/ 2009-11-27T19:19:04+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-to-participate-in-russian-project/ 2009-11-27T19:19:02+00:00 daily 0.8 http://www.pharma-marketer.com/indiaa%c2%a2aea%e2%84%a2s-ranbaxy-gains-as-valtrex-sales-begin-in-u-s/ 2009-11-27T19:18:59+00:00 daily 0.8 http://www.pharma-marketer.com/financing-drug-discovery-recent-deals/ 2009-11-27T19:18:56+00:00 daily 0.8 http://www.pharma-marketer.com/cytrx-announces-first-of-two-positive-developments-ahead/ 2009-11-27T19:18:54+00:00 daily 0.8 http://www.pharma-marketer.com/a-mostly-meaningless-fda-approval/ 2009-11-27T19:18:53+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-squibb-sees-perfect-timing-to-divest-huge-mead-johnson-nutrition-stake/ 2009-11-27T15:51:49+00:00 daily 0.8 http://www.pharma-marketer.com/merck-triumphs-in-defense-of-osteoporosis-drug-for-now/ 2009-11-27T15:51:46+00:00 daily 0.8 http://www.pharma-marketer.com/siga-shares-could-double-on-pending-government-news/ 2009-11-27T15:51:44+00:00 daily 0.8 http://www.pharma-marketer.com/friday-ramblings/ 2009-11-27T14:33:29+00:00 daily 0.8 http://www.pharma-marketer.com/merck-cholesterol-scrips-drop-as-niaspan-rises/ 2009-11-25T22:00:25+00:00 daily 0.8 http://www.pharma-marketer.com/a-schizophrenic-move-by-merck/ 2009-11-25T22:00:21+00:00 daily 0.8 http://www.pharma-marketer.com/still-enjoying-those-acquisitions-pfizer/ 2009-11-25T22:00:17+00:00 daily 0.8 http://www.pharma-marketer.com/prospecting-for-stocks-novartis/ 2009-11-25T22:00:11+00:00 daily 0.8 http://www.pharma-marketer.com/a-big-upgrade-for-amylin-pharmaceuticals/ 2009-11-25T22:00:05+00:00 daily 0.8 http://www.pharma-marketer.com/fda-grants-full-approval-to-jjs-hiv-drug/ 2009-11-25T22:00:01+00:00 daily 0.8 http://www.pharma-marketer.com/incyte-to-license-2-hematology-drugs-to-novartis/ 2009-11-25T15:04:03+00:00 daily 0.8 http://www.pharma-marketer.com/the-vytorin-limbo-how-low-can-you-go/ 2009-11-25T15:04:00+00:00 daily 0.8 http://www.pharma-marketer.com/health-care-bill-may-be-stalled-by-year-end-legislative-crunch/ 2009-11-25T15:03:56+00:00 daily 0.8 http://www.pharma-marketer.com/vaccine-makers-struggle-to-speed-output/ 2009-11-25T15:03:50+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-kindler-advises-executive-soul-searching/ 2009-11-25T15:03:47+00:00 daily 0.8 http://www.pharma-marketer.com/under-the-radar-healthcare-stocks-protox-pressure-biosciences-unilife/ 2009-11-25T15:03:44+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-looks-at-combination-pills-to-fix-hypertension-franchise/ 2009-11-25T15:03:42+00:00 daily 0.8 http://www.pharma-marketer.com/genzymes-renagel-renvela-franchise-investors-would-be-wise-to-reevaluate/ 2009-11-25T15:03:37+00:00 daily 0.8 http://www.pharma-marketer.com/human-genome-sciences-submits-biologics-license-application-to-fda-for-zalbin/ 2009-11-25T15:03:35+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-terminates-pact-with-idera/ 2009-11-25T15:03:30+00:00 daily 0.8 http://www.pharma-marketer.com/roche-ceo-sees-group-outpacing-market-in-2009-paper/ 2009-11-25T15:03:28+00:00 daily 0.8 http://www.pharma-marketer.com/light-blogging/ 2009-11-25T14:54:24+00:00 daily 0.8 http://www.pharma-marketer.com/vaccine-makers-struggle-to-modernize/ 2009-11-25T14:22:52+00:00 daily 0.8 http://www.pharma-marketer.com/scottish-clinic-to-test-dimebon/ 2009-11-25T13:16:52+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-incyte-strike-potential-1b-deal/ 2009-11-25T12:52:22+00:00 daily 0.8 http://www.pharma-marketer.com/weak-demand-hurts-geopharma-sales-profit/ 2009-11-25T03:13:41+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-cells-its-flu-vaccine-technology/ 2009-11-25T03:13:38+00:00 daily 0.8 http://www.pharma-marketer.com/fda-delays-combinatorx-drug-decision/ 2009-11-25T03:13:28+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-takes-aim-in-patent-row/ 2009-11-25T03:13:20+00:00 daily 0.8 http://www.pharma-marketer.com/can-drug-device-makers-innovate-themselves-to-extinction/ 2009-11-25T03:13:14+00:00 daily 0.8 http://www.pharma-marketer.com/analysts-predict-next-biotech-ipos/ 2009-11-24T21:09:39+00:00 daily 0.8 http://www.pharma-marketer.com/researchers-address-data-policies-for-developing-country-gwas/ 2009-11-24T20:49:43+00:00 daily 0.8 http://www.pharma-marketer.com/chinese-firm-files-69m-ipo/ 2009-11-24T20:24:20+00:00 daily 0.8 http://www.pharma-marketer.com/merger-distracts-pfizer-from-biotech-incubator/ 2009-11-24T18:04:57+00:00 daily 0.8 http://www.pharma-marketer.com/merck-says-judge-dismisses-key-case-alleging-fosamax-causes-bone-damage/ 2009-11-24T16:49:03+00:00 daily 0.8 http://www.pharma-marketer.com/medtronic-profit-rises-59-on-growth-in-heart-devices/ 2009-11-24T16:49:00+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-bristola%c2%a2aea%e2%84%a2s-plavix-ads-may-have-affected-price/ 2009-11-24T16:48:56+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-pulls-swine-flu-vaccines-in-canada/ 2009-11-24T16:48:52+00:00 daily 0.8 http://www.pharma-marketer.com/a-rorschach-on-health-care-pfizer-hit-with-28m-in-punitives/ 2009-11-24T16:48:49+00:00 daily 0.8 http://www.pharma-marketer.com/cytrx-corporation-key-developments-ahead/ 2009-11-24T16:48:42+00:00 daily 0.8 http://www.pharma-marketer.com/australia-pulls-guidelines-for-adhd-medicines/ 2009-11-24T16:48:37+00:00 daily 0.8 http://www.pharma-marketer.com/bankers-reveal-top-biotech-ipo-contenders-new-filer-ironwood-among-them/ 2009-11-24T16:48:33+00:00 daily 0.8 http://www.pharma-marketer.com/shire-applies-for-euro-approval-of-gaucher-drug/ 2009-11-24T16:48:30+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-sluggish-shire-gains-in-early-action/ 2009-11-24T16:48:28+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-signs-sales-deal-with-glaxo-for-viread/ 2009-11-24T16:48:21+00:00 daily 0.8 http://www.pharma-marketer.com/biomed-news-bytes-transcept-prourocare-sciclone-abio/ 2009-11-24T16:48:19+00:00 daily 0.8 http://www.pharma-marketer.com/fda-fast-tracks-arcas-gencaro/ 2009-11-24T16:29:05+00:00 daily 0.8 http://www.pharma-marketer.com/applied-organic-synthesis-chocolate-pecan-pie/ 2009-11-24T16:19:02+00:00 daily 0.8 http://www.pharma-marketer.com/did-state-medicaid-programs-finance-plavix-direct-to-consumer-advertising/ 2009-11-24T16:11:34+00:00 daily 0.8 http://www.pharma-marketer.com/oxagen-rounds-up-26-7m-in-vc/ 2009-11-24T16:07:24+00:00 daily 0.8 http://www.pharma-marketer.com/clavis-inks-380m-deal-with-clovis-oncology/ 2009-11-24T15:33:47+00:00 daily 0.8 http://www.pharma-marketer.com/fear-of-academic-chemistry/ 2009-11-24T15:02:41+00:00 daily 0.8 http://www.pharma-marketer.com/raptor-reports-results-from-two-programs/ 2009-11-24T14:06:10+00:00 daily 0.8 http://www.pharma-marketer.com/jubilant-signs-mou-with-alabama-researchers/ 2009-11-24T13:56:19+00:00 daily 0.8 http://www.pharma-marketer.com/it%e2%80%99s-a-harsh-business-reality/ 2009-11-24T13:19:11+00:00 daily 0.8 http://www.pharma-marketer.com/social-media-is-not-going-to-save-dtc-marketing-or-pharma/ 2009-11-24T13:19:11+00:00 daily 0.8 http://www.pharma-marketer.com/priorities/ 2009-11-24T12:58:45+00:00 daily 0.8 http://www.pharma-marketer.com/positive-opinion-for-mercks-elonva/ 2009-11-23T23:29:55+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-immunovaccine-in-animal-vaccine-deal/ 2009-11-23T23:29:51+00:00 daily 0.8 http://www.pharma-marketer.com/does-pfizer-ceo-regret-sale-of-consumer-products-to-jj/ 2009-11-23T23:29:47+00:00 daily 0.8 http://www.pharma-marketer.com/sanofis-viehbacher-backs-health-reform-may-change-companys-name/ 2009-11-23T23:29:45+00:00 daily 0.8 http://www.pharma-marketer.com/new-analysis-finds-vioxxs-heart-attack-risk-demonstrated-in-2001/ 2009-11-23T23:29:39+00:00 daily 0.8 http://www.pharma-marketer.com/recommended-books-for-medicinal-chemists-part-one/ 2009-11-23T22:02:25+00:00 daily 0.8 http://www.pharma-marketer.com/demystifying-clinical-trial-efficiency/ 2009-11-23T21:10:58+00:00 daily 0.8 http://www.pharma-marketer.com/k-c-nicolaou-call-your-office/ 2009-11-23T17:29:50+00:00 daily 0.8 http://www.pharma-marketer.com/cumberlands-injection-meets-study-goal/ 2009-11-23T16:34:29+00:00 daily 0.8 http://www.pharma-marketer.com/germanys-merck-will-expand-rd-in-china/ 2009-11-23T16:15:22+00:00 daily 0.8 http://www.pharma-marketer.com/king-may-climb-as-battered-drug-companies-lure-private-equity/ 2009-11-23T16:15:19+00:00 daily 0.8 http://www.pharma-marketer.com/boehringera%c2%a2aea%e2%84%a2s-pradaxa-matches-warfarin-as-clot-therapy-in-study/ 2009-11-23T16:15:16+00:00 daily 0.8 http://www.pharma-marketer.com/merck-claims-win-in-texas-lawsuit-over-vioxx/ 2009-11-23T16:15:13+00:00 daily 0.8 http://www.pharma-marketer.com/mixed-results-from-ception-cephalon-on-cinquil/ 2009-11-23T16:15:10+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-fda-issues-new-obesity-drug-heart-warning/ 2009-11-23T16:15:05+00:00 daily 0.8 http://www.pharma-marketer.com/icahn-makes-big-moves-in-healthcare-stocks/ 2009-11-23T16:15:01+00:00 daily 0.8 http://www.pharma-marketer.com/cms-moves-up-avastin-pricing-changes/ 2009-11-23T16:14:59+00:00 daily 0.8 http://www.pharma-marketer.com/good-news-for-bristol-myers/ 2009-11-23T16:14:57+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-withdraws-avodart-us-new-drug-application/ 2009-11-23T16:14:54+00:00 daily 0.8 http://www.pharma-marketer.com/encouraging-data-on-jjs-simponi/ 2009-11-23T16:14:52+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-advance-cephalon-falls-on-study/ 2009-11-23T16:14:50+00:00 daily 0.8 http://www.pharma-marketer.com/a-big-upgrade-for-allos-therapeutics/ 2009-11-23T16:14:42+00:00 daily 0.8 http://www.pharma-marketer.com/raptor-pharmas-ngx426-for-pain-relief-proves-effective-in-test/ 2009-11-23T16:14:39+00:00 daily 0.8 http://www.pharma-marketer.com/cytrx-technical-breakout-imminent/ 2009-11-23T16:14:36+00:00 daily 0.8 http://www.pharma-marketer.com/receptos-raises-25m-in-series-a/ 2009-11-23T15:53:50+00:00 daily 0.8 http://www.pharma-marketer.com/ironwood-looks-to-go-public-raise-172m/ 2009-11-23T15:49:54+00:00 daily 0.8 http://www.pharma-marketer.com/cephalon-hesitates-on-ception-drug-results/ 2009-11-23T14:47:14+00:00 daily 0.8 http://www.pharma-marketer.com/ozonides-as-drugs-what-will-they-think-of-next/ 2009-11-23T14:13:48+00:00 daily 0.8 http://www.pharma-marketer.com/merck-kgaa-will-expand-rd-in-china/ 2009-11-23T13:45:31+00:00 daily 0.8 http://www.pharma-marketer.com/uae-sets-up-150m-biologics-plant/ 2009-11-23T13:06:34+00:00 daily 0.8 http://www.pharma-marketer.com/what-we-didnt-hear-at-the-fda-part-15-meeting-on-social-media/ 2009-11-23T13:06:02+00:00 daily 0.8 http://www.pharma-marketer.com/why-allergan-and-medicis-should-embrace-the-botox-tax-in-senate-health-bill/ 2009-11-23T01:01:48+00:00 daily 0.8 http://www.pharma-marketer.com/why-jjs-stelara-launch-should-target-dermatologists-first/ 2009-11-23T01:01:41+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-chief-lays-out-distinctive-strategy/ 2009-11-23T01:01:38+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-takes-three-pronged-approach-in-china-to-fight-h1n1-flu/ 2009-11-22T20:54:50+00:00 daily 0.8 http://www.pharma-marketer.com/expiration-trade-behind-osiris-activity/ 2009-11-22T20:54:48+00:00 daily 0.8 http://www.pharma-marketer.com/dendreon-says-fda-will-disclose-provengea%c2%a2aea%e2%84%a2s-fate-by-may-1/ 2009-11-22T20:54:45+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-11-20-09/ 2009-11-22T14:46:37+00:00 daily 0.8 http://www.pharma-marketer.com/is-the-culture-within-pharma-ready-for-the-change-that-is-needed-to-embrace-new-media/ 2009-11-21T20:51:14+00:00 daily 0.8 http://www.pharma-marketer.com/may-day-for-dendreon/ 2009-11-21T19:28:17+00:00 daily 0.8 http://www.pharma-marketer.com/cornerstone-therapeutics-provides-a-response-to-fda-warning-letter-on-deconsal/ 2009-11-21T19:28:10+00:00 daily 0.8 http://www.pharma-marketer.com/inovio-merck-gain-novavax-falls-in-afternoon-action/ 2009-11-21T19:28:03+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-geodon-gets-expanded-fda-approval/ 2009-11-21T19:27:59+00:00 daily 0.8 http://www.pharma-marketer.com/jj-stays-true-to-its-diversified-model/ 2009-11-21T19:27:52+00:00 daily 0.8 http://www.pharma-marketer.com/this-baby-is-a-nice-addition-elonva/ 2009-11-21T19:27:44+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharma-mergers-good-news-or-bad/ 2009-11-21T19:27:34+00:00 daily 0.8 http://www.pharma-marketer.com/u-s-food-and-drug-administration-approves-abilifya%e2%80%9aa%c2%ae-aripiprazole-for-the-treatment-of-irritability-associated-with-au/ 2009-11-21T19:27:30+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-falling-off-a-patent-cliff/ 2009-11-21T19:27:26+00:00 daily 0.8 http://www.pharma-marketer.com/vitamin-beats-statin-is-mercks-zetia-in-trouble/ 2009-11-21T19:27:21+00:00 daily 0.8 http://www.pharma-marketer.com/u-s-court-of-appeals-upholds-astrazeneca-awp-settlement/ 2009-11-21T19:27:18+00:00 daily 0.8 http://www.pharma-marketer.com/dithering-over-statins-side-effects-label-finally-ends/ 2009-11-21T19:27:07+00:00 daily 0.8 http://www.pharma-marketer.com/evidence-does-not-connect-h1n1-vaccine-to-patient-deaths-who-says/ 2009-11-21T19:26:56+00:00 daily 0.8 http://www.pharma-marketer.com/phrma-reaffirms-its-commitment-to-support-the-health-reform/ 2009-11-21T19:26:45+00:00 daily 0.8 http://www.pharma-marketer.com/cosmo-pharma-offers-to-acquire-bioxell/ 2009-11-21T19:26:38+00:00 daily 0.8 http://www.pharma-marketer.com/aurobindo-pharma-sees-2-bn-sales-in-next-3-years/ 2009-11-21T19:26:33+00:00 daily 0.8 http://www.pharma-marketer.com/thallion-presents-poster-on-the-apoptotic-properties-of-tln-4601-at-the-aacr-nci-eortc-conference/ 2009-11-21T19:26:28+00:00 daily 0.8 http://www.pharma-marketer.com/4-star-stocks-poised-to-pop-merck/ 2009-11-20T20:19:34+00:00 daily 0.8 http://www.pharma-marketer.com/provenge-activists-try-again-for-fda-documents/ 2009-11-20T20:19:31+00:00 daily 0.8 http://www.pharma-marketer.com/but-these-reagents-where-are-they/ 2009-11-20T16:53:25+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-is-best-positioned-big-pharma-in-china-goldman/ 2009-11-20T16:06:10+00:00 daily 0.8 http://www.pharma-marketer.com/roches-actemra-successful-in-arthritis-study/ 2009-11-20T16:06:06+00:00 daily 0.8 http://www.pharma-marketer.com/secret-prempro-documents-to-surface-in-florida/ 2009-11-20T16:06:01+00:00 daily 0.8 http://www.pharma-marketer.com/possible-new-indication-for-progenics-relistor-could-revive-its-fortunes/ 2009-11-20T16:05:50+00:00 daily 0.8 http://www.pharma-marketer.com/opponents-of-botox-tax-go-big-baby-boomers-women/ 2009-11-20T16:05:40+00:00 daily 0.8 http://www.pharma-marketer.com/ten-minutes-that-mattered-gileads-martin/ 2009-11-20T16:04:39+00:00 daily 0.8 http://www.pharma-marketer.com/immunogen-bags-second-35m-deal-with-amgen/ 2009-11-20T15:45:17+00:00 daily 0.8 http://www.pharma-marketer.com/roche-touts-actemra-results-for-sjia/ 2009-11-20T15:02:35+00:00 daily 0.8 http://www.pharma-marketer.com/fda-extends-review-for-pain-drug/ 2009-11-20T14:47:31+00:00 daily 0.8 http://www.pharma-marketer.com/merck-shopping-in-the-uk/ 2009-11-20T13:54:14+00:00 daily 0.8 http://www.pharma-marketer.com/caterpillar-shot-fails-to-win-vote-on-safety/ 2009-11-20T13:44:38+00:00 daily 0.8 http://www.pharma-marketer.com/movetis-plots-european-ipo/ 2009-11-20T13:30:23+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-seven-tips-to-improve-your-next-fda-advisory-presentation/ 2009-11-20T13:03:04+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-dodges-a-bullet/ 2009-11-20T12:13:26+00:00 daily 0.8 http://www.pharma-marketer.com/u-s-house-votes-to-avert-cuts-in-medicare-payments-to-doctors/ 2009-11-20T12:13:24+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-this-stock-is-a-train-wreck/ 2009-11-20T12:13:21+00:00 daily 0.8 http://www.pharma-marketer.com/santarus-zegrid-facing-back-to-back-fda-approval-dates/ 2009-11-20T12:13:19+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-backs-stronger-benefit-claims-and-safety-profile-for-inhaler-drug-spiriva/ 2009-11-20T00:42:11+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharma-under-pressure-as-drug-patents-expire-and-pipeline-slows/ 2009-11-20T00:42:05+00:00 daily 0.8 http://www.pharma-marketer.com/merck-gives-snapshot-of-combined-company-47b-in-sales-just-7-6b-in-cash/ 2009-11-20T00:42:00+00:00 daily 0.8 http://www.pharma-marketer.com/ligand-pharmaceuticals-receives-2-million-from-research-partnership-with-merck/ 2009-11-20T00:41:54+00:00 daily 0.8 http://www.pharma-marketer.com/neurogesx-next-stop-u-s-market/ 2009-11-20T00:41:47+00:00 daily 0.8 http://www.pharma-marketer.com/getsocial/ 2009-11-19T22:01:41+00:00 daily 0.8 http://www.pharma-marketer.com/md-governor-applauds-expansion-of-emergent-biosolutions/ 2009-11-19T21:11:36+00:00 daily 0.8 http://www.pharma-marketer.com/is-google-the-new-fda/ 2009-11-19T21:10:15+00:00 daily 0.8 http://www.pharma-marketer.com/xarelto-approval-hopes-revived/ 2009-11-19T20:58:52+00:00 daily 0.8 http://www.pharma-marketer.com/what-are-the-best-med-chem-books/ 2009-11-19T17:51:55+00:00 daily 0.8 http://www.pharma-marketer.com/act-begins-stem-cell-blindness-trial/ 2009-11-19T16:30:42+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-to-begin-selling-generics-in-japan/ 2009-11-19T15:59:38+00:00 daily 0.8 http://www.pharma-marketer.com/obesity-and-ed-two-big-markets-one-tiny-company/ 2009-11-19T15:59:36+00:00 daily 0.8 http://www.pharma-marketer.com/genentech-biogen-idec-get-fda-request-on-application-for-rituxans-use-in-leukemia/ 2009-11-19T15:59:33+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-submits-brilinta-nda-to-fda/ 2009-11-19T15:59:30+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-to-launch-antimalarial-drug-study/ 2009-11-19T15:59:27+00:00 daily 0.8 http://www.pharma-marketer.com/u-s-panel-rejects-xolair-asthma-drug-for-children/ 2009-11-19T15:59:24+00:00 daily 0.8 http://www.pharma-marketer.com/hard-to-get-excited-about-bis-flibanserin/ 2009-11-19T15:59:20+00:00 daily 0.8 http://www.pharma-marketer.com/drug-lowers-cholesterol-stock-follows/ 2009-11-19T15:59:18+00:00 daily 0.8 http://www.pharma-marketer.com/jj-vs-10-year-t-bonds-the-power-of-rising-dividends/ 2009-11-19T15:59:14+00:00 daily 0.8 http://www.pharma-marketer.com/flu-shot-made-from-caterpillars-may-win-pivotal-u-s-backing/ 2009-11-19T15:59:09+00:00 daily 0.8 http://www.pharma-marketer.com/should-you-buy-it-alkermes/ 2009-11-19T15:59:06+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-drops-kidney-drug-plans-amid-pileup-of-bad-news/ 2009-11-19T15:59:02+00:00 daily 0.8 http://www.pharma-marketer.com/u-s-sees-low-demand-for-biocryst-flu-drug/ 2009-11-19T15:58:58+00:00 daily 0.8 http://www.pharma-marketer.com/poniard-pharmaceuticals-gamble-doesnt-pay-off/ 2009-11-19T15:58:54+00:00 daily 0.8 http://www.pharma-marketer.com/immupharma-ceo-slams-stock-plunge-after-drug-trial/ 2009-11-19T15:58:47+00:00 daily 0.8 http://www.pharma-marketer.com/plavix-label-change-good-for-effient-now-bad-for-brands-in-the-long-run/ 2009-11-19T15:58:00+00:00 daily 0.8 http://www.pharma-marketer.com/congress-wants-gao-to-probe-drug-prices/ 2009-11-19T15:57:48+00:00 daily 0.8 http://www.pharma-marketer.com/start-up-get-funding-for-microarray-work/ 2009-11-19T15:52:48+00:00 daily 0.8 http://www.pharma-marketer.com/its-a-matter-of-trust-or-lack-thereof/ 2009-11-19T15:04:00+00:00 daily 0.8 http://www.pharma-marketer.com/caterpillar-based-flu-shot-could-be-on-horizon/ 2009-11-19T14:48:06+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-files-brilinta-nda/ 2009-11-19T14:36:00+00:00 daily 0.8 http://www.pharma-marketer.com/market-puzzled-by-immupharmas-lupus-results/ 2009-11-19T13:43:08+00:00 daily 0.8 http://www.pharma-marketer.com/plavix-vs-effient/ 2009-11-19T13:29:41+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-says-yes-to-updated-prevnar/ 2009-11-19T13:08:34+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-backs-pfizers-enhanced-vaccine-for-kids/ 2009-11-19T12:10:30+00:00 daily 0.8 http://www.pharma-marketer.com/four-healthcare-stocks-on-fire/ 2009-11-19T12:10:28+00:00 daily 0.8 http://www.pharma-marketer.com/drugmaker-reinvents-itself-and-expands-footprint-internationally/ 2009-11-19T12:10:26+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-may-face-6000-seroquel-trials-as-judge-to-urge-cases-return/ 2009-11-19T12:10:23+00:00 daily 0.8 http://www.pharma-marketer.com/how-to-cut-clinical-trial-costs/ 2009-11-18T20:04:47+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-stocks-hot-right-now-ho-hum-in-the-long-run/ 2009-11-18T19:33:49+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-takes-dow-jones-to-task-on-its-blog/ 2009-11-18T19:33:47+00:00 daily 0.8 http://www.pharma-marketer.com/researchers-will-test-pfizer-pipeline-to-find-treatments-for-some-tropical-illnesses/ 2009-11-18T19:33:44+00:00 daily 0.8 http://www.pharma-marketer.com/crestor-shines-vitamin-d-intrigues-at-aha-confab/ 2009-11-18T19:33:41+00:00 daily 0.8 http://www.pharma-marketer.com/more-for-the-blogroll/ 2009-11-18T19:19:52+00:00 daily 0.8 http://www.pharma-marketer.com/risky-merck-cholesterol-program-shows-mid-stage-promise/ 2009-11-18T17:12:12+00:00 daily 0.8 http://www.pharma-marketer.com/on-the-radar-novembers-biotech-stocks-to-watch/ 2009-11-18T16:46:47+00:00 daily 0.8 http://www.pharma-marketer.com/az-wows-analysts-with-new-brilinta-data/ 2009-11-18T15:42:31+00:00 daily 0.8 http://www.pharma-marketer.com/ill-get-right-on-that-for-you-professor/ 2009-11-18T15:36:02+00:00 daily 0.8 http://www.pharma-marketer.com/answering-the-vytorin-question/ 2009-11-18T15:33:51+00:00 daily 0.8 http://www.pharma-marketer.com/mead-johnson-this-poison-pill-aids-investors/ 2009-11-18T15:33:47+00:00 daily 0.8 http://www.pharma-marketer.com/vivus-erection-drug-worked-within-30-minutes-in-study/ 2009-11-18T15:33:44+00:00 daily 0.8 http://www.pharma-marketer.com/drugmakers-differences-analysts-toolkit/ 2009-11-18T15:33:37+00:00 daily 0.8 http://www.pharma-marketer.com/another-genzyme-drug-goes-kaboom/ 2009-11-18T15:33:29+00:00 daily 0.8 http://www.pharma-marketer.com/nicox-to-sell-new-shares-as-fda-agrees-to-review-arthritis-drug/ 2009-11-18T15:33:06+00:00 daily 0.8 http://www.pharma-marketer.com/nicox-raising-149m-to-back-blockbuster-launch/ 2009-11-18T15:24:33+00:00 daily 0.8 http://www.pharma-marketer.com/trubion-ceo-out-in-management-shuffle/ 2009-11-18T14:46:55+00:00 daily 0.8 http://www.pharma-marketer.com/qiagen-plans-to-continue-deal-spree/ 2009-11-18T14:28:22+00:00 daily 0.8 http://www.pharma-marketer.com/italys-cosmo-to-snap-up-bioxell-in-41m-deal/ 2009-11-18T14:09:12+00:00 daily 0.8 http://www.pharma-marketer.com/confusing-news-on-mammograms-driving-more-people-online/ 2009-11-18T14:05:38+00:00 daily 0.8 http://www.pharma-marketer.com/on-a-hot-streak-vivus-posts-positive-ed-data/ 2009-11-18T13:48:26+00:00 daily 0.8 http://www.pharma-marketer.com/the-bite-of-the-bivalve-how-much-pressure-can-fda-take/ 2009-11-18T13:01:40+00:00 daily 0.8 http://www.pharma-marketer.com/biocryst-hopes-to-raise-57m-with-stock-offering/ 2009-11-18T03:56:18+00:00 daily 0.8 http://www.pharma-marketer.com/titan-pharmaceuticals-finally-reaching-its-potential/ 2009-11-18T03:56:16+00:00 daily 0.8 http://www.pharma-marketer.com/crestor-cuts-cardiovascular-problems-in-women/ 2009-11-18T03:56:14+00:00 daily 0.8 http://www.pharma-marketer.com/fda-sets-action-date-of-april-23-2010-for-review-of-pixantrone-nda/ 2009-11-17T23:49:11+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-idec-offers-to-buy-facet-for-356m/ 2009-11-17T23:49:08+00:00 daily 0.8 http://www.pharma-marketer.com/genta-announces-closing-of-10-million-in-two-offerings-of-common-stock-and-convertible-notes/ 2009-11-17T23:49:06+00:00 daily 0.8 http://www.pharma-marketer.com/teva-mulls-transfer-of-irish-jobs-to-israel/ 2009-11-17T23:49:04+00:00 daily 0.8 http://www.pharma-marketer.com/in-pfizers-cancer-battle-profit-but-little-progress/ 2009-11-17T23:49:01+00:00 daily 0.8 http://www.pharma-marketer.com/china-biotech-in-review-the-flight-to-fight-off-the-flu/ 2009-11-17T23:48:56+00:00 daily 0.8 http://www.pharma-marketer.com/summer-ends-with-biotech-buying-spree/ 2009-11-17T23:48:54+00:00 daily 0.8 http://www.pharma-marketer.com/salix-pharma-continues-to-rise-in-anticipation-of-fda-decision/ 2009-11-17T23:48:51+00:00 daily 0.8 http://www.pharma-marketer.com/three-blockbuster-drugs-seeking-nda-amexaen/ 2009-11-17T23:48:50+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-whistle-blowing-the-how-and-why/ 2009-11-17T23:48:47+00:00 daily 0.8 http://www.pharma-marketer.com/facet-biotech-should-dig-in-its-heels-over-biogen-bid/ 2009-11-17T23:48:41+00:00 daily 0.8 http://www.pharma-marketer.com/will-chinas-swine-flu-vaccine-work/ 2009-11-17T23:48:40+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeutics-looks-good-antigenics-looks-better/ 2009-11-17T23:48:37+00:00 daily 0.8 http://www.pharma-marketer.com/opexa-reports-additional-favorable-data-with-tovaxina%e2%80%9aa%c2%ae-for-multiple-sclerosis/ 2009-11-17T23:48:35+00:00 daily 0.8 http://www.pharma-marketer.com/roche-taps-new-pharma-head-after-genentech-buy/ 2009-11-17T23:48:34+00:00 daily 0.8 http://www.pharma-marketer.com/facet-biotech-rejects-biogen-idecs-bid/ 2009-11-17T23:48:32+00:00 daily 0.8 http://www.pharma-marketer.com/osiris-stem-cell-drug-fails/ 2009-11-17T23:48:28+00:00 daily 0.8 http://www.pharma-marketer.com/analyst-upgrades-pharmasset-citing-potential-for-developing-hepatitis-c-drug/ 2009-11-17T23:48:26+00:00 daily 0.8 http://www.pharma-marketer.com/geopharma-settles-with-consolidated-pharmaceutical/ 2009-11-17T23:48:24+00:00 daily 0.8 http://www.pharma-marketer.com/brilinta-bests-plavix-in-trial/ 2009-11-17T21:28:25+00:00 daily 0.8 http://www.pharma-marketer.com/vaccines-on-horizon-for-aids-alzheimers-herpes/ 2009-11-17T21:28:22+00:00 daily 0.8 http://www.pharma-marketer.com/oxigenes-developing-cancer-treatment-meets-safety-goals-in-midstage-study/ 2009-11-17T21:28:19+00:00 daily 0.8 http://www.pharma-marketer.com/poniard-recovers-on-phase-ii-picoplatin-results/ 2009-11-17T20:17:42+00:00 daily 0.8 http://www.pharma-marketer.com/side-effects-predicted/ 2009-11-17T18:14:57+00:00 daily 0.8 http://www.pharma-marketer.com/new-vaccine-questioned-pfizer/ 2009-11-17T17:50:23+00:00 daily 0.8 http://www.pharma-marketer.com/mead-johnson-may-become-bid-target-for-danone-nestle-heinz/ 2009-11-17T17:50:21+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-exchange-eases-downsizing/ 2009-11-17T17:50:19+00:00 daily 0.8 http://www.pharma-marketer.com/as-tax-breaks-for-pfizer-end-jobs-disappear/ 2009-11-17T17:50:16+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-smaller-flu-vaccine-doses-suffice/ 2009-11-17T17:50:13+00:00 daily 0.8 http://www.pharma-marketer.com/roche-applies-for-avastin-advanced-breast-cancer-use/ 2009-11-17T17:50:07+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-heartburn-pills-are-tied-to-deaths-in-artery-clearing/ 2009-11-17T17:50:04+00:00 daily 0.8 http://www.pharma-marketer.com/wuxi-pharma-feels-the-worst-of-the-downturn-is-over/ 2009-11-17T17:50:02+00:00 daily 0.8 http://www.pharma-marketer.com/fda-says-prilosec-can-block-benefits-of-plavix/ 2009-11-17T17:49:59+00:00 daily 0.8 http://www.pharma-marketer.com/intermune-hep-c-drug-hit-with-liver-tox-worry/ 2009-11-17T17:49:56+00:00 daily 0.8 http://www.pharma-marketer.com/isis-cholesterol-drug-effective-but-safety-a-worry/ 2009-11-17T17:49:53+00:00 daily 0.8 http://www.pharma-marketer.com/alkermes-jumps-cerus-intermune-slide/ 2009-11-17T17:49:51+00:00 daily 0.8 http://www.pharma-marketer.com/human-genomes-abthrax-faces-fda-delay/ 2009-11-17T17:49:46+00:00 daily 0.8 http://www.pharma-marketer.com/drug-price-outcry-threatens-to-derail-reform/ 2009-11-17T17:49:42+00:00 daily 0.8 http://www.pharma-marketer.com/merck-dodged-zetia-bullet-analysts-say/ 2009-11-17T17:49:39+00:00 daily 0.8 http://www.pharma-marketer.com/a-big-upgrade-for-sanofi-aventis/ 2009-11-17T17:49:37+00:00 daily 0.8 http://www.pharma-marketer.com/genentechs-biosimilar-lobbying-blitz-blasted-by-nyt/ 2009-11-17T16:48:59+00:00 daily 0.8 http://www.pharma-marketer.com/a-blogroll-update/ 2009-11-17T16:27:04+00:00 daily 0.8 http://www.pharma-marketer.com/isis-cholesterol-drug-hits-bulls-eye-in-pivotal-trial/ 2009-11-17T16:13:30+00:00 daily 0.8 http://www.pharma-marketer.com/is-it-a-business-or-socialized-medicine/ 2009-11-17T14:58:53+00:00 daily 0.8 http://www.pharma-marketer.com/neurogesx-wins-fda-approval-for-new-pain-patch/ 2009-11-17T14:05:03+00:00 daily 0.8 http://www.pharma-marketer.com/women-may-achieve-0-2-more-satisfying-sexual-events-per-week-with-bis-new-desire-pill/ 2009-11-17T13:51:28+00:00 daily 0.8 http://www.pharma-marketer.com/ucb-sharpens-axe-for-new-round-of-job-cuts/ 2009-11-17T13:51:26+00:00 daily 0.8 http://www.pharma-marketer.com/warren-delano/ 2009-11-17T13:35:49+00:00 daily 0.8 http://www.pharma-marketer.com/decode-files-for-ch-11-bankruptcy/ 2009-11-17T13:24:01+00:00 daily 0.8 http://www.pharma-marketer.com/new-adventures-of-old-fda/ 2009-11-17T11:12:03+00:00 daily 0.8 http://www.pharma-marketer.com/neurogesx-receives-food-and-drug-administration-approval-for-qutenza-pain-patch/ 2009-11-17T00:52:50+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-shares-jump-on-news-of-mead-johnson-split/ 2009-11-17T00:52:48+00:00 daily 0.8 http://www.pharma-marketer.com/getting-to-the-heart-of-the-merck-abbott-embargo-break/ 2009-11-17T00:52:46+00:00 daily 0.8 http://www.pharma-marketer.com/merck-shares-rise-as-wall-street-brushes-off-study-comparing-cholesterol-drugs-niaspan-zetia/ 2009-11-17T00:52:44+00:00 daily 0.8 http://www.pharma-marketer.com/twitter-in-pharma-%e2%80%93-interview-with-john-pugh-boehringer/ 2009-11-16T23:14:30+00:00 daily 0.8 http://www.pharma-marketer.com/ceis-critique-of-fdas-paid-search-stance-should-be-titled-the-little-search-engine-that-could/ 2009-11-16T20:53:15+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-to-split-off-mead-johnson/ 2009-11-16T17:26:30+00:00 daily 0.8 http://www.pharma-marketer.com/another-vytorin-mess-for-merck/ 2009-11-16T17:26:26+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-says-flu-vaccine-approved-in-france/ 2009-11-16T17:26:24+00:00 daily 0.8 http://www.pharma-marketer.com/bayer-novartis-sanofi-aventis-rated-new-a%c2%a2aea%cb%9cbuya%c2%a2aea%e2%84%a2-at-deutsche-bank/ 2009-11-16T17:26:21+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-could-pay-nabi-more-than-500-million-in-deal-to-develop-anti-smoking-vaccines/ 2009-11-16T17:26:17+00:00 daily 0.8 http://www.pharma-marketer.com/playing-the-options-game-in-rim-cel-sci-not-yet-trading-to-its-potential/ 2009-11-16T17:26:11+00:00 daily 0.8 http://www.pharma-marketer.com/video-cholesterol-drug-battle-merck-vs-abbott-labs/ 2009-11-16T17:26:04+00:00 daily 0.8 http://www.pharma-marketer.com/poniard-pharma-says-picoplatin-did-not-improve-survival-in-late-stage-study-shares-tumble/ 2009-11-16T17:26:00+00:00 daily 0.8 http://www.pharma-marketer.com/an-odd-mix-health-care-reform-higher-rx-prices/ 2009-11-16T17:25:58+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeutics-lavishes-free-stock-on-execs/ 2009-11-16T17:25:55+00:00 daily 0.8 http://www.pharma-marketer.com/human-genomes-anthrax-drug-denied-approval/ 2009-11-16T17:25:52+00:00 daily 0.8 http://www.pharma-marketer.com/fate-therapeutics-seals-30-m-series-b-gets-corporate-venture-on-board/ 2009-11-16T17:25:46+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-merck-lead-drug-stocks-higher/ 2009-11-16T17:25:41+00:00 daily 0.8 http://www.pharma-marketer.com/par-pharma-gets-fda-nod-for-generic-version-of-ultram/ 2009-11-16T17:25:35+00:00 daily 0.8 http://www.pharma-marketer.com/a-closer-look-at-cardiums-wound-healing-drug/ 2009-11-16T17:25:31+00:00 daily 0.8 http://www.pharma-marketer.com/contamination-issues-haunt-genzyme/ 2009-11-16T17:25:26+00:00 daily 0.8 http://www.pharma-marketer.com/cash-strapped-genta-slashes-staff-in-restructuring/ 2009-11-16T16:29:42+00:00 daily 0.8 http://www.pharma-marketer.com/fate-ready-to-expand-with-30m-series-b/ 2009-11-16T15:47:20+00:00 daily 0.8 http://www.pharma-marketer.com/spherix-skyrockets-on-promising-phiii-diabetes-data/ 2009-11-16T15:23:27+00:00 daily 0.8 http://www.pharma-marketer.com/spherix-skyrockets-on-promising-diabetes-data/ 2009-11-16T15:23:27+00:00 daily 0.8 http://www.pharma-marketer.com/fda-wants-more-info-on-hgs-anthrax-drug/ 2009-11-16T14:17:07+00:00 daily 0.8 http://www.pharma-marketer.com/nabi-scores-540-million-pact-with-gsk-for-nicvax/ 2009-11-16T14:07:33+00:00 daily 0.8 http://www.pharma-marketer.com/poniard-shares-crash-on-phiii-picoplatin-failure/ 2009-11-16T13:48:11+00:00 daily 0.8 http://www.pharma-marketer.com/lillys-new-development-star-signals-strategic-shift/ 2009-11-16T12:47:09+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-on-lilly-a-clarion-call-for-a-better-process/ 2009-11-16T12:27:52+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharma-willing-to-pay-for-biotech-innovation/ 2009-11-16T02:35:48+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-to-consider-new-flu-vaccine-technology/ 2009-11-16T02:35:44+00:00 daily 0.8 http://www.pharma-marketer.com/short-blood-supply-means-long-outlook-for-cerus/ 2009-11-16T02:35:36+00:00 daily 0.8 http://www.pharma-marketer.com/what-genentech-and-roche-got-from-congress-for-15m/ 2009-11-16T02:35:07+00:00 daily 0.8 http://www.pharma-marketer.com/saving-healthcare-dollars-now-a-common-sense-approach/ 2009-11-15T23:59:33+00:00 daily 0.8 http://www.pharma-marketer.com/why-the-drug-industry-needs-revitalized-dtc-marketing/ 2009-11-15T19:12:21+00:00 daily 0.8 http://www.pharma-marketer.com/phrmas-idea-for-a-seal-of-approval-of-internet-content/ 2009-11-15T17:11:35+00:00 daily 0.8 http://www.pharma-marketer.com/lexicon-says-ibs-drug-met-mid-stage-study-goal/ 2009-11-14T20:16:51+00:00 daily 0.8 http://www.pharma-marketer.com/trimeris-profit-sliced-in-half/ 2009-11-14T20:16:48+00:00 daily 0.8 http://www.pharma-marketer.com/law-firms-going-after-hemispherx/ 2009-11-14T20:16:46+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-issues-letters-to-u-s-healthcare-providers/ 2009-11-14T20:16:42+00:00 daily 0.8 http://www.pharma-marketer.com/merck-both-sides-now/ 2009-11-14T20:16:40+00:00 daily 0.8 http://www.pharma-marketer.com/spectrum-pharmaceuticals-inc-warming-up-or-cooling-off/ 2009-11-14T20:16:36+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-gets-rd-chief-from-outside-drugs-to-follow/ 2009-11-14T20:16:33+00:00 daily 0.8 http://www.pharma-marketer.com/questioning-pfizers-integrity/ 2009-11-14T20:16:30+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-brave-or-stupid/ 2009-11-14T20:16:28+00:00 daily 0.8 http://www.pharma-marketer.com/why-the-fda-needs-to-accept-phrmas-social-proposal/ 2009-11-14T20:16:25+00:00 daily 0.8 http://www.pharma-marketer.com/endo-pharma-to-pay-us-23-mn-to-lectec-to-settle-patent-litigation/ 2009-11-14T20:16:22+00:00 daily 0.8 http://www.pharma-marketer.com/drug-may-slow-down-parkinsons-alzheimers-and-huntingtons-diseases/ 2009-11-14T20:16:20+00:00 daily 0.8 http://www.pharma-marketer.com/nicox-reports-positive-data-for-cholesterol-drug/ 2009-11-14T20:16:17+00:00 daily 0.8 http://www.pharma-marketer.com/vials-of-5-genzyme-drugs-for-rare-diseases-may-be-contaminated-f-d-a-says/ 2009-11-14T20:16:14+00:00 daily 0.8 http://www.pharma-marketer.com/fda-social-media-guidelines-best-done-in-baby-steps/ 2009-11-14T15:42:54+00:00 daily 0.8 http://www.pharma-marketer.com/two-days-of-hearings-are-over-what-comes-next/ 2009-11-14T14:48:03+00:00 daily 0.8 http://www.pharma-marketer.com/female-desire-drug-sparking-libido-may-prove-sex-really-is-all-in-her-head/ 2009-11-13T17:55:01+00:00 daily 0.8 http://www.pharma-marketer.com/drug-companies-should-think-smaller/ 2009-11-13T17:54:59+00:00 daily 0.8 http://www.pharma-marketer.com/how-do-you-say-drug-development-in-mandarin/ 2009-11-13T17:54:56+00:00 daily 0.8 http://www.pharma-marketer.com/fda-extends-review-of-cadences-iv-drug-acetavance/ 2009-11-13T17:54:54+00:00 daily 0.8 http://www.pharma-marketer.com/cephalon-barr-settle-patent-infringement-suit/ 2009-11-13T17:54:52+00:00 daily 0.8 http://www.pharma-marketer.com/layoffs-sting-big-pharma/ 2009-11-13T17:54:50+00:00 daily 0.8 http://www.pharma-marketer.com/myriad-pharma-posts-smaller-1q-loss-after-spinoff/ 2009-11-13T17:54:49+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-idecs-social-media-ties-save-tysabri-again-fda-watching/ 2009-11-13T17:54:47+00:00 daily 0.8 http://www.pharma-marketer.com/piper-jaffray-sees-pharma-ma-activity-continuing/ 2009-11-13T17:54:44+00:00 daily 0.8 http://www.pharma-marketer.com/the-next-vytorin-study-why-is-everybody-so-worked-up/ 2009-11-13T17:54:43+00:00 daily 0.8 http://www.pharma-marketer.com/gsks-witty-doesnt-anticipate-dip-in-profit-margins/ 2009-11-13T17:54:40+00:00 daily 0.8 http://www.pharma-marketer.com/house-bill-wants-pharma-to-disclose-cme-funding/ 2009-11-13T16:59:47+00:00 daily 0.8 http://www.pharma-marketer.com/options-boil-on-biotech-buyout-rumors-cubist/ 2009-11-13T16:59:14+00:00 daily 0.8 http://www.pharma-marketer.com/another-win-for-mylan/ 2009-11-13T16:58:57+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-awaits-committee-outcome/ 2009-11-13T16:58:44+00:00 daily 0.8 http://www.pharma-marketer.com/talecris-to-create-259-jobs/ 2009-11-13T16:39:04+00:00 daily 0.8 http://www.pharma-marketer.com/prof-keith-fagnou/ 2009-11-13T16:12:38+00:00 daily 0.8 http://www.pharma-marketer.com/bioinvent-daiichi-sankyo-sign-antibody-pact/ 2009-11-13T15:39:32+00:00 daily 0.8 http://www.pharma-marketer.com/boehringer-bets-on-female-libido-drug/ 2009-11-13T15:24:25+00:00 daily 0.8 http://www.pharma-marketer.com/why-most-hcp-crm-programs-fail/ 2009-11-13T14:50:02+00:00 daily 0.8 http://www.pharma-marketer.com/is-the-fda-initiative-on-transparency-over-the-part-15-meeting-and-the-media/ 2009-11-13T14:42:16+00:00 daily 0.8 http://www.pharma-marketer.com/business-week-on-dtc/ 2009-11-13T14:22:53+00:00 daily 0.8 http://www.pharma-marketer.com/lumpy-assay-results/ 2009-11-13T13:53:13+00:00 daily 0.8 http://www.pharma-marketer.com/fda-extends-cadence-antibiotic-review/ 2009-11-13T13:44:32+00:00 daily 0.8 http://www.pharma-marketer.com/fda-extends-cadence-drug-review/ 2009-11-13T13:44:32+00:00 daily 0.8 http://www.pharma-marketer.com/alnylam-stakes-out-a-new-opportunity/ 2009-11-13T13:24:08+00:00 daily 0.8 http://www.pharma-marketer.com/yesterday-and-today-at-fdas-part-15-meeting-on-social-media/ 2009-11-13T12:52:57+00:00 daily 0.8 http://www.pharma-marketer.com/google-proposes-to-resuscitate-paid-search/ 2009-11-13T10:53:56+00:00 daily 0.8 http://www.pharma-marketer.com/trimeris-shares-tumble-as-sale-runs-into-trouble/ 2009-11-12T22:42:09+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharma-still-hungry-for-biotech-deals/ 2009-11-12T22:42:06+00:00 daily 0.8 http://www.pharma-marketer.com/optimer-completes-fidaxomicin-trial-enrollment/ 2009-11-12T20:46:44+00:00 daily 0.8 http://www.pharma-marketer.com/bayer-to-up-rd-spend-as-higgins-looks-to-the-future/ 2009-11-12T18:53:16+00:00 daily 0.8 http://www.pharma-marketer.com/ctic-reports-awaiting-fda-decision/ 2009-11-12T18:53:10+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-labs-says-it-will-pay-170m-upfront-for-experimental-chronic-pain-drug-from-pangenetics/ 2009-11-12T18:53:03+00:00 daily 0.8 http://www.pharma-marketer.com/endo-pharmaceuticals-paying-23-million-to-lectec-to-settle-patent-dispute/ 2009-11-12T18:52:58+00:00 daily 0.8 http://www.pharma-marketer.com/a-disturbing-signal-at-fda-social-media-conference/ 2009-11-12T18:44:24+00:00 daily 0.8 http://www.pharma-marketer.com/pangenetics-gets-170m-upfront-for-promising-pain-drug/ 2009-11-12T16:42:48+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharma-paying-more-for-new-biotech-deals/ 2009-11-12T16:29:53+00:00 daily 0.8 http://www.pharma-marketer.com/massaging-the-data-for-neurontin/ 2009-11-12T16:13:42+00:00 daily 0.8 http://www.pharma-marketer.com/while-the-fda-listens-to-presentations-on-social-media-a-ticking-time-bomb-continues-to-count-down/ 2009-11-12T15:57:47+00:00 daily 0.8 http://www.pharma-marketer.com/bayer-exec-says-company-will-hike-rd-spending/ 2009-11-12T15:27:35+00:00 daily 0.8 http://www.pharma-marketer.com/data-from-studies-of-pfizer-neurontin-drug-may-have-been-skewed/ 2009-11-12T14:52:18+00:00 daily 0.8 http://www.pharma-marketer.com/mannkind-trader-says-this-drug-firm-will-snap-up-50-by-mid-2010/ 2009-11-12T14:52:14+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharma-scramble-for-a-piece-of-the-vaccine-pie/ 2009-11-12T14:52:11+00:00 daily 0.8 http://www.pharma-marketer.com/band-aid-wont-stop-generic-bleeding-at-johnson-johnson/ 2009-11-12T14:52:06+00:00 daily 0.8 http://www.pharma-marketer.com/dendreon-loses-45-6m-in-q3/ 2009-11-12T14:51:59+00:00 daily 0.8 http://www.pharma-marketer.com/cytokinetics-market-potential/ 2009-11-12T14:51:51+00:00 daily 0.8 http://www.pharma-marketer.com/spectrum-posts-encouraging-zevalin-sales/ 2009-11-12T14:51:48+00:00 daily 0.8 http://www.pharma-marketer.com/what-pfizer-kkr-and-goldman-reportedly-want-generics/ 2009-11-12T14:51:42+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-gives-thumbs-down-to-rd-in-india/ 2009-11-12T14:51:38+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-chinas-big-rd-win-may-be-indias-loss/ 2009-11-12T14:24:33+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-hits-one-out-of-the-ballpark/ 2009-11-12T14:05:55+00:00 daily 0.8 http://www.pharma-marketer.com/beleaguered-altus-files-for-ch-7-bankruptcy/ 2009-11-12T13:55:14+00:00 daily 0.8 http://www.pharma-marketer.com/isis-spin-off-gets-a-fresh-injection-of-venture-funds/ 2009-11-12T13:28:38+00:00 daily 0.8 http://www.pharma-marketer.com/who-wants-to-talk-to-the-fda-about-google-and-facebook/ 2009-11-12T03:29:49+00:00 daily 0.8 http://www.pharma-marketer.com/regeneronsanofi-now-thats-what-i-call-a-drug-deal/ 2009-11-12T00:00:39+00:00 daily 0.8 http://www.pharma-marketer.com/ftc-expresses-concern-about-drug-makers-practices/ 2009-11-12T00:00:37+00:00 daily 0.8 http://www.pharma-marketer.com/marcial-is-eli-lilly-ripe-for-a-rebound/ 2009-11-12T00:00:35+00:00 daily 0.8 http://www.pharma-marketer.com/when-rival-drug-makers-compare-notes-on-safety-problems/ 2009-11-12T00:00:32+00:00 daily 0.8 http://www.pharma-marketer.com/pre-game-show-what-some-of-the-important-players-have-to-say-at-the-fda-part-15-meeting-on-social-media/ 2009-11-11T20:42:13+00:00 daily 0.8 http://www.pharma-marketer.com/go-spread-it-on-the-rosebushes/ 2009-11-11T20:19:47+00:00 daily 0.8 http://www.pharma-marketer.com/ims-reform-to-lift-drug-sales-3-5-annually/ 2009-11-11T20:04:16+00:00 daily 0.8 http://www.pharma-marketer.com/merck-ceo-mulls-successor-after-merger/ 2009-11-11T20:03:55+00:00 daily 0.8 http://www.pharma-marketer.com/a-pharmaceutical-webmaster-takes-action-on-sidewiki/ 2009-11-11T18:00:46+00:00 daily 0.8 http://www.pharma-marketer.com/against-panic/ 2009-11-11T17:24:43+00:00 daily 0.8 http://www.pharma-marketer.com/im-off-to-fda-hearing-heres-what-i-plan-to-show-ppts-and-tell-transcripts/ 2009-11-11T16:58:27+00:00 daily 0.8 http://www.pharma-marketer.com/former-pfizer-rd-exec-jumps-into-vc-game/ 2009-11-11T16:23:20+00:00 daily 0.8 http://www.pharma-marketer.com/telling-the-layoff-story/ 2009-11-11T16:22:32+00:00 daily 0.8 http://www.pharma-marketer.com/glaxoa%c2%a2aea%e2%84%a2s-swine-flu-shot-wins-u-s-approval-after-delay/ 2009-11-11T16:03:34+00:00 daily 0.8 http://www.pharma-marketer.com/study-confirms-clot-risks-with-anti-anemia-drugs/ 2009-11-11T16:03:28+00:00 daily 0.8 http://www.pharma-marketer.com/lexicon-pharmaceuticals-stuck-in-phase-ii/ 2009-11-11T16:03:18+00:00 daily 0.8 http://www.pharma-marketer.com/chelsea-therapeutics-there-are-safer-rebound-plays/ 2009-11-11T16:03:09+00:00 daily 0.8 http://www.pharma-marketer.com/fda-shouldna%c2%a2aea%e2%84%a2t-outsource-antibiotic-decisions/ 2009-11-11T16:03:04+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-ceo-out-to-play-nice-with-new-partners/ 2009-11-11T16:02:49+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-a-psychiatrist-and-big-seroquel-bucks/ 2009-11-11T16:02:43+00:00 daily 0.8 http://www.pharma-marketer.com/sanofia%c2%a2aea%e2%84%a2s-research-shift-billion-dollar-deal-venture-capital-fund/ 2009-11-11T16:02:34+00:00 daily 0.8 http://www.pharma-marketer.com/alexandria-plans-sprawling-rd-complex-in-india/ 2009-11-11T15:39:29+00:00 daily 0.8 http://www.pharma-marketer.com/webcast-of-the-fda-social-media-part-15-meeting/ 2009-11-11T14:55:33+00:00 daily 0.8 http://www.pharma-marketer.com/fda-offers-delayed-approval-for-glaxo-vax/ 2009-11-11T14:39:15+00:00 daily 0.8 http://www.pharma-marketer.com/cellerix-bags-40m-in-venture-funds-for-stem-cell-work/ 2009-11-11T14:13:28+00:00 daily 0.8 http://www.pharma-marketer.com/trin-pharma-names-stefan-wohlfeil-ceo/ 2009-11-11T14:07:27+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-expands-blockbuster-pact-with-regeneron/ 2009-11-11T13:09:55+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-chemistry-head-count-really/ 2009-11-11T12:43:47+00:00 daily 0.8 http://www.pharma-marketer.com/fighting-the-flu-vaccine-critics/ 2009-11-11T02:00:58+00:00 daily 0.8 http://www.pharma-marketer.com/enzon-beats-announces-sell-off/ 2009-11-11T02:00:51+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-promises-regeneron-980-million-for-research/ 2009-11-11T02:00:47+00:00 daily 0.8 http://www.pharma-marketer.com/teva-gets-fda-approval-for-generic-prevacid/ 2009-11-11T02:00:44+00:00 daily 0.8 http://www.pharma-marketer.com/justice-eyes-marketing-at-jj-forest/ 2009-11-11T02:00:39+00:00 daily 0.8 http://www.pharma-marketer.com/did-sequenom-insiders-sell-stock-before-data-corruption-was-revealed/ 2009-11-11T02:00:32+00:00 daily 0.8 http://www.pharma-marketer.com/cramer-jeers-jj-applauds-abbott/ 2009-11-11T02:00:21+00:00 daily 0.8 http://www.pharma-marketer.com/intouch-solutions-fda-testimony/ 2009-11-10T19:35:34+00:00 daily 0.8 http://www.pharma-marketer.com/teva-says-it-wants-to-add-3-more-patents-to-suit-against-moment-and-sandoz-over-copaxone/ 2009-11-10T18:11:40+00:00 daily 0.8 http://www.pharma-marketer.com/is-dr-reddys-laboratories-ready-to-run/ 2009-11-10T18:11:37+00:00 daily 0.8 http://www.pharma-marketer.com/gtc-cuts-45-workers-lines-up-retention-bonuses-for-execs/ 2009-11-10T18:11:34+00:00 daily 0.8 http://www.pharma-marketer.com/celgene-in-ash-abstract-spotlight/ 2009-11-10T18:11:31+00:00 daily 0.8 http://www.pharma-marketer.com/avanir-shares-jump-on-new-zenvia-data/ 2009-11-10T16:43:12+00:00 daily 0.8 http://www.pharma-marketer.com/working-in-the-drug-industry-today-remembering-whats-important/ 2009-11-10T15:57:40+00:00 daily 0.8 http://www.pharma-marketer.com/lab-equipment-any-h-cube-troubleshooters-out-there/ 2009-11-10T15:20:58+00:00 daily 0.8 http://www.pharma-marketer.com/a-hypothetical-letter-to-consumers-from-pharma/ 2009-11-10T15:08:42+00:00 daily 0.8 http://www.pharma-marketer.com/ironwood-lands-75m-asian-deal-for-linaclotide/ 2009-11-10T15:08:00+00:00 daily 0.8 http://www.pharma-marketer.com/why-im-still-buying-johnson-johnson-at-these-levels/ 2009-11-10T15:02:40+00:00 daily 0.8 http://www.pharma-marketer.com/merck-cholesterol-pill-sales-may-drop-20-more-on-study-finding/ 2009-11-10T15:02:38+00:00 daily 0.8 http://www.pharma-marketer.com/the-real-price-of-big-pharmas-huge-fines/ 2009-11-10T15:02:36+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-squibb-signs-development-deal-for-rheumatoid-arthritis-drug-with-alder-biopharma/ 2009-11-10T15:02:34+00:00 daily 0.8 http://www.pharma-marketer.com/courts-consolidate-dozens-of-cases-against-bayer-over-yaz/ 2009-11-10T15:02:31+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-cutbacks-reflect-difficulties-facing-big-pharma/ 2009-11-10T15:02:13+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-outlines-deep-cuts-in-rd-shakeup/ 2009-11-10T13:51:59+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panelists-at-the-upcoming-social-media-public-hearing/ 2009-11-10T13:24:03+00:00 daily 0.8 http://www.pharma-marketer.com/struggling-gtc-earmarks-retention-bonuses/ 2009-11-10T13:23:13+00:00 daily 0.8 http://www.pharma-marketer.com/what-if-fda-threw-a-party-and-no-one-came-biopharma-participation-in-the-part-15-social-media-meeting/ 2009-11-10T13:16:31+00:00 daily 0.8 http://www.pharma-marketer.com/biovex-snags-30m-to-pay-for-pivotal-trial/ 2009-11-10T12:59:36+00:00 daily 0.8 http://www.pharma-marketer.com/alder-bags-1b-ra-licensing-deal-for-lead-drug/ 2009-11-10T12:30:25+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-site-closures-an-analysis/ 2009-11-10T12:23:22+00:00 daily 0.8 http://www.pharma-marketer.com/guidant-the-gift-that-keeps-on-giving/ 2009-11-10T03:57:18+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-to-shutter-six-out-of-20-rd-sites/ 2009-11-09T23:51:37+00:00 daily 0.8 http://www.pharma-marketer.com/cypress-bioscience-says-3rd-quarter-loss-grew-due-to-costs-connected-to-launch-of-savella/ 2009-11-09T23:51:35+00:00 daily 0.8 http://www.pharma-marketer.com/generics-makers-line-up-to-sell-copies-of-pfizers-lipitor/ 2009-11-09T23:51:33+00:00 daily 0.8 http://www.pharma-marketer.com/three-core-biotech-holdings-isis-ligand-and-vical/ 2009-11-09T23:51:32+00:00 daily 0.8 http://www.pharma-marketer.com/j-allergan-medicis-rejoice/ 2009-11-09T23:51:30+00:00 daily 0.8 http://www.pharma-marketer.com/phrma-proposes-fda-approved-use-of-universal-safety-symbol-for-branded-tweets-se-ads/ 2009-11-09T23:16:43+00:00 daily 0.8 http://www.pharma-marketer.com/astra-zeneca-launches-corporate-blog-az-health-connections/ 2009-11-09T21:49:23+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharmas-crime-spree-perception-is-the-new-reality/ 2009-11-09T20:45:40+00:00 daily 0.8 http://www.pharma-marketer.com/xoma-waffles-on-timing-of-drug-partnership/ 2009-11-09T20:15:00+00:00 daily 0.8 http://www.pharma-marketer.com/200-pharma-whistleblowers-in-line-for-court/ 2009-11-09T20:14:53+00:00 daily 0.8 http://www.pharma-marketer.com/insurers-drugmakers-turn-to-senate-for-health-bill-changes/ 2009-11-09T20:14:42+00:00 daily 0.8 http://www.pharma-marketer.com/enzon-sells-specialty-drug-business-for-300m/ 2009-11-09T20:14:11+00:00 daily 0.8 http://www.pharma-marketer.com/ranbaxy-fda-issues-will-take-long-time-to-resolve/ 2009-11-09T20:14:05+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-new-layout/ 2009-11-09T18:50:59+00:00 daily 0.8 http://www.pharma-marketer.com/so-what-are-people-who-use-social-media-for-health-really-looking-for/ 2009-11-09T18:19:03+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-plans-massive-cuts-in-sweeping-rd-reorg/ 2009-11-09T17:48:04+00:00 daily 0.8 http://www.pharma-marketer.com/erilogue-suggests-patients-aren%e2%80%99t-asking-for-branded-rxs-but-this-research-is-seriously-flawed-and-just-plain-bad/ 2009-11-09T17:12:16+00:00 daily 0.8 http://www.pharma-marketer.com/d-pharm-inks-22m-chinese-licensing-pact/ 2009-11-09T16:55:53+00:00 daily 0.8 http://www.pharma-marketer.com/trius-sets-sights-on-86m-ipo/ 2009-11-09T16:53:48+00:00 daily 0.8 http://www.pharma-marketer.com/so-do-i-own-this-or-what-answer-what/ 2009-11-09T16:43:27+00:00 daily 0.8 http://www.pharma-marketer.com/enzon-to-focus-on-pipeline-following-327m-asset-sale/ 2009-11-09T16:17:14+00:00 daily 0.8 http://www.pharma-marketer.com/no-product-revenues-plenty-of-risk-buy-exelixis/ 2009-11-09T16:14:07+00:00 daily 0.8 http://www.pharma-marketer.com/boston-scientific-sets-296-million-settlement-on-devices/ 2009-11-09T16:14:04+00:00 daily 0.8 http://www.pharma-marketer.com/alcon-boosts-presence-in-eye-disease-market/ 2009-11-09T16:14:01+00:00 daily 0.8 http://www.pharma-marketer.com/house-senate-health-care-legislation-side-by-side-comparison/ 2009-11-09T16:13:57+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-broke-the-law-by-promoting-drugs-for-unapproved-uses/ 2009-11-09T16:13:54+00:00 daily 0.8 http://www.pharma-marketer.com/elan-biogen-change-tysabri-label-due-to-pml-risk/ 2009-11-09T16:13:46+00:00 daily 0.8 http://www.pharma-marketer.com/d-c-vaccine-conference-why-investors-should-stay-tuned/ 2009-11-09T16:13:40+00:00 daily 0.8 http://www.pharma-marketer.com/xenoport-and-glaxo-says-fda-review-of-neuropathic-pain-drug-extended-3-months-to-feb-2010/ 2009-11-09T16:13:35+00:00 daily 0.8 http://www.pharma-marketer.com/cephalons-upside-and-downside/ 2009-11-09T16:13:30+00:00 daily 0.8 http://www.pharma-marketer.com/forest-laboratories-steady-growth-in-sales-and-earnings/ 2009-11-09T16:13:23+00:00 daily 0.8 http://www.pharma-marketer.com/despite-omeros-flop-trius-and-other-biotech-ipo-hopefuls-might-fare-better/ 2009-11-09T16:13:19+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-aiming-for-30900-layoffs-through-2012/ 2009-11-09T16:13:11+00:00 daily 0.8 http://www.pharma-marketer.com/tethys-rounds-up-25m-for-diabetes-test/ 2009-11-09T16:03:52+00:00 daily 0.8 http://www.pharma-marketer.com/gtc-slashes-workforce-as-cash-reserves-dwindle/ 2009-11-09T16:02:21+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-dealmakers-hot-on-virtual-call-options/ 2009-11-09T15:26:32+00:00 daily 0.8 http://www.pharma-marketer.com/selling-it-and-selling-it-hard/ 2009-11-09T14:46:25+00:00 daily 0.8 http://www.pharma-marketer.com/risk-communication-advisory-committee-that-other-fda-meeting-this-week-dont-ignore-it/ 2009-11-09T14:29:39+00:00 daily 0.8 http://www.pharma-marketer.com/verilogues-market-research-is-bad-folks-i-mean-really-bad/ 2009-11-08T21:22:09+00:00 daily 0.8 http://www.pharma-marketer.com/dx-88-ecallantide-demonstrated-relief-of-symptoms-in-hereditary-angioedema-acute-attacks-in-all-attack-locations/ 2009-11-08T21:20:34+00:00 daily 0.8 http://www.pharma-marketer.com/genmab-to-cut-130-jobs-in-brooklyn-park-sell-biotech-factory/ 2009-11-08T21:20:31+00:00 daily 0.8 http://www.pharma-marketer.com/cramera%c2%a2aea%e2%84%a2s-8-picks-for-cancers-cure/ 2009-11-08T21:20:28+00:00 daily 0.8 http://www.pharma-marketer.com/halozyme-study-results-demonstrate-significantly-less-absorption-variability-for-insulin-lispro-administered-with-ph20-e/ 2009-11-08T21:20:26+00:00 daily 0.8 http://www.pharma-marketer.com/money-making-mood-stabilizers/ 2009-11-08T21:20:23+00:00 daily 0.8 http://www.pharma-marketer.com/living-without-blockbusters/ 2009-11-08T21:20:21+00:00 daily 0.8 http://www.pharma-marketer.com/santarus-inc-q3-2009-earnings-call-transcript/ 2009-11-08T21:20:18+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-blooms-at-eli-lilly/ 2009-11-08T21:20:17+00:00 daily 0.8 http://www.pharma-marketer.com/novexel-starts-phase-ii-clinical-trial-with-nxl103-in-adults-with-acute-bacterial-skin-and-skin-structure-infections-ab/ 2009-11-08T21:20:15+00:00 daily 0.8 http://www.pharma-marketer.com/why-we-need-a-healthy-biotech-industry/ 2009-11-08T21:20:12+00:00 daily 0.8 http://www.pharma-marketer.com/dr-reddya%c2%a2aea%e2%84%a2s-laboratories-rdy-best-pharma-stock-in-india/ 2009-11-08T21:20:09+00:00 daily 0.8 http://www.pharma-marketer.com/small-cap-biotechs-and-government-policy-makers-meet-in-d-c-otcadxsamexcvmcveimv/ 2009-11-08T21:20:07+00:00 daily 0.8 http://www.pharma-marketer.com/chinese-co-to-fund-d-pharm-phase-iii-trial/ 2009-11-08T21:20:04+00:00 daily 0.8 http://www.pharma-marketer.com/china-is-growth-market-for-novartis/ 2009-11-08T21:20:01+00:00 daily 0.8 http://www.pharma-marketer.com/an-exit-of-talent-from-dtc-marketing/ 2009-11-08T15:49:02+00:00 daily 0.8 http://www.pharma-marketer.com/customized-patient-ed-other-research-preliminary-findings/ 2009-11-07T16:09:21+00:00 daily 0.8 http://www.pharma-marketer.com/medivation-lags-expectations/ 2009-11-06T19:15:33+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-loss-to-jj-upheld-in-1-7-billion-patent-suit/ 2009-11-06T19:15:31+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-stock-mailbag-poniard-predictions/ 2009-11-06T19:15:28+00:00 daily 0.8 http://www.pharma-marketer.com/allos-buy-this-cheap-biotech-spec/ 2009-11-06T19:15:26+00:00 daily 0.8 http://www.pharma-marketer.com/q3-top-pharma-company-earnings-reports/ 2009-11-06T19:15:24+00:00 daily 0.8 http://www.pharma-marketer.com/videounder-the-flu-vaccine-veil/ 2009-11-06T19:15:23+00:00 daily 0.8 http://www.pharma-marketer.com/par-pharmaceutical-profit-jumps-revenue-nearly-doubles/ 2009-11-06T19:15:21+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-mixed-alkermes-slides-on-outlook/ 2009-11-06T19:15:19+00:00 daily 0.8 http://www.pharma-marketer.com/targacept-reports-1-3m-profit/ 2009-11-06T19:15:17+00:00 daily 0.8 http://www.pharma-marketer.com/jazz-pharmaceuticals-3rd-quarter-loss-narrows-on-sales-of-sleep-disorder-drug-xyrem/ 2009-11-06T19:15:15+00:00 daily 0.8 http://www.pharma-marketer.com/graceway-buys-gilead-drug-rights/ 2009-11-06T16:40:12+00:00 daily 0.8 http://www.pharma-marketer.com/light-sciences-lines-up-35m-in-credit-financing/ 2009-11-06T15:42:03+00:00 daily 0.8 http://www.pharma-marketer.com/the-top-4-healthcare-dividend-stocks-covered-call-trades/ 2009-11-06T15:03:00+00:00 daily 0.8 http://www.pharma-marketer.com/roche-hsbc-novartis-under-probe-in-korea-over-tamiflu-sales/ 2009-11-06T15:02:58+00:00 daily 0.8 http://www.pharma-marketer.com/myriads-not-doing-much/ 2009-11-06T15:02:55+00:00 daily 0.8 http://www.pharma-marketer.com/micromet-takes-back-medimmunes-blinatumomab-rights/ 2009-11-06T14:28:23+00:00 daily 0.8 http://www.pharma-marketer.com/gloucester-gains-fda-approval-of-ctcl-drug/ 2009-11-06T14:25:50+00:00 daily 0.8 http://www.pharma-marketer.com/thoughts-on-what-used-to-be-schering-plough/ 2009-11-06T13:55:48+00:00 daily 0.8 http://www.pharma-marketer.com/sequencing-cost-slides-to-4400-at-complete-genomics/ 2009-11-06T13:11:31+00:00 daily 0.8 http://www.pharma-marketer.com/video-battling-cancer-with-biotech/ 2009-11-06T04:16:30+00:00 daily 0.8 http://www.pharma-marketer.com/dutch-pull-pfizer-vaccine-batch-after-3-deaths/ 2009-11-06T04:16:28+00:00 daily 0.8 http://www.pharma-marketer.com/flawed-research-from-verilogue-suggests-patients-aren%e2%80%99t-asking-for-branded-rxs/ 2009-11-06T02:30:57+00:00 daily 0.8 http://www.pharma-marketer.com/slow-down-there-merck/ 2009-11-06T00:46:48+00:00 daily 0.8 http://www.pharma-marketer.com/dr-reddys-laboratories-showing-promising-growth/ 2009-11-06T00:46:45+00:00 daily 0.8 http://www.pharma-marketer.com/how-drug-advertising-restrictions-could-benefit-the-industry/ 2009-11-06T00:46:41+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-joins-the-list-of-corporate-bloggers/ 2009-11-05T21:26:35+00:00 daily 0.8 http://www.pharma-marketer.com/fda-public-hearing-not-deja-vu-all-over-again/ 2009-11-05T20:58:01+00:00 daily 0.8 http://www.pharma-marketer.com/abraxis-expands-in-phoenix/ 2009-11-05T20:46:46+00:00 daily 0.8 http://www.pharma-marketer.com/fda-hearings-and-emarketing-conferences/ 2009-11-05T20:28:00+00:00 daily 0.8 http://www.pharma-marketer.com/my-fda-social-media-hearing-presentations/ 2009-11-05T20:14:56+00:00 daily 0.8 http://www.pharma-marketer.com/is-edetailing-viable-today/ 2009-11-05T20:14:11+00:00 daily 0.8 http://www.pharma-marketer.com/ensuring-that-your-agency-relationship-works/ 2009-11-05T20:12:18+00:00 daily 0.8 http://www.pharma-marketer.com/genvec-wins-22m-vax-development-contract/ 2009-11-05T16:50:44+00:00 daily 0.8 http://www.pharma-marketer.com/genmab-axing-300-as-it-shifts-development-work-to-vendors/ 2009-11-05T16:49:21+00:00 daily 0.8 http://www.pharma-marketer.com/what-we-like-about-cubist-pharma/ 2009-11-05T16:44:28+00:00 daily 0.8 http://www.pharma-marketer.com/king-pharmaceuticals-reports-profit-fall/ 2009-11-05T16:44:25+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-cell-based-h1n1-vaccine-gets-german-ok/ 2009-11-05T16:44:21+00:00 daily 0.8 http://www.pharma-marketer.com/merck-ceo-a%c2%a2aea%cb%9cactively-lookinga%c2%a2aea%e2%84%a2-for-biotech-deals/ 2009-11-05T16:44:19+00:00 daily 0.8 http://www.pharma-marketer.com/has-gentas-energizer-bunny-of-cancer-drugs-finally-run-out-of-juice/ 2009-11-05T16:44:17+00:00 daily 0.8 http://www.pharma-marketer.com/astellas-cuts-annual-profit-outlook-on-yen-charges/ 2009-11-05T16:44:14+00:00 daily 0.8 http://www.pharma-marketer.com/fda-aims-to-fight-avoidable-harm-from-medicines/ 2009-11-05T16:44:09+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-jury-said-to-award-75-million-prempro-verdict-to-woman/ 2009-11-05T16:44:07+00:00 daily 0.8 http://www.pharma-marketer.com/lower-q3-loss-for-human-genome/ 2009-11-05T16:44:05+00:00 daily 0.8 http://www.pharma-marketer.com/biocryst-pharmaceuticals-receives-22-5-million-from-us-government-for-peramivir-order/ 2009-11-05T16:44:04+00:00 daily 0.8 http://www.pharma-marketer.com/supreme-court-seeks-pfizer-trovan-comment/ 2009-11-05T16:44:01+00:00 daily 0.8 http://www.pharma-marketer.com/hemispherx-biopharma-could-become-a-nice-rebound-story/ 2009-11-05T16:43:58+00:00 daily 0.8 http://www.pharma-marketer.com/nuvo-partner-win-fda-approval/ 2009-11-05T16:39:48+00:00 daily 0.8 http://www.pharma-marketer.com/biocryst-reaps-22-5m-windfall-on-iv-peramivir-order/ 2009-11-05T16:05:29+00:00 daily 0.8 http://www.pharma-marketer.com/biovitrum-merges-with-swedish-orphan-in-493m-deal/ 2009-11-05T15:33:30+00:00 daily 0.8 http://www.pharma-marketer.com/covering-fdas-part-15-meeting-on-social-media-and-medical-product-promotion/ 2009-11-05T15:12:33+00:00 daily 0.8 http://www.pharma-marketer.com/medimmune-vets-launch-biotech-with-10m-series-a/ 2009-11-05T13:57:35+00:00 daily 0.8 http://www.pharma-marketer.com/what-exactly-does-resveratrol-do/ 2009-11-05T13:35:21+00:00 daily 0.8 http://www.pharma-marketer.com/new-merck-in-the-hunt-for-biotech-buyouts-new-pacts/ 2009-11-05T12:44:24+00:00 daily 0.8 http://www.pharma-marketer.com/watson-pharma-beats-by-a-penny/ 2009-11-05T05:23:41+00:00 daily 0.8 http://www.pharma-marketer.com/an-ode-to-schering-plough/ 2009-11-05T05:23:39+00:00 daily 0.8 http://www.pharma-marketer.com/acne-wrinkle-treatments-help-medicis-post-profit/ 2009-11-05T05:23:38+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-preview-king-pharmaceuticals/ 2009-11-04T21:33:18+00:00 daily 0.8 http://www.pharma-marketer.com/zymogenetics-hit-with-restraining-orders/ 2009-11-04T21:33:16+00:00 daily 0.8 http://www.pharma-marketer.com/az-promoted-seroquel-as-superior-to-haldol-when-company-data-said-it-wasnt/ 2009-11-04T21:33:11+00:00 daily 0.8 http://www.pharma-marketer.com/drugmakers-payments-draw-heat/ 2009-11-04T21:33:07+00:00 daily 0.8 http://www.pharma-marketer.com/the-new-merck-day-1-a-catalog-of-impending-doom/ 2009-11-04T21:33:05+00:00 daily 0.8 http://www.pharma-marketer.com/still-waiting-for-details-on-mercka%c2%a2aea%e2%84%a2s-16000-job-cuts/ 2009-11-04T21:32:58+00:00 daily 0.8 http://www.pharma-marketer.com/merck-pfizer-jj-lead-drug-stocks-higher/ 2009-11-04T18:22:00+00:00 daily 0.8 http://www.pharma-marketer.com/how-to-market-a-drug-off-label/ 2009-11-04T18:21:58+00:00 daily 0.8 http://www.pharma-marketer.com/merck-schering-plough-debut-today-as-one-company/ 2009-11-04T18:21:57+00:00 daily 0.8 http://www.pharma-marketer.com/drugmakers-find-whistle-blowing-a-bitter-pill-to-swallow/ 2009-11-04T18:21:55+00:00 daily 0.8 http://www.pharma-marketer.com/stiefel-labs-shutters-its-hq/ 2009-11-04T17:00:51+00:00 daily 0.8 http://www.pharma-marketer.com/ironwood-upbeat-on-promising-linaclotide-phiii-data/ 2009-11-04T16:49:42+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-pfizer-launch-new-hiv-drug-venture/ 2009-11-04T16:32:27+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-strategy-chief-heralds-licensing-deals-bigger-chorus-role/ 2009-11-04T15:14:07+00:00 daily 0.8 http://www.pharma-marketer.com/genvec-shares-soar-on-orphan-cancer-drug-designation/ 2009-11-04T14:42:15+00:00 daily 0.8 http://www.pharma-marketer.com/the-real-meaning-of-jja%c2%a2aea%e2%84%a2s-layoffs/ 2009-11-04T14:30:20+00:00 daily 0.8 http://www.pharma-marketer.com/medco-earnings-rise-13-on-increased-demand-for-prescription-medicines/ 2009-11-04T14:30:14+00:00 daily 0.8 http://www.pharma-marketer.com/breast-cancer-vaccine-tests-german-mercka%c2%a2aea%e2%84%a2s-1-billion-strategy/ 2009-11-04T14:30:04+00:00 daily 0.8 http://www.pharma-marketer.com/cramer-finds-catalyst-for-celgenea%c2%a2aea%e2%84%a2s-stock/ 2009-11-04T14:30:01+00:00 daily 0.8 http://www.pharma-marketer.com/impax-swings-to-q3-profit/ 2009-11-04T14:29:58+00:00 daily 0.8 http://www.pharma-marketer.com/a-little-distracted-are-you-merck/ 2009-11-04T14:29:54+00:00 daily 0.8 http://www.pharma-marketer.com/two-healthcare-favorites-hmsyteva/ 2009-11-04T14:29:49+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-seeks-to-make-china-one-of-its-top-three-global-markets/ 2009-11-04T14:29:46+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-to-buy-85-of-chinese-vaccines-producer/ 2009-11-04T14:29:41+00:00 daily 0.8 http://www.pharma-marketer.com/merck-now-the-worlds-no-2-drugmaker-with-schering-plough-purchase-set-for-future-deals/ 2009-11-04T14:29:37+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharma-again-taking-shot-at-vaccines/ 2009-11-04T14:29:35+00:00 daily 0.8 http://www.pharma-marketer.com/omnicare-ivax-pay-112m-over-kickback-charges/ 2009-11-04T14:29:28+00:00 daily 0.8 http://www.pharma-marketer.com/soaring-cancer-market-spurs-blockbuster-vax-studies/ 2009-11-04T13:01:40+00:00 daily 0.8 http://www.pharma-marketer.com/are-you-now-or-have-you-ever-been/ 2009-11-04T12:28:02+00:00 daily 0.8 http://www.pharma-marketer.com/amylin-scores-a-hat-trick/ 2009-11-03T22:32:22+00:00 daily 0.8 http://www.pharma-marketer.com/jj-cutting-up-to-7-of-workforce/ 2009-11-03T19:59:02+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-dumps-191-sales-reps-as-part-of-cost-cutting/ 2009-11-03T19:59:00+00:00 daily 0.8 http://www.pharma-marketer.com/tevaa%c2%a2aea%e2%84%a2s-third-quarter-profit-gains-on-copaxone-barr/ 2009-11-03T19:58:59+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-to-invest-in-china/ 2009-11-03T19:58:57+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-gets-new-trial-over-27m-prempro-damages/ 2009-11-03T19:58:56+00:00 daily 0.8 http://www.pharma-marketer.com/liveblog-jj-execs-discuss-job-cuts/ 2009-11-03T19:58:54+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-launches-specialist-hiv-company/ 2009-11-03T19:58:53+00:00 daily 0.8 http://www.pharma-marketer.com/biogens-a-buy/ 2009-11-03T19:58:51+00:00 daily 0.8 http://www.pharma-marketer.com/dendreons-provenge-looks-likely-to-be-approved-in-mid-2010/ 2009-11-03T19:58:49+00:00 daily 0.8 http://www.pharma-marketer.com/titan-pharma-stock-remains-primed-to-spike/ 2009-11-03T19:58:48+00:00 daily 0.8 http://www.pharma-marketer.com/the-long-trade-in-chelsea-becomes-riskier/ 2009-11-03T19:58:47+00:00 daily 0.8 http://www.pharma-marketer.com/healthcare-reform-bill-positive-to-net-neutral-for-pharmaceutical-industry-according-to-analysis-by-morningstar-expert/ 2009-11-03T19:58:45+00:00 daily 0.8 http://www.pharma-marketer.com/rigel-reports-26-7m-loss-in-q3/ 2009-11-03T19:58:43+00:00 daily 0.8 http://www.pharma-marketer.com/stemcells-closes-12-5m-equity-financing/ 2009-11-03T19:58:41+00:00 daily 0.8 http://www.pharma-marketer.com/four-biotech-stocks-to-play-the-sector-pullback/ 2009-11-03T19:58:39+00:00 daily 0.8 http://www.pharma-marketer.com/merck-schering-plough-to-complete-merger-tuesday/ 2009-11-03T19:58:37+00:00 daily 0.8 http://www.pharma-marketer.com/top-10-blockbuster-biotech-drugs/ 2009-11-03T17:12:02+00:00 daily 0.8 http://www.pharma-marketer.com/alimera-refiles-80m-ipo-as-biotech-shares-slide/ 2009-11-03T16:51:08+00:00 daily 0.8 http://www.pharma-marketer.com/jj-raises-the-ax/ 2009-11-03T15:56:48+00:00 daily 0.8 http://www.pharma-marketer.com/drug-researchers-get-their-own-networking-site/ 2009-11-03T15:49:49+00:00 daily 0.8 http://www.pharma-marketer.com/chelseas-plan-to-change-endpoint-raises-fresh-doubts/ 2009-11-03T15:48:15+00:00 daily 0.8 http://www.pharma-marketer.com/that-didnt-take-very-long/ 2009-11-03T12:52:08+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-novartis-investing-1b-in-china-rd-ops/ 2009-11-03T12:36:06+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-investing-1b-in-china-rd-ops/ 2009-11-03T12:36:06+00:00 daily 0.8 http://www.pharma-marketer.com/after-new-approval-fda-adds-warnings-to-label-of-lilly-and-amylins-diabetes-drug-byetta/ 2009-11-03T02:54:03+00:00 daily 0.8 http://www.pharma-marketer.com/innovative-drug-companies-headline-the-gainers/ 2009-11-03T02:54:01+00:00 daily 0.8 http://www.pharma-marketer.com/fda-official-urges-caution-on-new-h1n1-drug/ 2009-11-03T02:54:00+00:00 daily 0.8 http://www.pharma-marketer.com/some-great-dtc-marketing-fairytales/ 2009-11-03T02:40:56+00:00 daily 0.8 http://www.pharma-marketer.com/what-will-fda-meeting-yield-not-much/ 2009-11-03T02:38:59+00:00 daily 0.8 http://www.pharma-marketer.com/is-search-becoming-to-complicated-for-health-information/ 2009-11-03T02:36:54+00:00 daily 0.8 http://www.pharma-marketer.com/the-fda-has-has-more-priorities-right-now-than-a-hearing-on-social-media/ 2009-11-03T02:34:34+00:00 daily 0.8 http://www.pharma-marketer.com/politicans-decide-to-punish-the-drug-industry-and-in-doing-so-punish-consumers-and-patients/ 2009-11-03T02:32:31+00:00 daily 0.8 http://www.pharma-marketer.com/how-to-implement-a-social-media-program-when-your-company-is-risk-adverse/ 2009-11-03T01:41:42+00:00 daily 0.8 http://www.pharma-marketer.com/emotion-can-powerful-when-used-to-sell/ 2009-11-03T01:37:03+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-lawsuit-bogus-abuse-of-legal-system/ 2009-11-03T01:27:41+00:00 daily 0.8 http://www.pharma-marketer.com/supreme-court-rejects-plavix-patent-challenge/ 2009-11-02T22:52:49+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-ceo-generates-news-trifecta/ 2009-11-02T22:52:47+00:00 daily 0.8 http://www.pharma-marketer.com/merck-fda-wont-accept-its-application-for-combo-cholesterol-pill-including-pfizers-lipitor/ 2009-11-02T22:52:45+00:00 daily 0.8 http://www.pharma-marketer.com/amylin-pharma-calls-ride-the-rally/ 2009-11-02T22:52:43+00:00 daily 0.8 http://www.pharma-marketer.com/biovex-ceo-upbeat-on-oncovex-data-hints-at-a-deal/ 2009-11-02T21:23:09+00:00 daily 0.8 http://www.pharma-marketer.com/dendreon-files-bla-for-provenge/ 2009-11-02T19:18:27+00:00 daily 0.8 http://www.pharma-marketer.com/drugmakers-place-caps-on-speaker-fees-study/ 2009-11-02T18:55:46+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-pasteur-presents-safety-data-on-menactrar-vaccine-given-to-infants-at-infectious-disease-society-meeting/ 2009-11-02T18:55:43+00:00 daily 0.8 http://www.pharma-marketer.com/valeant-q3-beats-estimates-raises-09-profit-view/ 2009-11-02T18:55:41+00:00 daily 0.8 http://www.pharma-marketer.com/study-anemia-meds-double-stroke-risk/ 2009-11-02T18:55:39+00:00 daily 0.8 http://www.pharma-marketer.com/video-amylin-ceo-on-diabetes-diet-drugs/ 2009-11-02T18:55:37+00:00 daily 0.8 http://www.pharma-marketer.com/report-pfizer-may-make-a-bid-for-protalix/ 2009-11-02T16:35:26+00:00 daily 0.8 http://www.pharma-marketer.com/quintiles-inks-cancer-trial-deal-with-eisai/ 2009-11-02T16:22:23+00:00 daily 0.8 http://www.pharma-marketer.com/gtx-shares-blitzed-by-fdas-toremifene-rejection/ 2009-11-02T15:12:01+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-backs-us-health-reform/ 2009-11-02T14:48:26+00:00 daily 0.8 http://www.pharma-marketer.com/human-genome-gsk-see-progress-with-lupus-drug/ 2009-11-02T14:48:22+00:00 daily 0.8 http://www.pharma-marketer.com/takeda-agrees-to-buy-rights-to-amylina%c2%a2aea%e2%84%a2s-obesity-drugs/ 2009-11-02T14:48:20+00:00 daily 0.8 http://www.pharma-marketer.com/schering-plough-reports-data-on-hepatitis-c-drug/ 2009-11-02T14:48:17+00:00 daily 0.8 http://www.pharma-marketer.com/will-pfizer-buy-protalix/ 2009-11-02T14:48:15+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-calendar-key-dates-for-november/ 2009-11-02T14:48:11+00:00 daily 0.8 http://www.pharma-marketer.com/dendreon-resubmits-provenge-to-fda/ 2009-11-02T14:48:08+00:00 daily 0.8 http://www.pharma-marketer.com/gtx-slides-after-fda-asks-for-more-toremifene-data/ 2009-11-02T14:48:06+00:00 daily 0.8 http://www.pharma-marketer.com/sloppy-end-of-year-fda-filings-have-lower-approval-odds/ 2009-11-02T14:48:04+00:00 daily 0.8 http://www.pharma-marketer.com/drugmaker-hires-private-eye-to-probe-fda-official/ 2009-11-02T14:48:01+00:00 daily 0.8 http://www.pharma-marketer.com/probiodrug-gains-54m-to-back-alzheimers-program/ 2009-11-02T13:43:49+00:00 daily 0.8 http://www.pharma-marketer.com/amylin-forges-1b-weight-loss-pact-with-takeda/ 2009-11-02T13:20:34+00:00 daily 0.8 http://www.pharma-marketer.com/pg-gets-warning-letter-fda-takes-it-back-pg-gets-warning-letter/ 2009-11-02T13:07:29+00:00 daily 0.8 http://www.pharma-marketer.com/hgss-groundbreaking-lupus-drug-promising-in-second-phase-iii/ 2009-11-02T12:49:07+00:00 daily 0.8 http://www.pharma-marketer.com/in-which-you-get-to-hear-the-phrase-hatch-waxman-again/ 2009-11-02T12:45:21+00:00 daily 0.8 http://www.pharma-marketer.com/industry-groups-will-eat-consumer-advocates-lunch-at-fda-social-media-public-hearing/ 2009-11-02T08:04:06+00:00 daily 0.8 http://www.pharma-marketer.com/celebrating-pharma-women-on-twitter/ 2009-11-01T20:01:24+00:00 daily 0.8 http://www.pharma-marketer.com/additional-data-from-fidaxomicins-phase-3-study-for-clostridium-difficile-infection-cdi-presented-at-idsa-annual-meet/ 2009-11-01T16:31:02+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-squibb-and-zymogenetics-present-final-phase-1b-results-for-peg-interferon-lambda-in-hepatitis-c/ 2009-11-01T16:31:00+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-announces-long-term-data-from-two-pivotal-phase-iii-studies-evaluating-vireada%e2%80%9aa%c2%ae-for-chronic-hepatitis-b/ 2009-11-01T16:30:59+00:00 daily 0.8 http://www.pharma-marketer.com/vertex-hep-c-drug-cures-80-at-new-dose-study/ 2009-11-01T16:30:57+00:00 daily 0.8 http://www.pharma-marketer.com/baracludea%e2%80%9aa%c2%ae-entecavir-demonstrated-greater-antiviral-efficacy-compared-to-adefovir-in-new-study-of-chronic-hepatitis-b/ 2009-11-01T16:30:55+00:00 daily 0.8 http://www.pharma-marketer.com/biotechs-buck-a%c2%a2aea%cb%9cgreena%c2%a2aea%e2%84%a2-retreat/ 2009-11-01T16:30:52+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-hopes-new-san-diego-facility-will-be-a-biotechnology-powerhouse/ 2009-11-01T16:30:50+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-tribulations-roundup-failed-trials-missed-targets-business-mishaps/ 2009-11-01T16:30:48+00:00 daily 0.8 http://www.pharma-marketer.com/tianyin-pharma-forms-jv-to-expand-antibiotics-business/ 2009-11-01T16:30:47+00:00 daily 0.8 http://www.pharma-marketer.com/alimera-sciences-re-files-for-ipo/ 2009-11-01T16:30:46+00:00 daily 0.8 http://www.pharma-marketer.com/china-biotech-week-in-review-is-cro-consolidation-a-new-theme/ 2009-11-01T16:30:42+00:00 daily 0.8 http://www.pharma-marketer.com/global-phase-iii-study-results-show-eribulin-meets-primary-endpoint-of-overall-survival/ 2009-10-31T19:52:31+00:00 daily 0.8 http://www.pharma-marketer.com/valeant-to-acquire-polish-products/ 2009-10-31T19:52:27+00:00 daily 0.8 http://www.pharma-marketer.com/sembiosys-enters-in-non-dilutive-financing-plan-of-arrangement/ 2009-10-31T19:52:22+00:00 daily 0.8 http://www.pharma-marketer.com/us-fda-seeks-more-data-from-transcepts-insomnia-drug-intermezzo/ 2009-10-31T19:52:19+00:00 daily 0.8 http://www.pharma-marketer.com/alexion-pharmaceuticals-inc-leads-tech-top-40-listings-in-connecticut/ 2009-10-31T19:52:12+00:00 daily 0.8 http://www.pharma-marketer.com/acelrx-announces-successful-completion-of-end-of-phase-2-meeting-on-arx-01-sufentanil-nanotab-pca-system-for-post-opera/ 2009-10-31T19:52:07+00:00 daily 0.8 http://www.pharma-marketer.com/astellas-and-theravance-announce-submission-of-telavancin-maa-for-the-treatment-of-nosocomial-pneumonia/ 2009-10-31T19:52:04+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-delivers-a-solid-performance-in-third-quarter-2009/ 2009-10-31T19:52:00+00:00 daily 0.8 http://www.pharma-marketer.com/woot-intouch-wins-best-web-site-at-mmm-awards/ 2009-10-31T18:20:45+00:00 daily 0.8 http://www.pharma-marketer.com/15-states-sue-amgen-alleging-kickback-scheme/ 2009-10-31T15:33:26+00:00 daily 0.8 http://www.pharma-marketer.com/gtxa%c2%a2aea%e2%84%a2s-stock-slides-before-conference-call/ 2009-10-31T15:33:24+00:00 daily 0.8 http://www.pharma-marketer.com/byetta-approved-for-expanded-use-as-first-line-treatment-for-type-2-diabetes/ 2009-10-31T15:33:22+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-drug-may-increase-stroke-risk-in-some-study/ 2009-10-31T15:33:20+00:00 daily 0.8 http://www.pharma-marketer.com/of-one-time-gains-and-pipelines/ 2009-10-31T15:33:18+00:00 daily 0.8 http://www.pharma-marketer.com/its-not-as-frightening-as-it-first-appears-mylan/ 2009-10-31T15:33:16+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-ceo-lechleiter-calls-for-repair-of-the-engine-of-biopharma-innovation/ 2009-10-31T15:33:14+00:00 daily 0.8 http://www.pharma-marketer.com/shrugging-off-the-side-effects/ 2009-10-31T15:33:12+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-ceo-animal-biz-combo-with-merck-a%c2%a2aea%cb%9cmore-likely-than-nota%c2%a2aea%e2%84%a2/ 2009-10-31T15:33:09+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-suing-impax-labs-over-generic-tricor/ 2009-10-31T15:33:07+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-transforming-aids/ 2009-10-31T15:33:05+00:00 daily 0.8 http://www.pharma-marketer.com/podcast-overview/ 2009-10-30T20:28:42+00:00 daily 0.8 http://www.pharma-marketer.com/warner-chilcott-closes-3-1-billion-buyout-of-procter-gambles-drug-unit/ 2009-10-30T18:25:58+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-103009/ 2009-10-30T17:28:27+00:00 daily 0.8 http://www.pharma-marketer.com/amicus-terminates-pact-cuts-20-of-staff/ 2009-10-30T14:53:11+00:00 daily 0.8 http://www.pharma-marketer.com/pay-attention-to-qlt/ 2009-10-30T14:39:56+00:00 daily 0.8 http://www.pharma-marketer.com/takeda-profit-jumps-full-year-sales-forecast-cut-on-strong-yen/ 2009-10-30T14:39:50+00:00 daily 0.8 http://www.pharma-marketer.com/jjs-new-acquisition-strategy-makes-sense/ 2009-10-30T14:39:46+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-net-profit-up-6-raises-guidance/ 2009-10-30T14:39:44+00:00 daily 0.8 http://www.pharma-marketer.com/shorts-using-any-bad-news-they-can-to-drive-spectrum-pharma-down/ 2009-10-30T14:39:41+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-pays-millions-to-settle-seroquel-cases/ 2009-10-30T14:39:39+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-then-and-now-shareholder-say-on-executive-pay/ 2009-10-30T14:39:37+00:00 daily 0.8 http://www.pharma-marketer.com/simcere-gains-majority-control-of-vaccine-subsidiary/ 2009-10-30T14:39:31+00:00 daily 0.8 http://www.pharma-marketer.com/biopharma-deals-of-the-week/ 2009-10-30T14:39:29+00:00 daily 0.8 http://www.pharma-marketer.com/human-genome-faces-binary-event/ 2009-10-30T14:39:26+00:00 daily 0.8 http://www.pharma-marketer.com/china-launches-biotech-vcs-new-tech-stock-market/ 2009-10-30T14:39:24+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-mailbag-the-reasons-for-this-selloff/ 2009-10-30T14:39:22+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-not-licensing-idenixs-hepatitis-c-drug/ 2009-10-30T14:39:19+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-dodges-a-bullet/ 2009-10-30T14:29:31+00:00 daily 0.8 http://www.pharma-marketer.com/23andme-faces-layoffs/ 2009-10-30T14:18:28+00:00 daily 0.8 http://www.pharma-marketer.com/fifty-years-of-scientific-history-for-you/ 2009-10-30T13:50:16+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-to-open-san-diego-biotech-center/ 2009-10-30T13:39:12+00:00 daily 0.8 http://www.pharma-marketer.com/genta-tanks-on-genasense-data/ 2009-10-30T13:39:04+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-takes-a-pass-on-idenix-drug/ 2009-10-30T13:12:54+00:00 daily 0.8 http://www.pharma-marketer.com/health-reform-negative-synergy/ 2009-10-30T12:48:33+00:00 daily 0.8 http://www.pharma-marketer.com/cholesterol-lowering-statin-drugs-like-lipitor-zocor-may-improve-flu-survival-study-finds/ 2009-10-30T00:36:28+00:00 daily 0.8 http://www.pharma-marketer.com/jj-salesman-says-he-sold-drug-for-unapproved-uses/ 2009-10-30T00:36:26+00:00 daily 0.8 http://www.pharma-marketer.com/u-s-ftc-oks-merck-schering-deal-with-conditions/ 2009-10-30T00:36:24+00:00 daily 0.8 http://www.pharma-marketer.com/a-lesson-in-reputation-management-from-the-cdc-in-h1n1-flu-vaccination/ 2009-10-29T21:32:35+00:00 daily 0.8 http://www.pharma-marketer.com/why-the-markets-up-but-mercks-down/ 2009-10-29T20:28:13+00:00 daily 0.8 http://www.pharma-marketer.com/swine-flu-vaccine-boosts-astrazeneca-quarterly-earns-but-investors-cautious-on-outlook/ 2009-10-29T20:28:11+00:00 daily 0.8 http://www.pharma-marketer.com/how-pfizer-rewards-its-bosses-for-eliminating-jobs/ 2009-10-29T20:28:09+00:00 daily 0.8 http://www.pharma-marketer.com/in-vermont-a-fierce-debate-over-free-drug-samples/ 2009-10-29T20:28:06+00:00 daily 0.8 http://www.pharma-marketer.com/the-best-ones-arent-over-here-any-more/ 2009-10-29T17:13:59+00:00 daily 0.8 http://www.pharma-marketer.com/genta-melanoma-drug-study-disappoints/ 2009-10-29T16:50:21+00:00 daily 0.8 http://www.pharma-marketer.com/roches-new-diabetes-drug-works-better-than-byetta/ 2009-10-29T16:50:15+00:00 daily 0.8 http://www.pharma-marketer.com/transcept-insomnia-drug-may-need-additional-study/ 2009-10-29T16:50:12+00:00 daily 0.8 http://www.pharma-marketer.com/allergan-posts-higher-third-quarter-profit/ 2009-10-29T16:50:08+00:00 daily 0.8 http://www.pharma-marketer.com/investor-daily-face-off-over-eli-lilly/ 2009-10-29T16:50:04+00:00 daily 0.8 http://www.pharma-marketer.com/more-pml-troubles-for-biogen-elan-ms-drug/ 2009-10-29T16:50:01+00:00 daily 0.8 http://www.pharma-marketer.com/biomarin-human-genome-lead-drug-stocks-higher/ 2009-10-29T16:49:55+00:00 daily 0.8 http://www.pharma-marketer.com/roche-diabetes-drug-beats-byetta/ 2009-10-29T15:43:33+00:00 daily 0.8 http://www.pharma-marketer.com/virdante-boosts-first-venture-round-to-48m/ 2009-10-29T15:40:51+00:00 daily 0.8 http://www.pharma-marketer.com/aldagen-mounts-fresh-attempt-to-pull-off-an-ipo/ 2009-10-29T15:30:09+00:00 daily 0.8 http://www.pharma-marketer.com/social-media-best-practices-for-pharma-are-needed-whatever-happens-at-fda/ 2009-10-29T15:19:20+00:00 daily 0.8 http://www.pharma-marketer.com/aryx-axes-staff-as-it-negotiates-new-deals/ 2009-10-29T14:09:07+00:00 daily 0.8 http://www.pharma-marketer.com/micromet-inks-475m-antibody-deal-with-sanofi/ 2009-10-29T14:01:16+00:00 daily 0.8 http://www.pharma-marketer.com/transcept-shares-battered-after-fda-denies-intermezzo-ok/ 2009-10-29T13:49:48+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-quarterly-profit-jumps-sales-up/ 2009-10-29T13:41:37+00:00 daily 0.8 http://www.pharma-marketer.com/unemployed-drug-reps-go-east-young-man-and-women/ 2009-10-29T13:41:33+00:00 daily 0.8 http://www.pharma-marketer.com/endo-pharmaceuticals-3rd-quarter-profit-dips-on-buyout-costs-pain-drugs-drive-revenue/ 2009-10-29T13:41:29+00:00 daily 0.8 http://www.pharma-marketer.com/four-med-chem-questions/ 2009-10-29T13:11:07+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-giving-2-execs-bonuses-after-wyeth-deal/ 2009-10-29T10:17:37+00:00 daily 0.8 http://www.pharma-marketer.com/stryker-unit-ex-chief-indicted-for-misleading-fda/ 2009-10-29T10:17:35+00:00 daily 0.8 http://www.pharma-marketer.com/uk-trust-sues-amgen-wyeth-over-enbrel-patent/ 2009-10-29T10:17:33+00:00 daily 0.8 http://www.pharma-marketer.com/four-high-flying-pharmaceutical-companies/ 2009-10-29T10:17:31+00:00 daily 0.8 http://www.pharma-marketer.com/agenda-astra-zeneca-feeling-some-pain/ 2009-10-28T22:46:49+00:00 daily 0.8 http://www.pharma-marketer.com/where-gsk-is-cutting-sales-reps-and-where-ita%c2%a2aea%e2%84%a2s-adding-them/ 2009-10-28T22:46:47+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-on-the-acquisitions-trail/ 2009-10-28T22:46:45+00:00 daily 0.8 http://www.pharma-marketer.com/sciclone-to-cut-17-of-u-s-staff/ 2009-10-28T22:46:43+00:00 daily 0.8 http://www.pharma-marketer.com/medicare-gives-eye-docs-their-way-on-avastin/ 2009-10-28T22:46:41+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-preview-allergan/ 2009-10-28T22:46:38+00:00 daily 0.8 http://www.pharma-marketer.com/google-wikki-is-just-another-way-to-tell-marketers-that-they-dont-control-the-message-anymore/ 2009-10-28T18:59:47+00:00 daily 0.8 http://www.pharma-marketer.com/the-spread-and-utility-of-sidewiki/ 2009-10-28T18:54:30+00:00 daily 0.8 http://www.pharma-marketer.com/fda-hearing-speakers-attendees-start-your-engines/ 2009-10-28T16:10:08+00:00 daily 0.8 http://www.pharma-marketer.com/nanotech-armor/ 2009-10-28T15:05:53+00:00 daily 0.8 http://www.pharma-marketer.com/nabriva-hauls-in-22m-in-fresh-vc-funds/ 2009-10-28T14:51:07+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-pulls-zactima-combination-submission/ 2009-10-28T14:37:34+00:00 daily 0.8 http://www.pharma-marketer.com/vertex-hep-c-drug-improves-cure-rates/ 2009-10-28T14:37:31+00:00 daily 0.8 http://www.pharma-marketer.com/swine-flu-vaccine-scarcity-stirs-anger-in-u-s-communities/ 2009-10-28T14:37:29+00:00 daily 0.8 http://www.pharma-marketer.com/boehringer-ingelheim-animal-health-closes-deal-to-acquire-a-significant-portion-of-the-fort-dodge-animal-health-business/ 2009-10-28T14:37:28+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-faces-hospira-apotex-in-patent-trial/ 2009-10-28T14:37:27+00:00 daily 0.8 http://www.pharma-marketer.com/video-a-look-at-johnson-johnson-mad-about-options/ 2009-10-28T14:37:25+00:00 daily 0.8 http://www.pharma-marketer.com/roche-wins-accutane-lawsuit-on-court-reversal/ 2009-10-28T14:37:23+00:00 daily 0.8 http://www.pharma-marketer.com/vivus-analyst-in-obesity-drug-side-effect-spat/ 2009-10-28T14:37:22+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-quarterly-profit-jumps-sales-up/ 2009-10-28T14:37:20+00:00 daily 0.8 http://www.pharma-marketer.com/fda-warns-sanofi-aventis-over-misleading-material/ 2009-10-28T14:37:16+00:00 daily 0.8 http://www.pharma-marketer.com/spectrum-pharmaceuticals-is-worth-a-close-watch/ 2009-10-28T14:37:14+00:00 daily 0.8 http://www.pharma-marketer.com/the-2009-biotech-graveyard/ 2009-10-28T14:37:13+00:00 daily 0.8 http://www.pharma-marketer.com/fda-experts-want-to-see-more-abthrax-data/ 2009-10-28T14:36:20+00:00 daily 0.8 http://www.pharma-marketer.com/ppd-buys-cro-creates-spin-offs-and-invests-100m-in-celtic/ 2009-10-28T14:21:03+00:00 daily 0.8 http://www.pharma-marketer.com/expect-fda-social-media-draft-guidance-before-end-of-2010/ 2009-10-28T13:40:37+00:00 daily 0.8 http://www.pharma-marketer.com/sciclone-axes-rd-staffers-following-trial/ 2009-10-28T12:50:09+00:00 daily 0.8 http://www.pharma-marketer.com/want-the-truth-search-for-it-on-google/ 2009-10-28T12:48:58+00:00 daily 0.8 http://www.pharma-marketer.com/vertex-unveils-fresh-set-of-promising-hep-c-data/ 2009-10-28T12:28:11+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-az-pulls-apps-for-once-promising-cancer-drug/ 2009-10-28T11:49:07+00:00 daily 0.8 http://www.pharma-marketer.com/az-pulls-apps-for-once-promising-cancer-drug/ 2009-10-28T11:49:07+00:00 daily 0.8 http://www.pharma-marketer.com/you-mean-you-dont-have-to-buy-them/ 2009-10-28T11:30:47+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-firm-cephalon-3q-profit-falls-2-7-percent/ 2009-10-28T03:06:17+00:00 daily 0.8 http://www.pharma-marketer.com/teva-may-make-acquisition-in-first-half-of-2010-hapoalim-says/ 2009-10-28T03:06:15+00:00 daily 0.8 http://www.pharma-marketer.com/reviving-tysabri/ 2009-10-27T23:49:05+00:00 daily 0.8 http://www.pharma-marketer.com/wall-street-500-axed-astrazeneca-reps-are-worth-only-5-cents/ 2009-10-27T23:49:03+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-and-mercks-loss-is-these-companies-gain/ 2009-10-27T23:48:59+00:00 daily 0.8 http://www.pharma-marketer.com/hefty-side-effect-for-kids-on-antipsychotics/ 2009-10-27T23:48:57+00:00 daily 0.8 http://www.pharma-marketer.com/dtc-marketing-new-media-consumers-want-a-conversation/ 2009-10-27T22:50:09+00:00 daily 0.8 http://www.pharma-marketer.com/dtc-marketing-new-media-its-now-or-could-be-never/ 2009-10-27T22:50:09+00:00 daily 0.8 http://www.pharma-marketer.com/gardasil-researcher-drops-a-bombshell/ 2009-10-27T19:18:35+00:00 daily 0.8 http://www.pharma-marketer.com/king-pharmaceuticals-licenses-us-sales-rights-for-cyanide-antidote-from-germany-based-merck/ 2009-10-27T19:18:32+00:00 daily 0.8 http://www.pharma-marketer.com/one-reason-big-pharma-backs-reform/ 2009-10-27T19:18:29+00:00 daily 0.8 http://www.pharma-marketer.com/we-asked-and-physicians-sounded-off/ 2009-10-27T17:34:26+00:00 daily 0.8 http://www.pharma-marketer.com/wasting-money-on-search-marketing-you-probably-are/ 2009-10-27T17:02:24+00:00 daily 0.8 http://www.pharma-marketer.com/iae%e2%84%a2m-speaking-at-boston-biotech-meetup-oct-27th-massbio/ 2009-10-27T16:14:45+00:00 daily 0.8 http://www.pharma-marketer.com/hgs-hit-with-anthrax-setback/ 2009-10-27T16:06:55+00:00 daily 0.8 http://www.pharma-marketer.com/arena-pharma-heralds-late-stage-obesity-data/ 2009-10-27T16:01:34+00:00 daily 0.8 http://www.pharma-marketer.com/keryx-biopharmaceuticals-next-price-movers-will-be-trial-news/ 2009-10-27T15:50:03+00:00 daily 0.8 http://www.pharma-marketer.com/genmab-surges-after-fda-clears-cancer-drug-shared-with-glaxo/ 2009-10-27T15:50:00+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-unita%c2%a2aea%e2%84%a2s-prempro-punitive-damages-verdict-remains-secret/ 2009-10-27T15:49:58+00:00 daily 0.8 http://www.pharma-marketer.com/medivation-lands-partner-for-prostate-cancer-drug/ 2009-10-27T15:49:55+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-may-face-a-backlash-over-diabetes-report/ 2009-10-27T15:49:50+00:00 daily 0.8 http://www.pharma-marketer.com/big-cap-biotech-worries-lead-sector-down/ 2009-10-27T15:49:48+00:00 daily 0.8 http://www.pharma-marketer.com/cel-scis-targets-stay-on-track/ 2009-10-27T15:49:41+00:00 daily 0.8 http://www.pharma-marketer.com/why-biogen-idec-is-likely-to-flinch-before-facet-biotech-in-their-game-of-chicken/ 2009-10-27T15:49:38+00:00 daily 0.8 http://www.pharma-marketer.com/white-house-sides-with-investors-against-merck/ 2009-10-27T15:49:33+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-gain-hospira-climbs-on-earnings-report/ 2009-10-27T15:49:30+00:00 daily 0.8 http://www.pharma-marketer.com/ligand-pharma-buying-metabasis-for-3-2-million-future-payments-metabasis-shares-slide/ 2009-10-27T15:49:27+00:00 daily 0.8 http://www.pharma-marketer.com/becton-set-for-acquisition/ 2009-10-27T15:49:24+00:00 daily 0.8 http://www.pharma-marketer.com/reduce-your-number-of-reductions-why-dont-you/ 2009-10-27T15:43:48+00:00 daily 0.8 http://www.pharma-marketer.com/roche-hiring-for-research-campus/ 2009-10-27T14:51:34+00:00 daily 0.8 http://www.pharma-marketer.com/icagen-shares-plunge-on-failed-asthma-trial/ 2009-10-27T14:49:56+00:00 daily 0.8 http://www.pharma-marketer.com/ligand-pharma-snaps-up-struggling-metabasis/ 2009-10-27T13:51:49+00:00 daily 0.8 http://www.pharma-marketer.com/medivation-forges-765m-cancer-deal-with-astellas/ 2009-10-27T12:28:46+00:00 daily 0.8 http://www.pharma-marketer.com/genmab-wins-23m-on-blockbuster-cancer-approval/ 2009-10-27T12:04:00+00:00 daily 0.8 http://www.pharma-marketer.com/fear-and-loathing-in-washington-dc/ 2009-10-27T11:20:34+00:00 daily 0.8 http://www.pharma-marketer.com/icagen-exercise-induced-asthma-drug-senicapoc-trial-fails-company-plans-to-halt-development/ 2009-10-27T02:29:49+00:00 daily 0.8 http://www.pharma-marketer.com/biomarin-to-buy-huxley-pharmaceuticals/ 2009-10-27T02:29:45+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-preview-glaxosmithkline-q3-earns-seen-up/ 2009-10-26T22:47:59+00:00 daily 0.8 http://www.pharma-marketer.com/vertex-pharma-books-larger-3rd-quarter-loss-as-collaboration-revenue-falls-costs-increase/ 2009-10-26T22:47:56+00:00 daily 0.8 http://www.pharma-marketer.com/whatever-tysabri-outcome-biogen-idec-should-survive/ 2009-10-26T22:47:54+00:00 daily 0.8 http://www.pharma-marketer.com/slow-diagnosis-hampers-uptake-of-fibromyalgia-drugs/ 2009-10-26T22:47:51+00:00 daily 0.8 http://www.pharma-marketer.com/unusual-call-volume-in-merck-options/ 2009-10-26T22:47:48+00:00 daily 0.8 http://www.pharma-marketer.com/when-fda-fails-to-follow-up-on-rapid-drug-approvals/ 2009-10-26T22:47:45+00:00 daily 0.8 http://www.pharma-marketer.com/cephalon-close-to-buying-bioassets-developer-of-sciatica-treatment/ 2009-10-26T19:13:56+00:00 daily 0.8 http://www.pharma-marketer.com/antigenics-buoyed-by-brain-cancer-study/ 2009-10-26T19:13:51+00:00 daily 0.8 http://www.pharma-marketer.com/video-vivus-ceo-on-diet-drug/ 2009-10-26T19:13:45+00:00 daily 0.8 http://www.pharma-marketer.com/shire-gets-boost-as-fda-backs-vyvanse-exclusivity/ 2009-10-26T19:13:39+00:00 daily 0.8 http://www.pharma-marketer.com/fda-doesnt-act-on-post-marketing-data/ 2009-10-26T19:13:30+00:00 daily 0.8 http://www.pharma-marketer.com/effient-and-onglyza-start-slowa%c2%a2aea%e2%80%9dand-that-may-not-be-a-bad-thing/ 2009-10-26T19:13:25+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-produces-snapshot-of-combined-company-66b-in-revenue-only-2-2b-in-cash/ 2009-10-26T19:13:20+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-laboratories-dividend-stock-analysis/ 2009-10-26T19:13:12+00:00 daily 0.8 http://www.pharma-marketer.com/last-call-on-fiercebiotechs-deal-making-survey/ 2009-10-26T16:07:06+00:00 daily 0.8 http://www.pharma-marketer.com/jj-wants-deals-with-rivals-to-share-risk/ 2009-10-26T15:55:04+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-use-of-experimental-antiviral-for-h1n1-flu/ 2009-10-26T15:54:56+00:00 daily 0.8 http://www.pharma-marketer.com/swine-flu-doesnt-need-to-save-novartis/ 2009-10-26T15:54:53+00:00 daily 0.8 http://www.pharma-marketer.com/ranbaxy-posts-profit-on-lower-costs-currencies/ 2009-10-26T15:54:51+00:00 daily 0.8 http://www.pharma-marketer.com/brain-disease-found-in-3rd-patient-on-rochea%c2%a2aea%e2%84%a2s-rituxan/ 2009-10-26T15:54:35+00:00 daily 0.8 http://www.pharma-marketer.com/for-astrazeneca-making-drugs-is-like-making-cars/ 2009-10-26T15:54:32+00:00 daily 0.8 http://www.pharma-marketer.com/supergen-glaxosmithkline-sign-collaboration-deal/ 2009-10-26T15:54:28+00:00 daily 0.8 http://www.pharma-marketer.com/sf-developers-blueprint-1b-biotech-campus/ 2009-10-26T15:40:31+00:00 daily 0.8 http://www.pharma-marketer.com/jj-ceo-sets-his-sights-on-new-drug-alliances/ 2009-10-26T15:28:31+00:00 daily 0.8 http://www.pharma-marketer.com/cephalon-snags-30m-option-on-bioassets/ 2009-10-26T14:57:17+00:00 daily 0.8 http://www.pharma-marketer.com/fdas-plan-for-risk-communication-part-2/ 2009-10-26T14:50:31+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-inks-375m-epigenetics-deal-with-supergen/ 2009-10-26T14:40:56+00:00 daily 0.8 http://www.pharma-marketer.com/enough-already-too-many-conferences-on-internet-marketing-are-overloading-people/ 2009-10-26T14:10:58+00:00 daily 0.8 http://www.pharma-marketer.com/disgraced-scientist-convicted-of-embezzlement/ 2009-10-26T13:11:10+00:00 daily 0.8 http://www.pharma-marketer.com/elements-i-have-yet-to-use/ 2009-10-26T12:48:11+00:00 daily 0.8 http://www.pharma-marketer.com/feds-ok-iv-peramivir-as-outbreak-shifts-focus-to-new-meds/ 2009-10-26T12:23:33+00:00 daily 0.8 http://www.pharma-marketer.com/divia%c2%a2aea%e2%84%a2s-laboratories-buy/ 2009-10-26T02:07:43+00:00 daily 0.8 http://www.pharma-marketer.com/my-chat-with-a-regulatory-vp/ 2009-10-26T01:50:32+00:00 daily 0.8 http://www.pharma-marketer.com/rules-of-engagement/ 2009-10-26T01:46:52+00:00 daily 0.8 http://www.pharma-marketer.com/venture-capital-flows-to-biotech-as-public-financing-takes-a-breather/ 2009-10-25T19:31:57+00:00 daily 0.8 http://www.pharma-marketer.com/not-50-growth-but-well-take-it-celgene/ 2009-10-24T17:32:00+00:00 daily 0.8 http://www.pharma-marketer.com/myriad-pharmaceuticals-azixatm-is-efficacious-in-a-model-of-human-brain-cancer-and-its-activity-is-additive-with-avas/ 2009-10-24T17:31:58+00:00 daily 0.8 http://www.pharma-marketer.com/merck-schering-doesnt-look-so-good/ 2009-10-24T17:31:55+00:00 daily 0.8 http://www.pharma-marketer.com/i-dont-need-no-massive-merger-bms/ 2009-10-24T17:31:52+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-seeks-cure-for-off-label-woes/ 2009-10-24T17:31:50+00:00 daily 0.8 http://www.pharma-marketer.com/ardea-presents-gout-data/ 2009-10-24T17:31:47+00:00 daily 0.8 http://www.pharma-marketer.com/medicines-co-gets-positive-eu-panel-result/ 2009-10-24T17:31:44+00:00 daily 0.8 http://www.pharma-marketer.com/cephs-nuvigil-faces-generic-threat/ 2009-10-24T17:31:42+00:00 daily 0.8 http://www.pharma-marketer.com/alexion-beats-raises-outlook/ 2009-10-24T17:31:39+00:00 daily 0.8 http://www.pharma-marketer.com/allergan-announces-victory-in-brimonidine-patent-infringement-case/ 2009-10-24T17:31:37+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-slaps-unilab-with-patent-suit-over-contested-drug/ 2009-10-24T17:31:34+00:00 daily 0.8 http://www.pharma-marketer.com/exelixis-and-bristol-myers-squibb-report-new-phase-2-data-for-xl184-in-patients-with-the-most-common-and-aggressive-form/ 2009-10-24T17:31:34+00:00 daily 0.8 http://www.pharma-marketer.com/emergency-use-authorization-granted-for-biocrysts-peramivir/ 2009-10-24T17:31:31+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-settles-zyprexa-suit-with-south-carolina/ 2009-10-24T17:31:30+00:00 daily 0.8 http://www.pharma-marketer.com/aeterna-zentaris-receives-us5-5-million-from-institutional-investors/ 2009-10-24T17:31:27+00:00 daily 0.8 http://www.pharma-marketer.com/canadian-judge-zyprexa-is-an-a%c2%a2aea%cb%9calmost-inventiona%c2%a2aea%e2%84%a2/ 2009-10-23T18:08:46+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-rejoins-pharma-stampede-to-india/ 2009-10-23T18:08:43+00:00 daily 0.8 http://www.pharma-marketer.com/fda-reviews-human-genomes-anthrax-medication/ 2009-10-23T18:08:37+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-elan-fall-as-tysabri-brain-disease-cases-rise/ 2009-10-23T18:08:32+00:00 daily 0.8 http://www.pharma-marketer.com/dr-reddya%c2%a2aea%e2%84%a2s-profit-doubles-on-sales-in-u-s-russia/ 2009-10-23T18:08:24+00:00 daily 0.8 http://www.pharma-marketer.com/isis-diabetes-drug-shows-promise/ 2009-10-23T18:08:14+00:00 daily 0.8 http://www.pharma-marketer.com/social-media-for-regulatory-and-legal/ 2009-10-23T18:07:47+00:00 daily 0.8 http://www.pharma-marketer.com/bms-on-the-prowl-for-deals/ 2009-10-23T14:54:41+00:00 daily 0.8 http://www.pharma-marketer.com/theravance-wins-20m-milestone-on-fda-approval/ 2009-10-23T14:19:56+00:00 daily 0.8 http://www.pharma-marketer.com/potentia-alcon-ink-amd-drug-deal/ 2009-10-23T14:10:04+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-102309/ 2009-10-23T13:58:32+00:00 daily 0.8 http://www.pharma-marketer.com/lobbyists-figure-heavily-in-biogenerics-debate/ 2009-10-23T13:44:41+00:00 daily 0.8 http://www.pharma-marketer.com/learning-from-a-plague-of-vaccination-woes/ 2009-10-23T13:27:58+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-ceo-lechleiter-touts-pipeline/ 2009-10-23T12:52:52+00:00 daily 0.8 http://www.pharma-marketer.com/liraglutide-bests-xenical-at-cutting-weight-blood-pressure/ 2009-10-23T12:05:13+00:00 daily 0.8 http://www.pharma-marketer.com/things-i-wont-work-with-straight-dimethyl-zinc/ 2009-10-23T11:47:48+00:00 daily 0.8 http://www.pharma-marketer.com/eu-oks-merckschering-plough-merger/ 2009-10-23T10:57:23+00:00 daily 0.8 http://www.pharma-marketer.com/novo-nordisk-drug-helps-healthy-lose-weight-cut-blood-pressure/ 2009-10-23T10:57:21+00:00 daily 0.8 http://www.pharma-marketer.com/amgens-denosumab-turned-down-again-but-it-may-not-be-as-bad-as-it-seems/ 2009-10-23T10:57:19+00:00 daily 0.8 http://www.pharma-marketer.com/allergana%c2%a2aea%e2%84%a2s-first-amendment-case-rems-vs-off-label-promotion-a%c2%a2aea%e2%80%9c-and-dtc/ 2009-10-23T10:57:15+00:00 daily 0.8 http://www.pharma-marketer.com/cost-cuts-buoy-drug-groupsa%c2%a2aea%e2%84%a2-profits/ 2009-10-23T03:17:34+00:00 daily 0.8 http://www.pharma-marketer.com/bio-box-eli-lilly-ceo-john-lechleiter/ 2009-10-22T23:48:13+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-wrap-around-flat-line-amgen-falls-on-drug-delay/ 2009-10-22T23:48:11+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-ceo-says-most-u-s-swine-flu-vaccine-coming-next-year/ 2009-10-22T23:48:08+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-adds-jobs-plans-cuts/ 2009-10-22T23:48:06+00:00 daily 0.8 http://www.pharma-marketer.com/buy-sell-more-wheeling-dealing-from-bristol-myers-ceo/ 2009-10-22T23:48:04+00:00 daily 0.8 http://www.pharma-marketer.com/good-luck-in-2010-amgen/ 2009-10-22T23:48:02+00:00 daily 0.8 http://www.pharma-marketer.com/unusual-call-activity-in-cephalon-options/ 2009-10-22T23:48:00+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-the-gift-that-keeps-on-giving/ 2009-10-22T23:47:57+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myersa%c2%a2aea%e2%84%a2-profit-rises-tops-analyst-estimates/ 2009-10-22T17:29:35+00:00 daily 0.8 http://www.pharma-marketer.com/teva-seeking-to-sell-generic-version-of-cephalona%c2%a2aea%e2%84%a2s-nuvigil-sleep-disorder-drug/ 2009-10-22T16:54:39+00:00 daily 0.8 http://www.pharma-marketer.com/proximagen-strikes-deal-to-buy-cambridge-biotechnology/ 2009-10-22T16:13:26+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-social-media-crips-vs-legalregulatory-bloods-call-for-a-peace-conference/ 2009-10-22T15:50:07+00:00 daily 0.8 http://www.pharma-marketer.com/iv-peramivir-may-get-swift-approval/ 2009-10-22T15:41:31+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-spells-out-fdas-d-mab-demands/ 2009-10-22T15:34:34+00:00 daily 0.8 http://www.pharma-marketer.com/mercks-quarterly-net-profit-triples-on-asset-sale/ 2009-10-22T15:34:04+00:00 daily 0.8 http://www.pharma-marketer.com/ge-lilly-develop-test-to-improve-cancer-treatments/ 2009-10-22T15:34:01+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-wont-share-wyeths-q3-numbers-layoff-announcements-due-this-week/ 2009-10-22T15:33:54+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-faces-a-trial-in-sex-discrimination-lawsuit-filed-by-female-sales-reps/ 2009-10-22T15:33:48+00:00 daily 0.8 http://www.pharma-marketer.com/pick-up-antigenics-at-a-bargain-price/ 2009-10-22T15:33:40+00:00 daily 0.8 http://www.pharma-marketer.com/celgene-earnings-rise-in-quarter/ 2009-10-22T15:33:38+00:00 daily 0.8 http://www.pharma-marketer.com/fda-delays-ruling-on-acordas-ms-drug-until-jan-22/ 2009-10-22T15:33:35+00:00 daily 0.8 http://www.pharma-marketer.com/schering-plough-discriminated-against-some-docs/ 2009-10-22T15:33:32+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-call-is-a-requiem-for-schering-plough/ 2009-10-22T15:33:29+00:00 daily 0.8 http://www.pharma-marketer.com/mixed-data-for-az-bms-diabetes-drug-in-new-study/ 2009-10-22T15:33:27+00:00 daily 0.8 http://www.pharma-marketer.com/c-r-bard-surpasses-zacks-estimate/ 2009-10-22T15:33:22+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-tasigna-seen-succeeding-top-drug-gleevec/ 2009-10-22T15:33:20+00:00 daily 0.8 http://www.pharma-marketer.com/evolva-hauls-in-28m-to-grease-arpida-merger/ 2009-10-22T15:13:08+00:00 daily 0.8 http://www.pharma-marketer.com/will-the-fda-part-15-meeting-on-social-media-actually-bring-on-a-global-freezing/ 2009-10-22T15:08:47+00:00 daily 0.8 http://www.pharma-marketer.com/sepracor-ceo-in-line-for-11m-golden-handshake/ 2009-10-22T14:56:25+00:00 daily 0.8 http://www.pharma-marketer.com/ge-launches-250m-life-sciences-vc-fund/ 2009-10-22T14:41:57+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-ups-sales-forecast-as-profits-rise/ 2009-10-22T11:57:52+00:00 daily 0.8 http://www.pharma-marketer.com/schering-plough-net-income-falls-17/ 2009-10-22T11:57:50+00:00 daily 0.8 http://www.pharma-marketer.com/red-flags-in-biotech/ 2009-10-22T11:32:21+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-reports-higher-third-quarter-profit/ 2009-10-22T01:09:45+00:00 daily 0.8 http://www.pharma-marketer.com/merck-3q-earnings-report-comes-as-it-works-to-close-its-41-billion-buyout-of-schering-plough/ 2009-10-22T01:09:44+00:00 daily 0.8 http://www.pharma-marketer.com/fda-requests-additional-studies-for-amgen-drug/ 2009-10-22T01:09:41+00:00 daily 0.8 http://www.pharma-marketer.com/what-will-happen-when-viagra-goes-generic/ 2009-10-22T01:09:38+00:00 daily 0.8 http://www.pharma-marketer.com/king-pharmaceuticals-gets-fda-request-on-stress-imaging-agent-potentially-delaying-approval/ 2009-10-21T21:18:18+00:00 daily 0.8 http://www.pharma-marketer.com/nice-stiff-arms-glaxos-tyverb-again/ 2009-10-21T21:18:15+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-preview-amgen/ 2009-10-21T21:18:13+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-preview-celgene/ 2009-10-21T21:18:10+00:00 daily 0.8 http://www.pharma-marketer.com/back-to-school/ 2009-10-21T20:07:35+00:00 daily 0.8 http://www.pharma-marketer.com/never-mind-the-delay-amgen-puts-dmab-on-its-website/ 2009-10-21T18:16:22+00:00 daily 0.8 http://www.pharma-marketer.com/amylin-loss-narrows/ 2009-10-21T18:16:19+00:00 daily 0.8 http://www.pharma-marketer.com/dtc-marketing-at-the-crossroads-free-webinar-october-29th/ 2009-10-21T16:53:24+00:00 daily 0.8 http://www.pharma-marketer.com/digital-pharma-conference-we-should-we-need-to/ 2009-10-21T16:51:08+00:00 daily 0.8 http://www.pharma-marketer.com/american-college-of-physicians-no-clinical-difference-in-ed-drugs-it-comes-down-to-patients-choice-and-cost/ 2009-10-21T16:46:15+00:00 daily 0.8 http://www.pharma-marketer.com/brick-by-brick-we-can-tear-down-the-wall-to-new-opportunities/ 2009-10-21T16:30:04+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-people/ 2009-10-21T15:24:26+00:00 daily 0.8 http://www.pharma-marketer.com/fda-declines-to-approve-kings-imaging-agent/ 2009-10-21T15:24:05+00:00 daily 0.8 http://www.pharma-marketer.com/az-bms-report-mixed-diabetes-drug-data/ 2009-10-21T15:19:33+00:00 daily 0.8 http://www.pharma-marketer.com/antigenics-shares-plunge-on-oncophage-rejection/ 2009-10-21T14:55:45+00:00 daily 0.8 http://www.pharma-marketer.com/start-up-adds-genentechs-levinson-to-the-board/ 2009-10-21T14:40:40+00:00 daily 0.8 http://www.pharma-marketer.com/elan-pins-hopes-on-multiple-sclerosis-drug/ 2009-10-21T14:29:13+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-swings-to-profit-on-solid-sales-year-ago-charges/ 2009-10-21T14:29:06+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-expands-in-diabetes-with-rights-to-novel-drug/ 2009-10-21T14:29:04+00:00 daily 0.8 http://www.pharma-marketer.com/take-your-position-amgen/ 2009-10-21T14:29:01+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharma-immune-to-obama-overhaul/ 2009-10-21T14:28:59+00:00 daily 0.8 http://www.pharma-marketer.com/will-novartis-be-found-guilty-of-denying-zometa-risks/ 2009-10-21T14:28:56+00:00 daily 0.8 http://www.pharma-marketer.com/europe-rejects-antigenics-cancer-vaccine/ 2009-10-21T14:28:53+00:00 daily 0.8 http://www.pharma-marketer.com/simcere-to-develop-osi-pharmaceutical-cancer-drug-in-china/ 2009-10-21T14:28:50+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-posts-lower-profit-cuts-view/ 2009-10-21T14:28:48+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-fired-manager-over-adverse-events/ 2009-10-21T14:28:43+00:00 daily 0.8 http://www.pharma-marketer.com/glycomimetics-lands-38m-round-to-fund-new-trials/ 2009-10-21T14:23:24+00:00 daily 0.8 http://www.pharma-marketer.com/fdas-strategic-plan-for-risk-communication-part-1/ 2009-10-21T13:25:49+00:00 daily 0.8 http://www.pharma-marketer.com/o-brave-new-world-that-has-such-companies-int/ 2009-10-21T12:16:48+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-snags-diabetes-drug-in-350m-licensing-pact/ 2009-10-21T12:11:48+00:00 daily 0.8 http://www.pharma-marketer.com/snowy-skyland-resort/ 2009-10-21T10:46:33+00:00 daily 0.8 http://www.pharma-marketer.com/gilead-q3-profit-higher-on-strong-flu-drug-royalties/ 2009-10-20T23:03:27+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-fills-its-pipe/ 2009-10-20T23:03:25+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-preview-lilly/ 2009-10-20T20:00:26+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-will-shut-down-fort-dodge-animal-healtha%c2%a2aea%e2%84%a2s-overland-park-operations/ 2009-10-20T20:00:23+00:00 daily 0.8 http://www.pharma-marketer.com/how-many-jobs-has-pfizer-cut-this-year/ 2009-10-20T16:21:15+00:00 daily 0.8 http://www.pharma-marketer.com/morphosys-daiichi-sankyo-enter-alliance-to-develop-antibodies/ 2009-10-20T16:21:07+00:00 daily 0.8 http://www.pharma-marketer.com/merck-in-a-post-blockbuster-world/ 2009-10-20T16:20:59+00:00 daily 0.8 http://www.pharma-marketer.com/forest-labs-profit-skids-24-pct-after-purchase-of-lung-drug-and-settling-lexapro-proceedings/ 2009-10-20T16:20:52+00:00 daily 0.8 http://www.pharma-marketer.com/vaxgen-full-results-show-aids-vaccine-is-of-modest-help/ 2009-10-20T16:20:42+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-reports-higher-profit/ 2009-10-20T16:20:32+00:00 daily 0.8 http://www.pharma-marketer.com/peregrine-continuing-to-accumulate-on-any-dips/ 2009-10-20T16:20:26+00:00 daily 0.8 http://www.pharma-marketer.com/amgens-denosumab-delay-not-a-deal-breaker-cancer-remains-the-big-question/ 2009-10-20T16:20:19+00:00 daily 0.8 http://www.pharma-marketer.com/video-sell-pfizer-against-the-grain/ 2009-10-20T16:20:14+00:00 daily 0.8 http://www.pharma-marketer.com/planning-to-complete-a-deal-soon/ 2009-10-20T16:15:22+00:00 daily 0.8 http://www.pharma-marketer.com/vcs-pick-up-deal-making-pace-in-solid-quarter/ 2009-10-20T15:46:05+00:00 daily 0.8 http://www.pharma-marketer.com/nyc-funds-seed-biotech-projects-with-5m-in-cash/ 2009-10-20T15:03:45+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-rd-czars-big-on-collaboration-quiet-on-cuts/ 2009-10-20T14:47:01+00:00 daily 0.8 http://www.pharma-marketer.com/promising-lupus-data-fuels-fresh-rise-in-hgs-shares/ 2009-10-20T13:21:17+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-earnings-rise-as-sales-fall-3/ 2009-10-20T13:19:55+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-glaxosmithkline-renal-cancer-drug/ 2009-10-20T13:19:53+00:00 daily 0.8 http://www.pharma-marketer.com/medco-plans-to-compare-plavix-effient-in-study/ 2009-10-20T13:19:47+00:00 daily 0.8 http://www.pharma-marketer.com/congresswoman-deny-pfizer-any-federal-funding/ 2009-10-20T13:19:46+00:00 daily 0.8 http://www.pharma-marketer.com/human-genome-glaxo-progress-with-lupus-treatment/ 2009-10-20T13:19:44+00:00 daily 0.8 http://www.pharma-marketer.com/new-biotech-launched-with-24m-piii-drug/ 2009-10-20T12:59:19+00:00 daily 0.8 http://www.pharma-marketer.com/rd-deals-drive-a-spike-in-ma-activity/ 2009-10-20T12:37:53+00:00 daily 0.8 http://www.pharma-marketer.com/what-pfizer-will-look-like-in-a-year/ 2009-10-20T11:52:12+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithklines-seasonal-flu-vaccine-fluarix-approved-for-children/ 2009-10-20T02:49:00+00:00 daily 0.8 http://www.pharma-marketer.com/what-will-pfizera%c2%a2aea%e2%84%a2s-rd-look-like-a-year-from-now/ 2009-10-20T02:48:57+00:00 daily 0.8 http://www.pharma-marketer.com/new-pfizer-animal-health-is-unveiled-with-acquisition-of-wyeth/ 2009-10-19T23:44:37+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-faces-merck-in-vaccine-price-war/ 2009-10-19T23:44:35+00:00 daily 0.8 http://www.pharma-marketer.com/endo-to-respond-to-fda-questions-on-fortesta-by-mid-2010/ 2009-10-19T23:44:33+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-preview-pfizer/ 2009-10-19T23:44:31+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-still-waiting-for-its-blockbuster/ 2009-10-19T23:44:29+00:00 daily 0.8 http://www.pharma-marketer.com/baxter-eyes-swine-flu-market/ 2009-10-19T23:44:27+00:00 daily 0.8 http://www.pharma-marketer.com/merck-starts-revealing-payments-to-doctor-speakers/ 2009-10-19T23:44:24+00:00 daily 0.8 http://www.pharma-marketer.com/genentech-brand-to-replace-roche-in-u-s/ 2009-10-19T23:44:23+00:00 daily 0.8 http://www.pharma-marketer.com/why-estimates-of-future-revenues-for-obesity-drugs-are-likely-off-the-mark/ 2009-10-19T23:44:21+00:00 daily 0.8 http://www.pharma-marketer.com/dtc-marketing-at-the-crossroads-webinar-october-29th/ 2009-10-19T21:24:19+00:00 daily 0.8 http://www.pharma-marketer.com/are-you-ready-for-the-future-of-dtc-marketing/ 2009-10-19T17:51:10+00:00 daily 0.8 http://www.pharma-marketer.com/new-tougher-fda-protecting-consumers-or-hurting-them/ 2009-10-19T17:45:05+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-mobilizing-for-push-into-itp-market/ 2009-10-19T17:41:22+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-marks-shift-to-more-diverse-operation/ 2009-10-19T17:28:56+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-fda-wants-more-data-on-bronchodilator/ 2009-10-19T17:28:51+00:00 daily 0.8 http://www.pharma-marketer.com/health-care-stocks-selling-for-a-fraction-of-their-worth/ 2009-10-19T17:28:48+00:00 daily 0.8 http://www.pharma-marketer.com/genentech-and-biogen-idec-receive-a-complete-response-from-fda-for-earlier-use-of-rituxan-for-rheumatoid-arthritis/ 2009-10-19T17:28:46+00:00 daily 0.8 http://www.pharma-marketer.com/oncothyreon-and-oncogenex-room-to-rise/ 2009-10-19T17:28:37+00:00 daily 0.8 http://www.pharma-marketer.com/talecris-says-fda-approved-prolastin-c-a-new-version-of-an-iv-drug-for-protein-deficiency/ 2009-10-19T17:28:35+00:00 daily 0.8 http://www.pharma-marketer.com/forest-labs-cypress-say-savella-helped-symptoms-of-fibromyalgia-in-late-stage-trial/ 2009-10-19T17:28:32+00:00 daily 0.8 http://www.pharma-marketer.com/human-genome-sciences-gets-milestone-payment-for-development-of-hepatitis-c-drug-zalbin/ 2009-10-19T17:28:29+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-pays-record-1-3-billion-penalty-for-drug-misbranding/ 2009-10-19T17:28:23+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-offers-buyouts-to-its-entire-sales-force/ 2009-10-19T17:28:21+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-says-fda-wants-more-data-on-prolia-as-a-bone-loss-treatment-delaying-potential-approval/ 2009-10-19T17:28:16+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-glaxos-cervical-cancer-vaccine/ 2009-10-19T17:28:14+00:00 daily 0.8 http://www.pharma-marketer.com/its-hard-to-have-vision-when-the-rest-of-the-world-wears-bifocals/ 2009-10-19T17:12:24+00:00 daily 0.8 http://www.pharma-marketer.com/delay-undercuts-h1n1-vaccine-campaign/ 2009-10-19T15:59:25+00:00 daily 0.8 http://www.pharma-marketer.com/5-star-stocks-poised-to-pop-novartis/ 2009-10-19T15:59:19+00:00 daily 0.8 http://www.pharma-marketer.com/facet-biotechs-board-of-directors-recommends-stockholders-continue-to-reject-biogen-idecs-tender-offer/ 2009-10-19T15:59:14+00:00 daily 0.8 http://www.pharma-marketer.com/wyeth-quits-on-relistor-surprise-victory-in-first-rems-test-market/ 2009-10-19T15:59:11+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-split-amgen-falls-on-fda-delay/ 2009-10-19T15:59:05+00:00 daily 0.8 http://www.pharma-marketer.com/flexion-garners-33m-in-series-a/ 2009-10-19T14:44:44+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-hit-with-fda-delay-on-blockbuster-copd-drug/ 2009-10-19T14:34:04+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-shares-sink-as-fda-delays-d-mab-approval/ 2009-10-19T14:10:50+00:00 daily 0.8 http://www.pharma-marketer.com/google-wave-an-update-after-nearly-a-week-of-use/ 2009-10-19T13:28:07+00:00 daily 0.8 http://www.pharma-marketer.com/short-topics-from-all-over/ 2009-10-19T12:56:18+00:00 daily 0.8 http://www.pharma-marketer.com/hgs-claims-75m-payday-as-hep-c-drug-heads-to-fda/ 2009-10-19T12:39:48+00:00 daily 0.8 http://www.pharma-marketer.com/three-biotechs-race-for-holy-grail-of-drug-development/ 2009-10-19T12:11:40+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-finally-wins-fda-approval-for-cervarix/ 2009-10-19T11:32:15+00:00 daily 0.8 http://www.pharma-marketer.com/digital-pharma-2009/ 2009-10-18T18:38:25+00:00 daily 0.8 http://www.pharma-marketer.com/forest-laboratories-and-cypress-bioscience-announce-study-shows-patients-treated-with-savella-experience-improvements-in/ 2009-10-18T18:28:28+00:00 daily 0.8 http://www.pharma-marketer.com/cp-690550-pfizers-oral-jak-inhibitor-demonstrates-response-both-alone-and-in-combination-with-methotrexate-at-24-wee/ 2009-10-18T18:28:25+00:00 daily 0.8 http://www.pharma-marketer.com/phase-iii-study-showed-two-years-of-actemraa%e2%80%9aa%c2%ae-tocilizumab-inhibited-progression-of-joint-damage-and-improved-disease-r/ 2009-10-18T18:28:23+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-pays-cvs-caremark-to-try-to-get-doctors-to-prescribe-cymbalta/ 2009-10-18T18:28:21+00:00 daily 0.8 http://www.pharma-marketer.com/i-will-present-survey-results-at-november-fda-hearing/ 2009-10-18T13:01:01+00:00 daily 0.8 http://www.pharma-marketer.com/large-cap-biotech-earnings-preview/ 2009-10-17T19:39:26+00:00 daily 0.8 http://www.pharma-marketer.com/talecris-biotherapeutics-announces-pricing-of-600-million-senior-notes-due-2016/ 2009-10-17T19:39:25+00:00 daily 0.8 http://www.pharma-marketer.com/peregrine-pharmaceuticals-announces-implementation-of-15-reverse-stock-split-to-take-effect-october-19-2009/ 2009-10-17T19:39:22+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-extends-hostile-takeover-offer-by-3-months/ 2009-10-17T19:39:20+00:00 daily 0.8 http://www.pharma-marketer.com/the-young-beautiful-forever-trade/ 2009-10-17T19:39:16+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-pharmaceuticals-corporation-prevails-in-medicaid-pricing-case-before-alabama-supreme-court/ 2009-10-17T19:39:08+00:00 daily 0.8 http://www.pharma-marketer.com/boys-use-of-gardasil-is-approved/ 2009-10-17T19:39:05+00:00 daily 0.8 http://www.pharma-marketer.com/new-england-journal-of-medicine-article-biogenerics-legislation-should-grant-5-years-exclusivity/ 2009-10-17T19:39:01+00:00 daily 0.8 http://www.pharma-marketer.com/targacept-drug-for-depression-lauded/ 2009-10-17T19:38:58+00:00 daily 0.8 http://www.pharma-marketer.com/videopfizer-ceo-on-merger-with-wyeth/ 2009-10-16T19:55:19+00:00 daily 0.8 http://www.pharma-marketer.com/why-the-health-care-bill-could-be-good-for-chantix/ 2009-10-16T19:55:15+00:00 daily 0.8 http://www.pharma-marketer.com/sanofis-pediatric-flu-vaccine-effective/ 2009-10-16T19:55:12+00:00 daily 0.8 http://www.pharma-marketer.com/cancer-therapeutics-ups-stake-in-nanotherapies/ 2009-10-16T16:01:50+00:00 daily 0.8 http://www.pharma-marketer.com/biotechs-back-from-the-dead/ 2009-10-16T15:42:33+00:00 daily 0.8 http://www.pharma-marketer.com/october-fda-calendar-stocks-tricks-or-treats/ 2009-10-16T15:42:22+00:00 daily 0.8 http://www.pharma-marketer.com/immunomedics-ignored-hgs-adored-as-annual-rheumatology-confab-kicks-off/ 2009-10-16T15:42:08+00:00 daily 0.8 http://www.pharma-marketer.com/savient-shares-rise-on-amgen-takeover-talk/ 2009-10-16T15:22:45+00:00 daily 0.8 http://www.pharma-marketer.com/new-bill-boosts-federal-funding-for-biotech/ 2009-10-16T14:27:39+00:00 daily 0.8 http://www.pharma-marketer.com/day-one-at-pfizer-2/ 2009-10-16T14:18:55+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-10-16-09/ 2009-10-16T13:48:24+00:00 daily 0.8 http://www.pharma-marketer.com/zombie-biotechs-become-life-of-the-wall-street-party/ 2009-10-16T13:22:52+00:00 daily 0.8 http://www.pharma-marketer.com/cytos-plummets-on-phase-ii-vax-failure/ 2009-10-16T13:19:44+00:00 daily 0.8 http://www.pharma-marketer.com/engineering-receptors-not-quite-there-yet-not-exactly/ 2009-10-16T13:17:52+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-merck-expected-to-feel-effects-of-generic-competition/ 2009-10-16T12:37:30+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-cuts-25-of-mood-stabilizer-abilifya%c2%a2aea%e2%84%a2s-sales-team/ 2009-10-16T12:37:27+00:00 daily 0.8 http://www.pharma-marketer.com/glaxoa%c2%a2aea%e2%84%a2s-cervarix-wins-japan-approval-before-gardasil/ 2009-10-16T12:37:25+00:00 daily 0.8 http://www.pharma-marketer.com/labor-dept-sales-reps-should-be-paid-overtime/ 2009-10-16T12:37:23+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-astrazeneca-cholesterol-drug-for-kids/ 2009-10-16T12:37:21+00:00 daily 0.8 http://www.pharma-marketer.com/cubist-3q-profit-rises-but-weighed-down-by-taxes/ 2009-10-16T12:37:18+00:00 daily 0.8 http://www.pharma-marketer.com/generics-firms-balk-at-460m-in-reform-fees/ 2009-10-16T12:37:14+00:00 daily 0.8 http://www.pharma-marketer.com/jury-14-7m-verdict-against-astrazeneca/ 2009-10-16T04:38:10+00:00 daily 0.8 http://www.pharma-marketer.com/moodys-downgrades-pfizer-on-wyeth-acquisition/ 2009-10-16T00:50:09+00:00 daily 0.8 http://www.pharma-marketer.com/an-ode-to-wyeth/ 2009-10-16T00:50:07+00:00 daily 0.8 http://www.pharma-marketer.com/trimeris-sales-of-aids-drug-fuzeon-drop-35/ 2009-10-16T00:50:05+00:00 daily 0.8 http://www.pharma-marketer.com/does-roches-q3-flout-diversification-theory/ 2009-10-16T00:50:04+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-may-cut-3-billion-in-research-with-wyeth-deal/ 2009-10-15T20:26:32+00:00 daily 0.8 http://www.pharma-marketer.com/budgeted-to-fail-good-is-the-enemy-of-great/ 2009-10-15T20:01:18+00:00 daily 0.8 http://www.pharma-marketer.com/why-is-dtc-marketing-so-slow-to-change/ 2009-10-15T19:59:21+00:00 daily 0.8 http://www.pharma-marketer.com/a-product-made-for-a-social-media-launch/ 2009-10-15T19:57:39+00:00 daily 0.8 http://www.pharma-marketer.com/pfizerwyeth-merger-could-eliminate-3b-rd-jobs/ 2009-10-15T18:48:28+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-is-a-winnervideo/ 2009-10-15T16:38:06+00:00 daily 0.8 http://www.pharma-marketer.com/on-the-radar-keep-an-eye-on-these-biotech-stocks/ 2009-10-15T16:38:02+00:00 daily 0.8 http://www.pharma-marketer.com/mylan-gets-fda-approval-for-generic-topamax/ 2009-10-15T16:37:59+00:00 daily 0.8 http://www.pharma-marketer.com/allos-closes-offering/ 2009-10-15T16:37:56+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-gain-baxter-slides-on-earnings-report/ 2009-10-15T16:37:53+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-sales-managers-gripe-about-lousy-training/ 2009-10-15T16:37:49+00:00 daily 0.8 http://www.pharma-marketer.com/biomed-news-bytes-intelgenx-pressure-biosciences/ 2009-10-15T16:37:45+00:00 daily 0.8 http://www.pharma-marketer.com/dainippon-and-sepracor-deal-emerges/ 2009-10-15T16:37:42+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-wyeth-deal-wraps-up-layoffs-to-follow/ 2009-10-15T16:37:38+00:00 daily 0.8 http://www.pharma-marketer.com/harvard-experts-champion-5-year-window-on-generic-protection/ 2009-10-15T15:07:47+00:00 daily 0.8 http://www.pharma-marketer.com/protalix-boosted-by-late-stage-gaucher-success/ 2009-10-15T14:49:57+00:00 daily 0.8 http://www.pharma-marketer.com/is-amgen-facing-a-significant-delay-on-denosumab/ 2009-10-15T14:35:23+00:00 daily 0.8 http://www.pharma-marketer.com/oxigene-swaps-shares-for-vaxgen-and-33m-in-cash/ 2009-10-15T14:17:24+00:00 daily 0.8 http://www.pharma-marketer.com/day-1-of-google-wave-a-blank-canvas/ 2009-10-15T13:33:47+00:00 daily 0.8 http://www.pharma-marketer.com/tamiflu-gives-roche-a-shot-in-the-arm/ 2009-10-15T13:31:58+00:00 daily 0.8 http://www.pharma-marketer.com/protalix-says-gaucher-drug-met-goals-in-trial/ 2009-10-15T13:31:57+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-in-tune-with-lillys-chorus-on-cheap-to-poc-idea-drug-development/ 2009-10-15T13:31:55+00:00 daily 0.8 http://www.pharma-marketer.com/no-schering-plough-ice-cream-for-you-ma-vt-mn-doctors/ 2009-10-15T12:42:19+00:00 daily 0.8 http://www.pharma-marketer.com/fall-from-grace/ 2009-10-15T12:14:19+00:00 daily 0.8 http://www.pharma-marketer.com/oxford-biomedica-soars-on-parkinsons-trial-success/ 2009-10-15T11:57:50+00:00 daily 0.8 http://www.pharma-marketer.com/oxford-biomedica-surges-on-parkinsons-trial-success/ 2009-10-15T11:57:50+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-backs-acorda-ms-drug-in-lopsided-vote/ 2009-10-15T11:34:06+00:00 daily 0.8 http://www.pharma-marketer.com/acorda-shares-soar-after-fda-panel-backs-ms-drug/ 2009-10-15T11:34:06+00:00 daily 0.8 http://www.pharma-marketer.com/little-turnaround-for-big-pharma/ 2009-10-15T02:09:33+00:00 daily 0.8 http://www.pharma-marketer.com/medtronics-passion-play-medical-device-maker-to-test-stent-as-alternative-to-viagra/ 2009-10-15T02:09:31+00:00 daily 0.8 http://www.pharma-marketer.com/analyst-says-bristol-myers-may-split-off-mead-johnson-shares-leading-to-gains-for-mead-stock/ 2009-10-15T02:09:29+00:00 daily 0.8 http://www.pharma-marketer.com/homes-of-bms-abbott-novartis-execs-targeted-in-late-night-protests-by-animal-rights-activists/ 2009-10-15T02:09:27+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-votes-yes-on-acorda-drug-efficacy/ 2009-10-15T02:09:25+00:00 daily 0.8 http://www.pharma-marketer.com/insulin-drugs-could-lose-6-1b-to-biosimilars/ 2009-10-15T02:09:23+00:00 daily 0.8 http://www.pharma-marketer.com/indian-drugmakersa%c2%a2aea%e2%84%a2-estimates-raised-at-goldman-sachs/ 2009-10-14T18:37:15+00:00 daily 0.8 http://www.pharma-marketer.com/senate-has-a%c2%a2aea%cb%9cmiles-to-goa%c2%a2aea%e2%84%a2-on-health-care-after-committee-vote/ 2009-10-14T18:37:13+00:00 daily 0.8 http://www.pharma-marketer.com/phytopharm-shares-soar-on-parkinsons-drug-promise/ 2009-10-14T18:37:10+00:00 daily 0.8 http://www.pharma-marketer.com/5-star-stocks-poised-to-pop-kv-pharmaceutical/ 2009-10-14T18:36:53+00:00 daily 0.8 http://www.pharma-marketer.com/ziopharm-oncology-says-cancer-drug-promising/ 2009-10-14T18:36:50+00:00 daily 0.8 http://www.pharma-marketer.com/senator-probes-medicare-shift-to-lucentis/ 2009-10-14T18:36:48+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-wins-u-s-antitrust-approval-to-buy-wyeth/ 2009-10-14T18:36:45+00:00 daily 0.8 http://www.pharma-marketer.com/merck-doubles-down-on-galapagos-discovery-deal/ 2009-10-14T15:45:37+00:00 daily 0.8 http://www.pharma-marketer.com/start-up-biotech-with-nobel-founder-8m-lands-in-florida/ 2009-10-14T15:31:45+00:00 daily 0.8 http://www.pharma-marketer.com/avexa-woos-investors-with-late-stage-prospects/ 2009-10-14T15:12:03+00:00 daily 0.8 http://www.pharma-marketer.com/wyeth-to-hand-over-relistor-10m-to-progenics/ 2009-10-14T15:09:03+00:00 daily 0.8 http://www.pharma-marketer.com/acorda-trading-halted-as-panel-reviews-ms-drug/ 2009-10-14T15:06:39+00:00 daily 0.8 http://www.pharma-marketer.com/busy-busy-us-attorneys/ 2009-10-14T14:49:52+00:00 daily 0.8 http://www.pharma-marketer.com/ziopharm-soars-on-promising-cancer-data/ 2009-10-14T14:48:28+00:00 daily 0.8 http://www.pharma-marketer.com/boehringers-branded-tweet-violates-fda-regulations-just-like-those-14-paid-search-ads-did/ 2009-10-14T14:32:26+00:00 daily 0.8 http://www.pharma-marketer.com/thestreet-venture-firm-hunts-for-biotech-breakthroughs/ 2009-10-14T14:10:33+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-ordered-to-pay-2-5-million-for-paxil-defects/ 2009-10-14T14:10:29+00:00 daily 0.8 http://www.pharma-marketer.com/corcept-therapeutics-pump-up-the-volume/ 2009-10-14T14:10:27+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-reports-37-spike-in-third-quarter-earnings/ 2009-10-14T14:10:25+00:00 daily 0.8 http://www.pharma-marketer.com/mylan-says-settlement-means-it-can-launch-generic-version-of-pfizer-drug-in-early-2011/ 2009-10-14T14:10:23+00:00 daily 0.8 http://www.pharma-marketer.com/jj-abbott-earnings-for-pharma-ita%c2%a2aea%e2%84%a2s-good-to-be-diversified/ 2009-10-14T14:10:20+00:00 daily 0.8 http://www.pharma-marketer.com/good-news-for-alkermes-pipeline/ 2009-10-14T14:10:18+00:00 daily 0.8 http://www.pharma-marketer.com/incyte-life-after-debt-part-i/ 2009-10-14T14:10:15+00:00 daily 0.8 http://www.pharma-marketer.com/progenics-regains-relistor-rights/ 2009-10-14T14:10:13+00:00 daily 0.8 http://www.pharma-marketer.com/azs-dave-brennan-personalization-partnership-business-implications/ 2009-10-14T14:10:11+00:00 daily 0.8 http://www.pharma-marketer.com/phytopharm-demonstrates-promise-of-parkinsons-drug/ 2009-10-14T11:48:37+00:00 daily 0.8 http://www.pharma-marketer.com/phytopharm-excites-analysts-with-promising-parkinsons-data/ 2009-10-14T11:48:37+00:00 daily 0.8 http://www.pharma-marketer.com/shire-and-sandoz-settle-adderall-xr-patent-suits/ 2009-10-14T02:39:04+00:00 daily 0.8 http://www.pharma-marketer.com/jj-needs-to-get-drugged-up/ 2009-10-14T02:39:00+00:00 daily 0.8 http://www.pharma-marketer.com/johnson-johnson-senate-health-plans-proposed-tax-on-medical-device-makers-could-cost-jobs/ 2009-10-14T02:38:57+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-preview-abbott-labs/ 2009-10-14T02:38:54+00:00 daily 0.8 http://www.pharma-marketer.com/lawsuit-schering-execs-sat-on-vytorin-results/ 2009-10-14T02:38:37+00:00 daily 0.8 http://www.pharma-marketer.com/a-big-upgrade-for-teva-pharmaceutical/ 2009-10-13T19:30:09+00:00 daily 0.8 http://www.pharma-marketer.com/those-zanies-at-angewandte-chemie/ 2009-10-13T17:49:46+00:00 daily 0.8 http://www.pharma-marketer.com/schwan-plans-to-scrutinize-genentech-pay/ 2009-10-13T16:09:33+00:00 daily 0.8 http://www.pharma-marketer.com/jj-reports-modestly-higher-earnings/ 2009-10-13T15:38:11+00:00 daily 0.8 http://www.pharma-marketer.com/dyax-says-sanofi-aventis-recently-licensed-eye-drug-and-cancer-drug-from-dyax-collaborators/ 2009-10-13T15:38:05+00:00 daily 0.8 http://www.pharma-marketer.com/vandas-fanapt-deal-just-okay/ 2009-10-13T15:37:59+00:00 daily 0.8 http://www.pharma-marketer.com/jj-shares-drop-on-lackluster-earnings/ 2009-10-13T15:37:54+00:00 daily 0.8 http://www.pharma-marketer.com/why-other-drugmakers-want-to-be-more-like-jj/ 2009-10-13T15:37:51+00:00 daily 0.8 http://www.pharma-marketer.com/opko-agrees-to-deal-with-schering-plough/ 2009-10-13T15:37:49+00:00 daily 0.8 http://www.pharma-marketer.com/novavax-gets-grant-for-respiratory-virus-vaccine/ 2009-10-13T15:37:46+00:00 daily 0.8 http://www.pharma-marketer.com/roche-to-give-genentech-employees-more-options/ 2009-10-13T15:37:43+00:00 daily 0.8 http://www.pharma-marketer.com/cel-scis-mystery-booster-writes-again/ 2009-10-13T15:37:40+00:00 daily 0.8 http://www.pharma-marketer.com/how-to-land-a-deal-survey/ 2009-10-13T14:40:48+00:00 daily 0.8 http://www.pharma-marketer.com/vanda-reaps-200m-upfront-in-novartis-drug-pact/ 2009-10-13T14:27:49+00:00 daily 0.8 http://www.pharma-marketer.com/the-cei-report-on-the-fda-and-internet-advertising-raising-essential-questions/ 2009-10-13T13:57:43+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-deal-spree-creates-closer-ties-with-dyax/ 2009-10-13T13:35:14+00:00 daily 0.8 http://www.pharma-marketer.com/cash-strapped-vion-ponders-its-next-or-last-move/ 2009-10-13T12:27:55+00:00 daily 0.8 http://www.pharma-marketer.com/chronic-fatigue-retroviruses-to-blame-or-not/ 2009-10-13T12:24:51+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-to-spend-up-to-eu460-million-for-prosensa-drugs/ 2009-10-13T12:11:07+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-on-twitter-j-novartis-has-most-followers-abbott-not-out-of-the-gate-yet/ 2009-10-13T12:11:05+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-forges-680m-rna-pact-with-prosensa/ 2009-10-13T12:04:00+00:00 daily 0.8 http://www.pharma-marketer.com/top-15-women-in-pharma/ 2009-10-13T11:53:49+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-to-buy-back-rights-to-drug-from-vanda/ 2009-10-13T02:30:49+00:00 daily 0.8 http://www.pharma-marketer.com/mating-season-for-drug-companies/ 2009-10-13T02:30:45+00:00 daily 0.8 http://www.pharma-marketer.com/nektar-presents-favorable-data/ 2009-10-12T23:21:53+00:00 daily 0.8 http://www.pharma-marketer.com/seasonal-vaccine-shortage-in-u-s-stoked-by-swine-flu-vigilance/ 2009-10-12T23:21:52+00:00 daily 0.8 http://www.pharma-marketer.com/lupin-sets-sights-on-birth-control-market/ 2009-10-12T23:21:50+00:00 daily 0.8 http://www.pharma-marketer.com/a-mixed-bag-for-traders-and-investors-in-healthcare/ 2009-10-12T23:21:48+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-preview-johnson-johnson/ 2009-10-12T23:21:47+00:00 daily 0.8 http://www.pharma-marketer.com/eye-on-fda-goes-kindle/ 2009-10-12T19:08:43+00:00 daily 0.8 http://www.pharma-marketer.com/merial-invests-us-70-million-in-nanchang-china/ 2009-10-12T18:04:37+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-suspends-lung-cancer-study/ 2009-10-12T18:04:33+00:00 daily 0.8 http://www.pharma-marketer.com/onyx-to-buy-proteolix-for-276-million-gaining-a-cancer-drug/ 2009-10-12T18:04:29+00:00 daily 0.8 http://www.pharma-marketer.com/health-workers-sue-to-void-fda-approval-of-swine-flu-vaccine/ 2009-10-12T18:04:27+00:00 daily 0.8 http://www.pharma-marketer.com/johnson-johnson-makes-4-deals-awaits-new-product-approvals-amid-slumping-sales/ 2009-10-12T18:04:24+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-silence-on-post-wyeth-merger-job-cuts-site-closures-has-everyone-on-edge/ 2009-10-12T18:04:19+00:00 daily 0.8 http://www.pharma-marketer.com/santarus-licenses-gi-disorder-drug-to-norgine/ 2009-10-12T18:04:15+00:00 daily 0.8 http://www.pharma-marketer.com/depomed-trial-disappoints-shares-plunge/ 2009-10-12T18:04:11+00:00 daily 0.8 http://www.pharma-marketer.com/why-im-taking-a-foothold-in-generex-now/ 2009-10-12T18:04:06+00:00 daily 0.8 http://www.pharma-marketer.com/econo-gloom-bypasses-pharma-earnings/ 2009-10-12T18:03:49+00:00 daily 0.8 http://www.pharma-marketer.com/becton-receives-fda-approval/ 2009-10-12T18:03:47+00:00 daily 0.8 http://www.pharma-marketer.com/earnings-preview-abbott-laboratories/ 2009-10-12T18:03:41+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-edge-higher-depomed-sinks-on-drug-data/ 2009-10-12T18:03:39+00:00 daily 0.8 http://www.pharma-marketer.com/stock-pickers-call-gilead-teva-investor-friendly/ 2009-10-12T18:03:36+00:00 daily 0.8 http://www.pharma-marketer.com/bdsi-insider-selling-was-a-blessing-for-investors/ 2009-10-12T18:03:32+00:00 daily 0.8 http://www.pharma-marketer.com/unless-youre-measuring-engagement-paid-search-is-a-waste-of-money/ 2009-10-12T17:58:16+00:00 daily 0.8 http://www.pharma-marketer.com/social-media-conversations-do-not-need-to-be-regulated/ 2009-10-12T17:53:50+00:00 daily 0.8 http://www.pharma-marketer.com/working-with-regulatory-and-legal-people/ 2009-10-12T17:49:13+00:00 daily 0.8 http://www.pharma-marketer.com/cubes-punishment-a-career-in-pharma/ 2009-10-12T17:47:41+00:00 daily 0.8 http://www.pharma-marketer.com/viagra-isnt-time-campaign-misses-the-target/ 2009-10-12T17:31:14+00:00 daily 0.8 http://www.pharma-marketer.com/viagras-new-camapaign-misses-the-mark-as-pfizer-shops-for-a-new-agency/ 2009-10-12T17:31:14+00:00 daily 0.8 http://www.pharma-marketer.com/stage-set-for-acorda-bounce/ 2009-10-12T16:37:47+00:00 daily 0.8 http://www.pharma-marketer.com/analyst-sees-new-life-in-life-sciences-sector/ 2009-10-12T16:37:30+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-finds-its-voice-on-twitter/ 2009-10-12T15:56:37+00:00 daily 0.8 http://www.pharma-marketer.com/raptor-shares-rocket-up-on-positive-liver-drug-data/ 2009-10-12T15:23:36+00:00 daily 0.8 http://www.pharma-marketer.com/day-off/ 2009-10-12T15:01:23+00:00 daily 0.8 http://www.pharma-marketer.com/upcoming-speaking-gig/ 2009-10-12T14:52:01+00:00 daily 0.8 http://www.pharma-marketer.com/depomed-shares-tank-on-disappointing-hot-flash-data/ 2009-10-12T13:49:34+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-halts-enrollment-in-phase-iii-cancer-study/ 2009-10-12T12:21:45+00:00 daily 0.8 http://www.pharma-marketer.com/sinclair-finds-new-ceo-to-lead-hunt-for-acquisitions/ 2009-10-12T12:00:58+00:00 daily 0.8 http://www.pharma-marketer.com/hot-heptares-inks-200m-tech-pact-with-novartis/ 2009-10-12T11:52:01+00:00 daily 0.8 http://www.pharma-marketer.com/onyx-strikes-851m-deal-to-buy-proteolix/ 2009-10-12T11:28:57+00:00 daily 0.8 http://www.pharma-marketer.com/httpfinance-yahoo-comnewsglaxo-expands-presence-in-zacks-3489011026-htmlx0-v1/ 2009-10-11T19:25:22+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-selzentry-poised-to-be-most-expensive-first-line-aids-drug/ 2009-10-11T19:25:06+00:00 daily 0.8 http://www.pharma-marketer.com/lupin-eyes-200-mn-opportunity-in-us-mkt/ 2009-10-11T19:25:03+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-vaccine-proves-beneficial/ 2009-10-10T20:18:02+00:00 daily 0.8 http://www.pharma-marketer.com/httpfinance-yahoo-comnewssanofi-vaccine-proves-zacks-2097164668-htmlx0-v1/ 2009-10-10T20:18:00+00:00 daily 0.8 http://www.pharma-marketer.com/locus-novartis-to-collaborate/ 2009-10-10T20:17:57+00:00 daily 0.8 http://www.pharma-marketer.com/analyst-trims-bristol-myers-squibb-to-neutral/ 2009-10-10T20:17:55+00:00 daily 0.8 http://www.pharma-marketer.com/jj-wheels-and-deals-awaits-new-product-approvals/ 2009-10-10T20:17:52+00:00 daily 0.8 http://www.pharma-marketer.com/macuclear-and-mystic-successfully-complete-phase-ib-clinical-trial-for-macular-degeneration/ 2009-10-10T20:17:49+00:00 daily 0.8 http://www.pharma-marketer.com/plexxikon-treats-initial-patient-with-first-in-class-drug-in-phase-1-trial/ 2009-10-10T20:17:46+00:00 daily 0.8 http://www.pharma-marketer.com/facet-investors-urged-to-deny-offer/ 2009-10-10T20:17:42+00:00 daily 0.8 http://www.pharma-marketer.com/hemispherx-ceo-carter-speaks-biobuzz/ 2009-10-10T20:17:41+00:00 daily 0.8 http://www.pharma-marketer.com/adventrx-pharmaceuticals-announces-closing-of-financing/ 2009-10-10T20:17:38+00:00 daily 0.8 http://www.pharma-marketer.com/dendreon-to-seek-fda-approval/ 2009-10-10T20:17:35+00:00 daily 0.8 http://www.pharma-marketer.com/avanir-acorda-move-on-ms-drug-updates/ 2009-10-10T20:17:32+00:00 daily 0.8 http://www.pharma-marketer.com/savient-pharma-recovers-after-analyst-upgrade/ 2009-10-10T20:17:25+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-expands-presence-in-china/ 2009-10-10T20:17:19+00:00 daily 0.8 http://www.pharma-marketer.com/ims-sees-brighter-outlook-for-global-drug-sales/ 2009-10-10T16:14:38+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-flu-vaccines-showed-robust-response/ 2009-10-10T16:14:35+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-settles-suit-with-south-carolina-over-zyprexa/ 2009-10-10T16:14:33+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-buys-global-rights-to-mrsa-antibiotic/ 2009-10-10T16:14:30+00:00 daily 0.8 http://www.pharma-marketer.com/the-inside-scoop-on-roches-integration-of-genentech/ 2009-10-10T16:14:29+00:00 daily 0.8 http://www.pharma-marketer.com/repros-therapeutics-stock-more-than-doubles-on-positive-study-results-for-androxal/ 2009-10-10T16:14:27+00:00 daily 0.8 http://www.pharma-marketer.com/advaxis-live-listeria-vaccine-induces-epitope-spreading/ 2009-10-10T16:14:25+00:00 daily 0.8 http://www.pharma-marketer.com/lpaths-isonep-is-well-tolerated-at-all-dose-levels-in-a-phase-1-trial-in-wet-amd-patients/ 2009-10-10T16:14:23+00:00 daily 0.8 http://www.pharma-marketer.com/targacept-announces-common-stock-offering/ 2009-10-10T16:14:22+00:00 daily 0.8 http://www.pharma-marketer.com/ims-health-ups-pharma-sales-view/ 2009-10-10T16:14:20+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-gets-rights-to-broad-spectrum-antibiotic/ 2009-10-10T16:14:18+00:00 daily 0.8 http://www.pharma-marketer.com/biostar-pharmaceuticals-inc-receives-the-chinese-military-drug-administration-clearance-to-begin-clinical-trial-for-zu/ 2009-10-10T16:14:16+00:00 daily 0.8 http://www.pharma-marketer.com/dr-reddy-lab-in-demand-as-gsk-eyes-stake/ 2009-10-10T16:14:13+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-says-doors-wide-open-to-eu-drugs-probe/ 2009-10-10T16:14:10+00:00 daily 0.8 http://www.pharma-marketer.com/centocor-ortho-biotech-schering-plough-get-european-approval-for-simponi/ 2009-10-10T16:14:07+00:00 daily 0.8 http://www.pharma-marketer.com/drugmaker-mannkind-chooses-lone-wolf-strategy/ 2009-10-10T16:14:04+00:00 daily 0.8 http://www.pharma-marketer.com/lexicon-to-offer-30-million-shares/ 2009-10-10T16:14:01+00:00 daily 0.8 http://www.pharma-marketer.com/continuing-to-accumulate-peregrine-pharma-at-current-levels/ 2009-10-10T16:13:58+00:00 daily 0.8 http://www.pharma-marketer.com/repros-says-it-will-sell-3-5m-shares-to-investors/ 2009-10-10T16:13:57+00:00 daily 0.8 http://www.pharma-marketer.com/freseniuss-app-gets-a-clearance-for-migraine-drug/ 2009-10-10T16:13:55+00:00 daily 0.8 http://www.pharma-marketer.com/european-approval-for-cimzia/ 2009-10-10T16:13:53+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-fails-to-receive-approval/ 2009-10-10T16:13:51+00:00 daily 0.8 http://www.pharma-marketer.com/hybrigenics-inecalcitol-shows-promising-preclinical-results-against-hormone-dependent-prostate-cancer/ 2009-10-10T16:13:49+00:00 daily 0.8 http://www.pharma-marketer.com/jj-earnings-expected-to-be-weighed-down-by-generics/ 2009-10-10T16:13:47+00:00 daily 0.8 http://www.pharma-marketer.com/3-slow-and-steady-healthcare-stocks/ 2009-10-10T16:13:45+00:00 daily 0.8 http://www.pharma-marketer.com/5-star-stocks-poised-to-pop-novo-nordisk/ 2009-10-10T16:13:44+00:00 daily 0.8 http://www.pharma-marketer.com/medicines-co-sues-teva-and-app-pharma-over-patents-supporting-anti-clotting-drug-angiomax/ 2009-10-10T16:13:40+00:00 daily 0.8 http://www.pharma-marketer.com/acordaa%c2%a2aea%e2%84%a2s-ms-drug-may-need-more-study-u-s-fda-says/ 2009-10-10T16:13:38+00:00 daily 0.8 http://www.pharma-marketer.com/spectrum-pharmaceuticals-says-fda-doesnt-approve-fusilev-for-colon-cancer-recommends-meeting/ 2009-10-10T16:13:33+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-promoted-seroquel-as-a%c2%a2aea%cb%9cweight-neutrala%c2%a2aea%e2%84%a2/ 2009-10-10T16:13:29+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-merck-among-global-bidders-for-inova-review-reports/ 2009-10-10T16:13:27+00:00 daily 0.8 http://www.pharma-marketer.com/industry-payments-to-surgeons-revisited/ 2009-10-10T16:13:25+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-mixed-avanir-jumps-on-ms-news/ 2009-10-10T16:13:23+00:00 daily 0.8 http://www.pharma-marketer.com/the-new-biotech-paradigm-survive-and-stay-independent/ 2009-10-10T16:13:20+00:00 daily 0.8 http://www.pharma-marketer.com/inovio-biomedical-dna-vaccine-delivery-innovator/ 2009-10-10T16:13:15+00:00 daily 0.8 http://www.pharma-marketer.com/hemispherx-ceo-spills-ampligen-beans-to-stock-cheerleader/ 2009-10-10T16:13:14+00:00 daily 0.8 http://www.pharma-marketer.com/what-the-bosses-of-az-novartis-and-schering-didnt-say-in-their-healthcare-roundtable/ 2009-10-10T16:13:12+00:00 daily 0.8 http://www.pharma-marketer.com/house-moves-closer-to-combined-health-measure-with-tax-changes/ 2009-10-10T16:13:08+00:00 daily 0.8 http://www.pharma-marketer.com/are-there-special-cases-for-correcting-misinformation-on-social-media-sites/ 2009-10-10T13:37:20+00:00 daily 0.8 http://www.pharma-marketer.com/how-should-pharma-companies-submit-social-media-content-for-fda-approval/ 2009-10-09T19:59:04+00:00 daily 0.8 http://www.pharma-marketer.com/paid-search-health-understanding-the-search-of-consumers-for-health-information/ 2009-10-09T19:32:37+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-looks-to-boost-its-rd-success-rate/ 2009-10-09T15:49:39+00:00 daily 0.8 http://www.pharma-marketer.com/avanir-stock-boosted-by-promising-zenvia-data/ 2009-10-09T15:23:30+00:00 daily 0.8 http://www.pharma-marketer.com/ill-see-your-conflicts-and-raise-you/ 2009-10-09T14:42:06+00:00 daily 0.8 http://www.pharma-marketer.com/a-bitter-pill-to-swallow-the-perils-in-off-label-promotion/ 2009-10-09T14:27:13+00:00 daily 0.8 http://www.pharma-marketer.com/fda-staffers-question-acordas-ms-drug/ 2009-10-09T13:52:27+00:00 daily 0.8 http://www.pharma-marketer.com/fda-rejects-new-indication-for-spectrum-drug/ 2009-10-09T13:09:22+00:00 daily 0.8 http://www.pharma-marketer.com/my-video-on-sidewiki-strategic-considerations/ 2009-10-09T13:08:52+00:00 daily 0.8 http://www.pharma-marketer.com/quebec-to-make-123m-biopharma-investment/ 2009-10-09T12:45:56+00:00 daily 0.8 http://www.pharma-marketer.com/is-fdas-sponsored-search-advertising-policy-increasing-consumer-risk/ 2009-10-09T12:41:57+00:00 daily 0.8 http://www.pharma-marketer.com/kansas-looks-to-boost-vc-with-50m-in-funding/ 2009-10-09T11:41:21+00:00 daily 0.8 http://www.pharma-marketer.com/an-open-letter-to-the-fda/ 2009-10-09T00:17:39+00:00 daily 0.8 http://www.pharma-marketer.com/hoist-petard-etc/ 2009-10-08T18:31:09+00:00 daily 0.8 http://www.pharma-marketer.com/yet-another-health-site-appears-except-they-forgot-to-ask-consumers-whats-important-to-them/ 2009-10-08T18:23:40+00:00 daily 0.8 http://www.pharma-marketer.com/so-many-sites-too-little-time/ 2009-10-08T18:19:13+00:00 daily 0.8 http://www.pharma-marketer.com/the-overuse-of-market-research-by-pharma/ 2009-10-08T18:01:49+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-companies-should-have-public-social-media-disclosure-policies-survey-results-show/ 2009-10-08T16:41:55+00:00 daily 0.8 http://www.pharma-marketer.com/13-of-parents-will-not-allow-their-children-to-be-vaccinated-against-swine-flu/ 2009-10-08T16:30:43+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-tucks-its-tail-and-runs-from-paid-search/ 2009-10-08T16:22:55+00:00 daily 0.8 http://www.pharma-marketer.com/cocaine-addiction-vax-shows-some-promise/ 2009-10-08T15:58:56+00:00 daily 0.8 http://www.pharma-marketer.com/disgraced-biopure-exec-sentenced-for-fake-cancer-claim/ 2009-10-08T15:34:59+00:00 daily 0.8 http://www.pharma-marketer.com/omeros-prices-ipo-as-it-fends-off-ex-cfos-accusations/ 2009-10-08T13:56:20+00:00 daily 0.8 http://www.pharma-marketer.com/as-pharma-consolidates-biotech-leaders-rethink-development-model/ 2009-10-08T12:47:31+00:00 daily 0.8 http://www.pharma-marketer.com/odyssey-thera-hits-pfizer-milestones/ 2009-10-08T12:47:15+00:00 daily 0.8 http://www.pharma-marketer.com/video-hospira-shares-shoot-higher/ 2009-10-08T12:47:13+00:00 daily 0.8 http://www.pharma-marketer.com/mannkind-slides-on-news/ 2009-10-08T12:47:11+00:00 daily 0.8 http://www.pharma-marketer.com/eu-nod-for-jjschering-ploughs-drug/ 2009-10-08T12:47:09+00:00 daily 0.8 http://www.pharma-marketer.com/peregrine-pharmaceuticals-forms-anti-viral-research-group-to-oversee-its-anti-ps-infectious-disease-collaborations/ 2009-10-08T12:47:07+00:00 daily 0.8 http://www.pharma-marketer.com/aspenbio-pharma-to-sell-7-2m-in-stock/ 2009-10-08T12:47:04+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-fund-raising-spikes-as-ma-deals-crater/ 2009-10-08T12:44:59+00:00 daily 0.8 http://www.pharma-marketer.com/retire-these-reactions/ 2009-10-08T12:32:46+00:00 daily 0.8 http://www.pharma-marketer.com/paratek-forges-485m-pact-with-novartis-on-blockbuster-antibiotic/ 2009-10-08T11:53:27+00:00 daily 0.8 http://www.pharma-marketer.com/regulatory-solutions-to-overcoming-space-limitations-in-pharma-social-media-communications/ 2009-10-08T11:24:57+00:00 daily 0.8 http://www.pharma-marketer.com/amarillo-biosciences-partners-with-intas-pharmaceuticals-to-treat-influenza-in-india/ 2009-10-07T21:16:33+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-sees-bigger-role-for-its-aids-drug/ 2009-10-07T21:16:31+00:00 daily 0.8 http://www.pharma-marketer.com/schering-plough-launches-schizophrenia-bi-polar-disorder-drug-after-buying-maker/ 2009-10-07T21:16:28+00:00 daily 0.8 http://www.pharma-marketer.com/cubist-pharmaceuticals-inc-endures-analyst-downgrade-cbst-teva-nvo/ 2009-10-07T21:16:25+00:00 daily 0.8 http://www.pharma-marketer.com/will-your-company-feel-free-to-fully-participate-in-the-part-15-meeting-on-social-media/ 2009-10-07T19:17:30+00:00 daily 0.8 http://www.pharma-marketer.com/epizyme-pulls-in-32m-in-vc-capital-new-investors/ 2009-10-07T19:09:16+00:00 daily 0.8 http://www.pharma-marketer.com/threshold-raises-35m/ 2009-10-07T16:25:21+00:00 daily 0.8 http://www.pharma-marketer.com/avanir-shares-boosted-by-news-of-zenvia-patent/ 2009-10-07T16:14:04+00:00 daily 0.8 http://www.pharma-marketer.com/alnylam-president-hints-at-spinoff-new-pacts/ 2009-10-07T15:58:34+00:00 daily 0.8 http://www.pharma-marketer.com/cardiokine-taps-glaxo-vet-as-new-ceo/ 2009-10-07T15:57:35+00:00 daily 0.8 http://www.pharma-marketer.com/more-thoughts-on-the-strategic-and-regulatory-implications-of-sidewiki/ 2009-10-07T15:35:24+00:00 daily 0.8 http://www.pharma-marketer.com/repros-shares-skyrocket-on-promising-testosterone-data/ 2009-10-07T14:20:01+00:00 daily 0.8 http://www.pharma-marketer.com/mannkind-shares-plunge-on-renewed-doubts-about-afresa/ 2009-10-07T14:00:02+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-reports-heavy-demand-for-swine-flu-vaccine/ 2009-10-07T13:15:48+00:00 daily 0.8 http://www.pharma-marketer.com/fda-sees-no-safety-issues-with-pfizer-hiv-drug/ 2009-10-07T13:15:47+00:00 daily 0.8 http://www.pharma-marketer.com/no-lupus-confab-invite-for-immunomedics/ 2009-10-07T13:15:44+00:00 daily 0.8 http://www.pharma-marketer.com/access-pharma-and-imedicor-sign-e-marketing-deal-for-mugard/ 2009-10-07T13:15:42+00:00 daily 0.8 http://www.pharma-marketer.com/fda-advisers-unanimously-back-glaxosmithkline-drug-for-kidney-cancer-despite-liver-risks/ 2009-10-07T13:15:37+00:00 daily 0.8 http://www.pharma-marketer.com/mannkind-tanks-acadia-rallies/ 2009-10-07T13:15:36+00:00 daily 0.8 http://www.pharma-marketer.com/5-star-stocks-poised-to-pop-inventiv-health/ 2009-10-07T13:15:34+00:00 daily 0.8 http://www.pharma-marketer.com/what-can-we-expect-from-obamas-fda/ 2009-10-07T13:15:32+00:00 daily 0.8 http://www.pharma-marketer.com/cel-sci-boosters-identity-in-question/ 2009-10-07T13:15:31+00:00 daily 0.8 http://www.pharma-marketer.com/astra-boss-hit-with-7m-fine-for-sex-harassment-reps-share-memories-of-bonkers-ceo/ 2009-10-07T13:15:29+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-jiangsu-walvax-biotech-form-joint-venture-to-produce-vaccines-for-china/ 2009-10-07T13:15:26+00:00 daily 0.8 http://www.pharma-marketer.com/ym-biosciences-inks-deal-to-acquire-cytopia/ 2009-10-07T13:15:25+00:00 daily 0.8 http://www.pharma-marketer.com/vertex-lowers-2009-guidance/ 2009-10-07T13:15:19+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-receives-fda-complete-response-letter-for-clolar/ 2009-10-07T13:15:17+00:00 daily 0.8 http://www.pharma-marketer.com/sequenom-meets-with-feds-over-test-debacle/ 2009-10-07T13:15:16+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-and-teva-raided-in-eu-antitrust-probe/ 2009-10-07T13:15:12+00:00 daily 0.8 http://www.pharma-marketer.com/europes-top-5-biotech-hotspots/ 2009-10-07T12:54:05+00:00 daily 0.8 http://www.pharma-marketer.com/a-nobel-for-ribosome-structure/ 2009-10-07T12:36:09+00:00 daily 0.8 http://www.pharma-marketer.com/does-social-media-have-an-impact-on-public-health-fda-wants-to-know/ 2009-10-07T12:20:20+00:00 daily 0.8 http://www.pharma-marketer.com/defining-the-optimal-user-experience-for-mobile/ 2009-10-06T21:37:33+00:00 daily 0.8 http://www.pharma-marketer.com/vax-developers-merge-land-15m-venture-round/ 2009-10-06T16:26:56+00:00 daily 0.8 http://www.pharma-marketer.com/traveling-updates-later/ 2009-10-06T15:56:26+00:00 daily 0.8 http://www.pharma-marketer.com/ibm-targets-faster-cheaper-sequencing/ 2009-10-06T15:56:23+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-backs-glaxos-new-kidney-cancer-drug/ 2009-10-06T15:50:29+00:00 daily 0.8 http://www.pharma-marketer.com/surmodics-shares-surge-on-200m-roche-pact/ 2009-10-06T14:17:29+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-narrowly-backs-schering-ploughs-pegintron-as-a-skin-cancer-medication/ 2009-10-06T13:44:02+00:00 daily 0.8 http://www.pharma-marketer.com/seattle-genetics-amicus-plunge-avi-depomed-rally/ 2009-10-06T13:44:00+00:00 daily 0.8 http://www.pharma-marketer.com/endo-pharma-upgraded-before-fda-ruling-on-fortesta-analyst-says-profits-will-top-views/ 2009-10-06T13:43:57+00:00 daily 0.8 http://www.pharma-marketer.com/isis-pharma-no-longer-paints-a-profoundly-bullish-picture/ 2009-10-06T13:43:54+00:00 daily 0.8 http://www.pharma-marketer.com/depomed-depo-up-29-on-trials/ 2009-10-06T13:43:51+00:00 daily 0.8 http://www.pharma-marketer.com/sequenom-says-it-is-in-contact-with-nasdaq-us-attorney-and-sec-after-investigation/ 2009-10-06T13:43:48+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-wins-while-cvs-loses-as-senate-weighs-obama-health-plan/ 2009-10-06T13:43:44+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-prefers-1-click-rule-for-presenting-fair-balance-in-social-media-other-internet-based-rx-ads/ 2009-10-06T11:19:38+00:00 daily 0.8 http://www.pharma-marketer.com/new-google-toys/ 2009-10-05T21:25:36+00:00 daily 0.8 http://www.pharma-marketer.com/viagra-leads-the-pack-but-wants-more-from-its-advertising/ 2009-10-05T18:22:40+00:00 daily 0.8 http://www.pharma-marketer.com/gsks-top-dealmaker-joins-fiercebiotech-panel/ 2009-10-05T16:32:21+00:00 daily 0.8 http://www.pharma-marketer.com/nasdaq-warns-targeted-genetics-extension-given/ 2009-10-05T16:30:53+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-reports-positive-phase-2-phn-drug-study/ 2009-10-05T16:30:38+00:00 daily 0.8 http://www.pharma-marketer.com/boehringer-sees-a%c2%a2aea%cb%9cuphill-battlea%c2%a2aea%e2%84%a2-with-merck-astra-in-diabetes/ 2009-10-05T16:30:36+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-to-sell-its-own-generic-version-of-plavix-la-lettre-says/ 2009-10-05T16:30:33+00:00 daily 0.8 http://www.pharma-marketer.com/resverlogix-the-canadian-biotech-blockbuster/ 2009-10-05T16:30:28+00:00 daily 0.8 http://www.pharma-marketer.com/cel-sci-may-be-in-for-a-bumpy-ride-this-week/ 2009-10-05T16:30:24+00:00 daily 0.8 http://www.pharma-marketer.com/5-biotech-stocks-to-keep-an-eye-on/ 2009-10-05T16:30:21+00:00 daily 0.8 http://www.pharma-marketer.com/lucentis-improves-sight-after-7-days-in-2-studies/ 2009-10-05T16:30:18+00:00 daily 0.8 http://www.pharma-marketer.com/sandoz-plans-to-sell-more-drugs-in-japan-may-acquire-companies/ 2009-10-05T16:30:14+00:00 daily 0.8 http://www.pharma-marketer.com/seattle-genetics-halts-lymphoma-drug-study/ 2009-10-05T16:30:11+00:00 daily 0.8 http://www.pharma-marketer.com/struggling-trimeris-gets-snapped-up-for-81m/ 2009-10-05T16:30:01+00:00 daily 0.8 http://www.pharma-marketer.com/allos-therapeutics-cancer-drug-folotyn-now-for-sale/ 2009-10-05T16:29:59+00:00 daily 0.8 http://www.pharma-marketer.com/fortunes-being-made-in-small-cap-pharmaceutical-stocks/ 2009-10-05T16:29:55+00:00 daily 0.8 http://www.pharma-marketer.com/combinatorx-shares-pop-on-fovea-news/ 2009-10-05T16:29:53+00:00 daily 0.8 http://www.pharma-marketer.com/eu-approves-astrazeneca-bristol-diabetes-drug/ 2009-10-05T16:29:49+00:00 daily 0.8 http://www.pharma-marketer.com/allergan-insists-doj-subpoena-and-lawsuit-v-fda-on-botox-are-unlinked/ 2009-10-05T16:29:46+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-chief-executive-will-call-on-the-us-government-to-give-the-food-and-drug-administration-a%c2%a2aea%cb%9ca-full-set-of-tee/ 2009-10-05T16:29:42+00:00 daily 0.8 http://www.pharma-marketer.com/amicus-gets-a-drubbing-after-gaucher-drug-disappoints/ 2009-10-05T15:53:25+00:00 daily 0.8 http://www.pharma-marketer.com/theraclone-inks-18m-antibody-pact/ 2009-10-05T15:37:34+00:00 daily 0.8 http://www.pharma-marketer.com/peregrine-posts-promising-data-on-phase-ii-lung-cancer-trial/ 2009-10-05T15:28:17+00:00 daily 0.8 http://www.pharma-marketer.com/a-nobel-for-telomerase/ 2009-10-05T14:32:36+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-trade-little-changed-qlt-rallies-on-sale/ 2009-10-05T12:00:41+00:00 daily 0.8 http://www.pharma-marketer.com/3rd-party-dissemination-of-altered-rx-drug-information-on-social-media-sites-survey-says/ 2009-10-05T11:09:04+00:00 daily 0.8 http://www.pharma-marketer.com/the-loss-of-talent-and-potential/ 2009-10-05T01:23:04+00:00 daily 0.8 http://www.pharma-marketer.com/when-are-third-party-online-discussions-not-independent-of-pharma-influence-survey-says/ 2009-10-05T01:20:55+00:00 daily 0.8 http://www.pharma-marketer.com/where-do-we-go-from-here/ 2009-10-05T01:19:48+00:00 daily 0.8 http://www.pharma-marketer.com/biocryst-clarifies-government-declaration-regarding-peramivir/ 2009-10-05T01:11:40+00:00 daily 0.8 http://www.pharma-marketer.com/amicus-therapeutics-announces-preliminary-results-of-phase-2-study-with-pliceratm-for-gaucher-disease/ 2009-10-05T01:11:38+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-nektar-deal-to-add-value/ 2009-10-05T01:11:37+00:00 daily 0.8 http://www.pharma-marketer.com/warning-potential-blockbuster-ahead/ 2009-10-05T01:11:35+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-keeps-dealing-with-solvay-purchase/ 2009-10-05T01:11:33+00:00 daily 0.8 http://www.pharma-marketer.com/neopharm-a-pipeline-with-multiple-catalysts/ 2009-10-05T01:11:32+00:00 daily 0.8 http://www.pharma-marketer.com/mylan-gets-us-fda-nod-for-generic-version-of-parkinsons-treatment-sinemet/ 2009-10-05T01:11:30+00:00 daily 0.8 http://www.pharma-marketer.com/ge-ceo-immelt-misdirected-on-healthcare/ 2009-10-05T01:11:27+00:00 daily 0.8 http://www.pharma-marketer.com/china-biotech-week-in-review-wyeth-pfizer-merger-allowed/ 2009-10-05T01:11:26+00:00 daily 0.8 http://www.pharma-marketer.com/fda-tells-doctors-new-heparin-formula-less-potent/ 2009-10-05T01:11:25+00:00 daily 0.8 http://www.pharma-marketer.com/downturn-threatens-biotechs-viability/ 2009-10-05T01:11:23+00:00 daily 0.8 http://www.pharma-marketer.com/addrenex-pharmaceuticals-files-snda-submission-for-clonicel-to-treat-adhd/ 2009-10-05T01:11:22+00:00 daily 0.8 http://www.pharma-marketer.com/capital-markets-open-up-to-biotechs/ 2009-10-05T01:11:20+00:00 daily 0.8 http://www.pharma-marketer.com/as-tv-drug-ads-increase-so-do-concerns/ 2009-10-05T01:11:19+00:00 daily 0.8 http://www.pharma-marketer.com/digipharm-2009-our-interview-with-jamie-heywood-patientslikeme/ 2009-10-04T19:15:35+00:00 daily 0.8 http://www.pharma-marketer.com/digipharm-2009-ae%e2%80%9c-our-interview-with-jamie-heywood-patientslikeme/ 2009-10-04T19:15:35+00:00 daily 0.8 http://www.pharma-marketer.com/what-criteria-determine-substantive-pharma-influence-over-content-on-social-media-sites-survey-says/ 2009-10-03T16:09:11+00:00 daily 0.8 http://www.pharma-marketer.com/fda-letters-caused-a-prompt-precipitous-prolonged-drop-in-pharma-paid-search-engine-advertising/ 2009-10-03T15:04:19+00:00 daily 0.8 http://www.pharma-marketer.com/doctors-prescribe-caution-with-sanofi-insulina%c2%a2aea%e2%84%a2s-ties-to-cancer/ 2009-10-02T16:47:15+00:00 daily 0.8 http://www.pharma-marketer.com/a-tale-of-novartis-vs-roche/ 2009-10-02T15:54:30+00:00 daily 0.8 http://www.pharma-marketer.com/impax-shipping-generic-of-adhd-drug-adderall-xr/ 2009-10-02T15:54:20+00:00 daily 0.8 http://www.pharma-marketer.com/teva-rivals-advance-on-oral-ms-drug-merck-kgaa-and-novartis-have-completed-phase-iii-trials-of-their-drugs-and-are-fil/ 2009-10-02T15:54:19+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-to-double-china-workforce/ 2009-10-02T15:54:17+00:00 daily 0.8 http://www.pharma-marketer.com/allergan-suing-u-s-to-void-rules-market-off-label-botox-uses/ 2009-10-02T15:54:16+00:00 daily 0.8 http://www.pharma-marketer.com/why-orexigens-empatic-news-is-good/ 2009-10-02T15:54:14+00:00 daily 0.8 http://www.pharma-marketer.com/caraco-pharmaceutical-laboratories-forest-laboratories-close-lexapro-settlement-deal/ 2009-10-02T15:54:12+00:00 daily 0.8 http://www.pharma-marketer.com/swine-flu-stocks-where-are-they-now/ 2009-10-02T15:54:09+00:00 daily 0.8 http://www.pharma-marketer.com/qlt-sells-u-s-unit-for-230m/ 2009-10-02T15:54:04+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-email-on-negligible-evidence-for-neurontin-as-a-bipolar-drug-is-focus-of-lawyers-tug-of-war/ 2009-10-02T15:54:01+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-astrazeneca-say-their-diabetes-drug-dapagliflozin-succeeded-in-late-stage-study/ 2009-10-02T15:53:57+00:00 daily 0.8 http://www.pharma-marketer.com/strange-bedfellows-rival-medical-firms-launch-joint-stent-study/ 2009-10-02T15:53:46+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-a-fountain-of-youth-stock/ 2009-10-02T15:53:36+00:00 daily 0.8 http://www.pharma-marketer.com/reminder-dtc-ads-ok-in-canada-not-in-us-whats-up-with-that/ 2009-10-02T15:03:05+00:00 daily 0.8 http://www.pharma-marketer.com/placebos-can-work-the-other-way-too/ 2009-10-02T12:46:37+00:00 daily 0.8 http://www.pharma-marketer.com/my-opinion-of-googles-decision-to-foist-sidewiki-upon-us/ 2009-10-02T12:42:06+00:00 daily 0.8 http://www.pharma-marketer.com/novel-diabetes-pill-from-astrazeneca-bristol-may-have-new-risk/ 2009-10-01T18:46:40+00:00 daily 0.8 http://www.pharma-marketer.com/jj-tries-to-buy-itself-a-pipeline/ 2009-10-01T18:46:36+00:00 daily 0.8 http://www.pharma-marketer.com/vertex-pharma-sees-wider-2009-loss-raises-cash-by-issuing-debt-and-selling-telaprevir-rights/ 2009-10-01T18:46:35+00:00 daily 0.8 http://www.pharma-marketer.com/the-novartis-astrazeneca-deal-worst-case-scenario/ 2009-10-01T18:46:34+00:00 daily 0.8 http://www.pharma-marketer.com/surviving-wednesdays-wild-ride-in-healthcare-and-biotech/ 2009-10-01T18:46:22+00:00 daily 0.8 http://www.pharma-marketer.com/traffic-record/ 2009-10-01T17:35:08+00:00 daily 0.8 http://www.pharma-marketer.com/hospitals-already-using-social-media/ 2009-10-01T16:21:28+00:00 daily 0.8 http://www.pharma-marketer.com/know-my-bones-goes-viral-on-twitter/ 2009-10-01T16:12:35+00:00 daily 0.8 http://www.pharma-marketer.com/google-wikki-gives-consumers-another-voice/ 2009-10-01T16:02:03+00:00 daily 0.8 http://www.pharma-marketer.com/china-requires-one-divestiture-for-pfizer-wyeth-merger/ 2009-10-01T14:25:48+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-signs-deal-to-buy-frances-fovea/ 2009-10-01T14:25:47+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-still-range-bound-despite-a-bet-otherwise/ 2009-10-01T14:25:44+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-idec-options-trading-soars/ 2009-10-01T14:25:42+00:00 daily 0.8 http://www.pharma-marketer.com/facet-biotechs-board-recommends-shareholders-reject-biogen-idecs-356-million-tender-offer/ 2009-10-01T14:25:40+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-expands-rd-pipeline-with-two-biotech-deals/ 2009-10-01T14:25:39+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-records-a-35-reduction-in-oil-and-gas-usage/ 2009-10-01T14:25:37+00:00 daily 0.8 http://www.pharma-marketer.com/biocryst-updates-the-obvious/ 2009-10-01T14:25:35+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-on-suicide-mission-in-drug-pricing-litigation/ 2009-10-01T14:25:33+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-kidney-cancer-drug-has-liver-risk-fda-says/ 2009-10-01T14:25:30+00:00 daily 0.8 http://www.pharma-marketer.com/how-to-get-useful-data-out-of-a-drug-patent/ 2009-10-01T12:22:59+00:00 daily 0.8 http://www.pharma-marketer.com/mixed-news-for-mercks-diabetes-drug/ 2009-10-01T11:13:04+00:00 daily 0.8 http://www.pharma-marketer.com/orexigen-vivus-shares-rise-on-obesity-drug-data/ 2009-10-01T11:13:03+00:00 daily 0.8 http://www.pharma-marketer.com/discovery-labs-pump-up-the-volume/ 2009-10-01T11:13:02+00:00 daily 0.8 http://www.pharma-marketer.com/stem-cell-summit-cant-excite-investors/ 2009-10-01T11:13:01+00:00 daily 0.8 http://www.pharma-marketer.com/more-questions-than-answers-from-elan/ 2009-10-01T11:12:59+00:00 daily 0.8 http://www.pharma-marketer.com/new-pharma-guidelines-no-ghostwriting-more-public-info/ 2009-10-01T11:12:58+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-on-the-move-digipharm-europe-2009/ 2009-10-01T06:02:48+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-on-the-move-ae%e2%80%9c-digipharm-europe-2009/ 2009-10-01T06:02:48+00:00 daily 0.8 http://www.pharma-marketer.com/the-evolution-of-the-e-patient/ 2009-10-01T05:05:56+00:00 daily 0.8 http://www.pharma-marketer.com/boston-scientific-jj-deal-is-latest-sign-of-stent-suit-detente/ 2009-09-30T20:09:39+00:00 daily 0.8 http://www.pharma-marketer.com/cancer-alert-probed-as-sanofi-novo-diabetes-drugs-put-to-test/ 2009-09-30T20:09:38+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-ceo-to-shop-for-biotech-vaccine-nonprescription-deals/ 2009-09-30T20:09:37+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-gets-australia-clearance-to-acquire-wyeth/ 2009-09-30T20:09:36+00:00 daily 0.8 http://www.pharma-marketer.com/us-regulators-subpoena-documents-of-brain-disease-with-drugmaker-elans-tysabri/ 2009-09-30T20:09:35+00:00 daily 0.8 http://www.pharma-marketer.com/video-top-biotech-stock-picks/ 2009-09-30T20:09:34+00:00 daily 0.8 http://www.pharma-marketer.com/h1n1-vaccine-is-top-flu-concern-for-u-s-businesses/ 2009-09-30T20:09:32+00:00 daily 0.8 http://www.pharma-marketer.com/good-news-for-novartis/ 2009-09-30T20:09:31+00:00 daily 0.8 http://www.pharma-marketer.com/new-deal-stent-makers-getting-settlement-fever/ 2009-09-30T20:09:29+00:00 daily 0.8 http://www.pharma-marketer.com/are-pharma-execs-in-legal-jeopardy/ 2009-09-30T20:09:28+00:00 daily 0.8 http://www.pharma-marketer.com/mylan-says-fda-approved-its-version-of-bristol-myers-drug-sinemet-for-parkinsons-disease/ 2009-09-30T20:09:27+00:00 daily 0.8 http://www.pharma-marketer.com/orexigen-says-trial-of-2nd-obesity-drug-meets-goal/ 2009-09-30T20:09:26+00:00 daily 0.8 http://www.pharma-marketer.com/healthcare-takeover-talk-continues/ 2009-09-30T20:09:25+00:00 daily 0.8 http://www.pharma-marketer.com/bayer-onyxa%c2%a2aea%e2%84%a2s-pill-doesna%c2%a2aea%e2%84%a2t-slow-breast-cancer-in-second-study/ 2009-09-30T20:09:24+00:00 daily 0.8 http://www.pharma-marketer.com/keryx-pharma-could-turn-into-a-real-winner-down-the-road/ 2009-09-30T20:09:23+00:00 daily 0.8 http://www.pharma-marketer.com/titan-pharma-investors-wait-will-be-well-worth-it/ 2009-09-30T20:09:21+00:00 daily 0.8 http://www.pharma-marketer.com/china-doubles-order-for-sinovac-swine-flu-vaccine/ 2009-09-30T20:09:20+00:00 daily 0.8 http://www.pharma-marketer.com/ignoring-patents/ 2009-09-30T17:18:00+00:00 daily 0.8 http://www.pharma-marketer.com/google-sidewiki-how-will-pharma-respond/ 2009-09-30T16:06:19+00:00 daily 0.8 http://www.pharma-marketer.com/googles-wacky-wiki-is-whack-pharma-should-demand-ability-to-block-it/ 2009-09-30T13:02:09+00:00 daily 0.8 http://www.pharma-marketer.com/microwaves-arent-magic/ 2009-09-30T11:34:39+00:00 daily 0.8 http://www.pharma-marketer.com/how-does-the-drug-industry-create-marketing-that-consumers-actively-chose-to-engage-with/ 2009-09-30T02:53:07+00:00 daily 0.8 http://www.pharma-marketer.com/guess-what-most-men-probably-dont-need-ed-drugs/ 2009-09-30T02:51:31+00:00 daily 0.8 http://www.pharma-marketer.com/what-techniques-are-used-by-pharma-to-monitor-adverse-events-on-social-media-sites-survey-says/ 2009-09-30T02:45:30+00:00 daily 0.8 http://www.pharma-marketer.com/the-little-secret-around-drugs-for-ed/ 2009-09-30T01:07:50+00:00 daily 0.8 http://www.pharma-marketer.com/its-hard-to-make-vaccines-sometimes-thats-a-good-thing/ 2009-09-29T20:08:00+00:00 daily 0.8 http://www.pharma-marketer.com/abbotts-vascular-segment-should-keep-pumping-growth-in-china/ 2009-09-29T20:06:45+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-to-launch-insulin-research-program/ 2009-09-29T20:06:44+00:00 daily 0.8 http://www.pharma-marketer.com/merck-diabetes-drug-cut-blood-sugar-over-two-years/ 2009-09-29T20:06:43+00:00 daily 0.8 http://www.pharma-marketer.com/fda-doubts-repros-proellex-can-be-safe/ 2009-09-29T20:06:41+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-zimulti-us-class-action-suit-dismissed/ 2009-09-29T20:06:39+00:00 daily 0.8 http://www.pharma-marketer.com/cervarix-a-step-closer-to-fda-approval/ 2009-09-29T20:06:37+00:00 daily 0.8 http://www.pharma-marketer.com/a-sale-may-be-sequenoms-only-option/ 2009-09-29T20:06:35+00:00 daily 0.8 http://www.pharma-marketer.com/sequenom-shares-plunge-on-test-setback-ceo-firing/ 2009-09-29T20:06:33+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-quarantines-cervarix-batch-after-u-k-death/ 2009-09-29T20:06:31+00:00 daily 0.8 http://www.pharma-marketer.com/dynavax-starts-new-hepatitis-test/ 2009-09-29T20:06:30+00:00 daily 0.8 http://www.pharma-marketer.com/valeant-paying-115-million-for-drug-rights/ 2009-09-29T20:06:29+00:00 daily 0.8 http://www.pharma-marketer.com/the-10q-detective-losing-sleep-over-cephalon/ 2009-09-29T20:06:28+00:00 daily 0.8 http://www.pharma-marketer.com/fda-delays-glaxo-cervical-cancer-vaccine-ruling-after-death-in-uk/ 2009-09-29T20:06:27+00:00 daily 0.8 http://www.pharma-marketer.com/pfizers-68-billion-buyout-of-wyeth-gets-clearance-in-china-still-awaiting-us-clearance/ 2009-09-29T20:06:26+00:00 daily 0.8 http://www.pharma-marketer.com/am-i-talking-to-myself/ 2009-09-29T20:01:57+00:00 daily 0.8 http://www.pharma-marketer.com/nobel-season-2009/ 2009-09-29T12:18:08+00:00 daily 0.8 http://www.pharma-marketer.com/bayera%c2%a2aea%e2%84%a2s-yaz-consumera%c2%a2aea%e2%84%a2s-death-probed-by-swiss-agency/ 2009-09-29T03:06:34+00:00 daily 0.8 http://www.pharma-marketer.com/merck-receives-positive-chmp-opinion-for-januviaa%e2%80%9aa%c2%ae-sitagliptin-and-janumeta%e2%80%9aa%c2%ae-sitagliptinmetformin-as-add-on-to-insu/ 2009-09-29T03:02:43+00:00 daily 0.8 http://www.pharma-marketer.com/affymax-may-sell-60m-in-stock-to-azimuth/ 2009-09-29T02:57:03+00:00 daily 0.8 http://www.pharma-marketer.com/dendreon-struts-its-stuff/ 2009-09-29T02:57:01+00:00 daily 0.8 http://www.pharma-marketer.com/cytokinetics-pump-up-the-volume/ 2009-09-29T02:57:00+00:00 daily 0.8 http://www.pharma-marketer.com/savient-laying-off-38-percent-of-staff/ 2009-09-29T02:56:59+00:00 daily 0.8 http://www.pharma-marketer.com/anesiva-receives-nasdaq-listing-compliance/ 2009-09-29T02:56:58+00:00 daily 0.8 http://www.pharma-marketer.com/bristols-high-hopes-for-belatacept/ 2009-09-29T02:56:57+00:00 daily 0.8 http://www.pharma-marketer.com/european-committee-recommends-wyeths-prevenar-13/ 2009-09-29T02:56:56+00:00 daily 0.8 http://www.pharma-marketer.com/jj-unit-gets-fda-approval-for-psoriasis-drug/ 2009-09-29T02:56:55+00:00 daily 0.8 http://www.pharma-marketer.com/keryx-biopharmaceuticals-inc-to-raise-20-million-in-registered-direct-offering/ 2009-09-29T02:56:54+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-pralatrexate-for-treatment-of-peripheral-t-cell-lymphoma-drug-discovered-and-developed-by-sri-internationa/ 2009-09-29T02:56:52+00:00 daily 0.8 http://www.pharma-marketer.com/johnson-johnson-and-elan-close-transaction-related-to-alzheimers-immunotherapy-program-and-equity-investment/ 2009-09-29T02:56:51+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-aventis-multaqr-dronedarone-recommended-for-approval-in-the-european-union/ 2009-09-29T02:56:46+00:00 daily 0.8 http://www.pharma-marketer.com/us-court-of-appeals-affirms-summary-judgment-decision-in-seroquel-patent-litigation/ 2009-09-29T02:56:44+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-to-share-vaccine-technology-with-brazil-as-part-of-sales-pact/ 2009-09-29T02:56:38+00:00 daily 0.8 http://www.pharma-marketer.com/taking-advantage-of-the-biodelivery-dip/ 2009-09-29T02:56:37+00:00 daily 0.8 http://www.pharma-marketer.com/have-to-like-the-risk-reward-in-antigenics-stock/ 2009-09-29T02:56:36+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-nears-deal-to-acquire-solvays-pharmaceutical-unit/ 2009-09-29T02:56:35+00:00 daily 0.8 http://www.pharma-marketer.com/watson-teva-positioning-for-generic-biotechnology-drugs/ 2009-09-29T02:56:34+00:00 daily 0.8 http://www.pharma-marketer.com/tianyin-pharma-hits-2009-targets-continues-rapid-growth/ 2009-09-29T02:56:33+00:00 daily 0.8 http://www.pharma-marketer.com/china-biotech-week-in-review-3-life-science-ipos-coming-up/ 2009-09-29T02:56:32+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-to-acquire-solvay-drug-unit-for-6-6-bln/ 2009-09-29T02:56:30+00:00 daily 0.8 http://www.pharma-marketer.com/bayeronyx-cancer-drug-possible-additional-indication-looks-promising/ 2009-09-29T02:56:30+00:00 daily 0.8 http://www.pharma-marketer.com/crucell-signs-flu-collaboration-deal-with-jj/ 2009-09-29T02:56:29+00:00 daily 0.8 http://www.pharma-marketer.com/gtx-has-a-date/ 2009-09-29T02:56:27+00:00 daily 0.8 http://www.pharma-marketer.com/video-sincerely-simcere-china-watch/ 2009-09-29T02:56:26+00:00 daily 0.8 http://www.pharma-marketer.com/abbotts-solvay-deal-dont-get-too-excited/ 2009-09-29T02:56:25+00:00 daily 0.8 http://www.pharma-marketer.com/why-mercks-gardasil-franchise-will-be-battered-by-entry-of-gsks-cervarix/ 2009-09-29T02:56:24+00:00 daily 0.8 http://www.pharma-marketer.com/another-diabetes-drug-is-linked-to-pancreas-inflammation/ 2009-09-29T02:56:22+00:00 daily 0.8 http://www.pharma-marketer.com/ma-action-in-the-swine-flu-market/ 2009-09-29T02:56:21+00:00 daily 0.8 http://www.pharma-marketer.com/viropharma-shares-rise-analyst-boosts-outlook/ 2009-09-29T02:56:20+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-merck-lead-drug-stocks-higher/ 2009-09-29T02:56:18+00:00 daily 0.8 http://www.pharma-marketer.com/roche-u-s-cancer-drug-trial-enrollment-suspended/ 2009-09-29T02:56:17+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-caught-up-in-bid-talk-as-us-mega-deals-lift-dow-and-ftse-100/ 2009-09-29T02:56:15+00:00 daily 0.8 http://www.pharma-marketer.com/10-health-care-stocks-to-consider-buying-now/ 2009-09-29T02:56:13+00:00 daily 0.8 http://www.pharma-marketer.com/benlysta-should-be-a-blockbuster/ 2009-09-29T02:56:11+00:00 daily 0.8 http://www.pharma-marketer.com/financing-activity-for-biotech-deals-heats-up/ 2009-09-29T02:56:11+00:00 daily 0.8 http://www.pharma-marketer.com/crucell-finds-partner-in-jj-after-wyeth-walks-away/ 2009-09-29T02:56:09+00:00 daily 0.8 http://www.pharma-marketer.com/cash-deal-helps-abbott/ 2009-09-29T02:56:08+00:00 daily 0.8 http://www.pharma-marketer.com/launch-of-novartis-drug-awaited/ 2009-09-29T02:56:07+00:00 daily 0.8 http://www.pharma-marketer.com/merck-shares-jump-on-flu-shot-distribution-deal/ 2009-09-29T02:56:06+00:00 daily 0.8 http://www.pharma-marketer.com/jjs-knockout-drug/ 2009-09-29T02:56:04+00:00 daily 0.8 http://www.pharma-marketer.com/sequenom-study-found-unreliable/ 2009-09-29T02:56:03+00:00 daily 0.8 http://www.pharma-marketer.com/questcor-pharmaceuticals-risky-but-cheap/ 2009-09-29T02:56:01+00:00 daily 0.8 http://www.pharma-marketer.com/along-the-way-something-happened/ 2009-09-29T00:40:40+00:00 daily 0.8 http://www.pharma-marketer.com/what-if-dtc-marketers-suddenly-awoke-from-their-funk/ 2009-09-29T00:37:10+00:00 daily 0.8 http://www.pharma-marketer.com/time-for-me-to-eat-crow-fda-is-holding-a-hearing-on-social-media-after-all/ 2009-09-28T21:41:36+00:00 daily 0.8 http://www.pharma-marketer.com/not-understanding-the-business-youre-in/ 2009-09-28T21:38:54+00:00 daily 0.8 http://www.pharma-marketer.com/you-dont-need-big-budgets-and-tv-to-launch-new-drugs/ 2009-09-28T21:23:07+00:00 daily 0.8 http://www.pharma-marketer.com/tv-advertising-doa/ 2009-09-28T21:20:34+00:00 daily 0.8 http://www.pharma-marketer.com/which-pfizer-wyeth-sites-will-close/ 2009-09-28T15:21:18+00:00 daily 0.8 http://www.pharma-marketer.com/fda-launches-twitter-feed-and-calls-for-public-hearing-on-social-media-internet/ 2009-09-28T15:20:19+00:00 daily 0.8 http://www.pharma-marketer.com/who-should-be-responsible-for-submitting-adverse-event-reports-to-fda/ 2009-09-28T14:12:49+00:00 daily 0.8 http://www.pharma-marketer.com/chew-on-this-enzyme/ 2009-09-28T12:39:12+00:00 daily 0.8 http://www.pharma-marketer.com/uncertainties-regarding-reporting-adverse-events-found-on-social-media-sites-survey-says/ 2009-09-27T13:40:13+00:00 daily 0.8 http://www.pharma-marketer.com/how-is-adverse-event-information-from-social-media-sources-processed-by-pharmacos-survey-says/ 2009-09-27T13:38:13+00:00 daily 0.8 http://www.pharma-marketer.com/challenges-handling-adverse-events-found-on-sm-sites-survey-says/ 2009-09-26T13:29:56+00:00 daily 0.8 http://www.pharma-marketer.com/the-details-of-the-baucus-bill/ 2009-09-25T17:16:18+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-9-25-09/ 2009-09-25T14:58:30+00:00 daily 0.8 http://www.pharma-marketer.com/the-health-care-advertising-dilemma/ 2009-09-25T14:11:57+00:00 daily 0.8 http://www.pharma-marketer.com/some-pharma-marketers-cant-see-the-unbranded-sm-forest-for-the-branded-sm-tree/ 2009-09-25T13:14:51+00:00 daily 0.8 http://www.pharma-marketer.com/faked-data-at-the-eth/ 2009-09-25T13:03:59+00:00 daily 0.8 http://www.pharma-marketer.com/internet-surpasses-newspapers-in-gobbling-up-the-decreasing-dtc-ad-spending-pie/ 2009-09-24T19:01:29+00:00 daily 0.8 http://www.pharma-marketer.com/can-big-pharma-embrace-open-branding/ 2009-09-24T16:09:53+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-getting-ready-to-launch-osteoporosis-drug-with-unbranded-site/ 2009-09-24T16:03:02+00:00 daily 0.8 http://www.pharma-marketer.com/how-digital-personalized-patient-ed-could-work/ 2009-09-24T16:00:53+00:00 daily 0.8 http://www.pharma-marketer.com/another-conference-more-obvious-insights/ 2009-09-24T15:57:59+00:00 daily 0.8 http://www.pharma-marketer.com/the-grant-application-treadmill/ 2009-09-24T15:51:15+00:00 daily 0.8 http://www.pharma-marketer.com/what-companies-should-do-between-now-and-the-part-15-hearing-on-social-media/ 2009-09-24T15:15:50+00:00 daily 0.8 http://www.pharma-marketer.com/get-your-fda-social-media-public-hearing-t-shirt/ 2009-09-24T14:02:35+00:00 daily 0.8 http://www.pharma-marketer.com/obesity-hope-springs-eternal-summer-2009-version/ 2009-09-24T11:27:15+00:00 daily 0.8 http://www.pharma-marketer.com/kleenex-soap-dispenser/ 2009-09-24T10:27:29+00:00 daily 0.8 http://www.pharma-marketer.com/how-to-register-for-fdas-part-15-meeting-on-social-media/ 2009-09-23T17:45:26+00:00 daily 0.8 http://www.pharma-marketer.com/dukoral/ 2009-09-23T16:10:48+00:00 daily 0.8 http://www.pharma-marketer.com/what-the-drug-industry-needs-to-do-now-to-survive/ 2009-09-23T15:50:13+00:00 daily 0.8 http://www.pharma-marketer.com/5-reflections-from-alaska/ 2009-09-23T15:44:41+00:00 daily 0.8 http://www.pharma-marketer.com/pnas-shuts-a-door/ 2009-09-23T15:29:53+00:00 daily 0.8 http://www.pharma-marketer.com/fdli-conference-part-4-the-final-day/ 2009-09-23T12:22:49+00:00 daily 0.8 http://www.pharma-marketer.com/statin-safety/ 2009-09-22T15:20:51+00:00 daily 0.8 http://www.pharma-marketer.com/are-jj-agents-trolling-for-adverse-events-on-the-internet/ 2009-09-22T14:28:37+00:00 daily 0.8 http://www.pharma-marketer.com/when-marketing-and-science-collide-how-are-consumers-supposed-to-determine-the-real-truth/ 2009-09-22T14:22:17+00:00 daily 0.8 http://www.pharma-marketer.com/social-media-is-not-the-answer-to-dtc-marketers-problems/ 2009-09-22T14:19:08+00:00 daily 0.8 http://www.pharma-marketer.com/the-fda-has-decided-to-call-a-public-hearing-on-the-use-of-social-mediaweb-2-0/ 2009-09-22T14:11:35+00:00 daily 0.8 http://www.pharma-marketer.com/social-media-drug-marketing-maybe-an-oxymoron/ 2009-09-22T14:03:50+00:00 daily 0.8 http://www.pharma-marketer.com/lifestyle-induced-chronic-illnessconditions-increasing-medial-costs-in-the-us/ 2009-09-22T13:28:00+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-twitterama-part-2-lessons-learned-from-a-pharma-company-that-uses-twitter/ 2009-09-22T12:34:33+00:00 daily 0.8 http://www.pharma-marketer.com/colorful-junk/ 2009-09-22T11:57:04+00:00 daily 0.8 http://www.pharma-marketer.com/fdli-conference-part-3-wrap-up-of-day-1/ 2009-09-22T10:58:47+00:00 daily 0.8 http://www.pharma-marketer.com/zetia-dtc-print-ad-with-fold-out/ 2009-09-22T10:21:03+00:00 daily 0.8 http://www.pharma-marketer.com/adpharm-gallery-open-house/ 2009-09-21T23:07:10+00:00 daily 0.8 http://www.pharma-marketer.com/adhd-disease-awareness-ad-in-poland-from-lilly/ 2009-09-21T17:04:23+00:00 daily 0.8 http://www.pharma-marketer.com/seasonique-dtc-print-ad/ 2009-09-21T16:51:48+00:00 daily 0.8 http://www.pharma-marketer.com/neulasta-dtc-print-ad-from-2007/ 2009-09-21T16:30:41+00:00 daily 0.8 http://www.pharma-marketer.com/fdli-conference-part-2-janet-woodcock-speech/ 2009-09-21T13:53:03+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-turns-hostile-in-356m-bid-to-acquire-facet/ 2009-09-21T13:46:56+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-influence-over-3rd-party-conversations-in-social-media/ 2009-09-21T13:44:08+00:00 daily 0.8 http://www.pharma-marketer.com/top-blog/ 2009-09-21T12:53:04+00:00 daily 0.8 http://www.pharma-marketer.com/nektar-scores-1-5b-development-deal-with-az/ 2009-09-21T12:42:02+00:00 daily 0.8 http://www.pharma-marketer.com/more-on-t2-and-degrees/ 2009-09-21T12:29:19+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-builds-a-blockbuster-case-for-denosumab/ 2009-09-21T12:03:10+00:00 daily 0.8 http://www.pharma-marketer.com/zoton-fastab/ 2009-09-21T10:22:21+00:00 daily 0.8 http://www.pharma-marketer.com/alli-in-poland/ 2009-09-21T10:00:59+00:00 daily 0.8 http://www.pharma-marketer.com/alli-in-spain/ 2009-09-21T09:58:47+00:00 daily 0.8 http://www.pharma-marketer.com/acetadote-for-acetaminophen-overdose/ 2009-09-21T09:35:47+00:00 daily 0.8 http://www.pharma-marketer.com/lassurance-maladie-tv-commercial/ 2009-09-21T09:09:54+00:00 daily 0.8 http://www.pharma-marketer.com/fdli-conference-part-1/ 2009-09-21T02:38:38+00:00 daily 0.8 http://www.pharma-marketer.com/2-can-play-that-game-pfizer-claims-witness-tampering-in-neurontin-case/ 2009-09-21T00:42:34+00:00 daily 0.8 http://www.pharma-marketer.com/sun-pharma-to-file-30-applications-for-generic-drugs-in-us/ 2009-09-21T00:42:32+00:00 daily 0.8 http://www.pharma-marketer.com/in-lillys-pipeline-profit-or-peril/ 2009-09-21T00:42:31+00:00 daily 0.8 http://www.pharma-marketer.com/genentech-biooncology-corporate-ad/ 2009-09-20T18:14:02+00:00 daily 0.8 http://www.pharma-marketer.com/cerezyme-for-gaucher-disease/ 2009-09-20T17:46:51+00:00 daily 0.8 http://www.pharma-marketer.com/revatio-hcp-print-ad/ 2009-09-20T17:10:58+00:00 daily 0.8 http://www.pharma-marketer.com/lets-respond-to-fdas-questions-regarding-its-regulation-of-social-media/ 2009-09-20T16:03:12+00:00 daily 0.8 http://www.pharma-marketer.com/cloderm/ 2009-09-20T13:33:48+00:00 daily 0.8 http://www.pharma-marketer.com/micardis/ 2009-09-20T13:31:56+00:00 daily 0.8 http://www.pharma-marketer.com/atryn-ae%e2%80%9c-connection/ 2009-09-20T13:17:03+00:00 daily 0.8 http://www.pharma-marketer.com/venofer-ae%e2%80%9c-toleration/ 2009-09-20T13:16:58+00:00 daily 0.8 http://www.pharma-marketer.com/trisenox-ae%e2%80%9c-rise-above/ 2009-09-20T13:16:52+00:00 daily 0.8 http://www.pharma-marketer.com/vfend-ae%e2%80%9c-tick-tick-tickae%c2%a6/ 2009-09-20T13:16:45+00:00 daily 0.8 http://www.pharma-marketer.com/tracleer-ae%e2%80%9c-stand/ 2009-09-20T13:16:34+00:00 daily 0.8 http://www.pharma-marketer.com/zyvox-ae%e2%80%9c-serious/ 2009-09-20T12:31:16+00:00 daily 0.8 http://www.pharma-marketer.com/tracleer-ae%e2%80%9c-goes-beyond/ 2009-09-20T12:30:53+00:00 daily 0.8 http://www.pharma-marketer.com/la-jolla-pharmaceutical-company-receives-notice-of-noncompliance-with-nasdaq-stock-market-listing-requirement/ 2009-09-19T14:54:16+00:00 daily 0.8 http://www.pharma-marketer.com/metabasis-therapeutics-receives-notice-of-noncompliance-with-nasdaq-listing-requirements/ 2009-09-19T14:54:15+00:00 daily 0.8 http://www.pharma-marketer.com/pdl-biopharma-announces-conversion-rate-adjustment-for-its-2-75-convertible-subordinated-notes-due-august-16-2023/ 2009-09-19T14:54:14+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-drug-gets-fda-ok/ 2009-09-19T14:54:13+00:00 daily 0.8 http://www.pharma-marketer.com/spectrum-pharmaceuticals-to-raise-up-to-50-million-from-institutional-investors-at-7-55-per-share/ 2009-09-19T14:54:12+00:00 daily 0.8 http://www.pharma-marketer.com/schering-plough-declares-dividend-of-6-5-cents/ 2009-09-19T14:54:12+00:00 daily 0.8 http://www.pharma-marketer.com/genova-bio-ends-relationship-with-bridge-bioresearch/ 2009-09-19T14:54:11+00:00 daily 0.8 http://www.pharma-marketer.com/health-care-stocks-that-have-a-good-prognosis/ 2009-09-19T14:53:59+00:00 daily 0.8 http://www.pharma-marketer.com/immunosyn-refutes-unfounded-rumors-in-marketplace/ 2009-09-19T14:53:48+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-new-hiv-test-from-abbott-laboratories/ 2009-09-19T14:53:47+00:00 daily 0.8 http://www.pharma-marketer.com/fda-announces-public-hearing-on-promotion-of-drugs-on-internet-via-social-media-this-is-not-a-hoax/ 2009-09-19T12:52:53+00:00 daily 0.8 http://www.pharma-marketer.com/revatio/ 2009-09-19T11:55:39+00:00 daily 0.8 http://www.pharma-marketer.com/tracleer-goes-beyond/ 2009-09-19T11:55:36+00:00 daily 0.8 http://www.pharma-marketer.com/zyvox-serious/ 2009-09-19T11:16:14+00:00 daily 0.8 http://www.pharma-marketer.com/tracleer-stand/ 2009-09-19T11:16:11+00:00 daily 0.8 http://www.pharma-marketer.com/fda-to-hold-part-15-hearing-on-social-media-and-pharma-finally/ 2009-09-19T02:56:28+00:00 daily 0.8 http://www.pharma-marketer.com/vivus-expects-to-raise-94-5m-from-stock-offering/ 2009-09-18T18:08:43+00:00 daily 0.8 http://www.pharma-marketer.com/nycomed-makes-4-4-5-bln-euro-solvay-bid-sources/ 2009-09-18T18:08:42+00:00 daily 0.8 http://www.pharma-marketer.com/the-next-biopharma-ma-targets/ 2009-09-18T18:08:30+00:00 daily 0.8 http://www.pharma-marketer.com/drugmaker-sanofi-aventis-buys-mercks-half-of-merial-step-needed-for-merck-to-buy-schering/ 2009-09-18T18:08:30+00:00 daily 0.8 http://www.pharma-marketer.com/dr-reddya%c2%a2aea%e2%84%a2s-climbs-on-glaxo-stake-purchase-report/ 2009-09-18T18:08:19+00:00 daily 0.8 http://www.pharma-marketer.com/hospira-ups-2009-guidance/ 2009-09-18T18:08:03+00:00 daily 0.8 http://www.pharma-marketer.com/genzymes-ms-drug-shows-promise/ 2009-09-18T18:07:52+00:00 daily 0.8 http://www.pharma-marketer.com/nextbio-raises-8m/ 2009-09-18T15:59:13+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-9-18-09/ 2009-09-18T15:17:58+00:00 daily 0.8 http://www.pharma-marketer.com/an-example-of-non-transparency-over-at-fdas-transparency-blog/ 2009-09-18T14:24:24+00:00 daily 0.8 http://www.pharma-marketer.com/except-for-the-helicopter-pfizer-got-this-top-gun-md-at-a-discounted-rate/ 2009-09-18T14:13:31+00:00 daily 0.8 http://www.pharma-marketer.com/the-vampire-tax-rises-again/ 2009-09-18T14:13:12+00:00 daily 0.8 http://www.pharma-marketer.com/china-aoxing-wins-ok-for-narcotic-drug-trial/ 2009-09-18T14:12:53+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-says-consultant-in-drug-cases-tried-to-sway-witness/ 2009-09-18T14:12:38+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-linked-birth-defect-of-fetus-to-paxil-ex-executive-says/ 2009-09-18T14:12:22+00:00 daily 0.8 http://www.pharma-marketer.com/bulls-bears-fight-over-biocryst/ 2009-09-18T14:12:07+00:00 daily 0.8 http://www.pharma-marketer.com/big-pharmas-future-death-spiral/ 2009-09-18T14:11:55+00:00 daily 0.8 http://www.pharma-marketer.com/two-positive-notes-for-arena-pharmaceuticals/ 2009-09-18T14:11:40+00:00 daily 0.8 http://www.pharma-marketer.com/bioheart-stem-cell-treatment-achieves-positive-response/ 2009-09-18T14:04:17+00:00 daily 0.8 http://www.pharma-marketer.com/ambrx-wyeth-ink-antibody-dev-deal/ 2009-09-18T13:26:28+00:00 daily 0.8 http://www.pharma-marketer.com/arenas-weight-lost-drug-its-phase-ii-goal/ 2009-09-18T12:18:40+00:00 daily 0.8 http://www.pharma-marketer.com/arenas-weight-loss-drug-hits-phase-iii-goal/ 2009-09-18T12:18:40+00:00 daily 0.8 http://www.pharma-marketer.com/175-times-and-then-the-catastrophe/ 2009-09-18T11:47:48+00:00 daily 0.8 http://www.pharma-marketer.com/adpharm-gallery-all-access-pass/ 2009-09-18T10:40:45+00:00 daily 0.8 http://www.pharma-marketer.com/tylenol-infants-ae%e2%80%9c-seal/ 2009-09-18T10:32:44+00:00 daily 0.8 http://www.pharma-marketer.com/alexion-ae%e2%80%9c-recruiting-for-ahus/ 2009-09-18T10:32:38+00:00 daily 0.8 http://www.pharma-marketer.com/alexion-ae%e2%80%9c-pnh-threatening/ 2009-09-18T10:32:34+00:00 daily 0.8 http://www.pharma-marketer.com/alexion-ae%e2%80%9c-pnh-vital-organ/ 2009-09-18T10:32:26+00:00 daily 0.8 http://www.pharma-marketer.com/alexion-ae%e2%80%9c-pnh-ongoing/ 2009-09-18T10:32:13+00:00 daily 0.8 http://www.pharma-marketer.com/cdc-1-in-3-teen-girls-got-cervical-cancer-vaccine/ 2009-09-17T22:36:56+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-paid-for-docs-helicopter-in-off-label-geodon-push-suit-claims/ 2009-09-17T22:36:55+00:00 daily 0.8 http://www.pharma-marketer.com/la-condoneria-ae%e2%80%9c-ad-2/ 2009-09-17T20:48:52+00:00 daily 0.8 http://www.pharma-marketer.com/la-condoneria-ae%e2%80%9c-ad-1/ 2009-09-17T20:48:31+00:00 daily 0.8 http://www.pharma-marketer.com/drugmaker-merck-british-research-charity-to-develop-vaccines-for-diseases-in-poor-countries/ 2009-09-17T19:34:20+00:00 daily 0.8 http://www.pharma-marketer.com/jj-elan-close-deal-on-alzheimers-program/ 2009-09-17T19:34:19+00:00 daily 0.8 http://www.pharma-marketer.com/rituxan-tests-positive-in-phase-iii-trial/ 2009-09-17T19:34:19+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-xenoport-report-positive-midstage-study-results-from-potential-pain-drug/ 2009-09-17T19:34:18+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-advance-sequenom-jumps-on-launch/ 2009-09-17T19:34:17+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-settlement-funds-whistleblower-program/ 2009-09-17T19:34:15+00:00 daily 0.8 http://www.pharma-marketer.com/sleepless-in-sanofi/ 2009-09-17T19:34:14+00:00 daily 0.8 http://www.pharma-marketer.com/la-condoneria-ae%e2%80%9c-ad-3/ 2009-09-17T19:33:33+00:00 daily 0.8 http://www.pharma-marketer.com/genentech-biooncology/ 2009-09-17T19:26:53+00:00 daily 0.8 http://www.pharma-marketer.com/cerezyme/ 2009-09-17T19:26:15+00:00 daily 0.8 http://www.pharma-marketer.com/alexion-pnh-ongoing/ 2009-09-17T19:26:08+00:00 daily 0.8 http://www.pharma-marketer.com/vfend-tick-tick-tick/ 2009-09-17T19:25:55+00:00 daily 0.8 http://www.pharma-marketer.com/trisenox-rise-above/ 2009-09-17T19:25:39+00:00 daily 0.8 http://www.pharma-marketer.com/venofer-toleration/ 2009-09-17T19:25:39+00:00 daily 0.8 http://www.pharma-marketer.com/thrombate-iii/ 2009-09-17T19:25:36+00:00 daily 0.8 http://www.pharma-marketer.com/alexion-pnh-vital-organ/ 2009-09-17T19:25:15+00:00 daily 0.8 http://www.pharma-marketer.com/atryn-connection/ 2009-09-17T19:25:15+00:00 daily 0.8 http://www.pharma-marketer.com/alexion-pnh-threatening/ 2009-09-17T19:25:14+00:00 daily 0.8 http://www.pharma-marketer.com/alexion-recruiting-for-ahus/ 2009-09-17T19:25:13+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-promising-pain-data-fuels-spike-in-xenoport-shares/ 2009-09-17T19:06:37+00:00 daily 0.8 http://www.pharma-marketer.com/promising-pain-data-fuels-spike-in-xenoport-shares/ 2009-09-17T19:06:37+00:00 daily 0.8 http://www.pharma-marketer.com/la-condoneria-ad-3/ 2009-09-17T17:57:46+00:00 daily 0.8 http://www.pharma-marketer.com/la-condoneria-ad-1/ 2009-09-17T17:57:46+00:00 daily 0.8 http://www.pharma-marketer.com/la-condoneria-ad-2/ 2009-09-17T17:57:46+00:00 daily 0.8 http://www.pharma-marketer.com/biotechs-showcase-partnering-opportunities/ 2009-09-17T16:13:31+00:00 daily 0.8 http://www.pharma-marketer.com/which-pharma-pipelines-rank-best/ 2009-09-17T15:44:14+00:00 daily 0.8 http://www.pharma-marketer.com/allergan-gets-fda-warning-on-latisse-web-site/ 2009-09-17T15:44:11+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-backs-auxiliums-auxl-xiaflex/ 2009-09-17T15:44:10+00:00 daily 0.8 http://www.pharma-marketer.com/cloak-and-dagger-developments-at-cel-sci-against-swine-flu/ 2009-09-17T15:44:09+00:00 daily 0.8 http://www.pharma-marketer.com/immunogen-amgen-forge-35m-pact-on-cancer-tech/ 2009-09-17T15:32:32+00:00 daily 0.8 http://www.pharma-marketer.com/merck-backs-150m-vax-developer-in-india/ 2009-09-17T15:24:23+00:00 daily 0.8 http://www.pharma-marketer.com/omeros-hopes-to-raise-up-to-81-6m-in-ipo/ 2009-09-17T15:17:43+00:00 daily 0.8 http://www.pharma-marketer.com/is-the-biotech-venture-glass-half-empty-or-half-full/ 2009-09-17T14:55:31+00:00 daily 0.8 http://www.pharma-marketer.com/fda-reads-my-blog-declares-latisse-web-site-misleading/ 2009-09-17T13:20:33+00:00 daily 0.8 http://www.pharma-marketer.com/seaside-gets-30m-to-pursue-new-autism-drug/ 2009-09-17T13:04:32+00:00 daily 0.8 http://www.pharma-marketer.com/renovo-maps-painful-restructuring-after-buyout-talks-end/ 2009-09-17T12:26:19+00:00 daily 0.8 http://www.pharma-marketer.com/crestor-ae%e2%80%9c-little-secret/ 2009-09-17T11:29:20+00:00 daily 0.8 http://www.pharma-marketer.com/crestor-ae%e2%80%9c-take-action/ 2009-09-17T11:29:08+00:00 daily 0.8 http://www.pharma-marketer.com/the-drug-business-a-turbulent-future/ 2009-09-17T11:25:47+00:00 daily 0.8 http://www.pharma-marketer.com/national-association-for-the-blind/ 2009-09-17T09:45:56+00:00 daily 0.8 http://www.pharma-marketer.com/fda-orders-warning-on-phenergan/ 2009-09-17T01:24:02+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-aims-big-in-copd-market/ 2009-09-17T01:24:02+00:00 daily 0.8 http://www.pharma-marketer.com/immunogen-licenses-technology-to-amgen/ 2009-09-17T01:24:00+00:00 daily 0.8 http://www.pharma-marketer.com/swine-a-chance-for-pharma-to-shine/ 2009-09-16T22:15:32+00:00 daily 0.8 http://www.pharma-marketer.com/a-rise-for-biopharma-in-the-fall/ 2009-09-16T21:31:28+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeutics-posts-follow-up-cancer-drug-data/ 2009-09-16T21:31:27+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-advance-lundbeck-up-4/ 2009-09-16T21:31:26+00:00 daily 0.8 http://www.pharma-marketer.com/stats-show-weakness-in-q4-ndas/ 2009-09-16T21:31:26+00:00 daily 0.8 http://www.pharma-marketer.com/toviaz-ae%e2%80%9c-mosaic/ 2009-09-16T21:30:26+00:00 daily 0.8 http://www.pharma-marketer.com/mederma-ae%e2%80%9c-live-with-scar/ 2009-09-16T21:29:59+00:00 daily 0.8 http://www.pharma-marketer.com/mirena-ae%e2%80%9c-wiped-out/ 2009-09-16T20:38:18+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-fda-panel-backs-auxiliums-xiaflex-therapy/ 2009-09-16T19:55:26+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-backs-auxiliums-xiaflex-therapy/ 2009-09-16T19:55:26+00:00 daily 0.8 http://www.pharma-marketer.com/respect-for-your-customers-and-audience/ 2009-09-16T19:02:13+00:00 daily 0.8 http://www.pharma-marketer.com/is-twitter-dumbing-the-message-on-healthcare-or-are-people-really-this-dumb/ 2009-09-16T18:59:47+00:00 daily 0.8 http://www.pharma-marketer.com/a-great-tool-to-understand-social-media-your-brand/ 2009-09-16T18:55:11+00:00 daily 0.8 http://www.pharma-marketer.com/any-change-even-a-change-for-the-better-is-always-accompanied-by-drawbacks-and-discomforts/ 2009-09-16T18:53:37+00:00 daily 0.8 http://www.pharma-marketer.com/dtc-marketers-continue-to-talk-to-the-wall-as-the-possible-demise-of-dtc-marketing-looms/ 2009-09-16T18:47:09+00:00 daily 0.8 http://www.pharma-marketer.com/neurocrine-signs-financing-deal-worth-up-to-75m/ 2009-09-16T18:23:00+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-short-term-traders-are-throwing-out-the-baby-with-the-bathwater/ 2009-09-16T18:22:59+00:00 daily 0.8 http://www.pharma-marketer.com/biocryst-warns-peramivir-sales-may-not-bring-profits/ 2009-09-16T18:22:58+00:00 daily 0.8 http://www.pharma-marketer.com/tylenol-infants-seal/ 2009-09-16T16:13:46+00:00 daily 0.8 http://www.pharma-marketer.com/keryx-lands-orphan-status-for-cancer-drug-shares-soar/ 2009-09-16T15:37:55+00:00 daily 0.8 http://www.pharma-marketer.com/chantix-ads-from-various-markets/ 2009-09-16T14:32:11+00:00 daily 0.8 http://www.pharma-marketer.com/bayer-outsider-as-ceo-may-point-to-split-of-drugmaker/ 2009-09-16T14:29:12+00:00 daily 0.8 http://www.pharma-marketer.com/federal-appeals-court-sides-with-amgen-over-roche-in-patent-dispute-over-anemia-drugs/ 2009-09-16T14:29:11+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-subsidiary-pleads-guilty-in-marketing-case/ 2009-09-16T14:29:10+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-h1n1-flu-vaccines/ 2009-09-16T14:29:09+00:00 daily 0.8 http://www.pharma-marketer.com/auxilium-pfizer-could-get-a-helping-hand/ 2009-09-16T14:29:09+00:00 daily 0.8 http://www.pharma-marketer.com/sinovac-gauging-the-health-of-a-drugmaker/ 2009-09-16T14:29:08+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-sells-asia-otc-business-for-310m/ 2009-09-16T14:29:07+00:00 daily 0.8 http://www.pharma-marketer.com/analyst-thinks-sales-of-arenas-lorcaserin-will-trail-other-obesity-drugs-downgrades-stock/ 2009-09-16T14:29:05+00:00 daily 0.8 http://www.pharma-marketer.com/vivus-can-teach-old-drugs-new-tricks-but-does-it-have-a-bidil-problem/ 2009-09-16T14:29:04+00:00 daily 0.8 http://www.pharma-marketer.com/savient-sticks-to-krystexxa-resubmission-target/ 2009-09-16T14:29:02+00:00 daily 0.8 http://www.pharma-marketer.com/can-anthera-whet-investors-appetite-for-biotech-ipos/ 2009-09-16T14:28:17+00:00 daily 0.8 http://www.pharma-marketer.com/my-time-to-quit/ 2009-09-16T14:25:06+00:00 daily 0.8 http://www.pharma-marketer.com/is-bayer-headed-for-a-breakup/ 2009-09-16T14:08:13+00:00 daily 0.8 http://www.pharma-marketer.com/savient-says-gout-drug-on-track-no-trial-needed/ 2009-09-16T13:51:27+00:00 daily 0.8 http://www.pharma-marketer.com/fda-cancer-chief-a-lightning-rod-for-patients-and-developers/ 2009-09-16T12:25:41+00:00 daily 0.8 http://www.pharma-marketer.com/the-swine-flu-vaccine-is-approved-if-you-build-it-will-they-come/ 2009-09-16T12:10:01+00:00 daily 0.8 http://www.pharma-marketer.com/fda-swiftly-clears-four-new-swine-flu-jabs/ 2009-09-16T11:58:43+00:00 daily 0.8 http://www.pharma-marketer.com/real-electrons/ 2009-09-16T11:36:40+00:00 daily 0.8 http://www.pharma-marketer.com/baxter-fails-to-deliver/ 2009-09-16T02:35:57+00:00 daily 0.8 http://www.pharma-marketer.com/from-the-osteoporosis-front-updates-on-potential-new-drugs/ 2009-09-16T02:35:56+00:00 daily 0.8 http://www.pharma-marketer.com/acorda-therapeutics-cites-additional-positive-safety-data-on-multiple-sclerosis-drug/ 2009-09-16T02:35:55+00:00 daily 0.8 http://www.pharma-marketer.com/bullish-case-for-vanda-loses-steam/ 2009-09-16T02:35:54+00:00 daily 0.8 http://www.pharma-marketer.com/biovail-to-pay-nearly-25m-in-kickbacks-case/ 2009-09-16T02:35:53+00:00 daily 0.8 http://www.pharma-marketer.com/pipeline-setback-for-sanofi-and-regeneron/ 2009-09-15T19:46:18+00:00 daily 0.8 http://www.pharma-marketer.com/timing-is-everything-2-stocks-poised-for-gainsregeneron-and-inovio/ 2009-09-15T19:46:16+00:00 daily 0.8 http://www.pharma-marketer.com/big-deals-equal-big-job-cuts-in-2009/ 2009-09-15T19:46:14+00:00 daily 0.8 http://www.pharma-marketer.com/pharmatech-product-directory-now-live/ 2009-09-15T17:49:28+00:00 daily 0.8 http://www.pharma-marketer.com/its-advertising-awards-season-again-mmm-beware-of-being-kanyed/ 2009-09-15T17:33:50+00:00 daily 0.8 http://www.pharma-marketer.com/wyeth-bone-drug-reduced-fractures-in-longer-study/ 2009-09-15T15:56:48+00:00 daily 0.8 http://www.pharma-marketer.com/chelsea-therapeutics-not-worth-speculating/ 2009-09-15T15:56:47+00:00 daily 0.8 http://www.pharma-marketer.com/a-p-pharma-merial-in-license-agreement/ 2009-09-15T15:56:46+00:00 daily 0.8 http://www.pharma-marketer.com/how-fda-chooses-to-use-twitter/ 2009-09-15T15:24:26+00:00 daily 0.8 http://www.pharma-marketer.com/vcs-invest-21-5m-in-alvines-celiac-drug-program/ 2009-09-15T15:01:24+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-shrinks/ 2009-09-15T14:51:06+00:00 daily 0.8 http://www.pharma-marketer.com/talecris-launches-ipo/ 2009-09-15T14:36:18+00:00 daily 0.8 http://www.pharma-marketer.com/europe-injecting-228m-into-drug-discovery-work/ 2009-09-15T14:30:51+00:00 daily 0.8 http://www.pharma-marketer.com/pieris-snares-10m-upfront-in-allergan-pact/ 2009-09-15T14:15:00+00:00 daily 0.8 http://www.pharma-marketer.com/irony-of-ironies-fda-opens-up-a-pharma-based-twitter-feed/ 2009-09-15T14:04:55+00:00 daily 0.8 http://www.pharma-marketer.com/biocryst-hypes-international-pacts-for-peramivir/ 2009-09-15T13:14:50+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-e-mails-over-paxil-study-must-be-turned-over-for-trial/ 2009-09-15T12:53:31+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-reports-progress-with-bronchodilator/ 2009-09-15T12:53:30+00:00 daily 0.8 http://www.pharma-marketer.com/elan-revises-partnership-deal-with-jj/ 2009-09-15T12:53:29+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-labs-wins-approval-for-drug-eluting-stent/ 2009-09-15T12:53:28+00:00 daily 0.8 http://www.pharma-marketer.com/merck-eu-approves-isentress-for-new-hiv-patients/ 2009-09-15T12:53:26+00:00 daily 0.8 http://www.pharma-marketer.com/bayer-names-dekkers-as-chief-executive-first-outsider-in-146-year-history/ 2009-09-15T12:53:25+00:00 daily 0.8 http://www.pharma-marketer.com/biocryst-pharma-makes-3-flu-drug-marketing-deals/ 2009-09-15T12:53:24+00:00 daily 0.8 http://www.pharma-marketer.com/viva-viagra-missile-guy-vows-to-continue-his-quixotic-fight-against-pfizer/ 2009-09-15T11:56:11+00:00 daily 0.8 http://www.pharma-marketer.com/industrial-research-more-grounded-in-reality-or-not/ 2009-09-15T11:22:22+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-novartis-gets-blockbuster-late-stage-data-in-copd-trial/ 2009-09-15T10:35:37+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-gets-blockbuster-late-stage-data-in-copd-trial/ 2009-09-15T10:35:37+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-jobs-falling-at-rapid-clip-study-concludes/ 2009-09-15T00:42:30+00:00 daily 0.8 http://www.pharma-marketer.com/diabetes-medication-may-get-new-life-as-cancer-treatment/ 2009-09-15T00:42:29+00:00 daily 0.8 http://www.pharma-marketer.com/takeout-rumors-lift-dendreon-bio-stocks/ 2009-09-15T00:42:26+00:00 daily 0.8 http://www.pharma-marketer.com/setback-for-sanofi-and-regeneron/ 2009-09-14T21:00:53+00:00 daily 0.8 http://www.pharma-marketer.com/gleeveca%c2%a2aea%e2%84%a2s-lesson-medical-success-trumps-small-market/ 2009-09-14T21:00:52+00:00 daily 0.8 http://www.pharma-marketer.com/the-clock-is-ticking-for-elan/ 2009-09-14T21:00:51+00:00 daily 0.8 http://www.pharma-marketer.com/has-big-pharma-found-pain-relief/ 2009-09-14T21:00:50+00:00 daily 0.8 http://www.pharma-marketer.com/videoeli-lilly-ceo-on-cost-cutting/ 2009-09-14T21:00:48+00:00 daily 0.8 http://www.pharma-marketer.com/go-ahead-use-my-meeting-discount/ 2009-09-14T20:43:19+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-depressant-drug-for-the-annoyingly-cheerful/ 2009-09-14T18:40:26+00:00 daily 0.8 http://www.pharma-marketer.com/teva-shares-off-mylan-files-for-generic-copaxone/ 2009-09-14T17:24:50+00:00 daily 0.8 http://www.pharma-marketer.com/breast-cancer-gene-testing-for-rochea%c2%a2aea%e2%84%a2s-herceptin-often-lacking/ 2009-09-14T17:24:47+00:00 daily 0.8 http://www.pharma-marketer.com/hemispherx-hasnt-called-fda-on-ampligen-review/ 2009-09-14T17:24:44+00:00 daily 0.8 http://www.pharma-marketer.com/is-there-a-drug-lag-between-the-us-and-europe-we-still-dont-know/ 2009-09-14T17:24:41+00:00 daily 0.8 http://www.pharma-marketer.com/jj-in-talks-to-reduce-1-5-bln-elan-deal-price-source/ 2009-09-14T17:24:36+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-unveils-companywide-reorganization-aimed-at-delivering-more-value-to-customers-company/ 2009-09-14T17:24:27+00:00 daily 0.8 http://www.pharma-marketer.com/novel-flu-drug-proves-effective-tamiflu-saves-lives-not-just-shortens-illness-studies-show/ 2009-09-14T17:24:24+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-cutting-5500-jobs-before-zyprexa-lapse/ 2009-09-14T17:24:20+00:00 daily 0.8 http://www.pharma-marketer.com/alexza-dives-on-migraine-drug-setback/ 2009-09-14T17:24:17+00:00 daily 0.8 http://www.pharma-marketer.com/theravance-wins-fda-ok-for-superbug-drug/ 2009-09-14T17:24:15+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-labsa%c2%a2aea%e2%84%a2-offer-spared-evalve-investors/ 2009-09-14T17:24:11+00:00 daily 0.8 http://www.pharma-marketer.com/fda-and-emea-grant-orphan-drug-designation-for-antisense-pharmas-investigational-drug-trabedersen-in-pancreatic-carcino/ 2009-09-14T17:24:07+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-guards-diet-pills-image-amid-probe/ 2009-09-14T17:24:04+00:00 daily 0.8 http://www.pharma-marketer.com/alcon-to-buy-swiss-biotech-firm-for-up-to-589-mln/ 2009-09-14T17:24:01+00:00 daily 0.8 http://www.pharma-marketer.com/emerging-pharmas-and-cros-need-each-other/ 2009-09-14T15:59:32+00:00 daily 0.8 http://www.pharma-marketer.com/alexza-shares-sink-after-drug-flunks-iib/ 2009-09-14T15:15:22+00:00 daily 0.8 http://www.pharma-marketer.com/alcon-scoops-up-esbatech-in-589m-buyout/ 2009-09-14T15:02:35+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-to-spur-rd-in-top-to-bottom-revamp/ 2009-09-14T14:42:25+00:00 daily 0.8 http://www.pharma-marketer.com/abstract-abstracts/ 2009-09-14T14:30:24+00:00 daily 0.8 http://www.pharma-marketer.com/are-organic-search-results-next-on-fdas-chopping-block/ 2009-09-14T13:16:46+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-theravance-wins-20m-milestone-on-superbug-drug-approval/ 2009-09-14T13:04:04+00:00 daily 0.8 http://www.pharma-marketer.com/theravance-wins-20m-milestone-on-superbug-drug-approval/ 2009-09-14T13:04:04+00:00 daily 0.8 http://www.pharma-marketer.com/regeneron-sanofi-pull-plug-on-late-stage-cancer-trial/ 2009-09-14T12:38:40+00:00 daily 0.8 http://www.pharma-marketer.com/salix-shares-surge-on-promising-pivotal-data/ 2009-09-14T12:16:53+00:00 daily 0.8 http://www.pharma-marketer.com/norman-borlaug/ 2009-09-14T11:48:07+00:00 daily 0.8 http://www.pharma-marketer.com/early-communications-means-early-warning-early-prep/ 2009-09-14T11:23:54+00:00 daily 0.8 http://www.pharma-marketer.com/institut-pasteur-ae%e2%80%9c-stomach-cancer-poster/ 2009-09-14T05:38:40+00:00 daily 0.8 http://www.pharma-marketer.com/telfast-ae%e2%80%9c-boy-2/ 2009-09-14T05:22:53+00:00 daily 0.8 http://www.pharma-marketer.com/spectrum-pharma-market-opportunities-for-zevalin-may-expand-significantly/ 2009-09-13T19:24:09+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-busy-with-bevy-of-small-deals/ 2009-09-13T19:24:09+00:00 daily 0.8 http://www.pharma-marketer.com/teva-ms-drug-laquinimod-works-two-ways/ 2009-09-13T19:24:08+00:00 daily 0.8 http://www.pharma-marketer.com/israel-stocks-mixed-teva-drug-advances-ceragon-jumps/ 2009-09-13T19:24:06+00:00 daily 0.8 http://www.pharma-marketer.com/chinabio-day-unveils-program-highlights/ 2009-09-13T19:24:04+00:00 daily 0.8 http://www.pharma-marketer.com/readers-ask-antares-genvec-xoma/ 2009-09-13T19:24:03+00:00 daily 0.8 http://www.pharma-marketer.com/swine-flu-expectation-game/ 2009-09-13T19:24:02+00:00 daily 0.8 http://www.pharma-marketer.com/target-ae%e2%80%9c-4-generics/ 2009-09-13T12:18:23+00:00 daily 0.8 http://www.pharma-marketer.com/target-ae%e2%80%9c-attached/ 2009-09-13T12:18:12+00:00 daily 0.8 http://www.pharma-marketer.com/bayer-drontal-ae%e2%80%9c-plus/ 2009-09-13T10:38:13+00:00 daily 0.8 http://www.pharma-marketer.com/telfast-ae%e2%80%9c-boy-1/ 2009-09-13T10:38:10+00:00 daily 0.8 http://www.pharma-marketer.com/telfast-ae%e2%80%9c-girl-1/ 2009-09-13T10:38:07+00:00 daily 0.8 http://www.pharma-marketer.com/telfast-ae%e2%80%9c-family/ 2009-09-13T10:38:04+00:00 daily 0.8 http://www.pharma-marketer.com/telfast-ae%e2%80%9c-farmer/ 2009-09-13T10:37:55+00:00 daily 0.8 http://www.pharma-marketer.com/telfast-ae%e2%80%9c-girl-2/ 2009-09-13T10:37:46+00:00 daily 0.8 http://www.pharma-marketer.com/target-attached/ 2009-09-13T09:54:31+00:00 daily 0.8 http://www.pharma-marketer.com/telfast-girl-2/ 2009-09-13T09:08:55+00:00 daily 0.8 http://www.pharma-marketer.com/telfast-farmer/ 2009-09-13T09:08:55+00:00 daily 0.8 http://www.pharma-marketer.com/telfast-boy-2/ 2009-09-13T09:08:54+00:00 daily 0.8 http://www.pharma-marketer.com/telfast-family/ 2009-09-13T09:08:54+00:00 daily 0.8 http://www.pharma-marketer.com/telfast-girl-1/ 2009-09-13T09:08:54+00:00 daily 0.8 http://www.pharma-marketer.com/telfast-boy-1/ 2009-09-13T09:08:54+00:00 daily 0.8 http://www.pharma-marketer.com/bayer-drontal-plus/ 2009-09-13T09:07:45+00:00 daily 0.8 http://www.pharma-marketer.com/isis-pharma-to-get-expanded-us-patent-for-single-stranded-rnai-technology/ 2009-09-12T19:40:52+00:00 daily 0.8 http://www.pharma-marketer.com/judge-declares-mistrial-in-first-fosamax-trial/ 2009-09-12T15:59:55+00:00 daily 0.8 http://www.pharma-marketer.com/merck-gains-on-fosamax-ruling/ 2009-09-12T15:59:54+00:00 daily 0.8 http://www.pharma-marketer.com/phase-3-trial-of-aflibercept-in-metastatic-pancreatic-cancer-discontinued/ 2009-09-12T15:59:53+00:00 daily 0.8 http://www.pharma-marketer.com/osiris-cfo-leaves-after-failure-of-stem-cell-drug/ 2009-09-12T15:59:52+00:00 daily 0.8 http://www.pharma-marketer.com/3-hot-biotech-bets-right-now/ 2009-09-12T15:59:51+00:00 daily 0.8 http://www.pharma-marketer.com/theravance-and-astellas-announce-fda-approval-of-vibativtm-telavancin-for-the-treatment-of-complicated-skin-and-skin/ 2009-09-12T15:59:50+00:00 daily 0.8 http://www.pharma-marketer.com/salix-gets-fda-marketing-ok-for-metozolv-odt/ 2009-09-12T15:59:48+00:00 daily 0.8 http://www.pharma-marketer.com/analyst-lists-five-biotech-companies-to-watch/ 2009-09-12T15:59:48+00:00 daily 0.8 http://www.pharma-marketer.com/institut-pasteur-ae%e2%80%9c-plasmodium/ 2009-09-12T14:05:31+00:00 daily 0.8 http://www.pharma-marketer.com/institut-pasteur-ae%e2%80%9c-stomach-cancer/ 2009-09-12T14:05:27+00:00 daily 0.8 http://www.pharma-marketer.com/institut-pasteur-ae%e2%80%9c-memory-loss/ 2009-09-12T14:05:22+00:00 daily 0.8 http://www.pharma-marketer.com/plavix-ae%e2%80%9c-living-proof/ 2009-09-12T10:49:21+00:00 daily 0.8 http://www.pharma-marketer.com/why-do-dtc-marketers-continue-to-spend-waste-so-much-money-on-tv/ 2009-09-12T01:16:04+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-settlement-a-cattle-call-for-more-whistleblowers-who-want-a-big-payday/ 2009-09-12T01:10:06+00:00 daily 0.8 http://www.pharma-marketer.com/2009-survey-of-health-care-consumers-health-care-is-a-consumer-market/ 2009-09-12T01:03:17+00:00 daily 0.8 http://www.pharma-marketer.com/plavix-living-proof/ 2009-09-11T20:09:54+00:00 daily 0.8 http://www.pharma-marketer.com/nycomed-said-to-be-close-to-getting-debt-funding-for-solvay-bid/ 2009-09-11T17:47:00+00:00 daily 0.8 http://www.pharma-marketer.com/zymogeneticsa%c2%a2aea%e2%84%a2-rheumatoid-arthritis-drug-test-goes-poorly/ 2009-09-11T15:49:21+00:00 daily 0.8 http://www.pharma-marketer.com/amylin-inks-diabetes-pact-with-biocon/ 2009-09-11T14:45:48+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-woes-trigger-a-50m-windfall-for-shire/ 2009-09-11T14:40:27+00:00 daily 0.8 http://www.pharma-marketer.com/discovery-labs-shares-boosted-as-fda-meeting-looms/ 2009-09-11T14:22:15+00:00 daily 0.8 http://www.pharma-marketer.com/intercytex-shares-suspended/ 2009-09-11T14:10:24+00:00 daily 0.8 http://www.pharma-marketer.com/study-swine-flu-vaccines-protect-people-after-a-single-jab/ 2009-09-11T13:58:28+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-to-defend-paxil-in-birth-defect-test-case-trial/ 2009-09-11T13:41:44+00:00 daily 0.8 http://www.pharma-marketer.com/glaxos-u-s-cervarix-approval-more-important-for-companys-pride-than-for-sales/ 2009-09-11T13:41:44+00:00 daily 0.8 http://www.pharma-marketer.com/another-positive-indication-for-amgens-denosumab/ 2009-09-11T13:41:43+00:00 daily 0.8 http://www.pharma-marketer.com/vivus-a-one-trick-pony/ 2009-09-11T13:41:42+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-cites-reduction-in-chronic-lower-back-pain-in-cymbalta-study/ 2009-09-11T13:41:42+00:00 daily 0.8 http://www.pharma-marketer.com/amylin-and-biocon-say-they-will-work-together-to-develop-diabetes-drug-combining-2-hormones/ 2009-09-11T13:41:41+00:00 daily 0.8 http://www.pharma-marketer.com/shire-set-for-50-million-windfall-on-demand-for-gaucher-drug/ 2009-09-11T13:41:41+00:00 daily 0.8 http://www.pharma-marketer.com/almirall-jumpstarts-copd-hopeful-aclidinium/ 2009-09-11T13:41:40+00:00 daily 0.8 http://www.pharma-marketer.com/reports-dr-reddys-not-seeking-to-sell-stake/ 2009-09-11T13:41:40+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-is-in-talks-on-patent-pools/ 2009-09-11T13:41:39+00:00 daily 0.8 http://www.pharma-marketer.com/taking-profits-from-swine-flu-with-tamiflu-1-comment/ 2009-09-11T13:41:38+00:00 daily 0.8 http://www.pharma-marketer.com/discovery-labs-fda-meeting-set-for-sept-29/ 2009-09-11T13:41:38+00:00 daily 0.8 http://www.pharma-marketer.com/sequencing-looms-as-a-game-changer/ 2009-09-11T12:40:41+00:00 daily 0.8 http://www.pharma-marketer.com/merck-kgaa-pulls-ahead-in-hot-oral-ms-drug-race/ 2009-09-11T12:22:32+00:00 daily 0.8 http://www.pharma-marketer.com/antioxidants-and-cancer-backwards/ 2009-09-11T12:14:56+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-oab-teaser-banner-ads/ 2009-09-11T10:34:38+00:00 daily 0.8 http://www.pharma-marketer.com/abilify-dtc-print-ad/ 2009-09-11T10:31:15+00:00 daily 0.8 http://www.pharma-marketer.com/lyrica-fibromyalgia-ad/ 2009-09-11T10:29:08+00:00 daily 0.8 http://www.pharma-marketer.com/crestor-ae%e2%80%9c-are-you-at-risk/ 2009-09-11T10:21:18+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-oab/ 2009-09-11T10:13:38+00:00 daily 0.8 http://www.pharma-marketer.com/sympramol/ 2009-09-11T10:13:26+00:00 daily 0.8 http://www.pharma-marketer.com/fda-wants-more-data-about-johnson-johnsons-ovarian-cancer-drug-yondelis/ 2009-09-11T02:06:07+00:00 daily 0.8 http://www.pharma-marketer.com/the-vanishing-vaccine-war/ 2009-09-11T02:06:04+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-labs-buys-device-maker/ 2009-09-11T02:05:57+00:00 daily 0.8 http://www.pharma-marketer.com/swine-flu-update-a-single-dose-vaccine-appears-to-work-study-shows/ 2009-09-11T02:05:51+00:00 daily 0.8 http://www.pharma-marketer.com/institut-pasteur-stomach-cancer-poster/ 2009-09-11T01:19:38+00:00 daily 0.8 http://www.pharma-marketer.com/institut-pasteur-memory-loss/ 2009-09-11T01:19:37+00:00 daily 0.8 http://www.pharma-marketer.com/institut-pasteur-stomach-cancer/ 2009-09-11T01:19:37+00:00 daily 0.8 http://www.pharma-marketer.com/institut-pasteur-plasmodium/ 2009-09-11T01:19:37+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-shares-flat-a-day-after-obama-speech-reaffirms-push-for-health-care-reform/ 2009-09-10T21:26:06+00:00 daily 0.8 http://www.pharma-marketer.com/goldman-sachs-on-healthcare-a%c2%a2aea%cb%9ca-stock-pickera%c2%a2aea%e2%84%a2s-paradisea%c2%a2aea%e2%84%a2/ 2009-09-10T21:26:04+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-rated-overweight-on-late-stage-pipeline/ 2009-09-10T21:26:02+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-moves-ahead-with-cervarix/ 2009-09-10T21:26:01+00:00 daily 0.8 http://www.pharma-marketer.com/the-future-is-on-demand-samples/ 2009-09-10T19:56:19+00:00 daily 0.8 http://www.pharma-marketer.com/fda-rejects-yondelis-doxil-combo-for-ovarian-cancer/ 2009-09-10T18:52:56+00:00 daily 0.8 http://www.pharma-marketer.com/warning-to-buzz-marketers-pfizer-did-not-get-the-joke-same-for-jj/ 2009-09-10T18:29:45+00:00 daily 0.8 http://www.pharma-marketer.com/glaxosmithkline-cut-at-socgen-on-threat-to-advair/ 2009-09-10T17:23:55+00:00 daily 0.8 http://www.pharma-marketer.com/onyxa%c2%a2aea%e2%84%a2s-nexavar-helps-breast-cancer-patients-ceo-says/ 2009-09-10T17:23:51+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-backs-gardasil-for-use-by-men/ 2009-09-10T17:23:35+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-maintains-facet-offer/ 2009-09-10T17:23:34+00:00 daily 0.8 http://www.pharma-marketer.com/report-large-majorities-of-public-blame-health-insurers-drug-industry-republicans-business-for-problems-with-our-cur/ 2009-09-10T17:23:32+00:00 daily 0.8 http://www.pharma-marketer.com/merck-reports-mixed-data-for-migraine-drug/ 2009-09-10T17:23:30+00:00 daily 0.8 http://www.pharma-marketer.com/judge-to-give-jury-cooling-off-period-in-fosamax-case/ 2009-09-10T17:23:29+00:00 daily 0.8 http://www.pharma-marketer.com/study-weakens-lillys-fight-against-price-controls/ 2009-09-10T17:23:27+00:00 daily 0.8 http://www.pharma-marketer.com/vivuss-qnexa-drug-approval-makes-it-a-nice-trade/ 2009-09-10T17:23:22+00:00 daily 0.8 http://www.pharma-marketer.com/vicals-swine-flu-vaccine-works-in-mice-rabbits/ 2009-09-10T17:23:19+00:00 daily 0.8 http://www.pharma-marketer.com/dynavax-generex-rocket-as-drug-stocks-dip/ 2009-09-10T17:23:17+00:00 daily 0.8 http://www.pharma-marketer.com/top-facet-investors-big-sell-off/ 2009-09-10T17:23:16+00:00 daily 0.8 http://www.pharma-marketer.com/merck-ends-development-of-an-experimental-migraine-treatment-cites-potential-liver-problems/ 2009-09-10T17:23:15+00:00 daily 0.8 http://www.pharma-marketer.com/generic-drugmaker-stocks-unaffected-following-obama-address-on-health-care-reform-plans/ 2009-09-10T17:23:14+00:00 daily 0.8 http://www.pharma-marketer.com/boehringer-ingelheim-likely-to-have-regulatory-submission-for-pradaxa-delayed/ 2009-09-10T17:23:13+00:00 daily 0.8 http://www.pharma-marketer.com/ms-drug-tysabri-reawakens-brain-virus-study/ 2009-09-10T17:22:56+00:00 daily 0.8 http://www.pharma-marketer.com/in-a-first-australias-chemgenex-files-nda-for-cancer-drug/ 2009-09-10T15:55:16+00:00 daily 0.8 http://www.pharma-marketer.com/argen-x-gins-13-6m-in-new-funds-for-mab-work/ 2009-09-10T15:43:19+00:00 daily 0.8 http://www.pharma-marketer.com/merck-scraps-one-migraine-drug-pushes-another/ 2009-09-10T15:31:13+00:00 daily 0.8 http://www.pharma-marketer.com/evolva-bags-struggling-arpida-in-merger-pact/ 2009-09-10T15:18:29+00:00 daily 0.8 http://www.pharma-marketer.com/52-perspectives-aeoecareer-outlook-for-pharma-biotechae%ef%bf%bd/ 2009-09-10T15:00:06+00:00 daily 0.8 http://www.pharma-marketer.com/complete-genomics-sequences-14-genomes-for-4k-each/ 2009-09-10T14:22:59+00:00 daily 0.8 http://www.pharma-marketer.com/complete-genomics-slashes-the-cost-of-genomic-sequencing/ 2009-09-10T14:22:59+00:00 daily 0.8 http://www.pharma-marketer.com/to-what-end/ 2009-09-10T12:21:51+00:00 daily 0.8 http://www.pharma-marketer.com/abilify-canada/ 2009-09-10T12:00:12+00:00 daily 0.8 http://www.pharma-marketer.com/sepracors-suitor-is-hard-to-understand/ 2009-09-10T09:27:27+00:00 daily 0.8 http://www.pharma-marketer.com/market-jitters-affect-allos/ 2009-09-10T09:27:26+00:00 daily 0.8 http://www.pharma-marketer.com/chugai-pharma-to-triple-tamiflu-supply-in-japan/ 2009-09-10T09:27:24+00:00 daily 0.8 http://www.pharma-marketer.com/exiting-facet-biotech-on-biogens-offer/ 2009-09-10T09:27:08+00:00 daily 0.8 http://www.pharma-marketer.com/roche-confirms-2009-pharma-company-goals/ 2009-09-10T09:27:05+00:00 daily 0.8 http://www.pharma-marketer.com/roche-sees-isolated-cases-of-tamiflu-resistance/ 2009-09-10T09:26:55+00:00 daily 0.8 http://www.pharma-marketer.com/novavaxs-vlp-technology-is-a-game-changer/ 2009-09-10T09:26:44+00:00 daily 0.8 http://www.pharma-marketer.com/xenoport-ends-study-of-back-spasm-drug-candidate/ 2009-09-10T09:26:38+00:00 daily 0.8 http://www.pharma-marketer.com/repros-therapeutics-finds-funding/ 2009-09-10T09:26:37+00:00 daily 0.8 http://www.pharma-marketer.com/why-funds-missed-facet-biotech/ 2009-09-10T09:26:20+00:00 daily 0.8 http://www.pharma-marketer.com/sector-snap-analyst-keeps-positive-biotech-view/ 2009-09-10T09:26:16+00:00 daily 0.8 http://www.pharma-marketer.com/osiris-drugs-failure-was-easy-to-envision/ 2009-09-10T09:26:15+00:00 daily 0.8 http://www.pharma-marketer.com/fda-backs-hpv-vaccines-as-panel-vote-looms/ 2009-09-10T09:26:03+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-rep-alleges-viagra-promoted-with-unapproved-materials/ 2009-09-10T09:25:58+00:00 daily 0.8 http://www.pharma-marketer.com/cornerstone-wins-factive-rights/ 2009-09-10T09:25:54+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-grows-strong-on-vaccines/ 2009-09-10T09:25:53+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeutics-fails-to-impress/ 2009-09-10T09:25:53+00:00 daily 0.8 http://www.pharma-marketer.com/prices-profits-and-the-economics-of-big-pharma/ 2009-09-10T09:25:52+00:00 daily 0.8 http://www.pharma-marketer.com/botox-may-get-1-billion-face-lift-as-allergan-migraine-drug/ 2009-09-10T09:25:49+00:00 daily 0.8 http://www.pharma-marketer.com/merck-jury-told-to-keep-deliberating-in-fosamax-case/ 2009-09-10T09:25:40+00:00 daily 0.8 http://www.pharma-marketer.com/cytrx-to-repsond-to-fda-letter-in-4q/ 2009-09-10T09:25:39+00:00 daily 0.8 http://www.pharma-marketer.com/vivus-obesity-drug-candidate-hits-weight-reduction-goals-in-2-late-stage-studies-shares-soar/ 2009-09-10T09:25:39+00:00 daily 0.8 http://www.pharma-marketer.com/red-hot-novavax-negotiating-vax-tech-transfers/ 2009-09-10T09:25:35+00:00 daily 0.8 http://www.pharma-marketer.com/sepracor-shareholders-sue-to-block-deal/ 2009-09-10T09:25:31+00:00 daily 0.8 http://www.pharma-marketer.com/fda-panel-backs-glaxos-cervical-vaccine-for-women/ 2009-09-10T09:25:30+00:00 daily 0.8 http://www.pharma-marketer.com/disappointment-for-osiris/ 2009-09-10T09:25:29+00:00 daily 0.8 http://www.pharma-marketer.com/targeted-genetics-sells-assets-to-genzyme/ 2009-09-10T09:25:29+00:00 daily 0.8 http://www.pharma-marketer.com/what-the-baucus-bill-could-mean-for-chantix/ 2009-09-10T09:25:28+00:00 daily 0.8 http://www.pharma-marketer.com/good-news-for-salix/ 2009-09-10T09:25:26+00:00 daily 0.8 http://www.pharma-marketer.com/abilify/ 2009-09-10T02:46:35+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-fda-expert-panel-backs-glaxos-hpv-vaccine/ 2009-09-09T18:56:54+00:00 daily 0.8 http://www.pharma-marketer.com/dynavax-shares-soar-as-fda-clears-hep-b-trial/ 2009-09-09T18:56:54+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-corporate/ 2009-09-09T17:43:10+00:00 daily 0.8 http://www.pharma-marketer.com/allis-new-marketing-strategy-enhance-product-claims-cast-treatment-effects-as-a-benefit/ 2009-09-09T15:47:10+00:00 daily 0.8 http://www.pharma-marketer.com/celebrex-football-banner/ 2009-09-09T15:14:50+00:00 daily 0.8 http://www.pharma-marketer.com/targeted-genetics-survives-near-death-experience/ 2009-09-09T14:52:50+00:00 daily 0.8 http://www.pharma-marketer.com/sepracor-investors-try-to-derail-2-6b-dainippon-buyout/ 2009-09-09T14:32:41+00:00 daily 0.8 http://www.pharma-marketer.com/celebrex-skater-banner/ 2009-09-09T14:27:27+00:00 daily 0.8 http://www.pharma-marketer.com/xoma-garners-6m-in-antibody-pact/ 2009-09-09T14:17:15+00:00 daily 0.8 http://www.pharma-marketer.com/gardasil-ccni-recommended/ 2009-09-09T13:51:35+00:00 daily 0.8 http://www.pharma-marketer.com/lipitor-ascot-and-cards-banner/ 2009-09-09T13:39:44+00:00 daily 0.8 http://www.pharma-marketer.com/fda-hands-ista-an-approval-for-itchy-eye-treatment/ 2009-09-09T13:09:45+00:00 daily 0.8 http://www.pharma-marketer.com/fueled-by-promising-obesity-data-vivus-shares-rocket-up/ 2009-09-09T12:58:34+00:00 daily 0.8 http://www.pharma-marketer.com/scratch-and-sniff-turns-into-zap-and-react/ 2009-09-09T12:27:25+00:00 daily 0.8 http://www.pharma-marketer.com/google-wave-3-how-will-google-wave-communications-be-regulated-if-at-all/ 2009-09-09T06:33:00+00:00 daily 0.8 http://www.pharma-marketer.com/kapidex-hcp-print-ad/ 2009-09-08T23:41:32+00:00 daily 0.8 http://www.pharma-marketer.com/miralax-hcp-print-ad/ 2009-09-08T23:19:33+00:00 daily 0.8 http://www.pharma-marketer.com/sec-sues-cellcyte-former-execs-for-lying-to-investors/ 2009-09-08T20:39:23+00:00 daily 0.8 http://www.pharma-marketer.com/cell-biosciences-inks-deal-for-alpha-innotech/ 2009-09-08T15:58:15+00:00 daily 0.8 http://www.pharma-marketer.com/opexa-shares-rocket-up-on-promising-ms-trial-data/ 2009-09-08T15:23:49+00:00 daily 0.8 http://www.pharma-marketer.com/fdas-reportable-food-registry/ 2009-09-08T14:45:35+00:00 daily 0.8 http://www.pharma-marketer.com/osiris-shares-blitzed-after-pivotal-prochymal-trials-fail/ 2009-09-08T13:39:15+00:00 daily 0.8 http://www.pharma-marketer.com/consistently-casey-vyvanse/ 2009-09-08T12:51:31+00:00 daily 0.8 http://www.pharma-marketer.com/solaraze-gel/ 2009-09-08T12:48:34+00:00 daily 0.8 http://www.pharma-marketer.com/follow-us-on-twitter/ 2009-09-08T12:24:21+00:00 daily 0.8 http://www.pharma-marketer.com/right-where-you-want-them/ 2009-09-08T12:13:00+00:00 daily 0.8 http://www.pharma-marketer.com/introducing-add-adhd-blog/ 2009-09-08T11:59:23+00:00 daily 0.8 http://www.pharma-marketer.com/facet-rejects-biogens-356m-bid-shares-rise/ 2009-09-08T11:58:57+00:00 daily 0.8 http://www.pharma-marketer.com/roche-reshuffles-management-in-biotech-makeover/ 2009-09-08T11:17:38+00:00 daily 0.8 http://www.pharma-marketer.com/even-mouthwash-ae%e2%80%9c-glasses-ae%e2%80%9c-tv-commercial/ 2009-09-08T04:28:25+00:00 daily 0.8 http://www.pharma-marketer.com/even-mouthwash-ae%e2%80%9c-cake/ 2009-09-08T04:28:19+00:00 daily 0.8 http://www.pharma-marketer.com/even-mouthwash-ae%e2%80%9c-roller-coaster/ 2009-09-08T04:28:10+00:00 daily 0.8 http://www.pharma-marketer.com/niaspan/ 2009-09-08T03:51:53+00:00 daily 0.8 http://www.pharma-marketer.com/target-4-generics/ 2009-09-08T03:09:54+00:00 daily 0.8 http://www.pharma-marketer.com/mirena-wiped-out/ 2009-09-08T03:09:53+00:00 daily 0.8 http://www.pharma-marketer.com/mederma-live-with-scar/ 2009-09-08T03:09:52+00:00 daily 0.8 http://www.pharma-marketer.com/toviaz-mosaic/ 2009-09-08T01:33:56+00:00 daily 0.8 http://www.pharma-marketer.com/lantus-crossing-guard/ 2009-09-08T01:33:52+00:00 daily 0.8 http://www.pharma-marketer.com/humalog-kwikpen/ 2009-09-08T01:33:47+00:00 daily 0.8 http://www.pharma-marketer.com/crestor-take-action/ 2009-09-08T01:33:43+00:00 daily 0.8 http://www.pharma-marketer.com/crestor-little-secret/ 2009-09-08T01:33:42+00:00 daily 0.8 http://www.pharma-marketer.com/marketing-team-players-should-pay-attention-to-the-e-in-team-ethics/ 2009-09-07T14:43:24+00:00 daily 0.8 http://www.pharma-marketer.com/dtc-at-the-crossroads/ 2009-09-07T14:20:03+00:00 daily 0.8 http://www.pharma-marketer.com/zyrtec-for-itchy-eye/ 2009-09-06T11:52:56+00:00 daily 0.8 http://www.pharma-marketer.com/zyrtec-print-ad-announcing-its-change-from-rx-to-otc/ 2009-09-06T11:47:57+00:00 daily 0.8 http://www.pharma-marketer.com/lexapro/ 2009-09-06T10:29:28+00:00 daily 0.8 http://www.pharma-marketer.com/lexapro-iprint-adi/ 2009-09-05T21:34:10+00:00 daily 0.8 http://www.pharma-marketer.com/desitin/ 2009-09-05T21:34:09+00:00 daily 0.8 http://www.pharma-marketer.com/sarafem-for-pmdd-from-2001/ 2009-09-05T18:53:26+00:00 daily 0.8 http://www.pharma-marketer.com/sarafem/ 2009-09-05T17:21:04+00:00 daily 0.8 http://www.pharma-marketer.com/cesamet-ae%e2%80%9c-web-banner/ 2009-09-05T12:44:23+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-infectious-diseases-ae%e2%80%9c-web-banner/ 2009-09-05T12:03:49+00:00 daily 0.8 http://www.pharma-marketer.com/cold-fx-ae%e2%80%9c-fight-the-flu/ 2009-09-05T10:58:33+00:00 daily 0.8 http://www.pharma-marketer.com/american-dental-association-ae%e2%80%9c-dental-floss/ 2009-09-05T10:58:21+00:00 daily 0.8 http://www.pharma-marketer.com/american-dental-association-dental-floss/ 2009-09-05T10:09:35+00:00 daily 0.8 http://www.pharma-marketer.com/ideas-while-you-sleep/ 2009-09-05T09:47:31+00:00 daily 0.8 http://www.pharma-marketer.com/sjcrh-ae%e2%80%9c-parents/ 2009-09-05T09:45:24+00:00 daily 0.8 http://www.pharma-marketer.com/sjcrh-parents/ 2009-09-05T08:57:40+00:00 daily 0.8 http://www.pharma-marketer.com/tabaconomia-ae%e2%80%9c-car/ 2009-09-04T21:15:58+00:00 daily 0.8 http://www.pharma-marketer.com/treehouse-ae%e2%80%9c-bath/ 2009-09-04T19:35:07+00:00 daily 0.8 http://www.pharma-marketer.com/treehouse-ae%e2%80%9c-bed/ 2009-09-04T19:34:58+00:00 daily 0.8 http://www.pharma-marketer.com/treehouse-ae%e2%80%9c-table/ 2009-09-04T19:34:49+00:00 daily 0.8 http://www.pharma-marketer.com/treehouse-table/ 2009-09-04T19:14:54+00:00 daily 0.8 http://www.pharma-marketer.com/treehouse-bed/ 2009-09-04T19:14:53+00:00 daily 0.8 http://www.pharma-marketer.com/treehouse-bath/ 2009-09-04T19:14:53+00:00 daily 0.8 http://www.pharma-marketer.com/funny-commercial-for-a-toothpaste-from-thailand/ 2009-09-04T19:09:19+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-whistleblowing-how-it-works/ 2009-09-04T18:57:31+00:00 daily 0.8 http://www.pharma-marketer.com/shire-prepares-marketing-efforts-for-intuniv/ 2009-09-04T18:09:31+00:00 daily 0.8 http://www.pharma-marketer.com/trialcard-ae%e2%80%9c-window/ 2009-09-04T16:33:18+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-ikyp-webkey/ 2009-09-04T16:30:18+00:00 daily 0.8 http://www.pharma-marketer.com/intelliscript-ae%e2%80%9c-smart-relationship/ 2009-09-04T16:28:02+00:00 daily 0.8 http://www.pharma-marketer.com/rx-4-good/ 2009-09-04T15:48:28+00:00 daily 0.8 http://www.pharma-marketer.com/healthbridge-ae%e2%80%9c-bridging-the-gap/ 2009-09-04T15:35:48+00:00 daily 0.8 http://www.pharma-marketer.com/mds-pharma-services-ae%e2%80%9c-milestone/ 2009-09-04T15:25:30+00:00 daily 0.8 http://www.pharma-marketer.com/a-look-back-and-forward/ 2009-09-04T15:01:39+00:00 daily 0.8 http://www.pharma-marketer.com/acura-king-fda-doesnt-need-new-trials-for-acurox/ 2009-09-04T14:30:29+00:00 daily 0.8 http://www.pharma-marketer.com/sepracor-says-its-staying-put/ 2009-09-04T14:09:43+00:00 daily 0.8 http://www.pharma-marketer.com/adheris-ae%e2%80%9c-top-of-mind/ 2009-09-04T13:55:33+00:00 daily 0.8 http://www.pharma-marketer.com/patients-do-not-want-to-use-social-media-to-talk-to-docs/ 2009-09-04T13:49:46+00:00 daily 0.8 http://www.pharma-marketer.com/array-biopharma-shares-down-on-mid-stage-ra-trial-failure/ 2009-09-04T13:26:18+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-assisted-antibody-discovery-may-lead-to-aids-vaccine/ 2009-09-04T12:45:06+00:00 daily 0.8 http://www.pharma-marketer.com/helicos-shares-buoyed-by-partnering-talks/ 2009-09-04T12:11:30+00:00 daily 0.8 http://www.pharma-marketer.com/sepracor-a-desirable-property/ 2009-09-04T12:07:36+00:00 daily 0.8 http://www.pharma-marketer.com/cold-fx-fight-the-flu/ 2009-09-04T08:48:26+00:00 daily 0.8 http://www.pharma-marketer.com/chinas-cro-industry-booms-as-pharma-demand-heats-up/ 2009-09-03T20:10:13+00:00 daily 0.8 http://www.pharma-marketer.com/obamas-health-care-message-hard-to-controlkey-lesson-you-dont-control-your-message-anymore/ 2009-09-03T19:16:13+00:00 daily 0.8 http://www.pharma-marketer.com/fda-to-address-deficiencies-in-post-marketing-surveillance/ 2009-09-03T18:35:52+00:00 daily 0.8 http://www.pharma-marketer.com/real-molecules/ 2009-09-03T18:23:20+00:00 daily 0.8 http://www.pharma-marketer.com/there%e2%80%99s-no-%e2%80%9ci%e2%80%9d-in-team/ 2009-09-03T17:45:54+00:00 daily 0.8 http://www.pharma-marketer.com/real-people-vs-celebrity-spokespeople/ 2009-09-03T17:34:18+00:00 daily 0.8 http://www.pharma-marketer.com/making-a-business-case-for-tweeting/ 2009-09-03T17:27:30+00:00 daily 0.8 http://www.pharma-marketer.com/multiple-posts/ 2009-09-03T16:01:04+00:00 daily 0.8 http://www.pharma-marketer.com/what-do-phone-sex-the-pittsburgh-symphony-orchestra-amgen-psoriasis-have-in-common/ 2009-09-03T15:10:49+00:00 daily 0.8 http://www.pharma-marketer.com/viagra-ae%e2%80%9c-web-banner/ 2009-09-03T15:09:11+00:00 daily 0.8 http://www.pharma-marketer.com/leo-snags-peplin-lesion-therapy-in-287m-buyout/ 2009-09-03T14:12:05+00:00 daily 0.8 http://www.pharma-marketer.com/there-was-a-time-when-we-were-proud-to-wear-drug-company-shirts/ 2009-09-03T13:59:39+00:00 daily 0.8 http://www.pharma-marketer.com/akela-slashes-staff-shutters-sites-in-restructuring/ 2009-09-03T13:54:36+00:00 daily 0.8 http://www.pharma-marketer.com/sustiva-ae%e2%80%9c-skyline/ 2009-09-03T13:53:26+00:00 daily 0.8 http://www.pharma-marketer.com/novartis-hails-single-dose-h1n1-success/ 2009-09-03T13:23:16+00:00 daily 0.8 http://www.pharma-marketer.com/genentech-witnesses-dramatic-tumor-effect-in-small-trial/ 2009-09-03T12:40:27+00:00 daily 0.8 http://www.pharma-marketer.com/bayer-snares-algetas-lead-cancer-med-in-800m-pact/ 2009-09-03T12:09:58+00:00 daily 0.8 http://www.pharma-marketer.com/dainippon-grabs-sepracor-for-2-6b/ 2009-09-03T11:47:43+00:00 daily 0.8 http://www.pharma-marketer.com/even-mouthwash-ae%e2%80%9c-scuba-diver/ 2009-09-03T11:29:45+00:00 daily 0.8 http://www.pharma-marketer.com/a-2-3-billion-dollar-attention-getter/ 2009-09-03T11:22:09+00:00 daily 0.8 http://www.pharma-marketer.com/viagra-web-banner/ 2009-09-03T08:46:49+00:00 daily 0.8 http://www.pharma-marketer.com/sustiva-skyline/ 2009-09-03T08:41:54+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-infectious-diseases-web-banner/ 2009-09-03T08:06:13+00:00 daily 0.8 http://www.pharma-marketer.com/cesamet-web-banner/ 2009-09-03T07:40:09+00:00 daily 0.8 http://www.pharma-marketer.com/at-last-a-search-engine-for-health/ 2009-09-02T23:36:35+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-pays-2-3-billion-for-deceptive-marketing-practices/ 2009-09-02T21:05:02+00:00 daily 0.8 http://www.pharma-marketer.com/among-americans-with-internet-access-about-12-percent-communicate-online-with-their-doctor%e2%80%99s-office/ 2009-09-02T18:58:52+00:00 daily 0.8 http://www.pharma-marketer.com/fondation-pour-la-recherche-medicale-print-ad/ 2009-09-02T18:27:06+00:00 daily 0.8 http://www.pharma-marketer.com/metabasis-ceo-jumps-to-merck/ 2009-09-02T17:33:49+00:00 daily 0.8 http://www.pharma-marketer.com/at-what-point-does-an-individual-stand-up-and-say-this-is-wrong/ 2009-09-02T16:49:46+00:00 daily 0.8 http://www.pharma-marketer.com/peregrine-shares-jump-after-drug-demos-brain-cancer-efficacy/ 2009-09-02T15:45:20+00:00 daily 0.8 http://www.pharma-marketer.com/manhattan-researchs-latest-ehealth-trends/ 2009-09-02T14:19:23+00:00 daily 0.8 http://www.pharma-marketer.com/danaher-to-pay-1-1b-for-two-bioresearch-tech-companies/ 2009-09-02T14:06:41+00:00 daily 0.8 http://www.pharma-marketer.com/eloxatin-ae%e2%80%9c-sailboat/ 2009-09-02T14:06:33+00:00 daily 0.8 http://www.pharma-marketer.com/what-if-your-brand-marketing-plan-was-reviewed-by-outsiders/ 2009-09-02T13:37:07+00:00 daily 0.8 http://www.pharma-marketer.com/ptc-inks-discovery-deals-with-roche-celgene-worth-2b/ 2009-09-02T13:35:57+00:00 daily 0.8 http://www.pharma-marketer.com/bestselling-drugs-of-2008/ 2009-09-02T12:50:11+00:00 daily 0.8 http://www.pharma-marketer.com/is-the-bar-set-too-low-for-new-cancer-drugs/ 2009-09-02T12:27:20+00:00 daily 0.8 http://www.pharma-marketer.com/twitters-for-the-dogs-and-other-indirect-customers/ 2009-09-02T12:24:38+00:00 daily 0.8 http://www.pharma-marketer.com/are-otcs-just-o-as-in-over/ 2009-09-02T12:02:48+00:00 daily 0.8 http://www.pharma-marketer.com/lexapro-forest-labs-and-the-hard-sell/ 2009-09-02T11:43:52+00:00 daily 0.8 http://www.pharma-marketer.com/earache-drops-ae%e2%80%9c-splash/ 2009-09-02T11:41:38+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-nitec-trumpets-successful-late-stage-ra-trial/ 2009-09-02T11:16:55+00:00 daily 0.8 http://www.pharma-marketer.com/nitec-trumpets-successful-late-stage-ra-trial/ 2009-09-02T11:16:55+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-finishes-21b-medarex-acquisition/ 2009-09-01T23:30:29+00:00 daily 0.8 http://www.pharma-marketer.com/drugmakers-launch-generic-imitrex/ 2009-09-01T23:30:28+00:00 daily 0.8 http://www.pharma-marketer.com/the-digital-wave-ae%e2%80%9c-delivering-education-and-services-to-healthcare-providers/ 2009-09-01T20:36:57+00:00 daily 0.8 http://www.pharma-marketer.com/jjs-cypress-enrollment-begins/ 2009-09-01T20:20:01+00:00 daily 0.8 http://www.pharma-marketer.com/vion-makes-case-for-leukemia-drug-to-fda-panel/ 2009-09-01T20:20:00+00:00 daily 0.8 http://www.pharma-marketer.com/novavax-says-vaccine-for-3-strains-of-flu-met-goal-in-study-shares-hit-3-year-high/ 2009-09-01T20:19:56+00:00 daily 0.8 http://www.pharma-marketer.com/medicines-cos-angiomax-promising/ 2009-09-01T20:19:55+00:00 daily 0.8 http://www.pharma-marketer.com/four-possibilities-for-pharma-firms-fair-values/ 2009-09-01T20:19:54+00:00 daily 0.8 http://www.pharma-marketer.com/twitter-for-patient-support-not-as-it-is-but-as-it-could-be/ 2009-09-01T20:17:02+00:00 daily 0.8 http://www.pharma-marketer.com/merck-launches-online-video-with-project-runway-hiv-spokesman/ 2009-09-01T17:31:16+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-unit-wins-340-million-un-contract/ 2009-09-01T17:08:26+00:00 daily 0.8 http://www.pharma-marketer.com/fda-genzyme-spar-in-cancer-drug-review/ 2009-09-01T17:08:22+00:00 daily 0.8 http://www.pharma-marketer.com/top-15-bestselling-drugs-of-2008/ 2009-09-01T17:08:17+00:00 daily 0.8 http://www.pharma-marketer.com/another-iron-reaction-hits-the-mat/ 2009-09-01T16:10:41+00:00 daily 0.8 http://www.pharma-marketer.com/the-digital-wave-%e2%80%93-delivering-education-and-services-to-healthcare-providers/ 2009-09-01T16:08:43+00:00 daily 0.8 http://www.pharma-marketer.com/icagen-boosted-by-upbeat-mid-stage-results-for-asthma/ 2009-09-01T15:41:00+00:00 daily 0.8 http://www.pharma-marketer.com/neurobiological-technologies-fades-to-black/ 2009-09-01T14:24:01+00:00 daily 0.8 http://www.pharma-marketer.com/return-on-investment-in-patient-recruitment/ 2009-09-01T14:16:14+00:00 daily 0.8 http://www.pharma-marketer.com/can-dtc-evolve-to-stay-relevant-to-empowered-patients/ 2009-09-01T14:15:52+00:00 daily 0.8 http://www.pharma-marketer.com/commercial-operations-outsourcing-a-leading-edge-response-to-the-financial-storm-affecting-the-life-sciences-industry/ 2009-09-01T14:13:48+00:00 daily 0.8 http://www.pharma-marketer.com/the-state-of-women-in-healthcare/ 2009-09-01T14:12:31+00:00 daily 0.8 http://www.pharma-marketer.com/skyepharma-needs-additional-flutiform-tests-delaying-us-start/ 2009-09-01T14:00:52+00:00 daily 0.8 http://www.pharma-marketer.com/basilea-jj-response-on-antibiotic-accepted-by-fda/ 2009-09-01T14:00:50+00:00 daily 0.8 http://www.pharma-marketer.com/spectrum-pharmaceuticals-sequenom-shares-rise-on-heavy-volume/ 2009-09-01T14:00:47+00:00 daily 0.8 http://www.pharma-marketer.com/acadia-parkinsons-drug-fails-phase-iii-study/ 2009-09-01T14:00:46+00:00 daily 0.8 http://www.pharma-marketer.com/endo-drug-faces-fda-decision-wednesday/ 2009-09-01T14:00:45+00:00 daily 0.8 http://www.pharma-marketer.com/shire-files-for-vela-us-approval-on-medicine-shortage/ 2009-09-01T14:00:42+00:00 daily 0.8 http://www.pharma-marketer.com/novavax-is-on-a-roll-with-mid-stage-vlp-success/ 2009-09-01T13:56:09+00:00 daily 0.8 http://www.pharma-marketer.com/acadia-shares-tank-after-parkinsons-drug-flunks-phase-iii/ 2009-09-01T13:38:48+00:00 daily 0.8 http://www.pharma-marketer.com/twitter-pharma-what-can-you-do/ 2009-09-01T13:32:35+00:00 daily 0.8 http://www.pharma-marketer.com/on-the-radar-five-biotech-companies-to-watch/ 2009-09-01T12:45:57+00:00 daily 0.8 http://www.pharma-marketer.com/back/ 2009-09-01T12:45:43+00:00 daily 0.8 http://www.pharma-marketer.com/jeternel-beauty-clinic-ae%e2%80%9c-beautiful/ 2009-09-01T12:36:05+00:00 daily 0.8 http://www.pharma-marketer.com/in-setback-fda-demands-new-work-on-skyepharmas-flutiform/ 2009-09-01T12:25:21+00:00 daily 0.8 http://www.pharma-marketer.com/jeternel-beauty-clinic-ae%e2%80%9c-attractive/ 2009-09-01T11:45:59+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-shire-races-to-fda-with-new-gaucher-drug-app/ 2009-09-01T11:42:00+00:00 daily 0.8 http://www.pharma-marketer.com/2009-flu-prevention-psa-contest/ 2009-09-01T08:23:35+00:00 daily 0.8 http://www.pharma-marketer.com/mercks-top-brass-stays-put/ 2009-09-01T04:01:35+00:00 daily 0.8 http://www.pharma-marketer.com/judge-rejects-schering-plough-tax-refund-request/ 2009-09-01T04:01:34+00:00 daily 0.8 http://www.pharma-marketer.com/merck-abbott-cholesterol-combo-pills-lack-evidence/ 2009-09-01T04:01:33+00:00 daily 0.8 http://www.pharma-marketer.com/what-are-they-smoking-tobacco-companies-sue-fda/ 2009-09-01T04:01:00+00:00 daily 0.8 http://www.pharma-marketer.com/the-answer-is-not-twitter/ 2009-09-01T03:49:46+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeutics-pixantrone-priority-review-or-not/ 2009-09-01T00:01:20+00:00 daily 0.8 http://www.pharma-marketer.com/biotechs-not-showing-much-life/ 2009-09-01T00:01:19+00:00 daily 0.8 http://www.pharma-marketer.com/a-step-forward-for-bayer/ 2009-08-31T19:57:52+00:00 daily 0.8 http://www.pharma-marketer.com/genzymes-ceo-on-the-hot-seat/ 2009-08-31T19:57:51+00:00 daily 0.8 http://www.pharma-marketer.com/calcium-sandoz-ae%e2%80%9c-bridge-support/ 2009-08-31T18:29:03+00:00 daily 0.8 http://www.pharma-marketer.com/medtronic-merck-roll-out-reorgs-shuffle-leadership/ 2009-08-31T17:08:21+00:00 daily 0.8 http://www.pharma-marketer.com/cardinal-health-spinoff-signals-new-direction/ 2009-08-31T16:53:59+00:00 daily 0.8 http://www.pharma-marketer.com/fda-accepts-pozens-nda-for-vimovo-update/ 2009-08-31T16:53:58+00:00 daily 0.8 http://www.pharma-marketer.com/merck-to-form-5-divisions-after-schering-buyout/ 2009-08-31T16:53:57+00:00 daily 0.8 http://www.pharma-marketer.com/new-blood-thinners-could-be-alternatives-to-coumadin-plavix/ 2009-08-31T16:53:56+00:00 daily 0.8 http://www.pharma-marketer.com/sdi-reports-takeda-touts-new-drugs-to-managed-care/ 2009-08-31T16:53:55+00:00 daily 0.8 http://www.pharma-marketer.com/ticker-shock-bristol-myers-feeling-effects-of-plavix/ 2009-08-31T16:53:54+00:00 daily 0.8 http://www.pharma-marketer.com/analyst-says-lillys-a-loser/ 2009-08-31T16:53:53+00:00 daily 0.8 http://www.pharma-marketer.com/cbo-says-house-bill-boosts-seniorsa%c2%a2aea%e2%84%a2-drug-premiums/ 2009-08-31T16:53:52+00:00 daily 0.8 http://www.pharma-marketer.com/genzymes-clolar-could-face-delay/ 2009-08-31T16:53:51+00:00 daily 0.8 http://www.pharma-marketer.com/new-merck-management-a-lot-like-the-old-merck-management/ 2009-08-31T16:53:50+00:00 daily 0.8 http://www.pharma-marketer.com/antidepressants-show-upside-in-economic-downturn/ 2009-08-31T16:53:49+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-facility-chief-in-the-hot-seat/ 2009-08-31T16:31:10+00:00 daily 0.8 http://www.pharma-marketer.com/chinese-experts-clear-sinovac-swine-flu-vax/ 2009-08-31T15:35:30+00:00 daily 0.8 http://www.pharma-marketer.com/sanofi-az-medicines-co-herald-heart-successes/ 2009-08-31T15:13:32+00:00 daily 0.8 http://www.pharma-marketer.com/merck-restructures-rd-licensing-ops-in-merger-revamp/ 2009-08-31T14:35:02+00:00 daily 0.8 http://www.pharma-marketer.com/claritin-ae%e2%80%9c-climber/ 2009-08-31T13:51:41+00:00 daily 0.8 http://www.pharma-marketer.com/study-could-boost-new-astra-zeneca-drug/ 2009-08-31T12:45:24+00:00 daily 0.8 http://www.pharma-marketer.com/wyeth-responds-to-criticism/ 2009-08-31T12:45:22+00:00 daily 0.8 http://www.pharma-marketer.com/regulatory-questions-for-astra-boehringer-drugs/ 2009-08-31T12:45:21+00:00 daily 0.8 http://www.pharma-marketer.com/sanofia%c2%a2aea%e2%84%a2s-experimental-anti-clot-drug-shows-promise/ 2009-08-31T12:45:19+00:00 daily 0.8 http://www.pharma-marketer.com/interview-with-access-pharma-ceo-updates-and-outlook/ 2009-08-31T12:45:18+00:00 daily 0.8 http://www.pharma-marketer.com/new-study-shows-abnormal-lipid-levels-are-highly-common-in-statin-treated-patients/ 2009-08-31T12:45:17+00:00 daily 0.8 http://www.pharma-marketer.com/full-boehringer-social-media-reporting-of-rely-trial-results/ 2009-08-31T12:14:08+00:00 daily 0.8 http://www.pharma-marketer.com/boehringers-pradaxa-beats-warfarin-in-major-study/ 2009-08-31T11:51:04+00:00 daily 0.8 http://www.pharma-marketer.com/brilinta-data-fuels-azs-hopes-for-megablockbuster/ 2009-08-31T11:29:57+00:00 daily 0.8 http://www.pharma-marketer.com/time-to-change-ae%e2%80%9c-scared-kids-ae%e2%80%9c-tv-commercial/ 2009-08-31T11:23:38+00:00 daily 0.8 http://www.pharma-marketer.com/time-to-change-ae%e2%80%9c-stigma-ae%e2%80%9c-tv-commercial/ 2009-08-31T11:18:12+00:00 daily 0.8 http://www.pharma-marketer.com/time-to-change-scared-kids-tv-commercial/ 2009-08-31T10:07:51+00:00 daily 0.8 http://www.pharma-marketer.com/time-to-change-stigma-tv-commercial/ 2009-08-31T10:07:51+00:00 daily 0.8 http://www.pharma-marketer.com/print-ad-not-quite-so/ 2009-08-31T09:50:19+00:00 daily 0.8 http://www.pharma-marketer.com/raptiva-ae%e2%80%9c-bridge/ 2009-08-31T00:08:23+00:00 daily 0.8 http://www.pharma-marketer.com/new-drugs-surprise-in-barcelona/ 2009-08-30T17:28:13+00:00 daily 0.8 http://www.pharma-marketer.com/new-large-scale-global-study-provides-additional-information-about-an-intensified-dose-regimen-of-plavixa%e2%80%9aa%c2%ae-in-acute-cor/ 2009-08-30T17:28:13+00:00 daily 0.8 http://www.pharma-marketer.com/phase-iii-head-to-head-trial-showed-ticagrelor-reduced-cardiovascular-death-and-heart-attacks-over-clopidogrel-in-acute/ 2009-08-30T17:28:12+00:00 daily 0.8 http://www.pharma-marketer.com/study-shows-otamixaban-substantially-reduced-complications-of-invasive-management-of-acute-coronary-syndromes/ 2009-08-30T17:28:11+00:00 daily 0.8 http://www.pharma-marketer.com/bioelectronics-announces-completion-of-clinical-study-preparing-fda-510k-pre-marketing-notifica/ 2009-08-30T17:28:09+00:00 daily 0.8 http://www.pharma-marketer.com/if-only-18-of-traditional-tv-campaigns-generate-a-positive-roi-why-is-the-drug-industry-so-in-love-with-tv/ 2009-08-30T02:04:36+00:00 daily 0.8 http://www.pharma-marketer.com/cyclacel-pharmaceuticals-announces-receipt-of-nasdaq-notice/ 2009-08-29T19:19:20+00:00 daily 0.8 http://www.pharma-marketer.com/molecular-insight-pharmaceuticals-files-universal-shelf-registration-statement/ 2009-08-29T19:19:19+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-helps-pfizer-deliver/ 2009-08-29T19:19:18+00:00 daily 0.8 http://www.pharma-marketer.com/daxas-shows-promise/ 2009-08-29T19:19:17+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stock-drag-video/ 2009-08-29T19:19:16+00:00 daily 0.8 http://www.pharma-marketer.com/generic-versions-of-biologic-medications-are-coming/ 2009-08-29T19:19:15+00:00 daily 0.8 http://www.pharma-marketer.com/mylan-begins-marketing-generic-benzaclin-to-treat-acne/ 2009-08-29T19:19:13+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-watson-pharmaceuticals-anda-for-levonorgestrel-tablets/ 2009-08-29T19:19:11+00:00 daily 0.8 http://www.pharma-marketer.com/novelos-therapeutics-secures-9-million-private-placement/ 2009-08-29T19:19:10+00:00 daily 0.8 http://www.pharma-marketer.com/takeda-to-begin-cardiovascular-outcomes-trial-for-alogliptin-to-treat-type-2-diabetes/ 2009-08-29T19:19:09+00:00 daily 0.8 http://www.pharma-marketer.com/mylans-subsidiary-notified-by-the-who-prequalification-of-medicines-programme/ 2009-08-29T19:19:07+00:00 daily 0.8 http://www.pharma-marketer.com/biosante-pharmaceuticals-comments-on-study-showing-no-increased-risk-of-breast-cancer-in-women-using-testosterone-for-lo/ 2009-08-29T19:19:06+00:00 daily 0.8 http://www.pharma-marketer.com/humalog-ae%e2%80%9c-restaurant/ 2009-08-29T16:04:47+00:00 daily 0.8 http://www.pharma-marketer.com/humalog-mix-25-ae%e2%80%9c-mountains/ 2009-08-29T14:58:14+00:00 daily 0.8 http://www.pharma-marketer.com/betadine-ae%e2%80%9c-scissor-cut/ 2009-08-29T13:50:31+00:00 daily 0.8 http://www.pharma-marketer.com/betadine-ae%e2%80%9c-bicycle-accident/ 2009-08-29T13:50:25+00:00 daily 0.8 http://www.pharma-marketer.com/betadine-ae%e2%80%9c-wood-cut/ 2009-08-29T13:50:13+00:00 daily 0.8 http://www.pharma-marketer.com/waters/ 2009-08-29T09:50:51+00:00 daily 0.8 http://www.pharma-marketer.com/aleve/ 2009-08-29T09:50:42+00:00 daily 0.8 http://www.pharma-marketer.com/phrma-answers-gop-leaders-appeaser-slur/ 2009-08-29T08:44:05+00:00 daily 0.8 http://www.pharma-marketer.com/cardinal-health-launches-in-pharmacy-ad-network/ 2009-08-29T08:43:32+00:00 daily 0.8 http://www.pharma-marketer.com/cnbc-and-a-dtc-ban/ 2009-08-29T08:42:50+00:00 daily 0.8 http://www.pharma-marketer.com/air-optix-aqua/ 2009-08-28T19:02:20+00:00 daily 0.8 http://www.pharma-marketer.com/hisamitsu-completes-noven-acquisition/ 2009-08-28T17:35:04+00:00 daily 0.8 http://www.pharma-marketer.com/eurand-says-fda-approved-pancreatic-enzyme-zenpep/ 2009-08-28T17:35:03+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-squibb-downgraded-on-share-price/ 2009-08-28T17:35:01+00:00 daily 0.8 http://www.pharma-marketer.com/invivos-pharma-deals-of-the-week/ 2009-08-28T17:35:00+00:00 daily 0.8 http://www.pharma-marketer.com/astellas-pfizer-agree-to-co-promote-caduet/ 2009-08-28T17:34:59+00:00 daily 0.8 http://www.pharma-marketer.com/fda-problems-with-genzyme-study-of-leukemia-drug/ 2009-08-28T17:34:58+00:00 daily 0.8 http://www.pharma-marketer.com/mucinex/ 2009-08-28T17:03:22+00:00 daily 0.8 http://www.pharma-marketer.com/halls-tv-commercial/ 2009-08-28T17:03:03+00:00 daily 0.8 http://www.pharma-marketer.com/constipation/ 2009-08-28T17:02:55+00:00 daily 0.8 http://www.pharma-marketer.com/advil-pm/ 2009-08-28T17:02:16+00:00 daily 0.8 http://www.pharma-marketer.com/aricept-bowling-alley-tv-commercial/ 2009-08-28T17:01:34+00:00 daily 0.8 http://www.pharma-marketer.com/the-inside-story-on-bones/ 2009-08-28T15:30:40+00:00 daily 0.8 http://www.pharma-marketer.com/claritin-climber/ 2009-08-28T15:30:36+00:00 daily 0.8 http://www.pharma-marketer.com/concert-study/ 2009-08-28T15:30:36+00:00 daily 0.8 http://www.pharma-marketer.com/fda-questions-genzyme-study-ahead-of-review/ 2009-08-28T15:23:08+00:00 daily 0.8 http://www.pharma-marketer.com/takeda-to-start-key-alogliptin-trial-next-month/ 2009-08-28T15:12:41+00:00 daily 0.8 http://www.pharma-marketer.com/experimental-obesity-drug-has-big-impact-on-diabetes/ 2009-08-28T14:46:50+00:00 daily 0.8 http://www.pharma-marketer.com/allergan-taps-twilight-star-for-acne-interactive/ 2009-08-28T14:24:56+00:00 daily 0.8 http://www.pharma-marketer.com/despite-downturn-biopharmas-boost-rd-spending/ 2009-08-28T14:24:28+00:00 daily 0.8 http://www.pharma-marketer.com/takeda-starting-cardiovascular-trial-on-diabetes-drug-syr-322/ 2009-08-28T13:34:51+00:00 daily 0.8 http://www.pharma-marketer.com/nycomed-smokera%c2%a2aea%e2%84%a2s-cough-drug-helps-lung-function-studies-show/ 2009-08-28T13:34:51+00:00 daily 0.8 http://www.pharma-marketer.com/facet-trubion-in-196m-collaboration-deal/ 2009-08-28T13:32:48+00:00 daily 0.8 http://www.pharma-marketer.com/twitter-for-brands-beyond-marketing/ 2009-08-28T13:27:31+00:00 daily 0.8 http://www.pharma-marketer.com/promising-results-for-nycomed-forest-copd-drug-daxas/ 2009-08-28T13:03:01+00:00 daily 0.8 http://www.pharma-marketer.com/reach-for-the-sky/ 2009-08-28T12:55:06+00:00 daily 0.8 http://www.pharma-marketer.com/are-biotechs-tough-times-over/ 2009-08-28T12:47:00+00:00 daily 0.8 http://www.pharma-marketer.com/defense-is-getting-old/ 2009-08-28T12:17:23+00:00 daily 0.8 http://www.pharma-marketer.com/aptamil-follow-on-tv-commercial/ 2009-08-28T11:03:25+00:00 daily 0.8 http://www.pharma-marketer.com/ertaczo/ 2009-08-28T10:31:10+00:00 daily 0.8 http://www.pharma-marketer.com/betadine-wood-cut/ 2009-08-28T09:20:52+00:00 daily 0.8 http://www.pharma-marketer.com/betadine-bicycle-accident/ 2009-08-28T09:20:52+00:00 daily 0.8 http://www.pharma-marketer.com/betadine-scissor-cut/ 2009-08-28T09:20:52+00:00 daily 0.8 http://www.pharma-marketer.com/drug-biotech-research-spending-hangs-tough/ 2009-08-28T06:22:58+00:00 daily 0.8 http://www.pharma-marketer.com/twin-problems-for-jj/ 2009-08-27T22:42:36+00:00 daily 0.8 http://www.pharma-marketer.com/setback-for-alkermes-pipeline/ 2009-08-27T22:42:34+00:00 daily 0.8 http://www.pharma-marketer.com/will-new-label-help-bristols-orencia/ 2009-08-27T22:42:32+00:00 daily 0.8 http://www.pharma-marketer.com/lonza-patheon-bid-still-holds-seeks-jll-talks/ 2009-08-27T22:42:31+00:00 daily 0.8 http://www.pharma-marketer.com/durect-signs-deal-to-supply-king-pharmaceuticals-with-painkiller-remoxy/ 2009-08-27T22:42:29+00:00 daily 0.8 http://www.pharma-marketer.com/aricepts-new-dtc-campaign/ 2009-08-27T21:41:01+00:00 daily 0.8 http://www.pharma-marketer.com/still-think-social-media-is-not-the-right-channel-for-your-brand-the-shame-and-disgrace-of-dtc-marketing/ 2009-08-27T21:14:12+00:00 daily 0.8 http://www.pharma-marketer.com/aricept-names-tv-commercial/ 2009-08-27T21:10:48+00:00 daily 0.8 http://www.pharma-marketer.com/orion-pharma/ 2009-08-27T17:14:10+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer/ 2009-08-27T17:14:10+00:00 daily 0.8 http://www.pharma-marketer.com/massbio-touts-new-biotech-jobs-bigger-pay/ 2009-08-27T15:49:15+00:00 daily 0.8 http://www.pharma-marketer.com/geron-offers-reassurance-on-its-esc-safety-record/ 2009-08-27T15:33:48+00:00 daily 0.8 http://www.pharma-marketer.com/report-omeros-plots-new-try-at-an-ipo/ 2009-08-27T15:10:56+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-orencia-small-change-big-impact/ 2009-08-27T14:48:35+00:00 daily 0.8 http://www.pharma-marketer.com/buzz-kill-viropharma-says-its-not-looking-for-teva-bid/ 2009-08-27T14:48:26+00:00 daily 0.8 http://www.pharma-marketer.com/bayer-falls-as-boehringera%c2%a2aea%e2%84%a2s-pradaxa-seen-challenging-xarelto/ 2009-08-27T14:48:17+00:00 daily 0.8 http://www.pharma-marketer.com/dont-bury-ariads-patent-yet/ 2009-08-27T14:48:15+00:00 daily 0.8 http://www.pharma-marketer.com/alkermes-says-johnson-johnson-ended-development-of-monthly-risperdal-consta-injection/ 2009-08-27T14:48:12+00:00 daily 0.8 http://www.pharma-marketer.com/geron-comments-on-fda-hold-on-spinal-cord-injury-trial/ 2009-08-27T14:48:08+00:00 daily 0.8 http://www.pharma-marketer.com/cell-therapeutics-could-be-a-real-winner-but-not-right-now/ 2009-08-27T14:48:03+00:00 daily 0.8 http://www.pharma-marketer.com/biodelivery-sciences-can-now-be-considered-a-long-term-growth-stock/ 2009-08-27T14:48:01+00:00 daily 0.8 http://www.pharma-marketer.com/ucb-immunomedics-drug-shows-promise-for-lupus/ 2009-08-27T14:48:00+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-pfizer-in-pact-for-lung-cancer-screening/ 2009-08-27T14:47:56+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-completes-initial-medarex-offer/ 2009-08-27T14:47:52+00:00 daily 0.8 http://www.pharma-marketer.com/cryo-cell-the-stem-cell-sectors-profit-leader/ 2009-08-27T14:47:49+00:00 daily 0.8 http://www.pharma-marketer.com/genzyme-appears-overbought-reiterating-near-term-sell/ 2009-08-27T14:47:46+00:00 daily 0.8 http://www.pharma-marketer.com/gene-variation-strongly-predicts-plavix-response/ 2009-08-27T14:47:43+00:00 daily 0.8 http://www.pharma-marketer.com/rings-of-the-future/ 2009-08-27T14:46:38+00:00 daily 0.8 http://www.pharma-marketer.com/gobalto-to-present-at-lifesciencefest-2009/ 2009-08-27T14:43:56+00:00 daily 0.8 http://www.pharma-marketer.com/gobalto-selected-to-present-at-lifesciencefest-2009/ 2009-08-27T14:43:56+00:00 daily 0.8 http://www.pharma-marketer.com/tis-the-season-tips-for-2010-planning/ 2009-08-27T14:37:56+00:00 daily 0.8 http://www.pharma-marketer.com/patients-are-searching-online-before-filling-rx/ 2009-08-27T14:08:41+00:00 daily 0.8 http://www.pharma-marketer.com/analysts-douse-hot-hgs-shares-with-splash-of-caution/ 2009-08-27T13:14:59+00:00 daily 0.8 http://www.pharma-marketer.com/ddmac-slaps-jj-journal-ad-pedinol-mailer/ 2009-08-27T12:56:56+00:00 daily 0.8 http://www.pharma-marketer.com/nurofen-for-children/ 2009-08-27T12:20:29+00:00 daily 0.8 http://www.pharma-marketer.com/kaloba/ 2009-08-27T12:20:28+00:00 daily 0.8 http://www.pharma-marketer.com/combantrin/ 2009-08-27T12:20:28+00:00 daily 0.8 http://www.pharma-marketer.com/prevenar/ 2009-08-27T12:20:28+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-new-lupus-trial-success-ignites-immunomedics-shares/ 2009-08-27T12:11:27+00:00 daily 0.8 http://www.pharma-marketer.com/altabax/ 2009-08-27T10:06:22+00:00 daily 0.8 http://www.pharma-marketer.com/jj-warns-of-allergic-reactions-with-hiv-drug/ 2009-08-27T03:46:07+00:00 daily 0.8 http://www.pharma-marketer.com/biogen-granted-more-time-in-drug-dispute-with-elan/ 2009-08-27T03:46:03+00:00 daily 0.8 http://www.pharma-marketer.com/52-perspectives-aeoekey-success-factors-in-contract-manufacturing-small-molecule-drugsae%ef%bf%bd/ 2009-08-27T01:32:49+00:00 daily 0.8 http://www.pharma-marketer.com/widex-hearing-aids/ 2009-08-27T01:32:21+00:00 daily 0.8 http://www.pharma-marketer.com/the-economy-patent-cliffs-and-fundingae%c2%a6whatae%e2%84%a2s-a-pharmaco-to-do/ 2009-08-27T00:10:01+00:00 daily 0.8 http://www.pharma-marketer.com/merck-says-european-union-agrees-to-review-intravenous-version-of-heart-drug-vernakalant/ 2009-08-26T23:56:26+00:00 daily 0.8 http://www.pharma-marketer.com/boehringer-ingelheim-axes-600-900-drug-sales-reps/ 2009-08-26T23:56:25+00:00 daily 0.8 http://www.pharma-marketer.com/schering-plough-asthma-drug-oral-contraceptive-being-reviewed-by-european-regulators/ 2009-08-26T23:56:23+00:00 daily 0.8 http://www.pharma-marketer.com/istas-eye-drug-shows-success/ 2009-08-26T23:56:21+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-falls-back-on-the-future/ 2009-08-26T23:56:20+00:00 daily 0.8 http://www.pharma-marketer.com/how-to-play-the-viropharma-buyout/ 2009-08-26T23:56:19+00:00 daily 0.8 http://www.pharma-marketer.com/gsk-seems-to-dismiss-hgs-rumour/ 2009-08-26T23:56:18+00:00 daily 0.8 http://www.pharma-marketer.com/twitter-and-drug-safety-a-paramount-concern/ 2009-08-26T20:37:16+00:00 daily 0.8 http://www.pharma-marketer.com/endo-pharmaceuticals-to-partner-with-prostrakan-to-commercialize-fortestatm-in-the-us/ 2009-08-26T16:49:36+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-says-fda-broadens-label-for-orencia/ 2009-08-26T16:49:34+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-comes-to-the-defense-of-its-alli/ 2009-08-26T16:49:34+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-unveils-214m-biotech-plant/ 2009-08-26T16:49:33+00:00 daily 0.8 http://www.pharma-marketer.com/human-genome-leads-biotech-stocks-north/ 2009-08-26T16:49:32+00:00 daily 0.8 http://www.pharma-marketer.com/vion-pharmaceuticals-onrigin-good-chance-of-fda-approval/ 2009-08-26T16:49:32+00:00 daily 0.8 http://www.pharma-marketer.com/jj-consolidating-management-starting-by-eliminating-new-comprehensive-care-business-unit/ 2009-08-26T16:49:30+00:00 daily 0.8 http://www.pharma-marketer.com/thalidomide-for-myeloma-whose-idea-was-it/ 2009-08-26T15:46:20+00:00 daily 0.8 http://www.pharma-marketer.com/rems-a-paper-tiger/ 2009-08-26T15:37:46+00:00 daily 0.8 http://www.pharma-marketer.com/nymox-spikes-on-startling-success-of-animal-cancer-study/ 2009-08-26T15:36:25+00:00 daily 0.8 http://www.pharma-marketer.com/amylin-picks-ex-novartis-exec-as-chairman/ 2009-08-26T14:56:58+00:00 daily 0.8 http://www.pharma-marketer.com/%e2%80%9cthis-claim-is-a-complete-misrepresentation-of-the-results-of-the-draelos-study%e2%80%9d/ 2009-08-26T14:37:42+00:00 daily 0.8 http://www.pharma-marketer.com/boehringer-ingelheim-broadens-youtube-twitter-efforts/ 2009-08-26T14:16:34+00:00 daily 0.8 http://www.pharma-marketer.com/endo-inks-210m-deal-for-testosterone-therapy/ 2009-08-26T13:47:28+00:00 daily 0.8 http://www.pharma-marketer.com/amgens-anemia-drug-fails-in-kidney-patient-study/ 2009-08-26T13:42:11+00:00 daily 0.8 http://www.pharma-marketer.com/galderma-distributed-bogus-pi-for-skin-drug-fda-claims/ 2009-08-26T13:42:10+00:00 daily 0.8 http://www.pharma-marketer.com/ariads-patent-rises-from-the-grave-to-smite-the-living/ 2009-08-26T12:18:52+00:00 daily 0.8 http://www.pharma-marketer.com/study-europeans-beat-yanks-at-the-rd-game/ 2009-08-26T12:02:22+00:00 daily 0.8 http://www.pharma-marketer.com/breaking-news-dainippon-readies-nda-after-schizophrenia-trial-delivers/ 2009-08-26T11:16:51+00:00 daily 0.8 http://www.pharma-marketer.com/jeternel-beauty-clinic-attractive/ 2009-08-26T08:39:43+00:00 daily 0.8 http://www.pharma-marketer.com/jeternel-beauty-clinic-beautiful/ 2009-08-26T08:39:43+00:00 daily 0.8 http://www.pharma-marketer.com/tabaconomia-car/ 2009-08-26T08:39:17+00:00 daily 0.8 http://www.pharma-marketer.com/art-copy/ 2009-08-26T08:17:00+00:00 daily 0.8 http://www.pharma-marketer.com/short-selling-investor-turns-to-drugs-in-search-of-next-big-hit/ 2009-08-25T23:45:09+00:00 daily 0.8 http://www.pharma-marketer.com/glaxo-deal-talk-boosts-human-genome-shares/ 2009-08-25T23:45:08+00:00 daily 0.8 http://www.pharma-marketer.com/merck-regaining-its-swagger/ 2009-08-25T23:45:08+00:00 daily 0.8 http://www.pharma-marketer.com/european-drug-makers-more-innovative-than-us-companies/ 2009-08-25T23:45:07+00:00 daily 0.8 http://www.pharma-marketer.com/acorda-confirms-fda-panel-review-date-for-ms-drug/ 2009-08-25T19:39:57+00:00 daily 0.8 http://www.pharma-marketer.com/swine-flu-vaccine-to-miss-target/ 2009-08-25T19:39:56+00:00 daily 0.8 http://www.pharma-marketer.com/allergan-more-than-skin-deep/ 2009-08-25T19:39:56+00:00 daily 0.8 http://www.pharma-marketer.com/shire-aims-big-in-hgt-segment/ 2009-08-25T19:39:55+00:00 daily 0.8 http://www.pharma-marketer.com/ucb-signs-german-license-deal-with-novartis/ 2009-08-25T16:14:34+00:00 daily 0.8 http://www.pharma-marketer.com/medicinova-acquiring-avigen-a-post-mortem/ 2009-08-25T16:14:32+00:00 daily 0.8 http://www.pharma-marketer.com/medtronic-quarterly-profit-falls-on-litigation-charges/ 2009-08-25T16:14:30+00:00 daily 0.8 http://www.pharma-marketer.com/vertex-set-to-see-more-volatility-on-hepatitis-drug-data-release/ 2009-08-25T16:14:29+00:00 daily 0.8 http://www.pharma-marketer.com/what-the-3-billion-pg-deal-says-about-the-drug-industry/ 2009-08-25T16:14:28+00:00 daily 0.8 http://www.pharma-marketer.com/protalix-receives-fda-fast-track-designation-for-prgcd/ 2009-08-25T16:14:27+00:00 daily 0.8 http://www.pharma-marketer.com/lack-of-knowledge-fuels-off-label-prescribing/ 2009-08-25T16:14:26+00:00 daily 0.8 http://www.pharma-marketer.com/raptor-pharmaceuticals-raises-5-million/ 2009-08-25T16:14:26+00:00 daily 0.8 http://www.pharma-marketer.com/karo-bio-says-wyeth-will-take-control-of-inflammatory-disease-research-from-collaboration/ 2009-08-25T16:14:25+00:00 daily 0.8 http://www.pharma-marketer.com/ligand-strikes-deal-to-buy-struggling-neurogen/ 2009-08-25T15:53:39+00:00 daily 0.8 http://www.pharma-marketer.com/medicago-shares-jump-after-regulators-clear-flu-trial/ 2009-08-25T15:48:50+00:00 daily 0.8 http://www.pharma-marketer.com/is-placebo-effect-to-blame-for-weak-rd-record/ 2009-08-25T15:37:28+00:00 daily 0.8 http://www.pharma-marketer.com/rumors-glaxo-eyes-bid-for-human-genome-sciences/ 2009-08-25T14:23:26+00:00 daily 0.8 http://www.pharma-marketer.com/new-offerings-by-pharma-on-youtube/ 2009-08-25T13:57:26+00:00 daily 0.8 http://www.pharma-marketer.com/will-alli-soon-be-the-only-fda-unapproved-otc-drug/ 2009-08-25T13:28:18+00:00 daily 0.8 http://www.pharma-marketer.com/protalix-gets-fast-track-for-its-red-hot-gaucher-drug/ 2009-08-25T13:19:40+00:00 daily 0.8 http://www.pharma-marketer.com/polymorphs-and-salts-india-raises-an-eyebrow/ 2009-08-25T13:11:19+00:00 daily 0.8 http://www.pharma-marketer.com/bracing-for-fda-review-gloucester-bags-29m-round/ 2009-08-25T12:51:22+00:00 daily 0.8 http://www.pharma-marketer.com/xolair-label-expanded-in-eu/ 2009-08-25T12:28:42+00:00 daily 0.8 http://www.pharma-marketer.com/cytrx-rises-on-preclinical-data-for-stroke-drug/ 2009-08-25T12:28:41+00:00 daily 0.8 http://www.pharma-marketer.com/ligand-pharmaceuticals-to-buy-neurogen-for-11-million-in-stock-rights-to-future-payouts/ 2009-08-25T12:28:40+00:00 daily 0.8 http://www.pharma-marketer.com/between-the-doc-and-pharmacy-patients-get-online-says-survey/ 2009-08-25T10:39:34+00:00 daily 0.8 http://www.pharma-marketer.com/mucinex-hcp/ 2009-08-25T09:34:05+00:00 daily 0.8 http://www.pharma-marketer.com/mucinex-dtc/ 2009-08-25T09:30:29+00:00 daily 0.8 http://www.pharma-marketer.com/rozerem/ 2009-08-25T08:33:45+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lillys-osteoporosis-drug-stopped-in-its-tracks/ 2009-08-25T04:22:14+00:00 daily 0.8 http://www.pharma-marketer.com/crucial-time-for-allos-therapeutics/ 2009-08-25T04:22:13+00:00 daily 0.8 http://www.pharma-marketer.com/analysis-warner-chilcott-pg/ 2009-08-25T04:22:12+00:00 daily 0.8 http://www.pharma-marketer.com/valeants-retigabine-fails-in-shingles-pain-study/ 2009-08-25T04:22:12+00:00 daily 0.8 http://www.pharma-marketer.com/biovail-to-develop-parkinson-drug/ 2009-08-25T04:22:10+00:00 daily 0.8 http://www.pharma-marketer.com/micromet-the-clock-is-ticking/ 2009-08-25T04:22:09+00:00 daily 0.8 http://www.pharma-marketer.com/fda-probes-liver-damage-with-weight-loss-pill-alli/ 2009-08-25T04:22:08+00:00 daily 0.8 http://www.pharma-marketer.com/jj-would-rather-not-say/ 2009-08-25T04:22:07+00:00 daily 0.8 http://www.pharma-marketer.com/can-pharma-market-adherence/ 2009-08-25T02:33:21+00:00 daily 0.8 http://www.pharma-marketer.com/the-short-term-outlook-for-dtc/ 2009-08-25T01:37:23+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-missing-the-social-media-party/ 2009-08-25T01:35:23+00:00 daily 0.8 http://www.pharma-marketer.com/do-patients-really-need-to-see-a-doctor-all-the-time/ 2009-08-25T01:33:36+00:00 daily 0.8 http://www.pharma-marketer.com/why-in-the-world-would-you-launch-a-dtc-tv-spot-when-the-side-effects-are-this-bad/ 2009-08-25T01:24:30+00:00 daily 0.8 http://www.pharma-marketer.com/biovail-will-pay-up-to-192m-for-parkinsona%c2%a2aea%e2%84%a2s-drug/ 2009-08-24T21:04:59+00:00 daily 0.8 http://www.pharma-marketer.com/no-fda-regulations-would-be-like-driving-on-a-highway-without-speed-limits/ 2009-08-24T17:49:21+00:00 daily 0.8 http://www.pharma-marketer.com/anemia-drugs-under-review/ 2009-08-24T17:47:29+00:00 daily 0.8 http://www.pharma-marketer.com/is-it-worth-investing-in-the-merck-schering-merger-now/ 2009-08-24T17:47:28+00:00 daily 0.8 http://www.pharma-marketer.com/jj-receives-letter-from-fda-delaying-action-on-experimental-seizure-drug-carisbamate/ 2009-08-24T17:47:28+00:00 daily 0.8 http://www.pharma-marketer.com/california-pharmacies-sue-to-block-pfizera%c2%a2aea%e2%84%a2s-purchase-of-wyeth/ 2009-08-24T17:47:27+00:00 daily 0.8 http://www.pharma-marketer.com/fda-allergan-aczone-ads-were-misleading/ 2009-08-24T17:47:26+00:00 daily 0.8 http://www.pharma-marketer.com/warner-chilcott-buys-pg-rx-drugs-division-for-31-billion/ 2009-08-24T17:07:39+00:00 daily 0.8 http://www.pharma-marketer.com/excedrin-dtc-print-ads/ 2009-08-24T16:52:38+00:00 daily 0.8 http://www.pharma-marketer.com/sponsors-run-to-gobaltocom-to-size-up-service-providers/ 2009-08-24T16:23:30+00:00 daily 0.8 http://www.pharma-marketer.com/santaris-inks-rna-development-pact-with-shire/ 2009-08-24T15:01:21+00:00 daily 0.8 http://www.pharma-marketer.com/key-valeant-drug-fails-mid-stage-pain-trial/ 2009-08-24T14:46:41+00:00 daily 0.8 http://www.pharma-marketer.com/the-new-sweet-spot-for-biotech-buyouts-1b-to-2b/ 2009-08-24T14:15:59+00:00 daily 0.8 http://www.pharma-marketer.com/complete-genomics-bags-45m-round-for-sequencing/ 2009-08-24T13:53:02+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-freedom-of-speech-and-ad-agencies/ 2009-08-24T12:42:33+00:00 daily 0.8 http://www.pharma-marketer.com/warner-chilcott-plots-31b-deal-for-pg-drugs-unit/ 2009-08-24T12:28:55+00:00 daily 0.8 http://www.pharma-marketer.com/arzoxifene-not-the-road-to-big-profits/ 2009-08-24T12:13:48+00:00 daily 0.8 http://www.pharma-marketer.com/ddmac-warns-allergan-galderma-labs-on-promo-materials/ 2009-08-24T11:46:41+00:00 daily 0.8 http://www.pharma-marketer.com/santhera-grabs-192-million-cns-licensing-deal/ 2009-08-24T10:57:30+00:00 daily 0.8 http://www.pharma-marketer.com/geodon/ 2009-08-23T15:40:30+00:00 daily 0.8 http://www.pharma-marketer.com/keppra/ 2009-08-23T15:09:18+00:00 daily 0.8 http://www.pharma-marketer.com/nutrini-pepti/ 2009-08-23T13:23:24+00:00 daily 0.8 http://www.pharma-marketer.com/mucodyne/ 2009-08-23T13:01:57+00:00 daily 0.8 http://www.pharma-marketer.com/nail-it/ 2009-08-23T10:48:51+00:00 daily 0.8 http://www.pharma-marketer.com/phoenix-childrenae%e2%84%a2s-hospital-brace/ 2009-08-22T16:54:23+00:00 daily 0.8 http://www.pharma-marketer.com/phoenix-childrenae%e2%84%a2s-hospital-crutches/ 2009-08-22T16:54:23+00:00 daily 0.8 http://www.pharma-marketer.com/phoenix-childrenae%e2%84%a2s-hospital-sling/ 2009-08-22T16:54:23+00:00 daily 0.8 http://www.pharma-marketer.com/concerta-print-ad/ 2009-08-22T11:00:23+00:00 daily 0.8 http://www.pharma-marketer.com/fondation-pour-la-recherche-medicale/ 2009-08-22T09:52:42+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-rise-genzyme-gains-on-upgrade/ 2009-08-21T17:49:55+00:00 daily 0.8 http://www.pharma-marketer.com/does-teva-have-shire-in-its-cross-hairs/ 2009-08-21T17:49:53+00:00 daily 0.8 http://www.pharma-marketer.com/lonza-makes-offer-valuing-patheon-at-460-million/ 2009-08-21T17:49:52+00:00 daily 0.8 http://www.pharma-marketer.com/medicines-co-withdraws-emea-application-for-antibiotic/ 2009-08-21T15:57:59+00:00 daily 0.8 http://www.pharma-marketer.com/astellas-reorganizes-rd-ops/ 2009-08-21T15:30:53+00:00 daily 0.8 http://www.pharma-marketer.com/weekly-roundup-82109/ 2009-08-21T15:00:59+00:00 daily 0.8 http://www.pharma-marketer.com/takeda-canadia-reacquires-actos-rights/ 2009-08-21T14:35:34+00:00 daily 0.8 http://www.pharma-marketer.com/lonza-offers-460m-for-patheon/ 2009-08-21T14:17:42+00:00 daily 0.8 http://www.pharma-marketer.com/medicinova-to-acquire-avigen-for-124-a-share/ 2009-08-21T13:50:20+00:00 daily 0.8 http://www.pharma-marketer.com/sun-pharmas-us-arm-facing-more-trouble/ 2009-08-21T13:50:18+00:00 daily 0.8 http://www.pharma-marketer.com/avi-biopharma-shares-down-on-stock-offering/ 2009-08-21T13:41:59+00:00 daily 0.8 http://www.pharma-marketer.com/aia-launches-website-for-global-patient-offerings/ 2009-08-21T13:38:36+00:00 daily 0.8 http://www.pharma-marketer.com/the-pharmaceutical-representative-life-ae%e2%80%9c-a-soap-opera/ 2009-08-21T13:36:43+00:00 daily 0.8 http://www.pharma-marketer.com/jcvi-moves-forward-with-pursuit-of-synthetic-life/ 2009-08-21T13:02:11+00:00 daily 0.8 http://www.pharma-marketer.com/senator-grassley-sees-pharma-ghost-writing-problems-do-you/ 2009-08-21T12:37:54+00:00 daily 0.8 http://www.pharma-marketer.com/medicinova-buys-avigen-in-37m-deal/ 2009-08-21T12:28:45+00:00 daily 0.8 http://www.pharma-marketer.com/obesity-shows-up-in-the-death-rate-right/ 2009-08-21T12:00:55+00:00 daily 0.8 http://www.pharma-marketer.com/lipitor-dtc-print-ads-from-2006/ 2009-08-21T10:29:49+00:00 daily 0.8 http://www.pharma-marketer.com/52-perspectives-aeoecurrent-outlook-on-conducting-clinical-trials-in-indiaae%ef%bf%bd/ 2009-08-21T03:46:14+00:00 daily 0.8 http://www.pharma-marketer.com/your-biggest-ally-in-implemention-of-social-media-programs-legal-regulatory-teams/ 2009-08-21T03:44:03+00:00 daily 0.8 http://www.pharma-marketer.com/dominoes-from-fda-advisory-panel-on-amgens-demonsaub-starting-to-fall/ 2009-08-21T03:42:05+00:00 daily 0.8 http://www.pharma-marketer.com/ghostwriting-what-is-right-and-wrong/ 2009-08-21T03:37:14+00:00 daily 0.8 http://www.pharma-marketer.com/miralax/ 2009-08-21T01:50:54+00:00 daily 0.8 http://www.pharma-marketer.com/epifoam/ 2009-08-21T01:50:53+00:00 daily 0.8 http://www.pharma-marketer.com/cervista/ 2009-08-21T01:50:53+00:00 daily 0.8 http://www.pharma-marketer.com/doxil/ 2009-08-21T01:41:37+00:00 daily 0.8 http://www.pharma-marketer.com/cornerstone-falls-short/ 2009-08-20T23:57:46+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-extends-medarex-tender-deadline/ 2009-08-20T23:57:45+00:00 daily 0.8 http://www.pharma-marketer.com/data-could-personalize-use-of-iressa-tarceva/ 2009-08-20T23:57:44+00:00 daily 0.8 http://www.pharma-marketer.com/biodelivery-sciences-attractive-under-5/ 2009-08-20T20:55:39+00:00 daily 0.8 http://www.pharma-marketer.com/fda-approves-glaxosmithklines-hiberix-vaccine/ 2009-08-20T20:55:38+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-stocks-gain-anika-rockets-on-drug-approval/ 2009-08-20T20:55:37+00:00 daily 0.8 http://www.pharma-marketer.com/results-in-the-new-england-journal-of-medicine-confirm-novartis-drug-femara-is-superior-to-tamoxifen-after-breast-cancer/ 2009-08-20T20:55:36+00:00 daily 0.8 http://www.pharma-marketer.com/zymogenetics-says-rivalae%e2%84%a2s-product-could-be-deadly/ 2009-08-20T20:55:35+00:00 daily 0.8 http://www.pharma-marketer.com/avi-biopharma-announces-stock-offering-pricing-shares-tumble/ 2009-08-20T20:55:34+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-to-pay-1575-million-to-west-virginia-in-zyprexa-suit/ 2009-08-20T20:55:33+00:00 daily 0.8 http://www.pharma-marketer.com/anika-shares-skyrocket-on-canadian-drug-approval/ 2009-08-20T15:59:44+00:00 daily 0.8 http://www.pharma-marketer.com/anadys-wins-investors-back-with-ambitious-trial-design/ 2009-08-20T15:50:54+00:00 daily 0.8 http://www.pharma-marketer.com/astrazeneca-gets-blockbuster-return-on-medimmune/ 2009-08-20T15:24:58+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-to-roll-out-trial-based-social-networking-site/ 2009-08-20T15:16:26+00:00 daily 0.8 http://www.pharma-marketer.com/poniard-strikes-deal-to-raise-60m-for-chemo-development/ 2009-08-20T14:50:36+00:00 daily 0.8 http://www.pharma-marketer.com/medimmune-taps-soccer-champs-for-flu-awareness/ 2009-08-20T14:44:27+00:00 daily 0.8 http://www.pharma-marketer.com/shire-plots-big-expansion-for-mass-developer/ 2009-08-20T14:36:37+00:00 daily 0.8 http://www.pharma-marketer.com/google-wave-part-2-what-pharma-should-be-thinking-about/ 2009-08-20T14:13:20+00:00 daily 0.8 http://www.pharma-marketer.com/tough-decisions-on-osteoporosis-drugs/ 2009-08-20T13:18:28+00:00 daily 0.8 http://www.pharma-marketer.com/vaccine-surprise-redeems-astrazenecaae%e2%84%a2s-medimmmune-buy/ 2009-08-20T13:18:28+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-will-make-clinical-trial-networking-site/ 2009-08-20T13:18:27+00:00 daily 0.8 http://www.pharma-marketer.com/why-pharma-wants-obamacare-there-are-reasons-it-could-be-good-for-drug-companies-and-theyre-not-what-you-think/ 2009-08-20T13:18:26+00:00 daily 0.8 http://www.pharma-marketer.com/the-medicines-co-no-non-sinister-deed-goes-unpunished/ 2009-08-20T13:18:25+00:00 daily 0.8 http://www.pharma-marketer.com/teva-pharmaceutical-predictable-growth-good-value/ 2009-08-20T13:18:25+00:00 daily 0.8 http://www.pharma-marketer.com/summary-box-glaxo-used-ghostwriting-to-push-paxil/ 2009-08-20T13:18:23+00:00 daily 0.8 http://www.pharma-marketer.com/hospira-restarts-shipments-of-generic-cancer-drug/ 2009-08-20T13:18:22+00:00 daily 0.8 http://www.pharma-marketer.com/im-back-from-my-road-trip-south/ 2009-08-20T12:39:45+00:00 daily 0.8 http://www.pharma-marketer.com/still-semaphoring-even-from-the-bottom-of-the-swimming-pool/ 2009-08-20T11:47:03+00:00 daily 0.8 http://www.pharma-marketer.com/tabaconomia-fridge/ 2009-08-20T09:41:08+00:00 daily 0.8 http://www.pharma-marketer.com/even-mouthwash-scuba-diver/ 2009-08-20T09:28:22+00:00 daily 0.8 http://www.pharma-marketer.com/even-mouthwash-roller-coaster/ 2009-08-20T09:28:22+00:00 daily 0.8 http://www.pharma-marketer.com/even-mouthwash-cake/ 2009-08-20T09:28:22+00:00 daily 0.8 http://www.pharma-marketer.com/even-mouthwash-glasses-tv-commercial/ 2009-08-20T09:27:28+00:00 daily 0.8 http://www.pharma-marketer.com/hard-to-swallow-ae%e2%80%9c-a-comedic-webseries-based-on-the-happenings-of-a-small-town-pharmacy/ 2009-08-20T08:52:28+00:00 daily 0.8 http://www.pharma-marketer.com/avi-biopharma-says-it-intends-to-launch-public-offering-of-company-shares/ 2009-08-20T02:56:36+00:00 daily 0.8 http://www.pharma-marketer.com/disclosure-trend-hits-pbm-drugmaker-deals/ 2009-08-20T02:56:35+00:00 daily 0.8 http://www.pharma-marketer.com/latisse-with-brooke-shields/ 2009-08-20T02:42:35+00:00 daily 0.8 http://www.pharma-marketer.com/introduction-to-gobalto-in-moving-pictures/ 2009-08-20T00:10:06+00:00 daily 0.8 http://www.pharma-marketer.com/amgens-climbing-up-the-ladder/ 2009-08-19T23:42:05+00:00 daily 0.8 http://www.pharma-marketer.com/panel-decision-to-benefit-jj/ 2009-08-19T23:42:04+00:00 daily 0.8 http://www.pharma-marketer.com/biotech-stock-mailbag-geron-oculus-biosante/ 2009-08-19T23:42:03+00:00 daily 0.8 http://www.pharma-marketer.com/merck-singulair-patent-upheld-in-teva-case/ 2009-08-19T19:55:23+00:00 daily 0.8 http://www.pharma-marketer.com/mylans-hiv-drug-gets-tentative-ok/ 2009-08-19T19:55:20+00:00 daily 0.8 http://www.pharma-marketer.com/time-to-sing-the-alma-mater/ 2009-08-19T19:34:05+00:00 daily 0.8 http://www.pharma-marketer.com/pfizer-clinical-trials-portal-stresses-privacy/ 2009-08-19T18:17:26+00:00 daily 0.8 http://www.pharma-marketer.com/forests-lung-disease-drug-fails-mid-stage-trial/ 2009-08-19T16:03:59+00:00 daily 0.8 http://www.pharma-marketer.com/fda-sends-jj-warning-letter-over-trial-conditions/ 2009-08-19T16:03:57+00:00 daily 0.8 http://www.pharma-marketer.com/why-im-buying-protalix/ 2009-08-19T16:03:57+00:00 daily 0.8 http://www.pharma-marketer.com/video-risk-reward-favors-xoma/ 2009-08-19T16:03:55+00:00 daily 0.8 http://www.pharma-marketer.com/csl-expects-profit-to-rise-on-plasma-sales-swine-flu-vaccine/ 2009-08-19T16:03:53+00:00 daily 0.8 http://www.pharma-marketer.com/eastern-europe-drug-market-worth-41bn-by-2014-but-rules-complex/ 2009-08-19T16:03:52+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-mixed-lilly-falls-on-drug-setback/ 2009-08-19T16:03:50+00:00 daily 0.8 http://www.pharma-marketer.com/bio-goes-viral-in-new-biotech-campaign/ 2009-08-19T15:43:22+00:00 daily 0.8 http://www.pharma-marketer.com/gentium-shares-sink-on-phase-iii-vein-drug-failure/ 2009-08-19T14:11:21+00:00 daily 0.8 http://www.pharma-marketer.com/jj-development-unit-slapped-with-fda-warning-letter/ 2009-08-19T13:53:22+00:00 daily 0.8 http://www.pharma-marketer.com/52-perspectives-aeoecurrent-outlook-on-conducting-clinical-trials-in-india-ae%ef%bf%bd/ 2009-08-19T13:43:17+00:00 daily 0.8 http://www.pharma-marketer.com/gerons-pioneering-esc-trial-put-on-hold-again/ 2009-08-19T13:36:49+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-twitterama-exlporing-the-use-of-twitter-in-pharma-and-healthcare/ 2009-08-19T13:33:53+00:00 daily 0.8 http://www.pharma-marketer.com/glenmark-forest-labs-copd-therapy-fails-mid-stage-trial/ 2009-08-19T13:19:45+00:00 daily 0.8 http://www.pharma-marketer.com/eli-lilly-dumps-one-of-its-brightest-drug-prospects/ 2009-08-19T13:02:48+00:00 daily 0.8 http://www.pharma-marketer.com/drug-companies-are-polar-bears-maybe-not/ 2009-08-19T12:40:24+00:00 daily 0.8 http://www.pharma-marketer.com/the-phrma-deal/ 2009-08-19T12:25:35+00:00 daily 0.8 http://www.pharma-marketer.com/lilly-not-submitting-osteo-drug-data-to-fda/ 2009-08-19T12:11:01+00:00 daily 0.8 http://www.pharma-marketer.com/studies-few-serious-side-effects-with-merck-hpv-vaccine-but-promotion-scheme-questionable/ 2009-08-19T12:10:59+00:00 daily 0.8 http://www.pharma-marketer.com/glaxoae%e2%84%a2s-avandia-has-more-heart-risks-than-actos-study-finds/ 2009-08-19T12:10:58+00:00 daily 0.8 http://www.pharma-marketer.com/3-reasons-not-to-predict-fda-action-matrixx-savient-dendreon/ 2009-08-19T12:10:57+00:00 daily 0.8 http://www.pharma-marketer.com/onglyza-and-the-type-2-diabetes-approval-path-the-map-is-still-sketchy/ 2009-08-19T12:10:55+00:00 daily 0.8 http://www.pharma-marketer.com/bioalliance-shares-rise-as-fda-clears-drug-application/ 2009-08-19T12:10:54+00:00 daily 0.8 http://www.pharma-marketer.com/bristol-myers-125-million-plavix-accord-tentatively-approved/ 2009-08-19T12:10:53+00:00 daily 0.8 http://www.pharma-marketer.com/restasis-clipboard/ 2009-08-19T11:50:31+00:00 daily 0.8 http://www.pharma-marketer.com/feeling-fine-with-big-pharma/ 2009-08-19T04:24:08+00:00 daily 0.8 http://www.pharma-marketer.com/pharma-majors-to-gain-from-india/ 2009-08-19T04:24:07+00:00 daily 0.8 http://www.pharma-marketer.com/even-dental-floss-chicken/ 2009-08-19T01:30:11+00:00 daily 0.8 http://www.pharma-marketer.com/even-dental-floss-octopus/ 2009-08-19T01:30:11+00:00 daily 0.8 http://www.pharma-marketer.com/geron-huge-potential-in-oncology-regenerative-med-pipeline/ 2009-08-19T00:11:27+00:00 daily 0.8 http://www.pharma-marketer.com/more-bad-news-for-vytorin-and-zetia/ 2009-08-19T00:11:26+00:00 daily 0.8 http://www.pharma-marketer.com/cancer-dtc-ads-increased-awareness-of-treatments/ 2009-08-18T21:01:10+00:00 daily 0.8 http://www.pharma-marketer.com/is-the-fda-becoming-too-cautious-now/ 2009-08-18T20:57:36+00:00 daily 0.8 http://www.pharma-marketer.com/79-of-online-audience-has-searched-for-health-information/ 2009-08-18T20:55:33+00:00 daily 0.8 http://www.pharma-marketer.com/amgen-banks-on-new-drug-best-in-class/ 2009-08-18T20:50:12+00:00 daily 0.8 http://www.pharma-marketer.com/durect-licenses-adhd-drug-to-orient-pharma/ 2009-08-18T20:50:11+00:00 daily 0.8 http://www.pharma-marketer.com/not-buying-cel-scis-swine-flu-pr/ 2009-08-18T20:50:09+00:00 daily 0.8 http://www.pharma-marketer.com/court-invalidates-1-of-lillys-gemzar-patents/ 2009-08-18T17:03:10+00:00 daily 0.8 http://www.pharma-marketer.com/cramer-likes-orexigen-should-you/ 2009-08-18T17:03:08+00:00 daily 0.8 http://www.pharma-marketer.com/king-pharma-financial-gauge-analysis-for-june-2009-quarter/ 2009-08-18T17:03:07+00:00 daily 0.8 http://www.pharma-marketer.com/genmab-slumps-as-glaxo-partnered-drug-hits-setback/ 2009-08-18T17:03:06+00:00 daily 0.8 http://www.pharma-marketer.com/abbott-announces-partnership-with-velcera-to-bring-new-pain-medication-for-dogs-to-market/ 2009-08-18T17:03:05+00:00 daily 0.8 http://www.pharma-marketer.com/novavax-virus-like-particle-vaccine-protects-against-2009-pandemic-h1n1-influenza-virus/ 2009-08-18T17:03:04+00:00 daily 0.8 http://www.pharma-marketer.com/big-french-pharma-moves-to-distance-itself-from-us-healthcare-protests/ 2009-08-18T17:03:02+00:00 daily 0.8 http://www.pharma-marketer.com/skystar-bio-pharmaceutical-significantly-undervalued/ 2009-08-18T17:02:59+00:00 daily 0.8 http://www.pharma-marketer.com/redefining-pfizer-and-the-way-it-researches-drugs/ 2009-08-18T17:02:58+00:00 daily 0.8 http://www.pharma-marketer.com/drug-stocks-diverge-novavax-jumps-on-flu-update/ 2009-08-18T17:02:56+00:00 daily 0.8 http://www.pharma-marketer.com/data-backs-avastin-as-second-line-treatment/ 2009-08-18T17:02:53+00:00 daily 0.8 http://www.pharma-marketer.com/h-h-h-holy-c-c-c-c-cow/ 2009-08-18T16:00:39+00:00 daily 0.8 http://www.pharma-marketer.com/flush-with-cash-intellikine-pioneers-pi3-kinase-chemistry/ 2009-08-18T15:45:56+00:00 daily 0.8 http://www.pharma-marketer.com/researchers-test-therapeutic-approach-to-aging/ 2009-08-18T15:36:36+00:00 daily 0.8 http://www.pharma-marketer.com/adamas-gets-40m-in-vc-funds-for-flu-neurology-work/ 2009-08-18T14:40:14+00:00 daily 0.8 http://www.pharma-marketer.com/transcepts-development-success-spurs-a-30-layoff/ 2009-08-18T13:57:06+00:00 daily 0.8 http://www.pharma-marketer.com/china-made-swine-flu-vaccine-protects-after-one-shot/ 2009-08-18T13:35:18+00:00 daily 0.8 http://www.pharma-marketer.com/united-therapeutics-growth-driven-by-approval-of-two-new-treatments/ 2009-08-18T13:35:17+00:00 daily 0.8 http://www.pharma-marketer.com/avigen-still-a-good-value/ 2009-08-18T13:35:15+00:00 daily 0.8 http://www.pharma-marketer.com/cleveland-boasts-stem-cell-research-hub/ 2009-08-18T13:34:55+00:00 daily 0.8 http://www.pharma-marketer.com/novavaxs-swine-flu-jab-effective-in-animal-study/